
<html lang="en"     class="pb-page"  data-request-id="f4ea76f1-5a5d-40f5-b323-8c4f7413ea5d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2014.57.issue-13;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm4011687;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Importance of Sphingosine Kinase (SphK) as a Target in Developing Cancer Therapeutics and Recent Developments in the Synthesis of Novel SphK Inhibitors" /></meta><meta name="dc.Creator" content="Daniel  Plano" /></meta><meta name="dc.Creator" content="Shantu  Amin" /></meta><meta name="dc.Creator" content="Arun K.  Sharma" /></meta><meta name="dc.Description" content="Sphingosine kinase (SphK) is an oncogenic lipid kinase that regulates the sphingolipid metabolic pathway that has been shown to play a role in numerous hyperproliferative/inflammatory diseases. The..." /></meta><meta name="Description" content="Sphingosine kinase (SphK) is an oncogenic lipid kinase that regulates the sphingolipid metabolic pathway that has been shown to play a role in numerous hyperproliferative/inflammatory diseases. The..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 11, 2014" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm4011687" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm4011687" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm4011687" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm4011687" /></link>
        
    
    

<title>Importance of Sphingosine Kinase (SphK) as a Target in Developing Cancer Therapeutics and Recent Developments in the Synthesis of Novel SphK Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm4011687" /></meta><meta property="og:title" content="Importance of Sphingosine Kinase (SphK) as a Target in Developing Cancer Therapeutics and Recent Developments in the Synthesis of Novel SphK Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0012.jpeg" /></meta><meta property="og:description" content="Sphingosine kinase (SphK) is an oncogenic lipid kinase that regulates the sphingolipid metabolic pathway that has been shown to play a role in numerous hyperproliferative/inflammatory diseases. The SphK isoforms (SphK1 and SphK2) catalyze the conversion of the proapoptotic substrate d-erythrosphingosine to the promitogenic/migratory product sphingosine 1-phosphate (S1P). Accumulation of S1P has been linked to the development/progression of cancer and various other diseases including, but not limited to, asthma, inflammatory bowel disease, rheumatoid arthritis, and diabetic nephropathy. SphK therefore represents a potential new target for developing novel therapeutics for cancer and other diseases. This finding has stimulated the development and evaluation of numerous SphK inhibitors over the past decade or so. In this review, we highlight the recent advancement in the field of SphK inhibitors including SphK1 and SphK2 specific inhibitors. Both sphingolipid based and nolipidic small molecule inhibitors and their importance in treatment of cancer and other diseases are discussed." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm4011687"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm4011687">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm4011687&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm4011687&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm4011687&amp;href=/doi/10.1021/jm4011687" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 5509-5524</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm4010863" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm401564r" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Importance of Sphingosine Kinase (SphK) as a Target in Developing Cancer Therapeutics and Recent Developments in the Synthesis of Novel SphK Inhibitors</span></h1><h2 class="article_header-subtitle"><span class="hlFld-SubTitle">Miniperspective</span></h2><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Plano">Daniel Plano</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shantu++Amin">Shantu Amin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arun+K.++Sharma">Arun K. Sharma</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Pharmacology, Penn State Hershey Cancer Institute, CH72, Penn State College of Medicine, 500 University Drive, Hershey, Pennsylvania 17033, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Organic and Pharmaceutical Chemistry, University of Navarra, Irunlarrea 1, E-31008 Pamplona, Spain</span></div><div class="corresp-info"><strong>*</strong>Phone: 717-531-0003, extension 285016. Fax: 717-531-0244. E-mail: <a href="/cdn-cgi/l/email-protection#11707a622025516162643f747564"><span class="__cf_email__" data-cfemail="97f6fce4a6a3d7e7e4e2b9f2f3e2">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm4011687&amp;href=/doi/10.1021%2Fjm4011687" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 5509–5524</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 28, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>31 July 2013</li><li><span class="item_label"><b>Published</b> online</span>11 February 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 July 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm4011687" title="DOI URL">https://doi.org/10.1021/jm4011687</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5509%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDaniel%2BPlano%252C%2BShantu%2BAmin%252C%2BArun%2BK.%2BSharma%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D13%26contentID%3Djm4011687%26title%3DImportance%2Bof%2BSphingosine%2BKinase%2B%2528SphK%2529%2Bas%2Ba%2BTarget%2Bin%2BDeveloping%2BCancer%2BTherapeutics%2Band%2BRecent%2BDevelopments%2Bin%2Bthe%2BSynthesis%2Bof%2BNovel%2BSphK%2BInhibitors%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5524%26publicationDate%3DJuly%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm4011687"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3127</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">66</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm4011687" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Importance of Sphingosine Kinase (SphK) as a Target in Developing Cancer Therapeutics and Recent Developments in the Synthesis of Novel SphK Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Plano&quot;},{&quot;first_name&quot;:&quot;Shantu&quot;,&quot;last_name&quot;:&quot;Amin&quot;},{&quot;first_name&quot;:&quot;Arun&quot;,&quot;last_name&quot;:&quot;K. Sharma&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;5509-5524&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm4011687&quot;},&quot;abstract&quot;:&quot;Sphingosine kinase (SphK) is an oncogenic lipid kinase that regulates the sphingolipid metabolic pathway that has been shown to play a role in numerous hyperproliferative/inflammatory diseases. The SphK isoforms (SphK1 and SphK2) catalyze the conversion of the proapoptotic substrate d-erythrosphingosine to the promitogenic/migratory product sphingosine 1-phosphate (S1P). Accumulation of S1P has been linked to the development/progression of cancer and various other diseases including, but not limited to, asthma, inflammatory bowel disease, rheumatoid arthritis, and diabetic nephropathy. SphK therefore represents a potential new target for developing novel therapeutics for cancer and other diseases. This finding has stimulated the development and evaluation of numerous SphK inhibitors over the past decade or so. In this review, we highlight the recent advancement in the field of SphK inhibitors including SphK1 and SphK2 specific inhibitors. Both sphingolipid based and nolipidic small molecule inhibitors and the&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4011687&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4011687" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4011687&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4011687" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4011687&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4011687" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm4011687&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4011687&amp;href=/doi/10.1021/jm4011687" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm4011687" /></input><a href="/doi/pdf/10.1021/jm4011687" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm4011687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm4011687%26sid%3Dliteratum%253Aachs%26pmid%3D24471412%26genre%3Darticle%26aulast%3DPlano%26date%3D2014%26atitle%3DImportance%2Bof%2BSphingosine%2BKinase%2B%2528SphK%2529%2Bas%2Ba%2BTarget%2Bin%2BDeveloping%2BCancer%2BTherapeutics%2Band%2BRecent%2BDevelopments%2Bin%2Bthe%2BSynthesis%2Bof%2BNovel%2BSphK%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D13%26spage%3D5509%26epage%3D5524%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jmcmar.2014.57.issue-13/production/jmcmar.2014.57.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0012.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Sphingosine kinase (SphK) is an oncogenic lipid kinase that regulates the sphingolipid metabolic pathway that has been shown to play a role in numerous hyperproliferative/inflammatory diseases. The SphK isoforms (SphK1 and SphK2) catalyze the conversion of the proapoptotic substrate <span class="smallcaps smallerCapital">d</span>-erythrosphingosine to the promitogenic/migratory product sphingosine 1-phosphate (S1P). Accumulation of S1P has been linked to the development/progression of cancer and various other diseases including, but not limited to, asthma, inflammatory bowel disease, rheumatoid arthritis, and diabetic nephropathy. SphK therefore represents a potential new target for developing novel therapeutics for cancer and other diseases. This finding has stimulated the development and evaluation of numerous SphK inhibitors over the past decade or so. In this review, we highlight the recent advancement in the field of SphK inhibitors including SphK1 and SphK2 specific inhibitors. Both sphingolipid based and nolipidic small molecule inhibitors and their importance in treatment of cancer and other diseases are discussed.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71452" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71452" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Sphingosine kinase (SphK) is a conserved lipid kinase that catalyzes the conversion of the sphingolipid sphingosine to sphingosine 1-phosphate (S1P). The two SphK isoforms (SphK1 and SphK2) regulate this sphingolipid metabolism; however, SphK1 is more closely linked to signaling pathways associated with cancer cell proliferation/survival, metastasis, and multidrug resistance (MDR).<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1-5)</a> SphK1 regulates the fate of cells by catalyzing the formation of promitogenic S1P at the expense of proapopototic ceramide. Overexpression of SphK1 is observed in many tumor tissues.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> Importantly, studies have shown that high SphK1 levels are a prognostic factor for decreased metastasis-free survival and overall poor outcome of patients.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a> On the basis of these and many related studies,<a onclick="showRef(event, 'ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14 ref15">(11-15)</a> inhibition of SphK1 is considered a novel approach for the treatment of cancers including metastatic cancer and/or MDR. Therefore, there has been extensive focus on the development of effective SphK inhibitors (SKIs) during the past 10 years. The classes of compounds identified include those derived from sphingolipids, natural products, and nolipidic small druglike molecules. The structure–activity relationship (SAR) studies using analogues of the lipid substrates of SphK, namely, sphingosine and <b>1</b> (FTY720), have been one of the main focuses of drug design.<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16-18)</a> The quest to identify a small druglike inhibitor started with a library screening reported in the year 2003,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and several optimization studies have been reported thereafter with variable success. So far, the development of SKIs has been hampered by the lack of a crystal structure of SphK1, and therefore, rational drug design was impractical. The recent report by Wang et al.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> describing the crystal structure of SphK1 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is expected to provide a new direction to SKI design, which may lead to more effective and specific inhibitors in the near future. This review focuses on the importance of targeting SphK, particularly in the treatment of cancer, highlights recent advances in the development of SKIs, and speculates on the future promise of these inhibitors.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Cartoon representation of the crystal structure of SphK1 in three different orientations (adapted from Protein Data Bank, PDB reference <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VZB">3VZB</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Sphingosine Kinase as a Therapeutic Target</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00673" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00673" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The potential of the sphingolipid metabolic pathway for the development of therapeutic targets for cancer has been recognized for years. The de novo sphingolipid synthesis pathway is a multistep process that begins with the condensation of serine and palmitoyl-CoA catalyzed by serine palmitoyl tranferase and yields 3-ketosphinganine.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The complex regulation of sphingolipid metabolism is well documented<a onclick="showRef(event, 'ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25">(22-25)</a> and is not the focus of this paper. The most important Cer-to-Sph-to-S1P conversion steps involve deacylation of ceramide by ceramidases to generate sphingosine and the subsequent conversion of sphingosine to S1P catalyzed by SphKs (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). There are two isoforms of SphKs known to catalyze this transformation: SphK1, which is found in the cytosol of eukaryotic cells and migrates to the plasma membrane upon activation; SphK2, which is localized to the nucleus. The S1P thus formed can be dephosphorylated by S1P phosphatases to generate sphingosine, which can be acylated to ceramide by ceramide synthase (CerS), closing the loop of the Cer/S1P interconversion (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The only exit point for this cycle is the irreversible cleavage of S1P to hexadecenal and phosphoethanolamide mediated by S1P lyase. Finally, S1P binds to a family of five G-protein-coupled receptors, termed S1PRs (S1P<sub>1–5</sub>), and can be transported outside of the cell.</div><div class="NLM_p">The dynamic balance between the two signaling arms of sphingolipids with opposite effects (i.e., S1P and its precursors, ceramide and sphingosine) is an important factor that determines cell fate.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> This dynamic balance between ceramide and S1P signaling, known as the Cer/S1P rheostat (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), can guide the cell toward either an apoptotic process or a survival process depending on the relative position of the rheostat. A shift toward ceramide can be achieved by stress signaling such as radiation and chemotherapy treatment or by using SKIs, driving cancer cells to undergo apoptosis and antiproliferation.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> On the other hand, a shift toward S1P accumulation drives cells to prosurvival, antiapoptosis, and/or chemoresistance conditions.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The Cer/S1P rheostat is functional not only in cancer disease but also in other diseases such as inflammatory, cardiovascular, and fibrotic diseases.<a onclick="showRef(event, 'ref22 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref24">(22, 24)</a> SphKs, particularly SphK1, play a central role in the sphingolipid metabolic pathway as the key enzymes regulating the equilibrium between proapoptotic ceramide/sphingosine (Cer/Sph) and promitogenic/prosurvival (S1P) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Therefore, there is a strong rationale for selectively targeting SphK1 as an anticancer therapeutic strategy. Thus, given its role in the Cer/S1P rheostat, the fact that overexpression of SphK1 is sufficient to promote the transformation of normal cells,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and the accumulating evidence linking its overexpression to development/progression of numerous cancers,<a onclick="showRef(event, 'ref19 ref28'); return false;" href="javascript:void(0);" class="ref ref19 ref28">(19, 28)</a> SphK1 is a novel target for development of anticancer therapeutic strategies. However, the sphingosine rheostat concept could be considered simplistic. Although biosynthetically ceramide lies upstream of sphingosine and S1P, there are conflicting reports regarding the effects of SphK1 inhibitors and Cer/S1P levels. Some of the reports have demonstrated no accumulation of Cer/S1P associated with inhibition of SphK1.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Role of SphK1/2 in Cer/S1P rheostat: effects on cancer cells and therapeutic intervention by SKIs treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Development of SKIs and Their Applications in Cancer Treatment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67212" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67212" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The SphK/S1P pathway is involved in multiple cellular processes and is implicated in the inhibition, maintenance, and progression stages of several diseases. Hence, SphK/S1P system is now considered to be a novel and innovative target in the treatment of several diseases. During the past decade, there has been a growing interest in the development of novel inhibitors of the SphK/S1P pathway. In this section, we will analyze different structural modulations carried out to date on known SKIs, based on different structure classes, in order to increase the activity and/or selectivity for one of the SphKs.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Spingosine-Based</h3><div class="NLM_p">Three well differentiated chemical regions are located in the sphingosine molecule: (1) a polar head, comprising an hydroxyl group, which can be phosphorylated; (2) a lipophilic tail, formed by a long hydrocarbon chain; (3) a linker that connects the polar head and the lipophilic tail, which is composed of a hydroxyl and an amine group (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The different structural modifications of sphingosine reported in the literature can be divided into two groups: (1) those modifications that leave the polar headgroup unchanged and (2) the modifications that alter the polar head.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Sphingosine structure and its key chemical regions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i6" class="anchor-spacer"></div><h4 class="article-section__title" id="_i6"> Unchanged Polar Head</h4><div class="NLM_p">Some of the first SKIs reported emerged from minor modifications of the sphingosine molecule, i.e., the removal of the 4,5-trans double bond presented in the lipophilic tail, resulting in <b>2</b> (safingol), and the methylation of the amine group located in the linker, giving <b>3</b> (DMS) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Neither <b>2</b> nor <b>3</b> can be considered as a specific SKI. Compound <b>2</b> is a competitive inhibitor of SphK1 (<i>K</i><sub>i</sub> ≈ 3–6 μM),<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> although it acts as substrate for SphK2 and can be incorporated into the sphingolipid metabolic pathway.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Compound <b>3</b> is an inhibitor of both SphK isoforms, presenting <i>K</i><sub>i</sub> values of 5 and 12 μM for SphK1 and SphK2, respectively.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Furthermore, they show inhibitory effects on important cellular kinases, such as protein kinase C (PKC), ceramide kinase (CK), phosphatidylinositol kinase (PI3K), mitogen-activated protein kinase (MAPK), and epidermal growth factor receptor (EGFR).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> It is noted here that the calculation of <i>K</i><sub>i</sub> values varies with the assay used and may not be compared between the publications. However, they do provide an idea of the selectivity of the novel compounds.</div><div class="NLM_p">Compound <b>2</b>, the synthetic <i>threo</i> stereoisomer of the naturally occurring <span class="smallcaps smallerCapital">d</span>-<i>erythro</i>-dihydrosphingosine, has been shown to induce cancer cell death through apoptosis<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and autophagy<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> in vitro in various cancer types. In addition, <b>2</b> has excelled as a promising agent for use in combination with other chemotherapeutic drugs.<a onclick="showRef(event, 'ref35 ref36 ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38 ref39">(35-39)</a> Compound <b>2</b> potentiates the cytotoxic effects of several chemotherapeutic agents, such as doxorubicin, irinotecan, cisplatin, and mitomycin C, in vitro and in vivo in various types of cancer.<a onclick="showRef(event, 'ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38">(35-38)</a> Recently, a phase I clinical trial in patients with advanced solid tumors has indicated that <b>2</b> can be safely administered in combination with cisplatin, showing only a reversible dose-dependent hepatic toxicity.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Nevertheless, none of these effects can be attributed only to its SphK inhibition, since it has also been shown to inhibit PKC. In fact, many of the synergetic effects shown by <b>2</b> seem to be mediated by the PKC inhibition.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> A recent study has shown that a novel liposomal formulation of <b>2</b> is able to extend the median survival time in an acute myeloid leukemia murine model.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Compound <b>3</b> has also been shown to induce apoptosis in a variety of human cancer cell lines<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> and acted synergetically with <i>N</i>-(4-hydroxyphenyl)retinamide in an ovarian carcinoma cell line.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Ghosh et al. have reported the synthesis of a variety of coumarin derivatives of <b>3</b>, although no improvement in the cytotoxicity was achieved with these derivatives.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Chemical structures of sphingosine-based SKIs grouped by the various modifications carried out over the sphingosine structure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">De Jonghe and co-workers<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> reported the synthesis and SphK inhibitory effects of several short-chain sphinganine and 3-fluorosphingosine analogues (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The results allowed them to establish an SAR: (1) a shortened lipophilic backbone (C<sub>12</sub>) was as potent as <b>3</b> in inhibiting sphingosine kinases; (2) the 4,5-trans double bond in the short-chain analogues had a significant inhibitory effect; (3) the replacement of the hydrocarbon backbone by an aromatic residue in the short-chain derivatives resulted in an increased inhibitory potency; (4) the replacement of hydroxyl group presented in the linker by a fluorine atom increases the inhibitory effect for the sphingosine and C<sub>12</sub>-sphingosine analogues.</div><div class="NLM_p">Another modification strategy involved coupling biologically active phenethyl isothiocyanate (PEITC) to sphinganine (<b>4</b>, PEITC-Sa) and sphingosine (<b>5</b>, PEITC-So) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) by the substitution on the amino group of the linker.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Although the authors did not report the inhibitory effect on SphK, both isothiocyanate derivatives exhibited higher cytotoxicity than sphingosine and sphinganine in the human myeloid leukemia cell line HL-60. Furthermore, <b>4</b> and <b>5</b> increased the therapeutic efficacy of 1-(β-<span class="smallcaps smallerCapital">d</span>-arabinofuranosyl)cytosine (araC).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_p">Recently, a patent application (WO2010078247) disclosed the development of novel sphingoguanidine derivatives. These derivatives combined a sphingolipid backbone, or a related analogue, with a guanidine moiety introduced at the sphingolipid C2 position. The purpose of these modifications was 2-fold: (1) the guanidine moiety can generate increased hydrogen bonding interactions with the catalytic site of SphK; (2) these compounds can act as dual site/dual mode SKIs, since guanidine is believed to be able to interact directly with ATP, impeding the phosphorylation reaction.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The most effective agent, <b>6</b> (LCL351) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), exhibited IC<sub>50</sub> values of 40 and 300 nM for inhibition of SphK1 and SphK2, respectively, thus exhibiting selectivity for SphK1 at lower doses.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Compound <b>6</b> showed an inhibitory effect on cell migration in DU145 (human prostate cancer) cells.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p">In 2008, Paugh et al. reported a new water-soluble sphingosine-based analogue <b>7</b> (SK1-I) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> An aromatic ring and a methyl group were incorporated into the lipophilic tail and to the amine group in the linker, respectively. Compound <b>7</b> was shown to be a competitive and selective inhibitor of SphK1 (IC<sub>50</sub> = 10 μM) without affecting SphK2, PKC, or several other protein kinases.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Compound <b>7</b> exerted a cytotoxic effect toward human leukemia and glioblastoma cancer cell lines in vitro and markedly reduced tumor growth in xenograft models.<a onclick="showRef(event, 'ref12 ref49'); return false;" href="javascript:void(0);" class="ref ref12 ref49">(12, 49)</a> These studies suggest that selective inhibition of SphK1 may be important in glioblastoma and leukemia, and thus, SphK1 can be considered as a promising target for treatment of these cancer types.</div><div class="NLM_p">One of the most studied sphingosine-based analogues is compound <b>1</b> (Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), which acts through T-lymphocyte-specific immunosuppression.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Compound <b>1</b> is phosphorylated by SphK2, and the fingolimod phosphate (FTY720-P) thus generated (but not parent compound <b>1</b>) acts as an agonist at four of the five S1PRs (excluding S1P<sub>2</sub>), with EC<sub>50</sub> values in the nanomolar range.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51, 52)</a> Compound <b>1</b> has been shown to prevent organ transplant rejection and used in the treatment of several autoimmune diseases, for which it is currently undergoing multiple clinical trials. Compound <b>1</b> has also been demonstrated to reduce tumor growth and prevent cancer progression in murine models of several types of cancer.<a onclick="showRef(event, 'ref53 ref54 ref55 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref53 ref54 ref55 ref56 ref57">(53-57)</a> Several recent reviews address its mechanism of action in depth and describe ongoing clinical trials of <b>1</b> for different diseases.<a onclick="showRef(event, 'ref58 ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref58 ref59 ref60">(58-60)</a> The U.S. Food and Drug Administration (FDA) approved <b>1</b> (Gylenia, Novartis) on September 22, 2010, to reduce relapses and delay disability progression in patients with relapsing forms of multiple sclerosis (MS) in the dose of 0.5 mg.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div><div class="NLM_p">The key structural features of <b>1</b> are (1) the aminodiol group, which is phosphorylated by SphK2; (2) the 1,4-disubstituted phenyl ring, which acts as a rigid linker group; and (3) the lipophilic tail, which is important for interactions with the hydrophobic binding pocket of the S1PRs.<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62, 63)</a> Two structurally related derivatives of <b>1</b> are the methyl ether <b>8</b> (FTY720-OCH<sub>3</sub>) (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), in which one of the prochiral hydroxyl groups of <b>1</b> is replaced by a methoxy group in order to block the site that is phosphorylated by SphK2,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> and <b>9</b> (FTY720-vinylphosphonate) (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The methyl ether derivative <b>8</b> is a specific competitive inhibitor of SphK2 (with respect to sphingosine), the inhibition being enantioselective for the (<i>R</i>)-FTY720-OCH<sub>3</sub> enantiomer, with a <i>K</i><sub>i</sub> value of 27 μM.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> By contrast, (<i>S</i>)-FTY720-vinylphosphonate is an uncompetitive inhibitor (with respect to sphingosine) and a mixed inhibitor (with respect to ATP) of SphK1.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> A number of reviews have reported data on the effects of <b>1</b> and its analogues in the inhibition of SphKs and their cancer therapeutic effects.<a onclick="showRef(event, 'ref24 ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref24 ref66 ref67">(24, 66, 67)</a></div><div class="NLM_p">Another analogue of <b>1</b>, the compound <b>10 (</b>SG-12) (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), maintains the lipophilic tail but incorporates a modified linker in which the OH group has been moved from the carbon bearing the amine to the adjacent carbon.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Compound <b>10</b> was shown to be a SphK2-selective inhibitor,<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> and it was reported that <b>10</b> accelerates Fas-mediated cell death in the murine B-lymphoma-derived cell line A20/2J.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Furthermore, <b>10</b> induces apoptosis via phosphorylation by SphK2 in SphK2 transfected A20/2J cells.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of <b>1</b> and its analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A potent, selective, and orally active S1P<sub>1</sub> agonist <b>11</b> (CS-0777) (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>)<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> represents another promising derivative of <b>1</b>. Compound <b>11</b> is phosphorylated in vivo, and its phosphate analogue (CS-0777-P) acts as a selective S1P<sub>1</sub> modulator, presenting ∼320-fold greater agonist activity for human S1P<sub>1</sub> relative to S1P<sub>3</sub>.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Although no anticancer activity is reported for <b>11</b> yet, it is currently in clinical trials for the treatment of multiple sclerosis (MS). Compound <b>11</b> was shown to be a safe and well-tolerated compound in an open-label pilot study conducted in 25 MS patients.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></div><div class="NLM_p last">In 2013, several novel derivatives of <b>1</b> were reported in which the polar head and/or linker was modulated. A series of tertiary amine and quaternary ammonium salt derivatives of <b>1</b> were also developed.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Nine of the 20 novel analogues were selective inhibitors of SphK1 over SphK2. For example, <b>12</b> (RB-005) and <b>13</b> (RB-019) (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) showed the highest selectivity for SphK1 over SphK2 (15.0- and 6.1-fold, respectively).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Some preliminary SARs were pointed out for compounds <b>12</b> and <b>13</b>. The hydroxyl group in the heterocyclic ring was found to be important for the inhibitory effect of <b>12</b>, since the replacement of the 4-OH group with a 4-methyl group compromised its Sphk1 activity and led to a moderate inhibitor of both SphK1 and SphK2. The size of the heterocyclic ring was also shown to be important, the seven member ring derivative being less selective and less potent than the six member ring present in <b>12</b>.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> A series of analogues of <b>1</b> wherein the lipophilic region was modulated were also reported in the same year.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The structure of these analogues contained an extra substituted aromatic ring in the lipophilic tail. These new analogues of <b>1</b> were evaluated in vitro against human hepatoma SMCC-7721 and human promyelocytic leukemia HL-60 cell lines. The authors found that the length of the lipophilic region plays a critical role in the activity, medium-length substituents being the most active ones.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7"> Changed Polar Head</h4><div class="NLM_p">The effectiveness of sphingoid bases seems to be limited by their phosphorylation by SphKs. Therefore, the compounds that cannot be phosphorylated would be more effective in suppressing cancer than the naturally occurring sphingoid base sphingosine. Considering that the hydroxyl group located in the polar head is responsible for phosphorylation, it seems logical to think that the removal of this hydroxyl group could be a good approach to obtain SKIs with better anticancer activities. This strategy was used to obtain <b>14</b> (enigmol) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), which is a structural analogue of sphingosine and <b>2</b>.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> The only structural change over sphingosine is the displacement of the hydroxyl group from position 1 to 5. Compound <b>14</b> is not phosphorylated and inhibits both SphK and CerS, albeit <b>14</b> did not alter the amount of cellular S1P.<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73, 74)</a> Furthermore, <b>14</b> demonstrated potent anticancer activity in cells derived from multiple types of cancers, as well as a significant oral efficacy in rodent models of colon and prostate cancers with no evidence of host toxicity at effective doses.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> In order to gain further knowledge of the structural features required for its bioactivity, Garnier-Amblard et al. examined the pharmacological roles of stereochemistry and N-methylation in the <b>14</b> structure.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> The four diastereomers synthesized by manipulating the C-3 and C-5 positions were shown to be active in vitro against prostate cancer cell lines.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Furthermore, two diastereomers, 2<i>S</i>,3<i>S</i>,5<i>R</i>-enigmol and 2<i>S</i>,3<i>R</i>,5<i>S</i>-enigmol, also caused statistically significant inhibition of tumor growth in nude mouse xenograft models of human prostate cancer.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Nevertheless, the <i>N</i>-methylenigmol showed significantly less oncolytic activity in vivo.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Another structural modification conducted recently is the fluorination of <b>14</b>. One of the two analogues obtained was more effective on inhibiting tumor growth rates in PC3 xenografts than <b>14</b>.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> To recapitulate, <b>14</b> is equally effective as standard prostate cancer therapies (androgen deprivation or docetaxel), and considering the anticancer effects of some of its analogues, <b>14</b> can be considered to be a very interesting scaffold for further development as a promising therapeutic potential.</div><div class="NLM_p">Several <i>N</i>-arylamide phosphonates (e.g., VPC44152 in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) were reported in 2007.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> These derivatives are structurally close-related analogues of S1P and present a potent and a subtype-selective agonistic and antagonistic activity against S1PRs (S1P<sub>1–5</sub>).<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Foss et al. concluded that the replacement of the phosphorus–oxygen bond present in S1P with a phosphorus–carbon bond provides bioactive agents with putative resistance to degradative phosphatase activity. Later, the same authors designed metabolically more stable S1PRs agonist prodrugs using the structures of these <i>N</i>-arylamide moieties as a starting point (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> These prodrugs, a series of 2-amino-2-heterocyclic propanols, present two different structural features: (1) removal of the phosphate group in the polar head and (2) introduction of some heterocycles (imidazole, oxazole, and oxadiazole) in the linker part.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> The oxazole-derived structure was most active for human SphK2.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Furthermore, a stereochemical preference of the quaternary carbon was crucial for phosphorylation by the kinases and altered binding affinities at the S1PRs.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> While in vitro data were initially quite promising, these new prodrugs did not prove to be viable therapeutic candidates after in vivo analysis of lymphocyte levels.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div><div class="NLM_p">In 2010, Mathews et al. reported for the first time the synthesis, evaluation, and SAR properties of a new class of amidine-based sphingosine analogues (Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Most of these compounds acted as competitive inhibitors of SphKs with varying degrees of enzyme selectivity and <i>K</i><sub>i</sub> values in the submicromolar range for both SphKs.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> These amidines decreased the S1P levels and initiated growth arrest in cultured vascular smooth muscle cells.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> The authors modulated various structural features in the three different chemical regions of these analogues, allowing them to establish some SAR properties: (1) in the polar head; substituting the carboxylic acid and the primary amide by an amidine group suggested that the unique electrostatic properties associated with amidines in aqueous environment and its direct interaction with ATP γ-phosphate are critical for the activity of these compounds;<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> (2) in the linker region; the elimination of chirality and the increase of steric bulk seem to improve the activity of these analogues as dual inhibitors, and furthermore, the inversion of benzamide seems to improve their selectivity for SphK1;<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> (3) in the lipophilic tail; varying linear hydrocarbon sizes revealed that the potency of these amidines increased at a length of 12 carbons for the alkyl group but decreased with 14 and 16 carbons.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> In a second approach, Kennedy et al.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a>optimized the structure of the most selective SphK1 inhibitor <b>15</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) synthesized by Mathews et al.,<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> by modulating several structural features in this compound to improve its potency and selectivity. They proved that (1) a bulky substitution at the tail terminus, such as cyclohexane, increases the potency and selectivity regardless of amide orientation, (2) the ideal cLogP value is around 4.2, and (3) the restriction of the dihedral angle between the position of the amide and that of the amidine should have an effect on selectivity and potency. After these SAR studies, an optimized amidine analogue was identified with <i>K</i><sub>i</sub> = 75 nM for SphK1 and an 80-fold selectivity index for this kinase versus the SphK2 subtype.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Additionally, they generated a SphK1 homology model from the crystal structure of DGKB and used it for the in silico design of novel amidine derivatives. This in silico design led to the synthesis of an oxazole derivative <b>16</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) with <i>K</i><sub>i</sub> = 47 nM and a 180-fold selectivity ratio for SphK1.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> The most potent and selective amidine derivatives were validated in human leukemia U937 cells, where they significantly reduced endogenous S1P levels at nanomolar concentrations.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Later, the same research group used all the SAR properties obtained previously for the amidine analogues<a onclick="showRef(event, 'ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref79 ref80">(79, 80)</a> and designed enantiomeric pairs of rigid proline analogues (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) with an amidine group in the polar head.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Both enantiomers showed <i>K</i><sub>i</sub> values in the submicromolar range for SphK1 and decreased the S1P levels in both cultured cells and mice.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The latest addition to this class of SKIs is <b>17</b> (SLR080811) (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) emerged by modifying the chemical structure of one of these enantiomers.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> The replacement of the amidine and the amide groups in proline analogues by guanidine and oxadiazole groups, respectively, in <b>17</b> entailed a dual effect: (1) enhanced half-life compared with the proline analogue<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> and more surprisingly (2) reversed selectivity for SphK isotypes, <b>17</b> being selective (approximately 1 order of magnitude more potent) for SphK2.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Kharel et al. demonstrated that administration of <b>17</b> to wild-type mice triggered a rapid increase in blood S1P levels, in contrast to SphK1 specific inhibition that lowers the circulating S1P levels.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of amidine derivatives obtained after various chemical modulations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Many of the SKIs, having a thiazolidine-2,4-dione structure, have been shown to inhibit ERK and Akt pathways as a downstream event of SphK inhibition. One of these thiazolidine-2,4-dione analogues, <b>18</b> (K145) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>),<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> presents two structural features that make it a very attractive scaffold: (1) the amino terminal group, which may be able to mimic the aminohydroxyl sphingosine base and (2) a phenyl ring with an alkyloxy chain. Liu et al. reported the synthesis and biological characterization of <b>18</b> and showed it to be a selective SphK2 inhibitor, with a <i>K</i><sub>i</sub> value of 4.30 μM and no inhibitory effect on SphK1 at concentrations of up to 10 μM.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> The treatment of human leukemia U903 cells with <b>18</b> caused a decrease of total S1P without significant effects on ceramide levels, as well as inhibitory and apoptotic effects.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Compound <b>18</b> also significantly inhibited tumor development in various mice models upon both intraperitoneal and oral administrations.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Since the window of SphK2 to SphK1 (10–4.3 μM) inhibition is very low, it would be difficult to achieve a concentration in vivo to claim that the antitumor effect is due to exclusive inhibition of SphK2.</div><div class="NLM_p last">To summarize, classes of sphingosine-based SKIs with both changed and unchanged polar heads, compounds specific to SphK1 and SphK2, and nonspecific inhibitors with varying efficacy have been reported. Taking into account all modifications carried out in the sphingosine-based SphKIs and the biological effects that these modifications entailed, several conclusions can be pointed out: (1) N-substitutions in the sphingosine structure (e.g., <b>3</b>, <b>5</b>, and <b>7</b>) do not seem to adversely affect the cytotoxic potency of the new derivatives. In fact, modifications in the linker region of sphingosine are generally well tolerated. (2) The introduction of a phenyl ring in the lipophilic region of sphingosine (e.g., in <b>1</b>, <b>7</b>, and <b>18</b>) typically does not reduce the inhibitory or anticancer effects of the sphingosine-based SKIs. By contrast, this phenyl ring increases their bioavailability, presenting a better druglike profile. (3) The substitution of the hydroxyl group in the polar head in order to prevent its phosphorylation by other polar groups (e.g., amidines and <b>18</b>) appears to be a valid approach in the design of novel sphingosine-based SKIs. Among these new polar groups, the SKIs with an amidine group in the polar head have been shown to be very promising molecules to further develop. Many of the sphingosine-based SKIs have been found to be effective against multiple diseases both in the preclinical studies and in the clinic. This modification strategy thus has the potential to create novel drugs for cancers as well as several other diseases.</div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Nolipidic Small Molecules</h3><div class="NLM_p">In 2003, a chemical library screening by French et al. revealed four different types of small molecules [<b>19</b> (SKI-I), <b>20</b> (SKI-II), SKI-III, and SKI-IV] (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) with SphK inhibitory effect at submicromolar to micromolar concentrations.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> These four derivatives were shown to be selective toward human SphK compared with a panel of human lipid and protein kinases, and they were not competitive inhibitors of the ATP-binding site of SphK.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Furthermore, they showed an antiproliferative action toward a panel of tumor cell lines and inhibited the endogenous human SphK activity in intact cells.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Further studies on three of these compounds (<b>19</b>, <b>20</b>, and SKI-V) (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) demonstrated their antitumor activity in mice without systemic toxicity.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Among these SKIs, the most extensively studied compound <b>20</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) is orally bioavailable and showed a significant inhibition of tumor growth in mice and a growth inhibitory effect in vitro toward several cancer cell lines.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Compound <b>20</b> induced Bcl-2-independent apoptosis in prostate adenocarcinoma cells,<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> inhibited colony formation,<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> and activated caspase-3 in both temozolomide-sensitive and resistant glioblastoma multiforme cells.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> In 2010, reports suggested novel mechanisms of action for <b>20</b> other than the direct inhibition of the enzymatic activity of SphK1 described by French et al.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Loveridge et al. showed that <b>20</b> induced proteosomal degradation of SphK1 in several cancer cell lines, and this is likely mediated by ceramide as a consequence of catalytic inhibition of SphK1.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Also, a new post-translational mechanism has been proposed for the activity of <b>20</b>.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Ren et al. reported that <b>20</b> acts by stimulating SphK1 protein degradation and consequently by this mechanism reduces SphK1 activity.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> This degradation of SphK1 occurred by a lysosomal route involving cathepsin B.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> These new mechanisms of action strongly suggest that additional targets of <b>20</b> may exist other than SphK1. In this regard, Antoon et al. have proposed a dual mechanism of action for <b>20</b> in human breast cancer: inhibition of SphK and inhibition of estrogen receptor (ER) signaling.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Compound <b>20</b> dose-dependently decreased estrogen-stimulated estrogen response element transcriptional activity and diminished mRNA levels of the ER-regulated genes progesterone receptor and steroid derived factor 1.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Furthermore, <b>20</b> binds to ER directly in the antagonist ligand-bind domain.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></div><div class="NLM_p">Different approaches have been used to improve some parameters of <b>19</b> and/or <b>20</b>. We have synthesized the prodrugs of both SKIs using the aspirinyl (Asp) backbone.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> The compounds <b>21</b> (SKI-I-Asp) and <b>22</b> (SKI-II-Asp) (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) were designed to take advantage of the fact that apart from an easy release of the parent compound by hydrolysis of the ester linkage by esterases on administration in vivo, aspirin will be released as a side product.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Both the parent SKIs (<b>19</b> and <b>20</b>) and their Asp derivatives (<b>21</b> and <b>22</b>) showed a similar cytotoxicity in vitro in most cancer cell lines tested, as well as equally potent inhibition of SphK1 at low doses (i.e., <1.25 μM).<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></div><div class="NLM_p">Although many studies have been carried out with <b>20</b>, originally the most active compound among the four SKIs reported by French et al.<a onclick="showRef(event, 'ref19 ref83'); return false;" href="javascript:void(0);" class="ref ref19 ref83">(19, 83)</a> was <b>19</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). However, poor correlation to Lipinski’s rule of five and poor oral bioavailabitiy limited its therapeutic potential. Thus, we carried out several structural modifications over <b>19</b> in order to comprehend the structural features critical for SphK inhibition and to establish a SAR to optimize the pharmacological properties of <b>19</b>.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> These studies established the following SAR properties:<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> (1) the naphthyl rings of <b>19</b> are not necessary for SphK1 inhibition; (2) larger substituents on the aromatic ring farther from pyrazole ring are preferred; (3) 4-OCH<sub>3</sub> group is the preferred substitution of the phenyl ring closest to pyrazole. All these structural modifications allowed improvement of the pharmacological properties of <b>19</b>, thereby leading to discovery of a refined compound <b>23</b> (SKI-178) (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Compound <b>23</b> possesses a similar inhibitory effect on SphK1 activity, albeit its selectivity toward SphK1 was increased and the log <i>P</i> and cLogD values were optimized, making <b>23</b> a more selective and more druglike small molecule than <b>19</b>.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Chemical structures of nolipidic small molecule SphK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The screening of a chemical library and the subsequent synthesis of several analogues resulted in an aryladamantane compound <b>24</b> (ABC294640) (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>), which selectively inhibits SphK2 activity in vitro, acting as a competitive inhibitor with respect to sphingosine with a <i>K</i><sub>i</sub> of 9.8 μM, and attenuates S1P formation.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Compound <b>24</b> suppresses the cell proliferation in vitro in several cancer cell lines and has an excellent oral bioavailability in vivo.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Furthermore, it has been shown to promote autophagy in cultured cells, leading to nonapoptotic cell death.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Above all, <b>24</b> showed a very promising delay and/or inhibitory activity in tumor growth in vivo in several xenografts rodent models, such as different types of breast cancer,<a onclick="showRef(event, 'ref91 ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref91 ref93 ref94">(91, 93, 94)</a> kidney,<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> and pancreatic cancer models.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Compound <b>24</b> is currently in a phase I clinical trial for patients with advanced solid tumors (ClinicalTrails.gov identifier, NCT01488513). A modification of the pyridylmethyl substituent on the amide group of <b>24</b> by a dihydroxyphenyl ring, leading to <b>25</b> (ABC294735) (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>), affected the selectivity of the compound.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> The new analogue <b>25</b>, thus formed, is a sphingosine-competitive inhibitor for both SphK1 and SphK2, with <i>K</i><sub>i</sub> values of 3.1 and 4.2 μM, respectively.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Although <b>24</b> and <b>25</b> distinctly affect SphKs, being SphK2 selective and dual SphK1/SphK2 inhibitors, respectively, both of them have been demonstrated to cause a comparable delay in the tumor growth in two xenograft models of pancreatic and kidney cancers.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> The tumor growth inhibition is potentiated by the coadministration of sorafenib for both compounds.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of nonlipidic small molecule SphK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, a new nolipidic SphK1 selective inhibitor <b>26</b> (PF-543) (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) was developed.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Its structure maintains the 1,2-amino alcohol motif presented in sphingosine, although the nitrogen in <b>26</b> is tertiary amine, forming part of a pyrrolidine ring. Compound <b>26</b> is a sphingosine-competitive inhibitor with <i>K</i><sub>i</sub> = 4.3 nM and is more than 100-fold selective for SphK1 over the SphK2 isoform.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> It also decreased the level of endogenous S1P 10-fold with proportional increase in the level of sphingosine.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Nevertheless and despite the dramatic change in the cellular S1P/sphingosine ratio, <b>26</b> did not show any effect on the proliferation and survival of 1483 human head and neck squamous cell carcinoma cells.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> These observations contradict the reports that selective inhibition of SphK1 alone, to decrease S1P levels and enhance sphingosine levels, is responsible for anticancer properties. A simultaneous inhibition of other signaling pathways, yet unknown, by several reported SKIs may be responsible for their activity. Compound <b>26</b> can be considered an ideal candidate to test the effects of the inhibition of SphK1 in vitro, but its effects in vivo have not been reported.</div><div class="NLM_p">Another example that proves the success of applying more than one medicinal chemistry technique in the design of novel SKIs is <b>27</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Initially, a thionicotinamide was identified as a SKI using a high throughput screening (HTS) approach.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> After further structural modifications and the establishment of the SAR properties, Pennington et al.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> replaced the sulfur atom of this thionicotinamide by an oxygen atom to yield <b>27</b>, which lacks a polar head. It has been shown to be a S1P<sub>1</sub> agonist (EC<sub>50</sub> = 35 nM) and to possess a >100-fold selectivity over S1P<sub>2–5</sub> subtypes.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Furthermore, <b>27</b> is orally bioavailable and shows a dramatic reduction of circulating lymphocytes in rats 24 h after a single oral dose.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> However, there is no report yet about the antitumor effects of this compound.</div><div class="NLM_p">The development of <b>28</b> (W-061) (Figures <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a> and <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>)<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> and its analogue <b>31</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>),<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> with a dihydronaphthalene scaffold, which are selective S1P<sub>1</sub> agonists over S1P<sub>3</sub> activity, represents another example of the successful application of the medicinal chemistry tools and SAR properties in the discovery of new and potent SKIs. First, compound <b>29</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>), which showed a submicromolar human S1P<sub>1</sub> agonist activity but no selectivity over S1P<sub>3</sub> and S1P<sub>5</sub>, emerged as a hit compound after a HTS of a compound library.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Then Kurata et al. investigated the SAR properties to improve S1P<sub>1</sub> agonist activity and selectivity over S1P<sub>3</sub>.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> They confirmed that the restriction of conformational flexibility improves the oral administration.<a onclick="showRef(event, 'ref100 ref101'); return false;" href="javascript:void(0);" class="ref ref100 ref101">(100, 101)</a> Furthermore, they found that (1) the π-electron density at the internal phenyl ring might be important for S1P<sub>1</sub> agonist activity and (2) the trans configuration might be beneficial to assist the basic nitrogen for interacting with S1P<sub>1</sub> receptor. After extensive SAR studies, a cinnamyl derivative <b>30</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>) was identified with improved in vitro S1P<sub>1</sub> agonist activity and selectivity.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Later, the same research group used one of these cinnamyl derivatives as the lead compound to further develop more potent and selective S1P<sub>1</sub> agonists by performing the following structural changes:<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> (1) length of the alkylene linker between the terminal and central phenyl rings; (2) conformational restriction of β-alanine group; (3) substituents on the central phenyl ring; (4) conversion of the cinnamyl moiety into several fused ring systems; (5) conversion of β-alanine to a cyclic amino acid. These structural modifications yielded a hydronaphthalene derivative <b>28</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>), which showed potent human S1P<sub>1</sub> agonist activity with excellent selectivity over S1P<sub>3</sub> and in vivo efficacy lowering peripheral lymphocyte counts in mice.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> In addition, a recent report has demonstrated that the daily oral administration of <b>28</b> resulted in improvement of DSS-induced colitis in a murine model.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Finally, Kurata et al. proved that the introduction of substituents on the propylene linker and the terminal benzene ring influences in vitro and peripheral lymphocyte lowering activities.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> The study led to the discovery of <b>31</b>, formed by the introduction of a (<i>S</i>)-methyl group and a <i>p</i>-chloro substitution on the propylene and the terminal phenyl group, respectively, with improved activity and in vivo efficacy without impairing selectivity over S1P<sub>3</sub> compared with <b>28</b>.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> Lately, S1PRs have attracted an increasing attention as novel therapeutic pathways for treating cancer. A recent review provides the latest advances in their biological and clinical properties, as well as an overview of the chemical and SAR of S1PRs inhibitors.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Chemical structures of <b>28</b> and its analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In conclusion, an effort to identify a small molecule as SKI initiated by French et al.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> about a decade ago has now come a long way and several promising compounds have been developed. Owing to their druglike small molecule structure, the nolipidic compounds, in fact, could be the most promising candidates to further develop in the search of novel specific SKIs with therapeutical applications. For example, the aryladamantane <b>24</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>), which is a selective SphK2 inhibitor that attenuates S1P formation, is currently in phase I clinical trial for patients with advanced solid tumors. Several other compounds such as SphK1 specific inhibitors <b>23</b> and <b>26</b>, SphK2 specific inhibitor <b>17</b>, and S1P<sub>1</sub> inhibitor <b>28</b> have emerged as ideal candidates to unravel the complex roles and functions of SphKs and S1PRs. The first report on crystal structure of SphK1 published earlier this year<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> is expected to help in designing better SphK1 inhibitors in near future.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Natural Compounds</h3><div class="NLM_p">The role of natural products as a source for remedies has been recognized since ancient times. Despite major scientific and technological advances in combinatorial chemistry, natural sources are still very useful in the drug discovery today. In fact, an analysis of a number of chemotherapeutic agents and their sources indicates that over 60% of approved drugs are derived from natural compounds.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Compounds from many natural sources have also been recognized as SKIs.</div><div id="sec3_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Marine Sources</h4><div class="NLM_p">Among all the natural sources, the marine environment has been shown to be a source of extremely potent compounds that have demonstrated significant activity as antitumor and cytotoxic drugs. One recent example of these marine derived SKIs is <b>32</b> (Jaspine B) (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>), also known as pachastrissamine, which was originally isolated from the sponge <i>Pachastrissa</i> sp. by Kuroda et al.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> The sphingoid base in <b>32</b> becomes part of a heterocyclic system (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>). Since its isolation, several total synthesis procedures have been developed for <b>32</b> and its analogues.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Compound <b>32</b> and its stereoisomers exhibited moderate to potent inhibitory activity against SphK1 and SphK2, the IC<sub>50</sub> values for these kinases being 4.6 and 6.6 μM, respectively.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Several reports have shown that <b>32</b> exerts a marked cytotoxic activity in various cultured cancer cells through a plethora of different mechanisms of action.<a onclick="showRef(event, 'ref105 ref108 ref109 ref110'); return false;" href="javascript:void(0);" class="ref ref105 ref108 ref109 ref110">(105, 108-110)</a> Since 2009, some isomers and different analogues of <b>32</b> have been developed and their cytotoxic activities evaluated.<a onclick="showRef(event, 'ref107 ref111 ref112 ref113 ref114'); return false;" href="javascript:void(0);" class="ref ref107 ref111 ref112 ref113 ref114">(107, 111-114)</a> Although none of them were found to be superior to <b>32</b>, most of these analogues showed cytotoxic activity in vitro.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of the SKIs obtained from different natural sources.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">A series of compounds have also been isolated from a marine bacterium,<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a><b>33</b> (B-5354c) (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>)<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> being the most extensively studied derivative. It is a noncompetitive inhibitor of both SphK isoforms with respect to sphingosine.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Compound <b>33</b> induces apoptosis in a dose dependent manner in prostate cancer cell lines and sensitizes LNCaP and PC-3 cells to docetaxel and camptothecin, respectively.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Likewise, <b>33</b> exerts a synergistic effect with camptothecin on tumor size in an orthotopically xenografted PC-3 cells model, along with a significant increase in the Cer/S1P sphingolipid ratio.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div></div><div id="sec3_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Other Sources</h4><div class="NLM_p">Compound <b>34</b> (phytosphingosine) (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) is a structurally similar analogue of sphingosine produced by microorganisms, yeast, plants, and fungi as their major membrane component, and it is phosphorylated by SphK2 but not by SphK1.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> It has been shown to trigger a mitochondria-involved apoptosis process in human non-small-cell lung and T-cell lymphoma Jurkat cells in vitro, although it has not been reported whether the SphK2 inhibition is involved in its activity.<a onclick="showRef(event, 'ref118 ref119'); return false;" href="javascript:void(0);" class="ref ref118 ref119">(118, 119)</a> Furthermore, <b>34</b> is also able to sensitize some cancer cells in vitro to the action of TRAIL,<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> arsenic trioxide<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> and ionizing radiation<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> through different pathways. Several analogues of <b>34</b> have been developed with some promising cytotoxic effects in vitro. The mono- and dimethylated analogues induced apoptosis in various human leukemia cell lines.<a onclick="showRef(event, 'ref122 ref123'); return false;" href="javascript:void(0);" class="ref ref122 ref123">(122, 123)</a> Finally, several <span class="smallcaps smallerCapital">d</span>-ribo-<b>34</b> analogues in combination with ionizing radiation have been shown to enhance cell death.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></div><div class="NLM_p">A cultured broth of <i>Trichopezizella barbata</i> yielded a sesquiterpene derivative <b>35</b> (F-12509A) (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>), which is a competitive inhibitor with respect to sphingosine, of both isoforms of SphKs.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> The total synthesis of <b>35</b> has been achieved in a highly efficient manner with nine steps and a 45% overall yield.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Compound <b>35</b> inhibits SphK1, leading to a concurrent blockade of S1P biosynthesis and ceramide accumulation in chemosensitive and chemoresistant HL-60 acute myeloid leukemia cells.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> It promoted apoptosis at low micromolar concentrations in HL-60 cells, regardless of the status of MDR.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> The increase in ceramide content from the Cer/S1P balance in the chronic myeloid leukemia LAMA cells is implicated in the apoptosis induction caused by <b>35</b>.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> It was cytotoxic to imatinib-sensitive and -resistant primary cells from chronic myeloid leukemia patients.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></div><div class="NLM_p">More recently, a study conducted by Brizuela et al. has shown that some dietary agents (epigallocatechin gallate, reverastrol, and a mixture of polyphenols from green tea and wine) inhibit the prostate cancer cell growth in vitro and in vivo by inhibiting the SphK1/S1P pathway.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Furthermore, a diet with the polyphenols extracted from green tea (polyphenon E) showed chemopreventive effect in an orthotopic PC-3/GFP prostate cancer model.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> These polyphenols cause a decrease in primary tumor volume, occurrence and number of metastases, and these effects have been associated with SphK1 inhibition.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a></div><div class="NLM_p last">Although none of the natural compounds reported so far has been shown to be potent or selective SKI, most of them have shown interesting anticancer activity and synergetic effects with various chemotherapeutic drugs (e.g., docetaxel and camptothecin) in vitro and in various rodent models.</div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Applications of SKIs in Other Diseases</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61805" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61805" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Apart from its role in cancer diagnosis and prognosis, the SphK/S1P pathway is also emerging as a descriptive biomarker of several other diseases, such as cardiovascular and inflammatory diseases, obesity, diabetes, ischemial/reperfusion injury, and fibrosis. A comprehensive review of the different roles of SphK/S1P in these diseases is contained in a report by Orr Gandy et al.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Several compounds that modulate the SphK/S1P pathway are in clinical development for inflammatory-related diseases.<a onclick="showRef(event, 'ref72 ref130'); return false;" href="javascript:void(0);" class="ref ref72 ref130">(72, 130)</a> Some of the SKIs listed in this paper (e.g., <b>1</b>, <b>3</b>, <b>20</b>, and <b>24</b>) have exerted effects in murine models for asthma, rheumatoid arthritis, and inflammatory bowel diseases. A more thorough report of these effects can be found in a review article published by Edmonds et al.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Song et al. have shown that <b>28</b> prevents the graft-versus-host disease and graft rejection in rat small bowel transplantation.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Recently, the modulation of the sphingolipid metabolism has emerged as a novel and promising target in parasitic malaria disease.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> The human malaria parasite <i>Plasmodium falciparum</i> contains the sphingomielin synthase and its inhibition blocks parasite proliferation in culture.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Compound <b>14</b> and other structurally close-related analogues of sphingosine have proven to possess in vitro antimalarial activity.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Nevertheless, the S1P is involved in many important cellular functions, including those that regulate normal cell behavior. The SphK/S1P contents are not completely well established, as descriptive biomarkers for some of these diseases and further studies are needed.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Summary and Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68135" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68135" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Several studies have shown the importance of targeting SphK to modulate sphingomyelin metabolsim in cancer therapy and in the treatment of several other diseases in animal models. Furthermore, the implication of sphingolipids in the development of MDR by cancer cells seems to be sufficiently proven and several reviews about this subject have been published.<a onclick="showRef(event, 'ref21 ref27 ref135'); return false;" href="javascript:void(0);" class="ref ref21 ref27 ref135">(21, 27, 135)</a> Among these sphingolipids, the SphK and some of their receptors have presented a relation with the MDR phenomena.<a onclick="showRef(event, 'ref136 ref137'); return false;" href="javascript:void(0);" class="ref ref136 ref137">(136, 137)</a> These inter-relationship results are particularly relevant to SphK1. Therefore, the demonstrated role of SphKs, particularly SphK1, in the development of MDR by cancer cells makes these kinases an attractive target in developing effective therapeutics to fight against cancer. In fact, various SKIs have shown cytotoxic effects in several resistant cancer cell lines in vitro<a onclick="showRef(event, 'ref85 ref93'); return false;" href="javascript:void(0);" class="ref ref85 ref93">(85, 93)</a> and in vivo.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> However, to establish true potential of this important target would require development of more efficient and selective SphK inhibitors. Mostly, the structural design of SphK inhibitors is often inspired from the structure of sphingosine. Identification of small druglike molecule inhibitors was initiated about a decade ago,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and continuing studies have now led to the identification of some fairly potent compounds as described in section “<a class="ref internalNav" href="#sec3_2" aria-label="Nolipidic Small Molecules">Nolipidic Small Molecules</a>” above. However, the lack of availability of crystal structure of SphKs had been a major hurdle in designing specific SKIs. The crystal structure of SphK1 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) was finally reported by Wang et al. in May 2013.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> This would now help design more specific and potent SphK1 inhibitors that might soon translate from bench to bedside. Indeed, a report on crystal structure guided rational design of SKIs has already been just published,<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> describing the design, synthesis, and identification of the first potent inhibitors of both isoforms of SphK. In contrast to SphK1, the characterization and physiological functions of SphK2 have not been fully elucidated. Despite this, many studies are now emerging that suggest a role of SphK2 in several diseases, including the development of solid tumors. These reports show that SphK2 can be considered as a potential and promising target in the treatment of cancer. A recent review article gathers the latest information on the roles, regulation, and inhibitors of SphK2.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a></div><div class="NLM_p last">Although the importance of SphK1 is well recognized, whether the inhibition of SphK1 alone is enough and whether SphK1 inhibition by the known SKIs is specific and has no other off-target effects that may be responsible for activity, remain uncertain. Indeed, a recent report has shown that inhibition of SphK1 or its down-regulation produces an increase of intracellular sphingosine along with the decrease of PKC activity, suggesting an intriguing link between SphK1, PKC, and the cell cycle machinery.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> By contrast, recent reports suggest that several small molecules that effectively inhibit SphK1 in the in vitro assays failed to show cytotoxicity to cancer cells.<a onclick="showRef(event, 'ref30 ref141'); return false;" href="javascript:void(0);" class="ref ref30 ref141">(30, 141)</a> This has raised questions on the role of SphK in cancer induction and that of specific SKIs in cancer treatment. A recent report by Schnute et al. has shown that in spite of being very effective SphK1 inhibitor, <b>26</b> had no effect on the proliferation and survival of the 1483 cells.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> A similar observation was recently also documented by Rex et al. who showed that two potent and specific SphK1/2 inhibitors did not reduce tumor cell growth in vitro or in vivo, in spite of the fact that they completely inhibited intracellular S1P production.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> These reports are in sharp contrast to a large body of literature that has demonstrated the promise of SKIs as cancer therapeutics but caution against the real role of SphK in cancer cells growth and proliferation. At the very least, it suggests that inhibition of SphK1 and/or SphK2 alone may not be sufficient. Therefore, identification of agents that inhibit SphK1 and/or SphK2 and are capable of controlling cancer cell growth probably in combination with off target effects would be the quest for drug discovery in the future for scientists working in this field. Taken together, it suggests that inhibition of SphK with one or more other pathways may be the ideal way to approach this issue. Thus, identification of these off targets that would work synergistically with SphK1 should also be the focus of future studies. The synergystic effects of SKIs with various chemotherapeutic agents, such as sorafenib and bortezomib,<a onclick="showRef(event, 'ref95 ref142 ref143'); return false;" href="javascript:void(0);" class="ref ref95 ref142 ref143">(95, 142, 143)</a> as well as sensitization of some cancer cell lines to the action of several other cytotoxic compounds<a onclick="showRef(event, 'ref13 ref144'); return false;" href="javascript:void(0);" class="ref ref13 ref144">(13, 144)</a> are examples of the feasibility of this dual targeting strategy. Thus, we think that coadministration of SKIs and a chemotherapeutic or cytotoxic agent might represent a novel strategy in the treatment of cancer, although more studies are required to pinpoint the importance of SphKs and possible contribution from other signaling pathways that simultaneously need to be targeted to show the desired effect.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm4011687" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86637" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86637" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arun K. Sharma</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Penn State Hershey Cancer Institute, CH72, Penn State College of Medicine, 500 University Drive, Hershey, Pennsylvania 17033, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3859534b090c78484b4d165d5c4d"><span class="__cf_email__" data-cfemail="96f7fde5a7a2d6e6e5e3b8f3f2e3">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Plano</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Penn State Hershey Cancer Institute, CH72, Penn State College of Medicine, 500 University Drive, Hershey, Pennsylvania 17033, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Organic and Pharmaceutical Chemistry, University of Navarra, Irunlarrea 1, E-31008 Pamplona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shantu Amin</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Penn State Hershey Cancer Institute, CH72, Penn State College of Medicine, 500 University Drive, Hershey, Pennsylvania 17033, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33815" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33815" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Daniel Plano</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=BIO-d3088e1819-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Daniel Plano</b> received his B.Sc. in Chemistry from the University of Navarra at Pamplona, Spain. He also received the European Ph.D. in Science (Chemistry), being awarded with the Extraordinary Ph.D. Award in 2010 by the School of Science of the University of Navarra (Spain). In 2011, he received a postdoctoral fellowship from the Navarra Government and joined the laboratory of Arun K. Sharma where he is working on developing novel small druglike molecules for cancer prevention and therapy.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Shantu Amin</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=BIO-d3088e1824-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Shantu Amin</b> received his Ph.D. from Stevens Institute of Technology (NJ) in 1975. At present, he is Professor of Pharmacology at Penn State College of Medicine, PA. The major focus of his research is on developing novel anticancer agents, elucidating their efficacy, and investigating the drug metabolism. Dr. Amin has also been involved in structure–activity studies with mutagenic and carcinogenic compounds and using this knowledge to develop appropriate chemopreventive agents. His laboratory is nationally recognized for developing synthetic strategies for novel small druglike molecules for cancer prevention and therapy.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Arun K. Sharma</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=BIO-d3088e1829-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Arun K. Sharma</b> received his Ph.D. in Heterocyclic Chemistry in 1997 from North-Eastern Hill University (India). At present, he is an Associate Professor of Pharmacology at the Penn State College of Medicine, PA, and Co-Director of the “Organic Synthesis Core” of the Penn State Hershey Cancer Institute, PA. The major focus of Dr. Sharma’s research has been on development of novel small druglike molecules and elucidation of their efficacy and mechanism of action, particularly in the in vitro and in vivo cancer models. He has expertise in the synthesis, metabolism, efficacy determination, pharmacokinetics, and development of small druglike molecules.</p></figure></div><div class="ack" id="ACK-d3088e1834-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35447" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35447" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank the Department of Pharmacology, Penn State College of Medicine, PA, and Penn State Hershey Cancer Institute, PA, for financial support. The authors also thank Dr. Kent Vrana, Chair, Department of Pharmacology, for editing the manuscript. D.P. acknowledges the support of his postdoctoral fellowship by Anabasid program granted by Navarra’s Government.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i18" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i18"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i19" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i19"> Abbreviations Used</h2><tr><td class="NLM_term">AKT</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">araC</td><td class="NLM_def"><p class="first last">1-(β-<span class="smallcaps smallerCapital">d</span>-arabinofuranosyl)cytosine</p></td></tr><tr><td class="NLM_term">Asp</td><td class="NLM_def"><p class="first last">aspirinyl</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine 5′-triphosphate</p></td></tr><tr><td class="NLM_term">Cer</td><td class="NLM_def"><p class="first last">ceramide</p></td></tr><tr><td class="NLM_term">CK</td><td class="NLM_def"><p class="first last">ceramide kinase</p></td></tr><tr><td class="NLM_term">DNA</td><td class="NLM_def"><p class="first last">deoxyribonucleic acid</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">effective concentration 50</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">estrogen receptor</p></td></tr><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular signal-regulated kinase</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">food and drug administration</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high throughput screening</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">inhibition concentration 50</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>i</sub></td><td class="NLM_def"><p class="first last">inhibition constant</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinases</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistance</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">multiple sclerosis</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphatidylinositol 3-kinase</p></td></tr><tr><td class="NLM_term">PKC</td><td class="NLM_def"><p class="first last">protein kinase C</p></td></tr><tr><td class="NLM_term">S1P</td><td class="NLM_def"><p class="first last">sphingosine 1-phosphate</p></td></tr><tr><td class="NLM_term">S1PR</td><td class="NLM_def"><p class="first last">sphingosine 1-phosphate receptor</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SphK</td><td class="NLM_def"><p class="first last">sphingosine kinase</p></td></tr><tr><td class="NLM_term">SphK1</td><td class="NLM_def"><p class="first last">sphingosine kinase 1</p></td></tr><tr><td class="NLM_term">SphK2</td><td class="NLM_def"><p class="first last">sphingosine kinase 2</p></td></tr><tr><td class="NLM_term">SKI</td><td class="NLM_def"><p class="first last">sphingosine kinase inhibitor</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33087" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33087" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 144 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Signorelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghidoni, R.</span><span> </span><span class="NLM_article-title">Breast cancer and sphingolipid signalling</span> <span class="citation_source-journal">J. Dairy Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1017%2FS0022029905001238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=16180715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFaisbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2005&pages=5-13&author=P.+Signorelliauthor=R.+Ghidoni&title=Breast+cancer+and+sphingolipid+signalling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Breast cancer and sphingolipid signalling</span></div><div class="casAuthors">Signorelli, Paola; Ghidoni, Riccardo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Dairy Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">Spec. Issue</span>),
    <span class="NLM_cas:pages">5-13</span>CODEN:
                <span class="NLM_cas:coden">JDRSAN</span>;
        ISSN:<span class="NLM_cas:issn">0022-0299</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review on the role of sphingolipid signaling in breast cancer.  Evidence of the alteration of sphingolipid metab. and signaling is discussed in breast cancer prevention and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokCuUJCGwfDbVg90H21EOLACvtfcHk0lhOsRhjCURejA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFaisbvE&md5=ac9ba7fb4f3d6bb22ef01084904ff385</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1017%2FS0022029905001238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0022029905001238%26sid%3Dliteratum%253Aachs%26aulast%3DSignorelli%26aufirst%3DP.%26aulast%3DGhidoni%26aufirst%3DR.%26atitle%3DBreast%2520cancer%2520and%2520sphingolipid%2520signalling%26jtitle%3DJ.%2520Dairy%2520Res.%26date%3D2005%26volume%3D72%26spage%3D5%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Huwiler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zangemeister-Wittke, U.</span><span> </span><span class="NLM_article-title">Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy</span> <span class="citation_source-journal">Crit. Rev. Oncol. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2Fj.critrevonc.2007.04.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=17560117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A280%3ADC%252BD2szoslynsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=150-159&author=A.+Huwilerauthor=U.+Zangemeister-Wittke&title=Targeting+the+conversion+of+ceramide+to+sphingosine+1-phosphate+as+a+novel+strategy+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy</span></div><div class="casAuthors">Huwiler Andrea; Zangemeister-Wittke Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">150-9</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">Sphingolipids not only function as structural components of cell membranes but also act as signaling molecules to regulate fundamental cellular responses, such as cell death and differentiation, proliferation and certain types of inflammation.  Particularly the cellular balance between ceramide and sphingosine 1-phosphate seems to be crucial for a cell's decision to either undergo apoptosis or proliferate, two events which are implicated in tumor development and growth.  Whereas ceramide possesses proapoptotic capacity in many cell types, sphingosine 1-phosphate acts as a counterplayer able to induce cell proliferation and protect cells from undergoing apoptosis.  Therefore, tipping the balance in favour of ceramide production, i.e. by inhibiting ceramidase or sphingosine kinase activities has potential to support its proapoptotic action and hence represents a promising rational approach to effective cancer therapy.  This review highlights most recent data on the regulation of cellular sphingolipid formation and their potential implication in tumor development, and provides perspectives for their use as targets in molecular intervention therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHzG4u3UWGahBrI9DTGjC0fW6udTcc2eZz-Cu3s6CJMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szoslynsg%253D%253D&md5=8f500fe7c676f103b50657e925bd9f11</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2007.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2007.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DHuwiler%26aufirst%3DA.%26aulast%3DZangemeister-Wittke%26aufirst%3DU.%26atitle%3DTargeting%2520the%2520conversion%2520of%2520ceramide%2520to%2520sphingosine%25201-phosphate%2520as%2520a%2520novel%2520strategy%2520for%2520cancer%2520therapy%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D2007%26volume%3D63%26spage%3D150%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Taha, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannun, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeid, L. M.</span><span> </span><span class="NLM_article-title">Sphingosine kinase: biochemical and cellular regulation and role in disease</span> <span class="citation_source-journal">J. Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.5483%2FBMBRep.2006.39.2.113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=16584625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsVCnsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2006&pages=113-131&author=T.+A.+Tahaauthor=Y.+A.+Hannunauthor=L.+M.+Obeid&title=Sphingosine+kinase%3A+biochemical+and+cellular+regulation+and+role+in+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine kinase: biochemical and cellular regulation and role in disease</span></div><div class="casAuthors">Taha, Tarek Assad; Hannun, Yusuf Awni; Obeid, Lina Marie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-131</span>CODEN:
                <span class="NLM_cas:coden">JBMBE5</span>;
        ISSN:<span class="NLM_cas:issn">1225-8687</span>.
    
            (<span class="NLM_cas:orgname">Korean Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Sphingolipids have emerged as mols. whose metab. is regulated leading to generation of bioactive products including ceramide, sphingosine, and sphingosine 1-phosphate (S1P).  The balance between the cellular levels of these bioactive products is increasingly recognized to be crit. to cell regulation, whereby ceramide and sphingosine cause apoptosis and growth arrest phenotypes and S1P mediates proliferative and angiogenic responses.  Sphingosine kinase (SK) is a key enzyme in modulating the levels of these lipids and is emerging as an important and regulated enzyme.  This review is directed toward mechanisms of regulation of SK and the emergence of its role in disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-KLKLbTMS1LVg90H21EOLACvtfcHk0lj5YXZX8DFkBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsVCnsbk%253D&md5=339350005fee5edb245f8b1f8703f26f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.5483%2FBMBRep.2006.39.2.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5483%252FBMBRep.2006.39.2.113%26sid%3Dliteratum%253Aachs%26aulast%3DTaha%26aufirst%3DT.%2BA.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26atitle%3DSphingosine%2520kinase%253A%2520biochemical%2520and%2520cellular%2520regulation%2520and%2520role%2520in%2520disease%26jtitle%3DJ.%2520Biochem.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D39%26spage%3D113%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Cuvillier, O.</span><span> </span><span class="NLM_article-title">Sphingosine kinase-1—a potential therapeutic target in cancer</span> <span class="citation_source-journal">Anti-Cancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=105-110&author=O.+Cuvillier&title=Sphingosine+kinase-1%E2%80%94a+potential+therapeutic+target+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuvillier%26aufirst%3DO.%26atitle%3DSphingosine%2520kinase-1%25E2%2580%2594a%2520potential%2520therapeutic%2520target%2520in%2520cancer%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2007%26volume%3D18%26spage%3D105%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Xia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamble, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wattenberg, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Andrea, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vadas, M. A.</span><span> </span><span class="NLM_article-title">An oncogenic role of sphingosine kinase</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1527</span><span class="NLM_x">–</span> <span class="NLM_lpage">1530</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2FS0960-9822%2800%2900834-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=11114522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD3cXoslGmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1527-1530&author=P.+Xiaauthor=J.+R.+Gambleauthor=L.+Wangauthor=S.+M.+Pitsonauthor=P.+A.+Morettiauthor=B.+W.+Wattenbergauthor=R.+J.+D%E2%80%99Andreaauthor=M.+A.+Vadas&title=An+oncogenic+role+of+sphingosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">An oncogenic role of sphingosine kinase</span></div><div class="casAuthors">Xia, P.; Gamble, J. R.; Wang, L.; Pitson, S. M.; Moretti, P. A. B.; Wattenberg, B. W.; D'Andrea, R. J.; Vadas, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">1527-1530</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Sphingosine kinase (SphK) is a highly conserved lipid kinase that phosphorylates sphingosine to form sphingosine-1-phosphate (S1P).  S1P/SphK has been implicated as a signaling pathway to regulate diverse cellular functions, including cell growth, proliferation and survival.  The authors report that cells overexpressing SphK have increased enzymic activity and acquire the transformed phenotype, as detd. by focus formation, colony growth in soft agar and the ability to form tumors in NOD/SCID mice.  This is the first demonstration that a wild-type lipid kinase gene acts as an oncogene.  Using a chem. inhibitor of SphK, or an SphK mutant that inhibits enzyme activation, the authors found that SphK activity is involved in oncogenic H-Ras-mediated transformation, suggesting a novel signaling pathway for Ras activation.  The findings not only point to a new signaling pathway in transformation but also to the potential of SphK inhibitors in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvWSPdMxVm3LVg90H21EOLACvtfcHk0lj5YXZX8DFkBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXoslGmsr4%253D&md5=edce66ee4b3aa1c6f071de8bdc59689e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0960-9822%2800%2900834-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-9822%252800%252900834-4%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DP.%26aulast%3DGamble%26aufirst%3DJ.%2BR.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DPitson%26aufirst%3DS.%2BM.%26aulast%3DMoretti%26aufirst%3DP.%2BA.%26aulast%3DWattenberg%26aufirst%3DB.%2BW.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DR.%2BJ.%26aulast%3DVadas%26aufirst%3DM.%2BA.%26atitle%3DAn%2520oncogenic%2520role%2520of%2520sphingosine%2520kinase%26jtitle%3DCurr.%2520Biol.%26date%3D2000%26volume%3D10%26spage%3D1527%26epage%3D1530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Alshaker, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottaviani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivats, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pchejetski, D.</span><span> </span><span class="NLM_article-title">Therapeutic potential of targeting SK1 in human cancers</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2013&pages=143-200&author=H.+Alshakerauthor=L.+Sauerauthor=D.+Monteilauthor=S.+Ottavianiauthor=S.+Srivatsauthor=T.+Bohlerauthor=D.+Pchejetski&title=Therapeutic+potential+of+targeting+SK1+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlshaker%26aufirst%3DH.%26aulast%3DSauer%26aufirst%3DL.%26aulast%3DMonteil%26aufirst%3DD.%26aulast%3DOttaviani%26aufirst%3DS.%26aulast%3DSrivats%26aufirst%3DS.%26aulast%3DBohler%26aufirst%3DT.%26aulast%3DPchejetski%26aufirst%3DD.%26atitle%3DTherapeutic%2520potential%2520of%2520targeting%2520SK1%2520in%2520human%2520cancers%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2013%26volume%3D117%26spage%3D143%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Heffernan-Stroud, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeid, L. M.</span><span> </span><span class="NLM_article-title">Sphingosine kinase 1 in cancer</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2013&pages=201-235&author=L.+A.+Heffernan-Stroudauthor=L.+M.+Obeid&title=Sphingosine+kinase+1+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeffernan-Stroud%26aufirst%3DL.%2BA.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26atitle%3DSphingosine%2520kinase%25201%2520in%2520cancer%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2013%26volume%3D117%26spage%3D201%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, G. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L. B.</span><span> </span><span class="NLM_article-title">Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1393</span><span class="NLM_x">–</span> <span class="NLM_lpage">1399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1158%2F1078-0432.CCR-08-1158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=19228740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitVOkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=1393-1399&author=W.+Liauthor=C.+P.+Yuauthor=J.+T.+Xiaauthor=L.+Zhangauthor=G.+X.+Wengauthor=H.+Q.+Zhengauthor=Q.+L.+Kongauthor=L.+J.+Huauthor=M.+S.+Zengauthor=Y.+X.+Zengauthor=M.+Liauthor=J.+Liauthor=L.+B.+Song&title=Sphingosine+kinase+1+is+associated+with+gastric+cancer+progression+and+poor+survival+of+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine Kinase 1 Is Associated with Gastric Cancer Progression and Poor Survival of Patients</span></div><div class="casAuthors">Li, Wen; Yu, Chun-Ping; Xia, Jin-tang; Zhang, Ling; Weng, Gui-Xiang; Zheng, Hai-qing; Kong, Qing-li; Hu, Li-juan; Zeng, Mu-Sheng; Zeng, Yi-xin; Li, Mengfeng; Li, Jun; Song, Li-Bing</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1393-1399</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The present study was to investigate the clin. significance of sphingosine kinase 1 (SPHK1), an oncoenzyme, in the development and progression of gastric cancer.  mRNA and protein levels of SPHK1 expression in normal gastric epithelial cells, gastric cancer cell lines, and paired gastric cancer lesions and the adjacent noncancerous tissues were examd. using reverse transcription-PCR and Western blotting.  Immunohistochem. was employed to analyze SPHK1 expression in 175 clinicopathol. characterized gastric cancer cases.  Statistical analyses were applied to derive prognostic and diagnostic assocns.  Levels of SPHK1 mRNA and protein were higher in gastric cancer cell lines than in normal gastric epithelial cells.  SPHK1 protein level was up-regulated in gastric cancer lesions compared with that in the paired adjacent noncancerous tissues.  Gastric cancer tissues from 115 of 175 (65.7%) patients revealed high level of SPHK1 protein expression in contrast to the undetectable or marginally detectable expression of SPHK1 in the adjacent noncancerous gastric tissues.  Significantly different expression levels of SPHK1 were found in patients at different clin. stages (P = 0.003), T classification (P = 0.035), and M classification (P = 0.020).  Patients with higher SPHK1 expression had shorter overall survival time, whereas those with lower SPHK1 expression survived longer.  Further multivariate anal. suggested that SPHK1 up-regulation was an independent prognostic indicator for the disease.  SPHK1 protein could be a useful marker for the prognosis of gastric cancer.  Further study on the potential use of SPHK1 as a therapeutic target is also warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6a-utjUoS77Vg90H21EOLACvtfcHk0lidN0eQO_0MHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitVOkt7k%253D&md5=5d65096d0960a7f58e68b82246439414</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-1158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-1158%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DC.%2BP.%26aulast%3DXia%26aufirst%3DJ.%2BT.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWeng%26aufirst%3DG.%2BX.%26aulast%3DZheng%26aufirst%3DH.%2BQ.%26aulast%3DKong%26aufirst%3DQ.%2BL.%26aulast%3DHu%26aufirst%3DL.%2BJ.%26aulast%3DZeng%26aufirst%3DM.%2BS.%26aulast%3DZeng%26aufirst%3DY.%2BX.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%2BB.%26atitle%3DSphingosine%2520kinase%25201%2520is%2520associated%2520with%2520gastric%2520cancer%2520progression%2520and%2520poor%2520survival%2520of%2520patients%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D1393%26epage%3D1399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span> </span><span class="NLM_article-title">Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy</span> <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=495&author=G.+Liuauthor=H.+Zhengauthor=Z.+Zhangauthor=Z.+Wuauthor=H.+Xiongauthor=J.+Liauthor=L.+Song&title=Overexpression+of+sphingosine+kinase+1+is+associated+with+salivary+gland+carcinoma+progression+and+might+be+a+novel+predictive+marker+for+adjuvant+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DXiong%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%26atitle%3DOverexpression%2520of%2520sphingosine%2520kinase%25201%2520is%2520associated%2520with%2520salivary%2520gland%2520carcinoma%2520progression%2520and%2520might%2520be%2520a%2520novel%2520predictive%2520marker%2520for%2520adjuvant%2520therapy%26jtitle%3DBMC%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span> </span><span class="NLM_article-title">Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6996</span><span class="NLM_x">–</span> <span class="NLM_lpage">7003</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1158%2F1078-0432.CCR-08-0754" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=18980995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlens7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=6996-7003&author=J.+Liauthor=H.+Y.+Guanauthor=L.+Y.+Gongauthor=L.+B.+Songauthor=N.+Zhangauthor=J.+Wuauthor=J.+Yuanauthor=Y.+J.+Zhengauthor=Z.+S.+Huangauthor=M.+Li&title=Clinical+significance+of+sphingosine+kinase-1+expression+in+human+astrocytomas+progression+and+overall+patient+survival"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Significance of Sphingosine Kinase-1 Expression in Human Astrocytomas Progression and Overall Patient Survival</span></div><div class="casAuthors">Li, Jun; Guan, Hong-Yu; Gong, Li-Yun; Song, Li-Bing; Zhang, Nu; Wu, Jueheng; Yuan, Jie; Zheng, Yi-Jie; Huang, Zheng-Song; Li, Mengfeng</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6996-7003</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: To characterize the expression of sphingosine kinase-1 (SPHK1) in human astrocytomas and to investigate the assocn. between SPHK1 expression and progression of astrocytomas.  Exptl. Design: The expression of SPHK1 in normal human astrocytes, astrocytoma cell lines, and four pairs of matched astrocytoma tissues and their adjacent normal brain tissues were detected by quant. reverse transcription-PCR and Western blot.  In addn., SPHK1 protein expression was examd. in 243 cases of histol. characterized astrocytomas by immunohistochem.  Statistical analyses were applied to test for prognostic and diagnostic assocns.  RESULTS: SPHK1 in astrocytoma cell lines was elevated at both mRNA and protein levels, and the SPHK1 mRNA and protein were significantly up-regulated by up to 6.8- and 40-fold, resp., in primary astrocytomas compared with those in the adjacent noncancerous brain tissues.  Immunohistochem. anal. showed that 100 of 243 (41.2%) paraffin-embedded archival astrocytoma biopsies exhibited high expression of SPHK1.  Statistical anal. suggested that the up-regulation of SPHK1 was significantly correlated with the histol. grade of astrocytoma (P = 0.000) and that patients with high SPHK1 level exhibited shorter survival time (P < 0.001).  Multivariate anal. revealed that SPHK1 up-regulation might be an independent prognostic indicator for the survival of patients with astrocytoma.  CONCLUSIONS: SPHK1 might represent a novel and useful prognostic marker for astrocytoma and play a role during the development and progression of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj1r4G3W_Fr7Vg90H21EOLACvtfcHk0lidN0eQO_0MHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlens7bK&md5=670030678fc952a28cdc711de723e96b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0754%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGuan%26aufirst%3DH.%2BY.%26aulast%3DGong%26aufirst%3DL.%2BY.%26aulast%3DSong%26aufirst%3DL.%2BB.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DY.%2BJ.%26aulast%3DHuang%26aufirst%3DZ.%2BS.%26aulast%3DLi%26aufirst%3DM.%26atitle%3DClinical%2520significance%2520of%2520sphingosine%2520kinase-1%2520expression%2520in%2520human%2520astrocytomas%2520progression%2520and%2520overall%2520patient%2520survival%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D6996%26epage%3D7003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Guan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span> </span><span class="NLM_article-title">Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e19946</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e19946&author=H.+Guanauthor=L.+Songauthor=J.+Caiauthor=Y.+Huangauthor=J.+Wuauthor=J.+Yuanauthor=J.+Liauthor=M.+Li&title=Sphingosine+kinase+1+regulates+the+Akt%2FFOXO3a%2FBim+pathway+and+contributes+to+apoptosis+resistance+in+glioma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DH.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DM.%26atitle%3DSphingosine%2520kinase%25201%2520regulates%2520the%2520Akt%252FFOXO3a%252FBim%2520pathway%2520and%2520contributes%2520to%2520apoptosis%2520resistance%2520in%2520glioma%2520cells%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De19946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Kapitonov, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegood, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hait, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almenara, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zipkin, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kordula, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">6915</span><span class="NLM_x">–</span> <span class="NLM_lpage">6923</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=6915-6923&author=D.+Kapitonovauthor=J.+C.+Allegoodauthor=C.+Mitchellauthor=N.+C.+Haitauthor=J.+A.+Almenaraauthor=J.+K.+Adamsauthor=R.+E.+Zipkinauthor=P.+Dentauthor=T.+Kordulaauthor=S.+Milstienauthor=S.+Spiegel&title=Targeting+sphingosine+kinase+1+inhibits+Akt+signaling%2C+induces+apoptosis%2C+and+suppresses+growth+of+human+glioblastoma+cells+and+xenografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKapitonov%26aufirst%3DD.%26aulast%3DAllegood%26aufirst%3DJ.%2BC.%26aulast%3DMitchell%26aufirst%3DC.%26aulast%3DHait%26aufirst%3DN.%2BC.%26aulast%3DAlmenara%26aufirst%3DJ.%2BA.%26aulast%3DAdams%26aufirst%3DJ.%2BK.%26aulast%3DZipkin%26aufirst%3DR.%2BE.%26aulast%3DDent%26aufirst%3DP.%26aulast%3DKordula%26aufirst%3DT.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DTargeting%2520sphingosine%2520kinase%25201%2520inhibits%2520Akt%2520signaling%252C%2520induces%2520apoptosis%252C%2520and%2520suppresses%2520growth%2520of%2520human%2520glioblastoma%2520cells%2520and%2520xenografts%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D6915%26epage%3D6923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Rosa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marciano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malapelle, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formisano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nappi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amato, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amato, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marfe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Vecchio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zannetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Stefano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlomagno, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veneziani, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troncone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Placido, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianco, R.</span><span> </span><span class="NLM_article-title">Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1158%2F1078-0432.CCR-12-1050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=23166225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFGhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=138-147&author=R.+Rosaauthor=R.+Marcianoauthor=U.+Malapelleauthor=L.+Formisanoauthor=L.+Nappiauthor=C.+D%E2%80%99Amatoauthor=V.+D%E2%80%99Amatoauthor=V.+Damianoauthor=G.+Marfeauthor=S.+Del+Vecchioauthor=A.+Zannettiauthor=A.+Grecoauthor=A.+De+Stefanoauthor=C.+Carlomagnoauthor=B.+M.+Venezianiauthor=G.+Tronconeauthor=S.+De+Placidoauthor=R.+Bianco&title=Sphingosine+kinase+1+overexpression+contributes+to+cetuximab+resistance+in+human+colorectal+cancer+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models</span></div><div class="casAuthors">Rosa, Roberta; Marciano, Roberta; Malapelle, Umberto; Formisano, Luigi; Nappi, Lucia; D'Amato, Claudia; D'Amato, Valentina; Damiano, Vincenzo; Marfe, Gabriella; Del Vecchio, Silvana; Zannetti, Antonella; Greco, Adelaide; De Stefano, Alfonso; Carlomagno, Chiara; Veneziani, Bianca Maria; Troncone, Giancarlo; De Placido, Sabino; Bianco, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">138-147</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Although the anti-EGF receptor (EGFR) monoclonal antibody cetuximab is an effective strategy in colorectal cancer therapy, its clin. use is limited by intrinsic or acquired resistance.  Alterations in the "sphingolipid rheostat"-the balance between the proapoptotic mol. ceramide and the mitogenic factor sphingosine-1-phosphate (S1P)-due to sphingosine kinase 1 (SphK1) overactivation have been involved in resistance to anticancer-targeted agents.  Moreover, cross-talks between SphK1 and EGFR-dependent signaling pathways have been described.  Exptl. design: We investigated SphK1 contribution to cetuximab resistance in colorectal cancer, in preclin. in vitro/in vivo models, and in tumor specimens from patients.  Results: SphK1 was found overexpressed and overactivated in colorectal cancer cells with intrinsic or acquired resistance to cetuximab.  SphK1 contribution to resistance was supported by the demonstration that SphK1 inhibition by N,N-dimethyl-sphingosine or silencing via siRNA in resistant cells restores sensitivity to cetuximab, whereas exogenous SphK1 overexpression in sensitive cells confers resistance to these agents.  Moreover, treatment of resistant cells with fingolimod (FTY720), a S1P receptor (S1PR) antagonist, resulted in resensitization to cetuximab both in vitro and in vivo, with inhibition of tumor growth, interference with signal transduction, induction of cancer cells apoptosis, and prolongation of mice survival.  Finally, a correlation between SphK1 expression and cetuximab response was found in colorectal cancer patients.  Clin Cancer Res; 19(1); 138-47. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYEnt3BNcDsrVg90H21EOLACvtfcHk0liAlkV2uYytxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFGhsg%253D%253D&md5=e8c6c153aeca808201d5d583f368821d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-1050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-1050%26sid%3Dliteratum%253Aachs%26aulast%3DRosa%26aufirst%3DR.%26aulast%3DMarciano%26aufirst%3DR.%26aulast%3DMalapelle%26aufirst%3DU.%26aulast%3DFormisano%26aufirst%3DL.%26aulast%3DNappi%26aufirst%3DL.%26aulast%3DD%25E2%2580%2599Amato%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Amato%26aufirst%3DV.%26aulast%3DDamiano%26aufirst%3DV.%26aulast%3DMarfe%26aufirst%3DG.%26aulast%3DDel%2BVecchio%26aufirst%3DS.%26aulast%3DZannetti%26aufirst%3DA.%26aulast%3DGreco%26aufirst%3DA.%26aulast%3DDe%2BStefano%26aufirst%3DA.%26aulast%3DCarlomagno%26aufirst%3DC.%26aulast%3DVeneziani%26aufirst%3DB.%2BM.%26aulast%3DTroncone%26aufirst%3DG.%26aulast%3DDe%2BPlacido%26aufirst%3DS.%26aulast%3DBianco%26aufirst%3DR.%26atitle%3DSphingosine%2520kinase%25201%2520overexpression%2520contributes%2520to%2520cetuximab%2520resistance%2520in%2520human%2520colorectal%2520cancer%2520models%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D138%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Cuvillier, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ader, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouquerel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brizuela, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gstalder, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malavaud, B.</span><span> </span><span class="NLM_article-title">Hypoxia, therapeutic resistance, and sphingosine 1-phosphate</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2013&pages=117-141&author=O.+Cuvillierauthor=I.+Aderauthor=P.+Bouquerelauthor=L.+Brizuelaauthor=C.+Gstalderauthor=B.+Malavaud&title=Hypoxia%2C+therapeutic+resistance%2C+and+sphingosine+1-phosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuvillier%26aufirst%3DO.%26aulast%3DAder%26aufirst%3DI.%26aulast%3DBouquerel%26aufirst%3DP.%26aulast%3DBrizuela%26aufirst%3DL.%26aulast%3DGstalder%26aufirst%3DC.%26aulast%3DMalavaud%26aufirst%3DB.%26atitle%3DHypoxia%252C%2520therapeutic%2520resistance%252C%2520and%2520sphingosine%25201-phosphate%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2013%26volume%3D117%26spage%3D117%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Pchejetski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doumerc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golzio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naymark, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teissie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waxman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malavaud, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuvillier, O.</span><span> </span><span class="NLM_article-title">Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1836</span><span class="NLM_x">–</span> <span class="NLM_lpage">1845</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1158%2F1535-7163.MCT-07-2322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=18644996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCgtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1836-1845&author=D.+Pchejetskiauthor=N.+Doumercauthor=M.+Golzioauthor=M.+Naymarkauthor=J.+Teissieauthor=T.+Kohamaauthor=J.+Waxmanauthor=B.+Malavaudauthor=O.+Cuvillier&title=Chemosensitizing+effects+of+sphingosine+kinase-1+inhibition+in+prostate+cancer+cell+and+animal+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models</span></div><div class="casAuthors">Pchejetski, Dimitri; Doumerc, Nicolas; Golzio, Muriel; Naymark, Maria; Teissie, Justin; Kohama, Takafumi; Waxman, Jonathan; Malavaud, Bernard; Cuvillier, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1836-1845</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We have previously reported that, in prostate cancer, inhibition of the oncogenic sphingosine kinase-1/sphingosine 1-phosphate (SphK1/S1P) pathway is a key element in chemotherapy-induced apoptosis.  Here, we show that selective pharmacol. inhibition of SphK1 triggers apoptosis in LNCaP and PC-3 prostate cancer cells, an effect that is reversed by SphK1 enforced expression.  More importantly, we show for the first time that the up-regulation of the SphK1/S1P pathway plays a crucial role in the resistance of prostate cancer cells to chemotherapy.  Importantly, pharmacol. SphK1 inhibition with the B-5354c compd. sensitizes LNCaP and PC-3 cells to docetaxel and camptothecin, resp.  In vivo, camptothecin and B-5354c alone display a limited effect on tumor growth in PC-3 cells, whereas in combination there is a synergy of effect on tumor size with a significant increase in the ceramide to S1P sphingolipid ratio.  To conclude, our study highlights the notion that drugs specifically designed to inhibit SphK1 could provide a means of enhancing the effects of conventional treatment through the prosurvival antiapoptotic SphK1/S1P pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxORZv-9TsMrVg90H21EOLACvtfcHk0liAlkV2uYytxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCgtLY%253D&md5=80c4217f39039e683331008a3ad54c31</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-2322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-2322%26sid%3Dliteratum%253Aachs%26aulast%3DPchejetski%26aufirst%3DD.%26aulast%3DDoumerc%26aufirst%3DN.%26aulast%3DGolzio%26aufirst%3DM.%26aulast%3DNaymark%26aufirst%3DM.%26aulast%3DTeissie%26aufirst%3DJ.%26aulast%3DKohama%26aufirst%3DT.%26aulast%3DWaxman%26aufirst%3DJ.%26aulast%3DMalavaud%26aufirst%3DB.%26aulast%3DCuvillier%26aufirst%3DO.%26atitle%3DChemosensitizing%2520effects%2520of%2520sphingosine%2520kinase-1%2520inhibition%2520in%2520prostate%2520cancer%2520cell%2520and%2520animal%2520models%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1836%26epage%3D1845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macritchie, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittman, R.</span><span> </span><span class="NLM_article-title">Synthesis of (S)-FTY720 vinylphosphonate analogues and evaluation of their potential as sphingosine kinase 1 inhibitors and activators</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2503</span><span class="NLM_x">–</span> <span class="NLM_lpage">2510</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=2503-2510&author=Z.+Liuauthor=N.+Macritchieauthor=S.+Pyneauthor=N.+J.+Pyneauthor=R.+Bittman&title=Synthesis+of+%28S%29-FTY720+vinylphosphonate+analogues+and+evaluation+of+their+potential+as+sphingosine+kinase+1+inhibitors+and+activators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DMacritchie%26aufirst%3DN.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DBittman%26aufirst%3DR.%26atitle%3DSynthesis%2520of%2520%2528S%2529-FTY720%2520vinylphosphonate%2520analogues%2520and%2520evaluation%2520of%2520their%2520potential%2520as%2520sphingosine%2520kinase%25201%2520inhibitors%2520and%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D2503%26epage%3D2510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Baek, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacRitchie, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittman, R.</span><span> </span><span class="NLM_article-title">Synthesis of selective inhibitors of sphingosine kinase 1</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2136</span><span class="NLM_x">–</span> <span class="NLM_lpage">2138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=2136-2138&author=D.+J.+Baekauthor=N.+MacRitchieauthor=N.+J.+Pyneauthor=S.+Pyneauthor=R.+Bittman&title=Synthesis+of+selective+inhibitors+of+sphingosine+kinase+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaek%26aufirst%3DD.%2BJ.%26aulast%3DMacRitchie%26aufirst%3DN.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DBittman%26aufirst%3DR.%26atitle%3DSynthesis%2520of%2520selective%2520inhibitors%2520of%2520sphingosine%2520kinase%25201%26jtitle%3DChem.%2520Commun.%26date%3D2013%26volume%3D49%26spage%3D2136%26epage%3D2138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Mei, T.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, X.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span> </span><span class="NLM_article-title">Suzuki coupling based synthesis and in vitro cytotoxic evaluation of fingolimod and analogues</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">2927</span><span class="NLM_x">–</span> <span class="NLM_lpage">2932</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=2927-2932&author=T.-W.+Meiauthor=Y.+Luoauthor=X.-J.+Fengauthor=W.+Luauthor=B.+Yang&title=Suzuki+coupling+based+synthesis+and+in+vitro+cytotoxic+evaluation+of+fingolimod+and+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMei%26aufirst%3DT.-W.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFeng%26aufirst%3DX.-J.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DB.%26atitle%3DSuzuki%2520coupling%2520based%2520synthesis%2520and%2520in%2520vitro%2520cytotoxic%2520evaluation%2520of%2520fingolimod%2520and%2520analogues%26jtitle%3DTetrahedron%26date%3D2013%26volume%3D69%26spage%3D2927%26epage%3D2932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">French, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrecengost, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberly, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. D.</span><span> </span><span class="NLM_article-title">Discovery and evaluation of inhibitors of human sphingosine kinase</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">5962</span><span class="NLM_x">–</span> <span class="NLM_lpage">5969</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=14522923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvVSisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=5962-5969&author=K.+J.+Frenchauthor=R.+S.+Schrecengostauthor=B.+D.+Leeauthor=Y.+Zhuangauthor=S.+N.+Smithauthor=J.+L.+Eberlyauthor=J.+K.+Yunauthor=C.+D.+Smith&title=Discovery+and+evaluation+of+inhibitors+of+human+sphingosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Evaluation of Inhibitors of Human Sphingosine Kinase</span></div><div class="casAuthors">French, Kevin J.; Schrecengost, Randy S.; Lee, Brian D.; Zhuang, Yan; Smith, Staci N.; Eberly, Justin L.; Yun, Jong K.; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5962-5969</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Sphingolipid-metabolizing enzymes control the dynamic balance of the cellular levels of bioactive lipids, including the proapoptotic compd. ceramide and the proliferative compd. sphingosine 1-phosphate.  Accumulating evidence indicates that sphingosine kinase (SK) plays a pivotal role in regulating tumor growth and that SK can act as an oncogene.  Despite the importance of SK for cell proliferation, pharmacol. inhibition of SK is an untested means of treating cancer because of the current lack of nonlipid inhibitors of this enzyme.  To further assess the involvement of SK in human tumors, levels of RNA for SK in paired samples of cDNA prepd. from tumors and normal adjacent tissue were analyzed.  Expression of SK RNA was significantly elevated in a variety of solid tumors, compared with normal tissue from the same patient.  To identify and evaluate inhibitors of SK, a medium throughput assay for recombinant human SK fused to glutathione S-transferase was developed, validated, and used to screen a library of synthetic compds.  A no. of novel inhibitors of human SK were identified, and several representative compds. were characterized in detail.  These compds. demonstrated activity at sub- to micromolar concns., making them more potent than any other reported SK inhibitor, and were selective toward SK compared with a panel of human lipid and protein kinases.  Kinetic studies revealed that the compds. were not competitive inhibitors of the ATP-binding site of SK.  The SK inhibitors were antiproliferative toward a panel of tumor cell lines, including lines with the multidrug resistance phenotype because of overexpression of either P-glycoprotein or multidrug resistance phenotype 1, and were shown to inhibit endogenous human SK activity in intact cells.  Furthermore, each inhibitor induced apoptosis concomitant with tumor cell cytotoxicity.  Methods for the synthesis of a series of aurone inhibitors of SK were established, and a prototypical dihydroxyaurone was found to have moderate antitumor activity in vivo in the absence of overt toxicity to the mice.  These compds. are the first examples of nonlipid inhibitors of SK with in vivo antitumor activity and so provide leads for addnl. development of inhibitors of this important mol. target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbSJdFV0GwMLVg90H21EOLACvtfcHk0lhyAZgtSrjrYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvVSisLk%253D&md5=7740d8beec597ce818711a61a4652f85</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrench%26aufirst%3DK.%2BJ.%26aulast%3DSchrecengost%26aufirst%3DR.%2BS.%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DS.%2BN.%26aulast%3DEberly%26aufirst%3DJ.%2BL.%26aulast%3DYun%26aufirst%3DJ.%2BK.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DDiscovery%2520and%2520evaluation%2520of%2520inhibitors%2520of%2520human%2520sphingosine%2520kinase%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D5962%26epage%3D5969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romanow, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meininger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, N.</span><span> </span><span class="NLM_article-title">Molecular basis of sphingosine kinase 1 substrate recognition and catalysis</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">798</span><span class="NLM_x">–</span> <span class="NLM_lpage">809</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2Fj.str.2013.02.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=23602659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Cmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=798-809&author=Z.+Wangauthor=X.+Minauthor=S.+H.+Xiaoauthor=S.+Johnstoneauthor=W.+Romanowauthor=D.+Meiningerauthor=H.+Xuauthor=J.+Liuauthor=J.+Daiauthor=S.+Anauthor=S.+Thibaultauthor=N.+Walker&title=Molecular+basis+of+sphingosine+kinase+1+substrate+recognition+and+catalysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Basis of Sphingosine Kinase 1 Substrate Recognition and Catalysis</span></div><div class="casAuthors">Wang, Zhulun; Min, Xiaoshan; Xiao, Shou-Hua; Johnstone, Sheree; Romanow, William; Meininger, David; Xu, Haoda; Liu, Jinsong; Dai, Jessica; An, Songzhu; Thibault, Stephen; Walker, Nigel</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">798-809</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Sphingosine kinase 1 (SphK1) is a lipid kinase that catalyzes the conversion of sphingosine to sphingosine-1-phosphate (S1P), which has been shown to play a role in lymphocyte trafficking, angiogenesis, and response to apoptotic stimuli.  As a central enzyme in modulating the S1P levels in cells, SphK1 emerges as an important regulator for diverse cellular functions and a potential target for drug discovery.  Here, the authors present the crystal structures of human SphK1 in the apo form and in complexes with a substrate sphingosine-like lipid, ADP, and an inhibitor at 2.0-2.3 Å resoln.  The SphK1 structures reveal a two-domain architecture in which its catalytic site is located in the cleft between the two domains and a hydrophobic lipid-binding pocket is buried in the C-terminal domain.  Comparative anal. of these structures with mutagenesis and kinetic studies provides insight into how SphK1 recognizes the lipid substrate and catalyzes ATP-dependent phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGhuSYFEdxbrVg90H21EOLACvtfcHk0lhyAZgtSrjrYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Cmsr8%253D&md5=61b387e356ae18e0420be5e543f2187e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2013.02.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2013.02.025%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DXiao%26aufirst%3DS.%2BH.%26aulast%3DJohnstone%26aufirst%3DS.%26aulast%3DRomanow%26aufirst%3DW.%26aulast%3DMeininger%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DAn%26aufirst%3DS.%26aulast%3DThibault%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DN.%26atitle%3DMolecular%2520basis%2520of%2520sphingosine%2520kinase%25201%2520substrate%2520recognition%2520and%2520catalysis%26jtitle%3DStructure%26date%3D2013%26volume%3D21%26spage%3D798%26epage%3D809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Selvam, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogretmen, B.</span><span> </span><span class="NLM_article-title">Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">216</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1007%2F978-3-7091-1511-4_1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=23563649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKls73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=2013&pages=3-27&author=S.+P.+Selvamauthor=B.+Ogretmen&title=Sphingosine+kinase%2Fsphingosine+1-phosphate+signaling+in+cancer+therapeutics+and+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance</span></div><div class="casAuthors">Selvam, Shanmugam Panneer; Ogretmen, Besim</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">216</span>
        (<span class="NLM_cas:issue">Sphingolipids in Disease</span>),
    <span class="NLM_cas:pages">3-27</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  In this chapter, roles of bioactive sphingolipids, specifically sphingosine kinase 1 (SK1) and 2 (SK2) and their product-sphingosine 1-phosphate (S1P)-will be reviewed with respect to regulation of cancer growth, metastasis, chemotherapeutics, and drug resistance.  Sphingolipids are known to be key bioeffector mols. that regulate cancer proliferation, angiogenesis, and cell death.  Sphingolipid mols. such as ceramide and S1P have been shown to control cancer cell death and proliferation, resp.  Roles of S1P have been described with respect to their intracellular and extracellular pro-survival and drug resistance functions mostly through S1P receptor (S1PR1-5) engagement.  Identification of novel intracellular SK/S1P targets has broadened the existing complex regulatory roles of bioactive sphingolipids in cancer pathogenesis and therapeutics.  Thus, deciphering the biochem. and mol. regulation of SK/S1P/S1PR signaling could permit development of novel therapeutic interventions to improve cancer therapy and/or overcome drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDlCQuZSOmH7Vg90H21EOLACvtfcHk0lhyAZgtSrjrYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKls73L&md5=63b61d0ab607548f512e9157336611b1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2F978-3-7091-1511-4_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-7091-1511-4_1%26sid%3Dliteratum%253Aachs%26aulast%3DSelvam%26aufirst%3DS.%2BP.%26aulast%3DOgretmen%26aufirst%3DB.%26atitle%3DSphingosine%2520kinase%252Fsphingosine%25201-phosphate%2520signaling%2520in%2520cancer%2520therapeutics%2520and%2520drug%2520resistance%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2013%26volume%3D216%26spage%3D3%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Hannun, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeid, L. M.</span><span> </span><span class="NLM_article-title">Principles of bioactive lipid signalling: lessons from sphingolipids</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1038%2Fnrm2329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=18216770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFOntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=139-150&author=Y.+A.+Hannunauthor=L.+M.+Obeid&title=Principles+of+bioactive+lipid+signalling%3A+lessons+from+sphingolipids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Principles of bioactive lipid signalling: lessons from sphingolipids</span></div><div class="casAuthors">Hannun, Yusuf A.; Obeid, Lina M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-150</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  It has become increasingly difficult to find an area of cell biol. in which lipids do not have important, if not key, roles as signaling and regulatory mols.  The rapidly expanding field of bioactive lipids is exemplified by many sphingolipids, such as ceramide, sphingosine, sphingosine-1-phosphate (S1P), ceramide-1-phosphate, and lyso-sphingomyelin, which have roles in the regulation of cell growth, death, senescence, adhesion, migration, inflammation, angiogenesis, and intracellular trafficking.  Deciphering the mechanisms of these varied cell functions necessitates an understanding of the complex pathways of sphingolipid metab. and the mechanisms that regulate lipid generation and lipid action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrJi0iM1f277Vg90H21EOLACvtfcHk0ljCE-XcEULc0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFOntg%253D%253D&md5=0bee4e560d083ef4c43f7d0b591a0997</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnrm2329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2329%26sid%3Dliteratum%253Aachs%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26atitle%3DPrinciples%2520of%2520bioactive%2520lipid%2520signalling%253A%2520lessons%2520from%2520sphingolipids%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2008%26volume%3D9%26spage%3D139%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Morad, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabot, M. C.</span><span> </span><span class="NLM_article-title">Ceramide-orchestrated signalling in cancer cells</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1038%2Fnrc3398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=23235911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVais7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=51-65&author=S.+A.+Moradauthor=M.+C.+Cabot&title=Ceramide-orchestrated+signalling+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide-orchestrated signalling in cancer cells</span></div><div class="casAuthors">Morad, Samy A. F.; Cabot, Myles C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-65</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  One crucial barrier to progress in the treatment of cancer has been the inability to control the balance between cell proliferation and apoptosis: enter ceramide.  Discoveries over the past 15 years have elevated this sphingolipid to the lofty position of a regulator of cell fate.  Ceramide, it turns out, is a powerful tumor suppressor, potentiating signalling events that drive apoptosis, autophagic responses and cell cycle arrest.  However, defects in ceramide generation and metab. in cancer cells contribute to tumor cell survival and resistance to chemotherapy.  This Review focuses on ceramide signalling and the targeting of specific metabolic junctures to amplify the tumor suppressive activities of ceramide.  The potential of ceramide-based therapeutics in the treatment of cancer is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo76pxQVHiNu7Vg90H21EOLACvtfcHk0ljCE-XcEULc0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVais7vL&md5=ad6eb1da2465b3db6298e747bd7d3f58</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnrc3398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3398%26sid%3Dliteratum%253Aachs%26aulast%3DMorad%26aufirst%3DS.%2BA.%26aulast%3DCabot%26aufirst%3DM.%2BC.%26atitle%3DCeramide-orchestrated%2520signalling%2520in%2520cancer%2520cells%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2013%26volume%3D13%26spage%3D51%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Orr Gandy, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeid, L. M.</span><span> </span><span class="NLM_article-title">Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2013&pages=157-166&author=K.+A.+Orr+Gandyauthor=L.+M.+Obeid&title=Targeting+the+sphingosine+kinase%2Fsphingosine+1-phosphate+pathway+in+disease%3A+review+of+sphingosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrr%2BGandy%26aufirst%3DK.%2BA.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26atitle%3DTargeting%2520the%2520sphingosine%2520kinase%252Fsphingosine%25201-phosphate%2520pathway%2520in%2520disease%253A%2520review%2520of%2520sphingosine%2520kinase%2520inhibitors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2013%26volume%3D1%26spage%3D157%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Chalfant, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">4605</span><span class="NLM_x">–</span> <span class="NLM_lpage">4612</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1242%2Fjcs.02637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=16219683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1CnurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2005&pages=4605-4612&author=C.+E.+Chalfantauthor=S.+Spiegel&title=Sphingosine+1-phosphate+and+ceramide+1-phosphate%3A+expanding+roles+in+cell+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling</span></div><div class="casAuthors">Chalfant, Charles E.; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4605-4612</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  The phosphorylated sphingolipid metabolites sphingosine 1-phosphate (S1P) and ceramide 1-phosphate (C1P) have emerged as potent bioactive agents.  Recent studies have begun to define new biol. functions for these lipids.  Generated by sphingosine kinases and ceramide kinase, they control numerous aspects of cell physiol., including cell survival and mammalian inflammatory responses.  Interestingly, S1P is involved in cyclooxygenase-2 induction and C1P is required for the activation and translocation of cPLA2.  This suggests that these two sphingolipid metabolites may act in concert to regulate prodn. of eicosanoids, important inflammatory mediators.  Whereas S1P functions mainly via G-protein-coupled receptors, C1P appears to bind directly to targets such as cPLA2 and protein phosphatase 1/2A.  S1P probably also has intracellular targets, and in plants it appears to directly regulate the G protein α subunit GPA1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQGTlv0qGkXLVg90H21EOLACvtfcHk0ljCE-XcEULc0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1CnurzP&md5=423d9f0836f031e20c92d3fd654f16ab</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1242%2Fjcs.02637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.02637%26sid%3Dliteratum%253Aachs%26aulast%3DChalfant%26aufirst%3DC.%2BE.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine%25201-phosphate%2520and%2520ceramide%25201-phosphate%253A%2520expanding%2520roles%2520in%2520cell%2520signaling%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2005%26volume%3D118%26spage%3D4605%26epage%3D4612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Cuvillier, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirianov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleuser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanek, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coso, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutkind, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">381</span><span class="NLM_x">, </span> <span class="NLM_fpage">800</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1038%2F381800a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=8657285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADyaK28XjvVKnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=1996&pages=800-803&author=O.+Cuvillierauthor=G.+Pirianovauthor=B.+Kleuserauthor=P.+G.+Vanekauthor=O.+A.+Cosoauthor=S.+Gutkindauthor=S.+Spiegel&title=Suppression+of+ceramide-mediated+programmed+cell+death+by+sphingosine-1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate</span></div><div class="casAuthors">Cuvillier, Olivier; Pirianov, Grisha; Kleuser, Burkhard; Vanek, Philip G.; Coso, Omar A.; Gutkind, J. Silvio; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">381</span>
        (<span class="NLM_cas:issue">6585</span>),
    <span class="NLM_cas:pages">800-803</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Ceramide is an important regulatory participant of programmed cell death (apoptosis) induced by tumor-necrosis factor (TMF)-α and Fas ligand, members of the TNF superfamily.  Conversely, sphingosine and sphingosine-1-phosphate, which are metabolites of ceramide, induce mitogenesis and have been implicated as second messengers in cellular proliferation induced by platelet-derived growth factor and serum.  Here we report that sphingosine-1-phosphate prevents the appearance of the key features of apoptosis, namely intranucleosomal DNA fragmentation and morphol. changes, which result from increased concns. of ceramide.  Furthermore, inhibition of ceramide-mediated apoptosis by activation of protein kinase C results from stimulation of sphingosine kinase and the concomitant increase in intracellular sphingosine-1-phosphate.  Finally sphingosine-1-phosphate not only stimulates the extracellular signal-regulated kinase (ERK) pathway, it counteracts the ceramide-induced activation of stress-activated protein kinase of ceramide and sphingosine-1-phosphate and their regulatory effects on different family members of mitogen-activated protein kinases dets. the fate of the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3xEuzICMjarVg90H21EOLACvtfcHk0ljCE-XcEULc0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvVKnsro%253D&md5=50d91e59dc03600594fd0a236ecc2838</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2F381800a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F381800a0%26sid%3Dliteratum%253Aachs%26aulast%3DCuvillier%26aufirst%3DO.%26aulast%3DPirianov%26aufirst%3DG.%26aulast%3DKleuser%26aufirst%3DB.%26aulast%3DVanek%26aufirst%3DP.%2BG.%26aulast%3DCoso%26aufirst%3DO.%2BA.%26aulast%3DGutkind%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSuppression%2520of%2520ceramide-mediated%2520programmed%2520cell%2520death%2520by%2520sphingosine-1-phosphate%26jtitle%3DNature%26date%3D1996%26volume%3D381%26spage%3D800%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Ponnusamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers-Needham, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senkal, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saddoughi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentelle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selvam, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogretmen, B.</span><span> </span><span class="NLM_article-title">Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance</span> <span class="citation_source-journal">Future Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1603</span><span class="NLM_x">–</span> <span class="NLM_lpage">1624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.2217%2Ffon.10.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=21062159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2rsbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=1603-1624&author=S.+Ponnusamyauthor=M.+Meyers-Needhamauthor=C.+E.+Senkalauthor=S.+A.+Saddoughiauthor=D.+Sentelleauthor=S.+P.+Selvamauthor=A.+Salasauthor=B.+Ogretmen&title=Sphingolipids+and+cancer%3A+ceramide+and+sphingosine-1-phosphate+in+the+regulation+of+cell+death+and+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance</span></div><div class="casAuthors">Ponnusamy, Suriyan; Meyers-Needham, Marisa; Senkal, Can E.; Saddoughi, Sahar A.; Sentelle, David; Selvam, Shanmugam Panneer; Salas, Arelis; Ogretmen, Besim</div><div class="citationInfo"><span class="NLM_cas:title">Future Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1603-1624</span>CODEN:
                <span class="NLM_cas:coden">FOUNBN</span>;
        ISSN:<span class="NLM_cas:issn">1479-6694</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids have emerged as bioeffector mols., controlling various aspects of cell growth and proliferation in cancer, which is becoming the deadliest disease in the world.  These lipid mols. have also been implicated in the mechanism of action of cancer chemotherapeutics.  Ceramide, the central mol. of sphingolipid metab., generally mediates antiproliferative responses, such as cell growth inhibition, apoptosis induction, senescence modulation, endoplasmic reticulum stress responses and/or autophagy.  Interestingly, recent studies suggest de novo-generated ceramides may have distinct and opposing roles in the promotion/suppression of tumors, and that these activities are based on their fatty acid chain lengths, subcellular localization and/or direct downstream targets.  For example, in head and neck cancer cells, ceramide synthase 6/C16-ceramide addiction was revealed, and this was assocd. with increased tumor growth, whereas downregulation of its synthesis resulted in ER stress-induced apoptosis.  By contrast, ceramide synthase 1-generated C18-ceramide has been shown to suppress tumor growth in various cancer models, both in situ and in vivo.  In addn., ceramide metab. to generate sphingosine-1-phosphate (S1P) by sphingosine kinases 1 and 2 mediates, with or without the involvement of G-protein-coupled S1P receptor signaling, prosurvival, angiogenesis, metastasis and/or resistance to drug-induced apoptosis.  Importantly, recent findings regarding the mechanisms by which sphingolipid metab. and signaling regulate tumor growth and progression, such as identifying direct intracellular protein targets of sphingolipids, have been key for the development of new chemotherapeutic strategies.  Thus, in this article, we will present conclusions of recent studies that describe opposing roles of de novo-generated ceramides by ceramide synthases and/or S1P in the regulation of cancer pathogenesis, as well as the development of sphingolipid-based cancer therapeutics and drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo16aaSjjevSLVg90H21EOLACvtfcHk0lgg9Hn_6xlfTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2rsbjJ&md5=8f65136dd6ed29f852181b7140ddde6f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2217%2Ffon.10.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffon.10.116%26sid%3Dliteratum%253Aachs%26aulast%3DPonnusamy%26aufirst%3DS.%26aulast%3DMeyers-Needham%26aufirst%3DM.%26aulast%3DSenkal%26aufirst%3DC.%2BE.%26aulast%3DSaddoughi%26aufirst%3DS.%2BA.%26aulast%3DSentelle%26aufirst%3DD.%26aulast%3DSelvam%26aufirst%3DS.%2BP.%26aulast%3DSalas%26aufirst%3DA.%26aulast%3DOgretmen%26aufirst%3DB.%26atitle%3DSphingolipids%2520and%2520cancer%253A%2520ceramide%2520and%2520sphingosine-1-phosphate%2520in%2520the%2520regulation%2520of%2520cell%2520death%2520and%2520drug%2520resistance%26jtitle%3DFuture%2520Oncol.%26date%3D2010%26volume%3D6%26spage%3D1603%26epage%3D1624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Johnson, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crellin, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogretmen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boylan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harley, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeid, L. M.</span><span> </span><span class="NLM_article-title">Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue</span> <span class="citation_source-journal">J. Histochem. Cytochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1159</span><span class="NLM_x">–</span> <span class="NLM_lpage">1166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1369%2Fjhc.4A6606.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=15923363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVersbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2005&pages=1159-1166&author=K.+R.+Johnsonauthor=K.+Y.+Johnsonauthor=H.+G.+Crellinauthor=B.+Ogretmenauthor=A.+M.+Boylanauthor=R.+A.+Harleyauthor=L.+M.+Obeid&title=Immunohistochemical+distribution+of+sphingosine+kinase+1+in+normal+and+tumor+lung+tissue"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue</span></div><div class="casAuthors">Johnson, Korey R.; Johnson, Kristy Y.; Crellin, Heather G.; Ogretmen, Besim; Boylan, Alice M.; Harley, Russell A.; Obeid, Lina M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1159-1166</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">Sphingosine kinase 1 (SK1) is a key enzyme crit. to the sphingolipid metabolic pathway responsible for catalyzing the formation of the bioactive lipid sphingosine-1-phosphate.  SK1-mediated prodn. of sphingosine-1-phosphate has been shown to stimulate such biol. processes as cell growth, differentiation, migration, angiogenesis, and inhibition of apoptosis.  In this study, cell type-specific immunolocalization of SK1 was examd. in the bronchus/terminal bronchiole of the lung.  Strong immunopos. staining was evident at the apical surface of pseudostratified epithelial cells of the bronchus and underlying smooth muscle cells, submucosal serous glands, immature chondrocytes, type II alveolar cells, foamy macrophages, endothelial cells of blood vessels, and neural bundles.  Immunohistochem. screening for SK1 expression was performed in 25 samples of normal/tumor patient matched non-small-cell lung cancer tissue and found that 25 of 25 tumor samples (carcinoid [5 samples], squamous [10 samples], and adenocarcinoma tumors [10 samples]), exhibited overwhelmingly pos. immunostaining for SK1 as compared with patient-matched normal tissue.  In addn., an approx. 2-fold elevation of SK1 mRNA expression was obsd. in lung cancer tissue vs. normal tissue, as well as in several other solid tumors.  Taken together, these findings define the localization of SK1 in lung and provide clues as to how SK1 may play a role in normal lung physiol. and the pathophysiol. of lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc9RJ87kecebVg90H21EOLACvtfcHk0lgg9Hn_6xlfTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVersbrP&md5=4b68bb0bcd702b0f2e87cd49dd38fe9f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1369%2Fjhc.4A6606.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1369%252Fjhc.4A6606.2005%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DK.%2BR.%26aulast%3DJohnson%26aufirst%3DK.%2BY.%26aulast%3DCrellin%26aufirst%3DH.%2BG.%26aulast%3DOgretmen%26aufirst%3DB.%26aulast%3DBoylan%26aufirst%3DA.%2BM.%26aulast%3DHarley%26aufirst%3DR.%2BA.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26atitle%3DImmunohistochemical%2520distribution%2520of%2520sphingosine%2520kinase%25201%2520in%2520normal%2520and%2520tumor%2520lung%2520tissue%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2005%26volume%3D53%26spage%3D1159%26epage%3D1166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Kharel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellett, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomsig, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2011&pages=345-353&author=Y.+Kharelauthor=T.+P.+Mathewsauthor=A.+M.+Gellettauthor=J.+L.+Tomsigauthor=P.+C.+Kennedyauthor=M.+L.+Moyerauthor=T.+L.+Macdonaldauthor=K.+R.+Lynch&title=Sphingosine+kinase+type+1+inhibition+reveals+rapid+turnover+of+circulating+sphingosine+1-phosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DMathews%26aufirst%3DT.%2BP.%26aulast%3DGellett%26aufirst%3DA.%2BM.%26aulast%3DTomsig%26aufirst%3DJ.%2BL.%26aulast%3DKennedy%26aufirst%3DP.%2BC.%26aulast%3DMoyer%26aufirst%3DM.%2BL.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DSphingosine%2520kinase%2520type%25201%2520inhibition%2520reveals%2520rapid%2520turnover%2520of%2520circulating%2520sphingosine%25201-phosphate%26jtitle%3DBiochem.%2520J.%26date%3D2011%26volume%3D440%26spage%3D345%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Schnute, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McReynolds, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasten, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerome, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rains, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrencik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronin, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saabye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Highkin, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cukyne, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawadzke, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterkin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyanar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholten, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemirovskiy, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittwer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagiec, M. M.</span><span> </span><span class="NLM_article-title">Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">444</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1042%2FBJ20111929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=22397330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Kltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2012&pages=79-88&author=M.+E.+Schnuteauthor=M.+D.+McReynoldsauthor=T.+Kastenauthor=M.+Yatesauthor=G.+Jeromeauthor=J.+W.+Rainsauthor=T.+Hallauthor=J.+Chrencikauthor=M.+Krausauthor=C.+N.+Croninauthor=M.+Saabyeauthor=M.+K.+Highkinauthor=R.+Broadusauthor=S.+Ogawaauthor=K.+Cukyneauthor=L.+E.+Zawadzkeauthor=V.+Peterkinauthor=K.+Iyanarauthor=J.+A.+Scholtenauthor=J.+Wendlingauthor=H.+Fujiwaraauthor=O.+Nemirovskiyauthor=A.+J.+Wittwerauthor=M.+M.+Nagiec&title=Modulation+of+cellular+S1P+levels+with+a+novel%2C+potent+and+specific+inhibitor+of+sphingosine+kinase-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1</span></div><div class="casAuthors">Schnute, Mark E.; McReynolds, Matthew D.; Kasten, Tom; Yates, Matthew; Jerome, Gina; Rains, John W.; Hall, Troii; Chrencik, Jill; Kraus, Michelle; Cronin, Ciaran N.; Saabye, Matthew; Highkin, Maureen K.; Broadus, Richard; Ogawa, Shinji; Cukyne, Kristin; Zawadzke, Laura E.; Peterkin, Vincent; Iyanar, Kaliapan; Scholten, Jeffrey A.; Wendling, Jay; Fujiwara, Hideji; Nemirovskiy, Olga; Wittwer, Arthur J.; Nagiec, Marek M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">444</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-88</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">SphK (sphingosine kinase) is the major source of the bioactive lipid and GPCR (G-protein-coupled receptor) agonist S1P (sphingosine 1-phosphate).  S1P promotes cell growth, survival and migration, and is a key regulator of lymphocyte trafficking.  Inhibition of S1P signalling has been proposed as a strategy for treatment of inflammatory diseases and cancer.  In the present paper we describe the discovery and characterization of PF-543, a novel cell-permeant inhibitor of SphK1.  PF-543 inhibits SphK1 with a Ki of 3.6 nM, is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform.  In 1483 head and neck carcinoma cells, which are characterized by high levels of SphK1 expression and an unusually high rate of S1P prodn., PF-543 decreased the level of endogenous S1P 10-fold with a proportional increase in the level of sphingosine.  In contrast with past reports that show that the growth of many cancer cell lines is SphK1-dependent, specific inhibition of SphK1 had no effect on the proliferation and survival of 1483 cells, despite a dramatic change in the cellular S1P/sphingosine ratio.  PF-543 was effective as a potent inhibitor of S1P formation in whole blood, indicating that the SphK1 isoform of sphingosine kinase is the major source of S1P in human blood.  PF-543 is the most potent inhibitor of SphK1 described to date and it will be useful for dissecting specific roles of SphK1-driven S1P signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrenMsEAHJOo7Vg90H21EOLACvtfcHk0li6jb3Ac8FD2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Kltrw%253D&md5=7615a3b0e28e4f798e30bf27998dbad0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1042%2FBJ20111929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20111929%26sid%3Dliteratum%253Aachs%26aulast%3DSchnute%26aufirst%3DM.%2BE.%26aulast%3DMcReynolds%26aufirst%3DM.%2BD.%26aulast%3DKasten%26aufirst%3DT.%26aulast%3DYates%26aufirst%3DM.%26aulast%3DJerome%26aufirst%3DG.%26aulast%3DRains%26aufirst%3DJ.%2BW.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DChrencik%26aufirst%3DJ.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DCronin%26aufirst%3DC.%2BN.%26aulast%3DSaabye%26aufirst%3DM.%26aulast%3DHighkin%26aufirst%3DM.%2BK.%26aulast%3DBroadus%26aufirst%3DR.%26aulast%3DOgawa%26aufirst%3DS.%26aulast%3DCukyne%26aufirst%3DK.%26aulast%3DZawadzke%26aufirst%3DL.%2BE.%26aulast%3DPeterkin%26aufirst%3DV.%26aulast%3DIyanar%26aufirst%3DK.%26aulast%3DScholten%26aufirst%3DJ.%2BA.%26aulast%3DWendling%26aufirst%3DJ.%26aulast%3DFujiwara%26aufirst%3DH.%26aulast%3DNemirovskiy%26aufirst%3DO.%26aulast%3DWittwer%26aufirst%3DA.%2BJ.%26aulast%3DNagiec%26aufirst%3DM.%2BM.%26atitle%3DModulation%2520of%2520cellular%2520S1P%2520levels%2520with%2520a%2520novel%252C%2520potent%2520and%2520specific%2520inhibitor%2520of%2520sphingosine%2520kinase-1%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D444%26spage%3D79%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Buehrer, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, R. M.</span><span> </span><span class="NLM_article-title">Inhibition of sphingosine kinase in vitro and in platelets. Implications for signal transduction pathways</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">3154</span><span class="NLM_x">–</span> <span class="NLM_lpage">3159</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=3154-3159&author=B.+M.+Buehrerauthor=R.+M.+Bell&title=Inhibition+of+sphingosine+kinase+in+vitro+and+in+platelets.+Implications+for+signal+transduction+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuehrer%26aufirst%3DB.%2BM.%26aulast%3DBell%26aufirst%3DR.%2BM.%26atitle%3DInhibition%2520of%2520sphingosine%2520kinase%2520in%2520vitro%2520and%2520in%2520platelets.%2520Implications%2520for%2520signal%2520transduction%2520pathways%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D3154%26epage%3D3159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Hamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakazawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yura, Y.</span><span> </span><span class="NLM_article-title">Induction of endonuclease G-mediated apopotosis in human oral squamous cell carcinoma cells by protein kinase C inhibitor safingol</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=47-56&author=M.+Hamadaauthor=T.+Sumiauthor=S.+Iwaiauthor=M.+Nakazawaauthor=Y.+Yura&title=Induction+of+endonuclease+G-mediated+apopotosis+in+human+oral+squamous+cell+carcinoma+cells+by+protein+kinase+C+inhibitor+safingol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHamada%26aufirst%3DM.%26aulast%3DSumi%26aufirst%3DT.%26aulast%3DIwai%26aufirst%3DS.%26aulast%3DNakazawa%26aufirst%3DM.%26aulast%3DYura%26aufirst%3DY.%26atitle%3DInduction%2520of%2520endonuclease%2520G-mediated%2520apopotosis%2520in%2520human%2520oral%2520squamous%2520cell%2520carcinoma%2520cells%2520by%2520protein%2520kinase%2520C%2520inhibitor%2520safingol%26jtitle%3DApoptosis%26date%3D2006%26volume%3D11%26spage%3D47%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Coward, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrosini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truman, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haimovitz-Friedman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegood, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrill, A. H.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span> </span><span class="NLM_article-title">Safingol (<span class="smallcaps smallerCapital">l</span>-threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=184-193&author=J.+Cowardauthor=G.+Ambrosiniauthor=E.+Musiauthor=J.+P.+Trumanauthor=A.+Haimovitz-Friedmanauthor=J.+C.+Allegoodauthor=E.+Wangauthor=A.+H.+Merrillauthor=G.+K.+Schwartz&title=Safingol+%28l-threo-sphinganine%29+induces+autophagy+in+solid+tumor+cells+through+inhibition+of+PKC+and+the+PI3-kinase+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoward%26aufirst%3DJ.%26aulast%3DAmbrosini%26aufirst%3DG.%26aulast%3DMusi%26aufirst%3DE.%26aulast%3DTruman%26aufirst%3DJ.%2BP.%26aulast%3DHaimovitz-Friedman%26aufirst%3DA.%26aulast%3DAllegood%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26atitle%3DSafingol%2520%2528l-threo-sphinganine%2529%2520induces%2520autophagy%2520in%2520solid%2520tumor%2520cells%2520through%2520inhibition%2520of%2520PKC%2520and%2520the%2520PI3-kinase%2520pathway%26jtitle%3DAutophagy%26date%3D2009%26volume%3D5%26spage%3D184%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Ling, L. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, G. N.</span><span> </span><span class="NLM_article-title">The role of reactive oxygen species and autophagy in safingol-induced cell death</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">e129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1038%2Fcddis.2011.12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=21390063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFeis74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=e129&author=L.+U.+Lingauthor=K.+B.+Tanauthor=H.+Linauthor=G.+N.+Chiu&title=The+role+of+reactive+oxygen+species+and+autophagy+in+safingol-induced+cell+death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The role of reactive oxygen species and autophagy in safingol-induced cell death</span></div><div class="casAuthors">Ling, L.-U.; Tan, K.-B.; Lin, H.; Chiu, G. N. C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">March</span>),
    <span class="NLM_cas:pages">e129/1-e129/12</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Safingol is a sphingolipid with promising anticancer potential, which is currently in phase I clin. trial.  Yet, the underlying mechanisms of its action remain largely unknown.  We reported here that safingol-induced primarily accidental necrotic cell death in MDA-MB-231 and HT-29 cells, as shown by the increase in the percentage of cells stained pos. for 7-aminoactinomycin D, collapse of mitochondria membrane potential and depletion of intracellular ATP.  Importantly, safingol treatment produced time- and concn.-dependent reactive oxygen species (ROS) generation.  Autophagy was triggered following safingol treatment, as reflected by the formation of autophagosomes, acidic vacuoles, increased light chain 3-II and Atg biomarkers expression.  Interestingly, scavenging ROS with N-acetyl-L-cysteine could prevent the autophagic features and reverse safingol-induced necrosis.  Our data also suggested that autophagy was a cell repair mechanism, as suppression of autophagy by 3-methyladenine or bafilomycin A1 significantly augmented cell death on 2-5 μM safingol treatment.  In addn., Bcl-xL and Bax might be involved in the regulation of safingol-induced autophagy.  Finally, glucose uptake was shown to be inhibited by safingol treatment, which was assocd. with an increase in p-AMPK expression.  Taken together, our data suggested that ROS was the mediator of safingol-induced cancer cell death, and autophagy is likely to be a mechanism triggered to repair damages from ROS generation on safingol treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnXFKfBZe5NbVg90H21EOLACvtfcHk0li6jb3Ac8FD2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFeis74%253D&md5=8c2777ffe9de16f269e756300acf8d66</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2011.12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2011.12%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DL.%2BU.%26aulast%3DTan%26aufirst%3DK.%2BB.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DChiu%26aufirst%3DG.%2BN.%26atitle%3DThe%2520role%2520of%2520reactive%2520oxygen%2520species%2520and%2520autophagy%2520in%2520safingol-induced%2520cell%2520death%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2011%26volume%3D2%26spage%3De129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Schwartz, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casper, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodworth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venuti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zervos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storniolo, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelsen, D. P.</span><span> </span><span class="NLM_article-title">A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">543</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=9815717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADyaK2sXislGitLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=537-543&author=G.+K.+Schwartzauthor=D.+Wardauthor=L.+Saltzauthor=E.+S.+Casperauthor=T.+Spiessauthor=E.+Mullenauthor=J.+Woodworthauthor=R.+Venutiauthor=P.+Zervosauthor=A.+M.+Stornioloauthor=D.+P.+Kelsen&title=A+pilot+clinical%2Fpharmacological+study+of+the+protein+kinase+C-specific+inhibitor+safingol+alone+and+in+combination+with+doxorubicin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin</span></div><div class="casAuthors">Schwartz, Gary K.; Ward, David; Saltz, Leonard; Casper, Ephraim S.; Spiess, Tara; Mullen, Eillen; Woodworth, Jim; Venuti, Robert; Zervos, Peter; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">537-543</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We performed a pilot clin. trial with safingol (L-threo-dihydrosphingosine), a protein kinase C-specific inhibitor that potentiates the effect of doxorubicin (DOX) in tumor-bearing animals.  Safingol was initially administered as a 1-h infusion at escalating doses.  Fourteen days later, patients received the same dose of safingol in combination with a fixed dose of DOX.  The combination was repeated at 3-wk intervals.  Safingol dose levels ranged from 15 to 120 mg/m2.  The plasma levels achieved at the final dose level were comparable to those assocd. with potentiation of DOX in animals.  The mean Cmax and area under the curve for safingol at the 120 mg/m2 dose level were 1040 ± 196 ng/mL and 1251 ± 317 mg × h/mL, resp.  The mean plasma half-life for safingol was 3.97 ± 2.51 h, the mean estd. clearance was 3140 ± 765 mL/min, and the mean vol. of distribution was of 995 ± 421 L.  Coadministration of a fixed dose of DOX did not significantly change the pharmacokinetics of safingol, nor did increasing doses of safingol significantly affect the pharmacokinetics of DOX.  Minor responses were obsd. in three patients with pancreatic cancer and one patient with angiosarcoma of the scalp.  This pilot Phase I study indicates that the protein kinase C inhibitor safingol can be given safely with 45 mg/m2 of DOX at a dose that is potentially pharmacol. active without dose-limiting toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpZj2Ku7dLqrVg90H21EOLACvtfcHk0li5k7VtznrTBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXislGitLc%253D&md5=dab6b7b4e13b06881a87f6b4a733f148</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26aulast%3DWard%26aufirst%3DD.%26aulast%3DSaltz%26aufirst%3DL.%26aulast%3DCasper%26aufirst%3DE.%2BS.%26aulast%3DSpiess%26aufirst%3DT.%26aulast%3DMullen%26aufirst%3DE.%26aulast%3DWoodworth%26aufirst%3DJ.%26aulast%3DVenuti%26aufirst%3DR.%26aulast%3DZervos%26aufirst%3DP.%26aulast%3DStorniolo%26aufirst%3DA.%2BM.%26aulast%3DKelsen%26aufirst%3DD.%2BP.%26atitle%3DA%2520pilot%2520clinical%252Fpharmacological%2520study%2520of%2520the%2520protein%2520kinase%2520C-specific%2520inhibitor%2520safingol%2520alone%2520and%2520in%2520combination%2520with%2520doxorubicin%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1997%26volume%3D3%26spage%3D537%26epage%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Ling, L. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, G. N.</span><span> </span><span class="NLM_article-title">The role of protein kinase C in the synergistic interaction of safingol and irinotecan in colon cancer cells</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1463</span><span class="NLM_x">–</span> <span class="NLM_lpage">1471</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=19885570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWksrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2009&pages=1463-1471&author=L.+U.+Lingauthor=H.+Linauthor=K.+B.+Tanauthor=G.+N.+Chiu&title=The+role+of+protein+kinase+C+in+the+synergistic+interaction+of+safingol+and+irinotecan+in+colon+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The role of protein kinase C in the synergistic interaction of safingol and irinotecan in colon cancer cells</span></div><div class="casAuthors">Ling, Leong-Uung; Lin, Huimin; Tan, Kuan-Boone; Chiu, Gigi N. C.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1463-1471</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Colon cancer represents one of the most common solid tumors in adults.  Although 5-fluorouracil (5-FU) and irinotecan have been frequently administered in colon cancer patients, low response rates to these single drug therapies were reported.  It is therefore imperative to search for new targeted combination therapies that are effective.  In this study, we investigated the anti-cancer effect of safingol as a single agent or in combination with irinotecan using HT-29 and LS-174T colon cancer cells as our in vitro models.  As a single agent, safingol was more potent than irinotecan and 5-FU, with IC50 values of 2.5±1.1 μM and 3.4±1.0 μM achieved in HT-29 and LS-174T cells, resp.  However, protein kinase C (PKC) was not inhibited with concns. of safingol which could induce substantial cell kill.  The combination of safingol/irinotecan at 1:1 molar ratio was found to be additive in HT-29 cells (CI=0.94) and synergistic in LS-174T cells (CI=0.68), and resulted in concn.- and time-dependent down-regulation of p-PKC and p-MARCKS.  The drug effect of the safingol/irinotecan combination was further modulated in the presence of a PKC stimulator (phorbol 12-myristate 13-acetate) or a PKC inhibitor (staurosporine).  Furthermore, the 1:1 safingol/irinotecan combination inhibited the adhesion of colon cancer cells to the extracellular matrix 4-h post-treatment.  Taken together, modulation of the PKC pathway could be a possible mol. basis for the obsd. synergism of the safingol/irinotecan combination, and these results demonstrate the therapeutic potential of this drug combination in colon cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Xiev9mnD77Vg90H21EOLACvtfcHk0li5k7VtznrTBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWksrjI&md5=6a23c5f461d5e64ed5a19157013c7f49</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DL.%2BU.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DK.%2BB.%26aulast%3DChiu%26aufirst%3DG.%2BN.%26atitle%3DThe%2520role%2520of%2520protein%2520kinase%2520C%2520in%2520the%2520synergistic%2520interaction%2520of%2520safingol%2520and%2520irinotecan%2520in%2520colon%2520cancer%2520cells%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2009%26volume%3D35%26spage%3D1463%26epage%3D1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Kedderis, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bozigian, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleeman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Susick, R. L.,  Jr.</span><span> </span><span class="NLM_article-title">Toxicity of the protein kinase C inhibitor safingol administered alone and in combination with chemotherapeutic agents</span> <span class="citation_source-journal">Fundam. Appl. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1006%2Ffaat.1995.1056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=7665004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADyaK2MXmslehu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1995&pages=201-217&author=L.+B.+Kedderisauthor=H.+P.+Bozigianauthor=J.+M.+Kleemanauthor=R.+L.+Hallauthor=T.+E.+Palmerauthor=S.+D.+Harrisonauthor=R.+L.+Susick&title=Toxicity+of+the+protein+kinase+C+inhibitor+safingol+administered+alone+and+in+combination+with+chemotherapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity of the protein kinase C inhibitor safingol administered alone and in combination with chemotherapeutic agents</span></div><div class="casAuthors">Kedderis, Lorrene Buckley; Bozigian, Haig P.; Kleeman, James M.; Hall, Robert L.; Palmer, Thomas E.; Harrison, Steadman D., Jr.; Susick, Robert L., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental and Applied Toxicology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-17</span>CODEN:
                <span class="NLM_cas:coden">FAATDF</span>;
        ISSN:<span class="NLM_cas:issn">0272-0590</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Safingol [(2S,3S)-2-amino-1,3-octadecanediol] potentiates the toxicity of doxorubicin (DOX) and cisplatin (CIS) against tumor cells in vitro and in vivo.  The present studies were conducted in rats and dog to evaluate safingol toxicity when administered i.v. as a single agent and to evaluate safingol's ability to potentiate the toxicity of established chemotherapeutic agents to normal tissues in vivo.  In an escalating dose study, dogs were administered safingol i.v. at 5, 10, 20, 30, 40, and 75 mg/kg on Days 1 through 6.  Necropsies were performed on Day 7.  Red urine was obsd. at 10 mg/kg and higher.  Icterus was obsd. following 40 mg/kg with addnl. signs of hypoactivity and anorexia occurring after 75 mg/kg.  Clin. and microscopic pathol. revealed marked hepatotoxicity, venous degeneration and necrosis at injection sites, and evidence of intravascular hemolysis.  Doses of 5, 20, or 40 mg safingol/kg were utilized in single i.v. dose rat and dog studies.  No evidence of adverse systemic toxicity was seen ≤20 mg/kg in either species [for rats: Cmax = 12,600 (males) or 17,133 (females) ng/mL, AUC = 3853 (males) or 4365 (females) ng × h/mL (no sex differences)].  Local effects of venous irritation or intravascular hemolysis were obsd. at all doses in rats and at 20 and 40 mg/kg in dogs.  A dose of 40 mg/kg [for rats: Cmax = 31,233 (males) or 91,300 (females) ng/mL, AUC = 11,519 (males) or 18,620 (females) ng × h/mL; for dogs: Cmax = 9033 ng/mL, AUC = 11,094 ng × h/mL (combined sex)] was assocd. with clin. pathol. and renal histomorphol. changes considered consequent to intravascular hemolysis in both species, lethality and testicular toxicity in rats, and clin. biochem. changes indicative of hepatobiliary injury in dogs.  Studies indicated that hemolysis occurred during infusion, was not caused by circulating levels of safingol, and was a function of dose concn. and vein of delivery.  Safingol at 10 or 20 mg/kg was administered i.v. to rats 30-60 min prior to myelosuppressive i.v. doses of DOX, CIS, or cyclophosphamide (CYP).  Hematol., plus renal function and morphol. for CIS-treated animals, was assessed 4 and 14 days later.  Safingol did not potentiate DOX-, CIS-, or CYP-mediated leukopenia/thrombocytopenia.  A minimal enhancement of CIS-mediated decrease in GFR and increase in creatinine was obsd. at 20 mg safingol/kg.  Dogs were administered 20 mg safingol/kg i.v. followed 60 min later by 0.5 or 1.25 mg DOX/kg or 0.75 or 2.0 mg CIS/kg.  A complete toxicol. assessment 4 and 29 days postdose failed to show potentiation of DOX toxicity by safingol or vice versa.  A renal lesion was inferred in dogs administered 20 mg/kg safingol and 2 mg/kg CIS based on minimal to slight renal tubular regeneration obsd. 4 wk post-treatment.  There were no effects of safingol on the pharmacokinetic profiles of DOX or CIS or vice versa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdr-m28OPeYLVg90H21EOLACvtfcHk0li5k7VtznrTBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmslehu70%253D&md5=0f8d01c8ee17cba0db23e00caf1a217f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1006%2Ffaat.1995.1056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Ffaat.1995.1056%26sid%3Dliteratum%253Aachs%26aulast%3DKedderis%26aufirst%3DL.%2BB.%26aulast%3DBozigian%26aufirst%3DH.%2BP.%26aulast%3DKleeman%26aufirst%3DJ.%2BM.%26aulast%3DHall%26aufirst%3DR.%2BL.%26aulast%3DPalmer%26aufirst%3DT.%2BE.%26aulast%3DHarrison%26aufirst%3DS.%2BD.%26aulast%3DSusick%26aufirst%3DR.%2BL.%26atitle%3DToxicity%2520of%2520the%2520protein%2520kinase%2520C%2520inhibitor%2520safingol%2520administered%2520alone%2520and%2520in%2520combination%2520with%2520chemotherapeutic%2520agents%26jtitle%3DFundam.%2520Appl.%2520Toxicol.%26date%3D1995%26volume%3D25%26spage%3D201%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Schwartz, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haimovitz-Friedman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhupar, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehleiter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maslak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loganzo, F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelsen, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuks, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albino, A. P.</span><span> </span><span class="NLM_article-title">Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">1394</span><span class="NLM_x">–</span> <span class="NLM_lpage">1399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1093%2Fjnci%2F87.18.1394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=7658500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADyaK2MXoslKiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1995&pages=1394-1399&author=G.+K.+Schwartzauthor=A.+Haimovitz-Friedmanauthor=S.+K.+Dhuparauthor=D.+Ehleiterauthor=P.+Maslakauthor=L.+Laiauthor=F.+Loganzoauthor=D.+P.+Kelsenauthor=Z.+Fuksauthor=A.+P.+Albino&title=Potentiation+of+apoptosis+by+treatment+with+the+protein+kinase+C-specific+inhibitor+safingol+in+mitomycin+C-treated+gastric+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells</span></div><div class="casAuthors">Schwartz, Gary K.; Haimovitz-Friedman, Adriana; Dhupar, Scott K.; Ehleiter, Desiree; Maslak, Peter; Lai, Lawrence; Loganzo, Frank Jr.; Kelsen, David P.; Fuks, Zvi; Albino, Anthony P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1394-9</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">National Cancer Institute</span>)
        </div><div class="casAbstract">Background: Protein kinase C (PKC) is a family of enzymes that function in processes relevant to carcinogenesis, tumor cell metastasis, and apoptosis.  Safingol, an optical isomer (the L-threo enantiomer) of dihydrosphingosine, is a specific inhibitor of PKC and might represent a novel agent for anticancer therapy.  Preclin. animal studies show that safingol alone has a minimal effect on tumor cell growth, but combining this compd. with conventional chemotherapy agents dramatically potentiates their antitumor effects.  It has been suggested that many chemotherapeutic agents exert their antitumor effects by inducing apoptosis.  Purpose: We wanted to det. the extent to which safingol, alone or in combination with a std. chemotherapeutic agent (mitomycin C [MMC]), would promote apoptosis in gastric cancer cells in vitro.  Furthermore, we investigated whether the induction of apoptosis in the treated cells was affected by their p53 tumor suppressor status or their drug-resistance status.  Method: SK-GT-5 (p53-deficient and MMC-resistant) and MKN-74 (p53 wild-type and MMC-sensitive) gastric cancer cells were exposed to either no drug, safingol (50 μM) alone, MMC (5 μg/mL) alone, or a combination of safingol (50 μM) and MMC (5 μg/mL).  In some expts., cells were exposed simultaneously to safingol and the PKC activator, 3-phorbol 12-myristate 13-acetate (PMA), prior to treatment with MMC.  Apoptosis was measured by two methods: (1) quant. fluorescence microscopy of nuclear chromatin condensation in cells stained with the dye, bisbenzamide trihydrochloride (Hoechst-33258), and (2) terminal deoxynucleotidyl transferase (TdT) labeling of the 3'-OH ends of DNA fragments produced in apoptotic cells.  Results: As detd. by quant. fluorescence microscopy, exposure of SK-GT-5 cells to safingol alone induced apoptosis in 2% (mean) of the cells, and MMC alone increased that level to 18%.  However, the combination of safingol and MMC induced apoptosis in 39% of the cells (for the drug combination vs. MMC alone).  With MKN-74 cells, safingol alone induced apoptosis in 8% of the cells, whereas MMC alone induced apoptosis in 40% of treated cells and the combination of safingol and MMC induced apoptosis in 83% of the cells.  Similar results were obtained with the TdT assay.  Simultaneous exposure of cells to safingol and PMA abrogated the safingol-mediated enhancement of MMC-induced apoptosis.  Conclusions: The PKC inhibitor safingol enhances the cytotoxic effect of the chemotherapeutic agent MMC in gastric cancer cells by promoting drug-induced apoptosis.  The induction of apoptosis occurs regardless of the p53 status or the drug-resistance status of the cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDxzSlEEQqV7Vg90H21EOLACvtfcHk0liy3iYV9aOQmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslKiu7s%253D&md5=55abbac0383b98f9e90a684dba523a87</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F87.18.1394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F87.18.1394%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26aulast%3DHaimovitz-Friedman%26aufirst%3DA.%26aulast%3DDhupar%26aufirst%3DS.%2BK.%26aulast%3DEhleiter%26aufirst%3DD.%26aulast%3DMaslak%26aufirst%3DP.%26aulast%3DLai%26aufirst%3DL.%26aulast%3DLoganzo%26aufirst%3DF.%26aulast%3DKelsen%26aufirst%3DD.%2BP.%26aulast%3DFuks%26aufirst%3DZ.%26aulast%3DAlbino%26aufirst%3DA.%2BP.%26atitle%3DPotentiation%2520of%2520apoptosis%2520by%2520treatment%2520with%2520the%2520protein%2520kinase%2520C-specific%2520inhibitor%2520safingol%2520in%2520mitomycin%2520C-treated%2520gastric%2520cancer%2520cells%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1995%26volume%3D87%26spage%3D1394%26epage%3D1399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Dickson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvajal, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrill, A. H.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cane, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span> </span><span class="NLM_article-title">A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2484</span><span class="NLM_x">–</span> <span class="NLM_lpage">2492</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1158%2F1078-0432.CCR-10-2323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=21257722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslCgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=2484-2492&author=M.+A.+Dicksonauthor=R.+D.+Carvajalauthor=A.+H.+Merrillauthor=M.+Gonenauthor=L.+M.+Caneauthor=G.+K.+Schwartz&title=A+phase+I+clinical+trial+of+safingol+in+combination+with+cisplatin+in+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase I Clinical Trial of Safingol in Combination with Cisplatin in Advanced Solid Tumors</span></div><div class="casAuthors">Dickson, Mark A.; Carvajal, Richard D.; Merrill, Alfred H., Jr.; Gonen, Mithat; Cane, Lauren M.; Schwartz, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2484-2492</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is an important mediator of cancer cell growth and proliferation.  Prodn. of S1P is catalyzed by sphingosine kinase 1 (SphK).  Safingol, (L-threo-dihydrosphingosine) is a putative inhibitor of SphK.  We conducted a phase I trial of safingol (S) alone and in combination with cisplatin (C).  A 3 + 3 dose escalation was used.  For safety, S was given alone 1 wk before the combination.  S + C were then administered every 3 wk.  S was given over 60 to 120 min, depending on dose.  Sixty minutes later, C was given over 60 min.  The C dose of 75 mg/m2 was reduced in cohort 4 to 60 mg/m2 due to excessive fatigue.  Forty-three patients were treated, 41 were evaluable for toxicity, and 37 for response.  The max. tolerated dose (MTD) was S 840 mg/m2 over 120 min C 60 mg/m2, every 3 wk.  Dose-limiting toxicity (DLT) attributed to cisplatin included fatigue and hyponatremia.  DLT from S was hepatic enzyme elevation.  S pharmacokinetic parameters were linear throughout the dose range with no significant interaction with C. Patients treated at or near the MTD achieved S levels of more than 20 μmol/L and maintained levels greater than and equal to 5 μmol/L for 4 h.  The best response was stable disease in 6 patients for on av. 3.3 mo (range 1.8-7.2 m).  One patient with adrenal cortical cancer had significant regression of liver and lung metastases and another had prolonged stable disease.  S was assocd. with a dose-dependent redn. in S1P in plasma.  Safingol, the first putative SphK inhibitor to enter clin. trials, can be safely administered in combination with cisplatin.  Reversible dose-dependent hepatic toxicity was seen, as expected from preclin. data.  Target inhibition was achieved with downregulation of S1P.  The recommended phase II dose is S 840 mg/m2 and C 60 mg/m2, every 3 wk.  Clin Cancer Res; 17(8); 2484-92.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-0rFxPBZYBLVg90H21EOLACvtfcHk0liy3iYV9aOQmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslCgt7g%253D&md5=fb09e8c3a4903928616a53f942b7a6b9</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-10-2323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-10-2323%26sid%3Dliteratum%253Aachs%26aulast%3DDickson%26aufirst%3DM.%2BA.%26aulast%3DCarvajal%26aufirst%3DR.%2BD.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26aulast%3DGonen%26aufirst%3DM.%26aulast%3DCane%26aufirst%3DL.%2BM.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26atitle%3DA%2520phase%2520I%2520clinical%2520trial%2520of%2520safingol%2520in%2520combination%2520with%2520cisplatin%2520in%2520advanced%2520solid%2520tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D2484%26epage%3D2492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Sachs, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safa, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, R. L.</span><span> </span><span class="NLM_article-title">Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">26639</span><span class="NLM_x">–</span> <span class="NLM_lpage">26648</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=26639-26648&author=C.+W.+Sachsauthor=A.+R.+Safaauthor=S.+D.+Harrisonauthor=R.+L.+Fine&title=Partial+inhibition+of+multidrug+resistance+by+safingol+is+independent+of+modulation+of+P-glycoprotein+substrate+activities+and+correlated+with+inhibition+of+protein+kinase+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSachs%26aufirst%3DC.%2BW.%26aulast%3DSafa%26aufirst%3DA.%2BR.%26aulast%3DHarrison%26aufirst%3DS.%2BD.%26aulast%3DFine%26aufirst%3DR.%2BL.%26atitle%3DPartial%2520inhibition%2520of%2520multidrug%2520resistance%2520by%2520safingol%2520is%2520independent%2520of%2520modulation%2520of%2520P-glycoprotein%2520substrate%2520activities%2520and%2520correlated%2520with%2520inhibition%2520of%2520protein%2520kinase%2520C%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D26639%26epage%3D26648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Tan, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, L. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunte, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chng, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, G. N.</span><span> </span><span class="NLM_article-title">In vivo efficacy of a novel liposomal formulation of safingol in the treatment of acute myeloid leukemia</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2012&pages=290-298&author=K.+B.+Tanauthor=L.+U.+Lingauthor=R.+M.+Bunteauthor=W.+J.+Chngauthor=G.+N.+Chiu&title=In+vivo+efficacy+of+a+novel+liposomal+formulation+of+safingol+in+the+treatment+of+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DK.%2BB.%26aulast%3DLing%26aufirst%3DL.%2BU.%26aulast%3DBunte%26aufirst%3DR.%2BM.%26aulast%3DChng%26aufirst%3DW.%2BJ.%26aulast%3DChiu%26aufirst%3DG.%2BN.%26atitle%3DIn%2520vivo%2520efficacy%2520of%2520a%2520novel%2520liposomal%2520formulation%2520of%2520safingol%2520in%2520the%2520treatment%2520of%2520acute%2520myeloid%2520leukemia%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2012%26volume%3D160%26spage%3D290%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Sweeney, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakakura, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirahama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masamune, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakomori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span> </span><span class="NLM_article-title">Sphingosine and its methylated derivative <i>N</i>,<i>N</i>-dimethylsphingosine (DMS) induce apoptosis in a variety of human cancer cell lines</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1002%2F%28SICI%291097-0215%2819960503%2966%3A3%3C358%3A%3AAID-IJC16%3E3.0.CO%3B2-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=8621258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADyaK28XjtVGqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1996&pages=358-366&author=E.+A.+Sweeneyauthor=C.+Sakakuraauthor=T.+Shirahamaauthor=A.+Masamuneauthor=H.+Ohtaauthor=S.+Hakomoriauthor=Y.+Igarashi&title=Sphingosine+and+its+methylated+derivative+N%2CN-dimethylsphingosine+%28DMS%29+induce+apoptosis+in+a+variety+of+human+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine and its methylated derivative N,N-dimethylsphingosine (DMS) induce apoptosis in a variety of human cancer cell lines</span></div><div class="casAuthors">Sweeney, Elizabeth A.; Sakakura, Chouhei; Shirahama, Tsutomu; Masamune, Atsushi; Ohta, Hideki; Hakomori, Sen-itiroh; Igarashi, Yasuyuki</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">358-366</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss</span>)
        </div><div class="casAbstract">In the study of apoptosis initiated by various signals including ligands binding to cell membrane receptors such as Fas and TNFRI, the sphingomyelin pathway and its resulting metabolites, the sphingolipids, have been suggested to be involved in the signaling pathway.  In earlier studies we presented data which indicated that sphingosine (Sph) itself was increased during apoptosis induced by phorbol myristate acetate (PMA) in HL60 cells and tumor necrosis factor (TNF) in neutrophils, and when added exogenously was able to induce apoptosis.  We report here that Sph and its methylated deriv. N,N,-dimethylsphingosine (DMS) are able to induce apoptosis in cancer cells of both hematopoietic and carcinoma origin.  In human leukemic cell lines CMK-7, HL60 and U937, treatment with 20 μM Sph for 6 h caused apoptosis in up to 90% of cells.  Human colonic carcinoma cells HT29, HRT18, MKN74 and COLO205 were shown to be more susceptible to apoptosis upon addn. of DMS (>50%) than of Sph (<50%), yet were weakly or not sensitive to N,N,N-trimethylysphingosine (TMS).  Under the same conditions, in the presence of serum, neither Sph-1-phosphate nor ceramide analogs C2-, C6- or C8-ceramide were able to induce apoptosis in any cell lines.  However, in the absence of serum, ceramide analogs induced apoptosis in leukemia cell lines after 18 h, yet much less so than Sph or DMS.  Furthermore, apoptosis induced by Sph or DMS could not be inhibited by the ceramide synthase inhibitor fumonisin BI.  Apoptosis was not induced by sphingolipids in primary culture cells, such as HUVEC or rat mesangial cells, but was apparent in transformed rat mesangial cells.  Addnl., apoptosis induced by Sph, DMS or C2Cer was inhibited by protease inhibitors.  Our data further support the evidence that the catabolic pathway of sphingomyelin involving Sph and other metabolites is an integral part of the apoptosis pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWSI61qE-VTLVg90H21EOLACvtfcHk0lj9bKxM5tE5WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtVGqsbg%253D&md5=de7edea7f4af6f79f95cbc46737409e9</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2819960503%2966%3A3%3C358%3A%3AAID-IJC16%3E3.0.CO%3B2-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252819960503%252966%253A3%253C358%253A%253AAID-IJC16%253E3.0.CO%253B2-7%26sid%3Dliteratum%253Aachs%26aulast%3DSweeney%26aufirst%3DE.%2BA.%26aulast%3DSakakura%26aufirst%3DC.%26aulast%3DShirahama%26aufirst%3DT.%26aulast%3DMasamune%26aufirst%3DA.%26aulast%3DOhta%26aufirst%3DH.%26aulast%3DHakomori%26aufirst%3DS.%26aulast%3DIgarashi%26aufirst%3DY.%26atitle%3DSphingosine%2520and%2520its%2520methylated%2520derivative%2520N%252CN-dimethylsphingosine%2520%2528DMS%2529%2520induce%2520apoptosis%2520in%2520a%2520variety%2520of%2520human%2520cancer%2520cell%2520lines%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1996%26volume%3D66%26spage%3D358%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Shirahama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakakura, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singhal, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakomori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span> </span><span class="NLM_article-title">In vitro and in vivo induction of apoptosis by sphingosine and <i>N</i>,<i>N</i>-dimethylsphingosine in human epidermoid carcinoma KB-3-1 and its multidrug-resistant cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=9815681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADyaK2sXhsVOmtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=257-264&author=T.+Shirahamaauthor=E.+A.+Sweeneyauthor=C.+Sakakuraauthor=A.+K.+Singhalauthor=K.+Nishiyamaauthor=S.+Akiyamaauthor=S.+Hakomoriauthor=Y.+Igarashi&title=In+vitro+and+in+vivo+induction+of+apoptosis+by+sphingosine+and+N%2CN-dimethylsphingosine+in+human+epidermoid+carcinoma+KB-3-1+and+its+multidrug-resistant+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo induction of apoptosis by sphingosine and N,N-dimethylsphingosine in human epidermoid carcinoma KB-3-1 and its multidrug-resistant cells</span></div><div class="casAuthors">Shirahama, Tsutomu; Sweeney, Elizabeth A.; Sakakura, Chouhei; Singhal, Anil K.; Nishiyama, Kenryu; Akiyama, Shin-Ichi; Hakomori, Sen-Itiroh; Igarashi, Yasuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">257-264</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Sphingolipid breakdown products, including ceramide and sphingosine, regulate cell growth, cell differentiation, and apoptosis.  We examd. the effect of various agents, including sphingolipids, on apoptosis induction in human epidermoid carcinoma KB-3-1 and its multidrug-resistant (MDR) subclone KB-C2 cells which express P-glycoprotein.  Adriamycin (ADM) induced apoptosis in KB-3-1 cells but not in KB-C2 MDR cells at the concn. of 50 μg/mL.  On the other hand, 15 μM sphingosine or its methylated deriv. N,N-demethylsphingosine (DMS) induced apoptosis in both cell types in vitro.  These results suggested that KB-C2 MDR cells were resistant to apoptosis induction by ADM but sensitive to that by sphingosine and DMS.  Ceramide and sphingosine-1-phosphate, the initial metabolites of sphingosine, failed to induce apoptosis under the same exptl. condition as sphingosine/DMS.  The protein kinase C (PKC) inhibitors H7 and staurosporine did not induce apoptosis in either cell line, suggesting that PKC-independent signaling is involved in apoptosis induced by sphingosine and DMS, although both sphingosine and DMS have been shown to down-regulate PKC.  Furthermore, DMS significantly inhibited the growth of KB-3-1 as well as KB-C2 MDR tumors in vivo, with evidence of increased apoptosis.  The intracellular level of exogenously added [3H]sphingosine or [14C]ADM did not differ between the KB-3-1 parent cell line and its MDR subclone KB-C2, whereas that of [14C]ADM was reduced in KB-C2 MDR cells compared to KB-3-1 cells.  These results suggest that P-glycoprotein acts as a transporter for ADM but not for sphingosine or DMS.  Furthermore, DMS at the concns. which induce apoptosis in KB-C2 cells did not affect the level of [14C]ADM.  Because sphingosine and DMS induce apoptosis regardless of P-glycoprotein expression, they may provide a new strategy and a promising approach to the treatment of anticancer drug-resistant cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVLz_ArPmHSLVg90H21EOLACvtfcHk0lj9bKxM5tE5WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsVOmtrw%253D&md5=6379fe541c2139e8579428f2f29f16e7</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShirahama%26aufirst%3DT.%26aulast%3DSweeney%26aufirst%3DE.%2BA.%26aulast%3DSakakura%26aufirst%3DC.%26aulast%3DSinghal%26aufirst%3DA.%2BK.%26aulast%3DNishiyama%26aufirst%3DK.%26aulast%3DAkiyama%26aufirst%3DS.%26aulast%3DHakomori%26aufirst%3DS.%26aulast%3DIgarashi%26aufirst%3DY.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520induction%2520of%2520apoptosis%2520by%2520sphingosine%2520and%2520N%252CN-dimethylsphingosine%2520in%2520human%2520epidermoid%2520carcinoma%2520KB-3-1%2520and%2520its%2520multidrug-resistant%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1997%26volume%3D3%26spage%3D257%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegood, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symolon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrill, A. H.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaze-Andersson, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabot, M. C.</span><span> </span><span class="NLM_article-title"><i>N</i>-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2967</span><span class="NLM_x">–</span> <span class="NLM_lpage">2976</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1158%2F1535-7163.MCT-08-0549" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=18790777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=2967-2976&author=H.+Wangauthor=B.+J.+Maurerauthor=Y.+Y.+Liuauthor=E.+Wangauthor=J.+C.+Allegoodauthor=S.+Kellyauthor=H.+Symolonauthor=Y.+Liuauthor=A.+H.+Merrillauthor=V.+Gouaze-Anderssonauthor=J.+Y.+Yuauthor=A.+E.+Giulianoauthor=M.+C.+Cabot&title=N-%284-Hydroxyphenyl%29retinamide+increases+dihydroceramide+and+synergizes+with+dimethylsphingosine+to+enhance+cancer+cell+killing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing</span></div><div class="casAuthors">Wang, Hongtao; Maurer, Barry J.; Liu, Yong-Yu; Wang, Elaine; Allegood, Jeremy C.; Kelly, Samuel; Symolon, Holly; Liu, Ying; Merrill, Alfred H., Jr.; Gouaze-Andersson, Valerie; Yu, Jing Yuan; Giuliano, Armando E.; Cabot, Myles C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2967-2976</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Fenretinide [N-(4-hydroxyphenyl)retinamide (4-HPR)] is cytotoxic in many cancer cell types.  Studies have shown that elevation of ceramide species plays a role in 4-HPR cytotoxicity.  To det. 4-HPR activity in a multidrug-resistant cancer cell line as well as to study ceramide metab., MCF-7/AdrR cells (redesignated NCI/ADR-RES) were treated with 4-HPR and sphingolipids were analyzed.  TLC anal. of cells radiolabeled with [3H]palmitic acid showed that 4-HPR elicited a dose-responsive increase in radioactivity migrating in the ceramide region of the chromatogram and a decrease in cell viability.  Results from liq. chromatog./electrospray tandem mass spectrometry revealed large elevations in dihydroceramides (N-acylsphinganines), but not desatd. ceramides, and large increases in complex dihydrosphingolipids (dihydrosphingomyelins, monohexosyldihydroceramides), sphinganine, and sphinganine 1-phosphate.  To test the hypothesis that elevation of sphinganine participates in the cytotoxicity of 4-HPR, cells were treated with the sphingosine kinase inhibitor D-erythro-N,N-dimethylsphingosine (DMS), with and without 4-HPR.  After 24 h, the 4-HPR/DMS combination caused a 9-fold increase in sphinganine that was sustained through +48 h, decreased sphinganine 1-phosphate, and increased cytotoxicity.  Increased dihydrosphingolipids and sphinganine were also found in HL-60 leukemia cells and HT-29 colon cancer cells treated with 4-HPR.  The 4-HPR/DMS combination elicited increased apoptosis in all three cell lines.  We propose that a mechanism of 4-HPR-induced cytotoxicity involves increases in dihydrosphingolipids, and that the synergy between 4-HPR and DMS is assocd. with large increases in cellular sphinganine.  These studies suggest that enhanced clin. efficacy of 4-HPR may be realized through regimens contg. agents that modulate sphingoid base metab. [Mol Cancer Ther 2008;7(9):2967-76].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdweYx84viqLVg90H21EOLACvtfcHk0lj9bKxM5tE5WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsL7P&md5=7b7fd8cf6ac930a7864f80c634cc999c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0549%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DMaurer%26aufirst%3DB.%2BJ.%26aulast%3DLiu%26aufirst%3DY.%2BY.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DAllegood%26aufirst%3DJ.%2BC.%26aulast%3DKelly%26aufirst%3DS.%26aulast%3DSymolon%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26aulast%3DGouaze-Andersson%26aufirst%3DV.%26aulast%3DYu%26aufirst%3DJ.%2BY.%26aulast%3DGiuliano%26aufirst%3DA.%2BE.%26aulast%3DCabot%26aufirst%3DM.%2BC.%26atitle%3DN-%25284-Hydroxyphenyl%2529retinamide%2520increases%2520dihydroceramide%2520and%2520synergizes%2520with%2520dimethylsphingosine%2520to%2520enhance%2520cancer%2520cell%2520killing%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D2967%26epage%3D2976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Ghosh, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auzenne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farquhar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klostergaard, J.</span><span> </span><span class="NLM_article-title"><i>N</i>,<i>N</i>-Dimethylsphingosine-coumarin: synthesis, chemical characterization, and biological evaluation</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">735</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc060285q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1SisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=731-735&author=S.+C.+Ghoshauthor=E.+Auzenneauthor=D.+Farquharauthor=J.+Klostergaard&title=N%2CN-Dimethylsphingosine-coumarin%3A+synthesis%2C+chemical+characterization%2C+and+biological+evaluation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">N,N-Dimethylsphingosine-Coumarin: Synthesis, Chemical Characterization, and Biological Evaluation</span></div><div class="casAuthors">Ghosh, Sukhen C.; Auzenne, Edmond; Farquhar, David; Klostergaard, Jim</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">731-735</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Coumarin derivs. of N,N-dimethylsphingosine (DMSP) were prepd. and chem. characterized.  They were apparently biol. equiv. to DMSP in terms of tumor cell cytotoxicity and were used to establish the rapid mitochondrial localization of this sphingolipid in tumor cells, followed closely by its marked redn. of mitochondrial membrane potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLeyQEpM489LVg90H21EOLACvtfcHk0ljzS-28EUh5WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1SisLo%253D&md5=659f957e3b8842c294f69c8cd96b63d9</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fbc060285q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc060285q%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DS.%2BC.%26aulast%3DAuzenne%26aufirst%3DE.%26aulast%3DFarquhar%26aufirst%3DD.%26aulast%3DKlostergaard%26aufirst%3DJ.%26atitle%3DN%252CN-Dimethylsphingosine-coumarin%253A%2520synthesis%252C%2520chemical%2520characterization%252C%2520and%2520biological%2520evaluation%26jtitle%3DBioconjugate%2520Chem.%26date%3D2007%26volume%3D18%26spage%3D731%26epage%3D735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">De Jonghe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Overmeire, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Calenbergh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Keukeleire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herdewijn, P.</span><span> </span><span class="NLM_article-title">Structure–activity relationship of short-chain sphingoid bases as inhibitors of sphingosine kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">3175</span><span class="NLM_x">–</span> <span class="NLM_lpage">3180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=3175-3180&author=S.+De+Jongheauthor=I.+Van+Overmeireauthor=S.+Poultonauthor=C.+Hendrixauthor=R.+Bussonauthor=S.+Van+Calenberghauthor=D.+De+Keukeleireauthor=S.+Spiegelauthor=P.+Herdewijn&title=Structure%E2%80%93activity+relationship+of+short-chain+sphingoid+bases+as+inhibitors+of+sphingosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BJonghe%26aufirst%3DS.%26aulast%3DVan%2BOvermeire%26aufirst%3DI.%26aulast%3DPoulton%26aufirst%3DS.%26aulast%3DHendrix%26aufirst%3DC.%26aulast%3DBusson%26aufirst%3DR.%26aulast%3DVan%2BCalenbergh%26aufirst%3DS.%26aulast%3DDe%2BKeukeleire%26aufirst%3DD.%26aulast%3DSpiegel%26aufirst%3DS.%26aulast%3DHerdewijn%26aufirst%3DP.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520of%2520short-chain%2520sphingoid%2520bases%2520as%2520inhibitors%2520of%2520sphingosine%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D3175%26epage%3D3180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Johnson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvis, W. D.</span><span> </span><span class="NLM_article-title">Intrinsic cytotoxicity and chemomodulatory actions of novel phenethylisothiocyanate sphingoid base derivatives in HL-60 human promyelocytic leukemia cells</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">452</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1124%2Fjpet.103.060665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=14724218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1yhtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=452-461&author=C.+R.+Johnsonauthor=J.+Chunauthor=R.+Bittmanauthor=W.+D.+Jarvis&title=Intrinsic+cytotoxicity+and+chemomodulatory+actions+of+novel+phenethylisothiocyanate+sphingoid+base+derivatives+in+HL-60+human+promyelocytic+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Intrinsic cytotoxicity and chemomodulatory actions of novel phenethylisothiocyanate sphingoid base derivatives in HL-60 human promyelocytic leukemia cells</span></div><div class="casAuthors">Johnson, Charlene R.; Chun, Jiong; Bittman, Robert; Jarvis, W. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">452-461</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The protein kinase C (PKC) isoenzyme superfamily represents a popular target in pharmacol. interventions designed to elicit apoptosis directly in tumor cells or to potentiate the lethal effects of antineoplastic agents.  Numerous observations support the clin. utility of PKC inhibition by exptl. sphingolipid derivs. such as safingol.  The present studies document the cytotoxicity and chemomodulatory capacity of phenethylisothiocyanate derivs. of sphinganine and sphingosine (PEITC-Sa and PEITC-So) in the human myeloid leukemia cell line HL-60.  The biol. actions of these novel derivs. were compared directly with those of the parent compds. sphinganine and sphingosine.  Exposure to natural and modified sphingoid bases promoted extensive apoptotic cell death.  The PEITC-sphingoid base derivs. exhibited higher cytotoxicity than their natural counterparts and were also distinctly superior to the clin. relevant sphingoid base analog safingol.  In each instance, lethality was shown to correlate with inhibition of conventional and novel PKC isoforms and downstream loss of extracellular signal-regulated kinase (ERK)1/ERK2.  The involvement of these signaling systems in potentiating the lethal actions of 1-(β-D-arabinofuranosyl)cytosine (araC) was also examd. with regard to the differential actions of PEITC-Sa and PEITC-So to that of the parent compds. as well as safingol.  Exposure to araC alone rapidly increased PKC activity.  In the presence of PEITC-Sa or PEITC-So, the therapeutic efficacy of araC increased markedly; moreover, potentiation was directly related to the loss of araC-stimulated PKC activity.  These findings demonstrate that PEITC-substituted sphingoid base analogs exert potent antineoplastic effects in human leukemia cells.  We suggest that these synthetic lipids represent potentially useful agents in the development of conventional PKC/novel PKC-directed chemotherapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq-bD5W5tmEbVg90H21EOLACvtfcHk0ljzS-28EUh5WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1yhtLY%253D&md5=b710e421e795d81adfebd363920bf531</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.060665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.060665%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BR.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DJarvis%26aufirst%3DW.%2BD.%26atitle%3DIntrinsic%2520cytotoxicity%2520and%2520chemomodulatory%2520actions%2520of%2520novel%2520phenethylisothiocyanate%2520sphingoid%2520base%2520derivatives%2520in%2520HL-60%2520human%2520promyelocytic%2520leukemia%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D452%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Sharma, A. K.</span><span> </span><span class="NLM_article-title">Sphingo-guanidines and their use as inhibitors of sphingosine kinase (WO2010078247)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">807</span><span class="NLM_x">–</span> <span class="NLM_lpage">812</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1517%2F13543776.2011.573787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvFant7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=807-812&author=A.+K.+Sharma&title=Sphingo-guanidines+and+their+use+as+inhibitors+of+sphingosine+kinase+%28WO2010078247%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingo-guanidines and their use as inhibitors of sphingosine kinase (WO2010078247)</span></div><div class="casAuthors">Sharma, Arun K.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">807-812</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The sphingolipid metabolic pathway controls the balance of bioactive lipids including apoptotic ceramide and proliferative sphingosine 1-phosphate and, therefore, represents a potential source of new therapeutic targets for numerous diseases.  Targets, such as sphingosine kinases (SphK), have been extensively studied, and numerous strategies have been used to develop inhibitors against these enzymes.  The WO2010078247 patent application shows the development of some novel sphingo-guanidines, including their water sol. salts, as inhibitors of SphK, and for use in treating and/or preventing diseases and disorders related to undesirable ceramidase, ceramidase-related or SphK activity, including cancer and other proliferative diseases.  The synthesis of two agents D-erythro-2-N-(1''-carboxamidino)sphingosine hydrochloride (LCL146) and L-erythro-2-N-(1''-carboxamidino)sphingosine hydrochloride (LCL351) is described and they have been shown to inhibit SphK activity, be cytotoxic to cancer cells and decrease the migration rate of human prostate (DU145) cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBfjfoEioO3LVg90H21EOLACvtfcHk0ljzS-28EUh5WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvFant7s%253D&md5=7781d42d080ae55a9b237b4fb797d16c</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.573787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.573787%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DA.%2BK.%26atitle%3DSphingo-guanidines%2520and%2520their%2520use%2520as%2520inhibitors%2520of%2520sphingosine%2520kinase%2520%2528WO2010078247%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D807%26epage%3D812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Paugh, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paugh, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahmani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapitonov, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almenara, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kordula, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zipkin, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">1382</span><span class="NLM_x">–</span> <span class="NLM_lpage">1391</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2008&pages=1382-1391&author=S.+W.+Paughauthor=B.+S.+Paughauthor=M.+Rahmaniauthor=D.+Kapitonovauthor=J.+A.+Almenaraauthor=T.+Kordulaauthor=S.+Milstienauthor=J.+K.+Adamsauthor=R.+E.+Zipkinauthor=S.+Grantauthor=S.+Spiegel&title=A+selective+sphingosine+kinase+1+inhibitor+integrates+multiple+molecular+therapeutic+targets+in+human+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaugh%26aufirst%3DS.%2BW.%26aulast%3DPaugh%26aufirst%3DB.%2BS.%26aulast%3DRahmani%26aufirst%3DM.%26aulast%3DKapitonov%26aufirst%3DD.%26aulast%3DAlmenara%26aufirst%3DJ.%2BA.%26aulast%3DKordula%26aufirst%3DT.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BK.%26aulast%3DZipkin%26aufirst%3DR.%2BE.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DA%2520selective%2520sphingosine%2520kinase%25201%2520inhibitor%2520integrates%2520multiple%2520molecular%2520therapeutic%2520targets%2520in%2520human%2520leukemia%26jtitle%3DBlood%26date%3D2008%26volume%3D112%26spage%3D1382%26epage%3D1391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, H. P.</span><span> </span><span class="NLM_article-title">Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=91-101&author=J.+Chunauthor=H.+P.+Hartung&title=Mechanism+of+action+of+oral+fingolimod+%28FTY720%29+in+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DHartung%26aufirst%3DH.%2BP.%26atitle%3DMechanism%2520of%2520action%2520of%2520oral%2520fingolimod%2520%2528FTY720%2529%2520in%2520multiple%2520sclerosis%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2010%26volume%3D33%26spage%3D91%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieschl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zollinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">21453</span><span class="NLM_x">–</span> <span class="NLM_lpage">21457</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1074%2Fjbc.C200176200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=11967257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=21453-21457&author=V.+Brinkmannauthor=M.+D.+Davisauthor=C.+E.+Heiseauthor=R.+Albertauthor=S.+Cottensauthor=R.+Hofauthor=C.+Brunsauthor=E.+Prieschlauthor=T.+Baumrukerauthor=P.+Hiestandauthor=C.+A.+Fosterauthor=M.+Zollingerauthor=K.+R.+Lynch&title=The+immune+modulator+FTY720+targets+sphingosine+1-phosphate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span></div><div class="casAuthors">Brinkmann, Volker; Davis, Michael D.; Heise, Christopher E.; Albert, Rainer; Cottens, Sylvain; Hof, Robert; Bruns, Christian; Prieschl, Eva; Baumruker, Thomas; Hiestand, Peter; Foster, Carolyn A.; Zollinger, Markus; Lynch, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21453-21457</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Immunosuppressant drugs such as cyclosporin have allowed widespread organ transplantation, but their utility remains limited by toxicities, and they are ineffective in chronic management of autoimmune diseases such as multiple sclerosis.  In contrast, the immune modulating drug FTY720 is efficacious in a variety of transplant and autoimmune models without inducing a generalized immunosuppressed state and is effective in human kidney transplantation.  FTY720 elicits a lymphopenia resulting from a reversible redistribution of lymphocytes from circulation to secondary lymphoid tissues by unknown mechanisms.  Using FTY720 and several analogs, we show now that FTY720 is phosphorylated by sphingosine kinase; the phosphorylated compd. is a potent agonist at four sphingosine 1-phosphate receptors and represents the therapeutic principle in a rodent model of multiple sclerosis.  Our results suggest that FTY720, after phosphorylation, acts through sphingosine 1-phosphate signaling pathways to modulate chemotactic responses and lymphocyte trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6zyZnHOYNbVg90H21EOLACvtfcHk0ljG-tk1hh7KAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D&md5=b59856fffa9ebae7fb8182d18daa025f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200176200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200176200%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DHof%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPrieschl%26aufirst%3DE.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DThe%2520immune%2520modulator%2520FTY720%2520targets%2520sphingosine%25201-phosphate%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D21453%26epage%3D21457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=346-349&author=S.+Mandalaauthor=R.+Hajduauthor=J.+Bergstromauthor=E.+Quackenbushauthor=J.+Xieauthor=J.+Milliganauthor=R.+Thorntonauthor=G.+J.+Sheiauthor=D.+Cardauthor=C.+Keohaneauthor=M.+Rosenbachauthor=J.+Haleauthor=C.+L.+Lynchauthor=K.+Rupprechtauthor=W.+Parsonsauthor=H.+Rosen&title=Alteration+of+lymphocyte+trafficking+by+sphingosine-1-phosphate+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DShei%26aufirst%3DG.%2BJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DRupprecht%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520lymphocyte%2520trafficking%2520by%2520sphingosine-1-phosphate%2520receptor%2520agonists%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D346%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Azuma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimaru, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukui, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshiga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuoka, Y.</span><span> </span><span class="NLM_article-title">Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1410</span><span class="NLM_x">–</span> <span class="NLM_lpage">1419</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=11888913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD38Xit1Khur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=1410-1419&author=H.+Azumaauthor=S.+Takaharaauthor=N.+Ichimaruauthor=J.+D.+Wangauthor=Y.+Itohauthor=Y.+Otsukiauthor=J.+Morimotoauthor=R.+Fukuiauthor=M.+Hoshigaauthor=T.+Ishiharaauthor=N.+Nonomuraauthor=S.+Suzukiauthor=A.+Okuyamaauthor=Y.+Katsuoka&title=Marked+prevention+of+tumor+growth+and+metastasis+by+a+novel+immunosuppressive+agent%2C+FTY720%2C+in+mouse+breast+cancer+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models</span></div><div class="casAuthors">Azuma, Haruhito; Takahara, Shiro; Ichimaru, Naotsugu; Wang, Jing Ding; Itoh, Yuko; Otsuki, Yoshinori; Morimoto, Junji; Fukui, Ryosuke; Hoshiga, Masaaki; Ishihara, Tadashi; Nonomura, Norio; Suzuki, Seiichi; Okuyama, Akihiko; Katsuoka, Yoji</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1410-1419</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">In vitro treatment with FTY720 induced dramatic apoptosis in a mouse breast cancer cell line, JygMC(A).  Electron microscopy revealed distinct changes on the cell surface with decreased filopodias and microvilli in cancer cells treated with FTY720 at 2 μM and clear evidence of apoptosis at 10 μM.  The effect of FTY720 was significantly less in normal fibroblasts than in the cancer cells, indicating greater susceptibility of cancer cells to the agent.  The in vivo effect of 3 different doses of FTY720 (2, 5, and 10 mg/kg/day) was tested in a mouse breast cancer model created by inoculating JygMC(A) cells (s.c.) into the flank region of BALB/c-nu/nu mice.  Tumor growth was markedly suppressed without notable side effects.  In addn., tumor metastasis, which was evident in control mice, was prevented even at the low dose (2 mg/kg/day), resulting in prolongation of animal survival.  FTY720 treatment (2 μM) of the cancer cells caused marked cytoskeletal change, with deformed and decreased filopodias, in cancer cells.  In addn., it decreased the ability of the cancer cells to adhere and migrate to extracellular matrix components and markedly reduced the expression of integrins on the cancer cell surface.  These results indicate that FTY720 is a potent anticancer agent that induces apoptosis and is markedly effective for prevention of metastasis.  The changes of cellular structure with redn. of integrin expression may be one of its underlying mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd_Xhpm-HtJ7Vg90H21EOLACvtfcHk0ljw9OZ46h6fkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xit1Khur4%253D&md5=fa650d7e1d6ae59cb9e5f8b1a09f3704</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAzuma%26aufirst%3DH.%26aulast%3DTakahara%26aufirst%3DS.%26aulast%3DIchimaru%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DJ.%2BD.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DOtsuki%26aufirst%3DY.%26aulast%3DMorimoto%26aufirst%3DJ.%26aulast%3DFukui%26aufirst%3DR.%26aulast%3DHoshiga%26aufirst%3DM.%26aulast%3DIshihara%26aufirst%3DT.%26aulast%3DNonomura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DOkuyama%26aufirst%3DA.%26aulast%3DKatsuoka%26aufirst%3DY.%26atitle%3DMarked%2520prevention%2520of%2520tumor%2520growth%2520and%2520metastasis%2520by%2520a%2520novel%2520immunosuppressive%2520agent%252C%2520FTY720%252C%2520in%2520mouse%2520breast%2520cancer%2520models%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D1410%26epage%3D1419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Azuma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuoka, Y.</span><span> </span><span class="NLM_article-title">Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">2372</span><span class="NLM_x">–</span> <span class="NLM_lpage">2377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1097%2F01.ju.0000064938.32318.91" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=12771800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktlOisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2003&pages=2372-2377&author=H.+Azumaauthor=S.+Takaharaauthor=S.+Horieauthor=S.+Mutoauthor=Y.+Otsukiauthor=Y.+Katsuoka&title=Induction+of+apoptosis+in+human+bladder+cancer+cells+in+vitro+and+in+vivo+caused+by+FTY720+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of Apoptosis in Human Bladder Cancer Cells In Vitro and In Vivo Caused by FTY720 Treatment</span></div><div class="casAuthors">Azuma, Haruhito; Takahara, Shiro; Horie, Shigeo; Muto, Satoru; Otsuki, Yoshinori; Katsuoka, Yoji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (Hagerstown, MD, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2372-2377</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">FTY720 is a unique immunosuppressant that induces apoptosis in activated lymphocytes but not in other hematopoietic cells.  We examd. whether FTY720 has anticancer effects on human bladder cancer cells by inducing apoptosis and we investigated its mol. pathway.  MATERIALS AND METHODS We used the 3 human bladder cancer cell lines T24, UMUC3 and HT1197, and the human fibroblast derived cell line CRL-2096 (American Type Tissue Collection, Rockville, Maryland) in this study.  The difference in drug susceptibility to FTY720 in cancer cells and fibroblasts was examd. by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and cell growth assays.  FTY720 induced apoptosis was detd. by morphol. anal. under light and electron microscopy, and DNA electrophoresis, and its mol. pathway was evaluated by Western blot anal. focusing on the p42/p44 mitogen activated protein kinase pathway.  We then tested the in vivo effect of this agent using 2 mouse models of human bladder cancer xenograft.  RESULTS FTY720 treatment in vitro induced selective apoptosis in cancer cells at a concn. of less than 10 μM. Morphol. anal. revealed features characteristic of apoptosis, including small cytoplasm with fragmented nuclei and condensed chromatin.  DNA electrophoresis confirmed apoptosis, as evidenced by a distinct oligosomal ladder.  Western blot anal. revealed that the agent significantly inhibited hepatocyte growth factor induced p42/p44 mitogen activated protein kinase activity.  The in vivo anticancer effect was clearly confirmed by significantly decreased tumor growth without notable side effects in the 2 xenograft models.  CONCLUSIONS FTY720 treatment may induce selective apoptosis in vitro as well as in vivo in cancer cells.  We suggest that FTY720 is a potent and clin. applicable anticancer agent for bladder cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLUVoMc3LO8rVg90H21EOLACvtfcHk0ljw9OZ46h6fkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktlOisLY%253D&md5=48b7aff671b4fcb1f64117dd3b62614c</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1097%2F01.ju.0000064938.32318.91&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.ju.0000064938.32318.91%26sid%3Dliteratum%253Aachs%26aulast%3DAzuma%26aufirst%3DH.%26aulast%3DTakahara%26aufirst%3DS.%26aulast%3DHorie%26aufirst%3DS.%26aulast%3DMuto%26aufirst%3DS.%26aulast%3DOtsuki%26aufirst%3DY.%26aulast%3DKatsuoka%26aufirst%3DY.%26atitle%3DInduction%2520of%2520apoptosis%2520in%2520human%2520bladder%2520cancer%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%2520caused%2520by%2520FTY720%2520treatment%26jtitle%3DJ.%2520Urol.%26date%3D2003%26volume%3D169%26spage%3D2372%26epage%3D2377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimaru, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morozumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, H.</span><span> </span><span class="NLM_article-title">A novel immunosuppressive drug, FTY720, prevents the cancer progression induced by cyclosporine</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">181</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2FS0304-3835%2801%2900799-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=12175531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFyhtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2002&pages=165-171&author=T.+Tanakaauthor=S.+Takaharaauthor=M.+Hatoriauthor=K.+Suzukiauthor=J.+Wangauthor=N.+Ichimaruauthor=S.+Suzukiauthor=K.+Morozumiauthor=A.+Okuyamaauthor=H.+Yamanaka&title=A+novel+immunosuppressive+drug%2C+FTY720%2C+prevents+the+cancer+progression+induced+by+cyclosporine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">A novel immunosuppressive drug, FTY720, prevents the cancer progression induced by cyclosporine</span></div><div class="casAuthors">Tanaka, Toshiyuki; Takahara, Shiro; Hatori, Motoaki; Suzuki, Kazuhiro; Wang, Jing-Ding; Ichimaru, Naotsugu; Suzuki, Seiichi; Morozumi, Kunio; Okuyama, Akihiko; Yamanaka, Hidetoshi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-171</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Cyclosporine A (CsA), the most frequently used immunosuppressive drug, has been reported to induce cancer by a cell-autonomous mechanism.  Herein, we report that FTY720, a novel immunosuppressant, prevents CsA-induced alterations in both morphol. and cell motility at a low concn. (0.1 μM) and induces the CsA-treated cancer cells to undergo apoptosis at a higher concn. (more than 5 μM).  The inhibitory activity of FTY720 is unrelated to the decrease of TGF-β.  We believe that a combination treatment with FTY720 and CsA not only results in a synergistic effect on allografts, but also, reduces the incidence of cancer in transplant patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW7OE56oNZ9rVg90H21EOLACvtfcHk0ljw9OZ46h6fkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFyhtLw%253D&md5=0058cb67c2ef95cfe70d70e10650713c</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2FS0304-3835%2801%2900799-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3835%252801%252900799-6%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DTakahara%26aufirst%3DS.%26aulast%3DHatori%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DIchimaru%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DMorozumi%26aufirst%3DK.%26aulast%3DOkuyama%26aufirst%3DA.%26aulast%3DYamanaka%26aufirst%3DH.%26atitle%3DA%2520novel%2520immunosuppressive%2520drug%252C%2520FTY720%252C%2520prevents%2520the%2520cancer%2520progression%2520induced%2520by%2520cyclosporine%26jtitle%3DCancer%2520Lett.%26date%3D2002%26volume%3D181%26spage%3D165%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Ubai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azuma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotake, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuoka, Y.</span><span> </span><span class="NLM_article-title">FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=17352219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs1Wnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=75-88&author=T.+Ubaiauthor=H.+Azumaauthor=Y.+Kotakeauthor=T.+Inamotoauthor=K.+Takaharaauthor=Y.+Itoauthor=S.+Kiyamaauthor=T.+Sakamotoauthor=S.+Horieauthor=S.+Mutoauthor=S.+Takaharaauthor=Y.+Otsukiauthor=Y.+Katsuoka&title=FTY720+induced+Bcl-associated+and+Fas-independent+apoptosis+in+human+renal+cancer+cells+in+vitro+and+significantly+reduced+in+vivo+tumor+growth+in+mouse+xenograft"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720 induced bcl-associated and fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft</span></div><div class="casAuthors">Ubai, Takanobu; Azuma, Haruhito; Kotake, Yatsugu; Inamoto, Teruo; Takahara, Kiyoshi; Ito, Yuko; Kiyama, Satoshi; Sakamoto, Takeshi; Horie, Shigeo; Muto, Satoru; Takahara, Shiro; Otsuki, Yoshinori; Katsuoka, Yoji</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1A</span>),
    <span class="NLM_cas:pages">75-88</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">A unique immunosuppressant, FTY720, selectively induces apoptosis in activated lymphocytes, but not in other hematopoietic cells.  The potential that this unique mechanism could provide anticancer potential by inducing apoptosis in the human renal cancer cell line, ACHN, which is resistant to cisplatin, and its mol. pathway was investigated.  The difference in drug susceptibility to FTY720 between cancer cells and non-cancer cells was examd. by MTT assay and flow cytometry.  Apoptosis assay, including TUNEL staining, electron microscopy and DNA electrophoresis, was performed and the mol. pathway of FTY720 was evaluated by real time RT-PCR and Western blot.  The in vivo effect of FTY720 was evaluated using a murine zenograft model.  The susceptibility to FTY720 was significantly higher in ACHN cancer cells than in normal renal tubular cells (HK-2) at a concn. of less than 30 μM, while the susceptibility to cisplatin was even higher in HK-2 than in ACHN.  Cancer cells treated with FTY720 showed findings typical of apoptosis with highly condensed nuclear chromatin and fragmented nuclei.  The mol. anal. revealed that FTY720-induced apoptosis was mediated by a Fas-independent, Bcl-assocd. signal transduction pathway, and that inhibition of extracellular signal-regulated kinase (ERK) activity was involved in its underlying mechanism of action.  FTY720 treatment significantly prevented in vivo tumor growth without any severe adverse reactions, while cisplatin treatment did not inhibit tumor growth despite exhibiting severe side-effects.  FTY720 may be a promising candidate for a new anticancer therapy of renal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZLNZFAtYm4rVg90H21EOLACvtfcHk0liOnkU0WCxGFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs1Wnsrs%253D&md5=0e878aa779dd89c3eef3b1dd2e47972e</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUbai%26aufirst%3DT.%26aulast%3DAzuma%26aufirst%3DH.%26aulast%3DKotake%26aufirst%3DY.%26aulast%3DInamoto%26aufirst%3DT.%26aulast%3DTakahara%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DKiyama%26aufirst%3DS.%26aulast%3DSakamoto%26aufirst%3DT.%26aulast%3DHorie%26aufirst%3DS.%26aulast%3DMuto%26aufirst%3DS.%26aulast%3DTakahara%26aufirst%3DS.%26aulast%3DOtsuki%26aufirst%3DY.%26aulast%3DKatsuoka%26aufirst%3DY.%26atitle%3DFTY720%2520induced%2520Bcl-associated%2520and%2520Fas-independent%2520apoptosis%2520in%2520human%2520renal%2520cancer%2520cells%2520in%2520vitro%2520and%2520significantly%2520reduced%2520in%2520vivo%2520tumor%2520growth%2520in%2520mouse%2520xenograft%26jtitle%3DAnticancer%2520Res.%26date%3D2007%26volume%3D27%26spage%3D75%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Zheng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span> </span><span class="NLM_article-title">PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2010&pages=218-228&author=T.+Zhengauthor=X.+Mengauthor=J.+Wangauthor=X.+Chenauthor=D.+Yinauthor=Y.+Liangauthor=X.+Songauthor=S.+Panauthor=H.+Jiangauthor=L.+Liu&title=PTEN-+and+p53-mediated+apoptosis+and+cell+cycle+arrest+by+FTY720+in+gastric+cancer+cells+and+nude+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DT.%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DYin%26aufirst%3DD.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DPTEN-%2520and%2520p53-mediated%2520apoptosis%2520and%2520cell%2520cycle%2520arrest%2520by%2520FTY720%2520in%2520gastric%2520cancer%2520cells%2520and%2520nude%2520mice%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2010%26volume%3D111%26spage%3D218%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Takabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paugh, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">“Inside-out” signaling of sphingosine-1-phosphate: therapeutic targets</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=181-195&author=K.+Takabeauthor=S.+W.+Paughauthor=S.+Milstienauthor=S.+Spiegel&title=%E2%80%9CInside-out%E2%80%9D+signaling+of+sphingosine-1-phosphate%3A+therapeutic+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakabe%26aufirst%3DK.%26aulast%3DPaugh%26aufirst%3DS.%2BW.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3D%25E2%2580%259CInside-out%25E2%2580%259D%2520signaling%2520of%2520sphingosine-1-phosphate%253A%2520therapeutic%2520targets%26jtitle%3DPharmacol.%2520Rev.%26date%3D2008%26volume%3D60%26spage%3D181%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Kunkel, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maceyka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">702</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=688-702&author=G.+T.+Kunkelauthor=M.+Maceykaauthor=S.+Milstienauthor=S.+Spiegel&title=Targeting+the+sphingosine-1-phosphate+axis+in+cancer%2C+inflammation+and+beyond"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKunkel%26aufirst%3DG.%2BT.%26aulast%3DMaceyka%26aufirst%3DM.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DTargeting%2520the%2520sphingosine-1-phosphate%2520axis%2520in%2520cancer%252C%2520inflammation%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D688%26epage%3D702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cong, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span> </span><span class="NLM_article-title">FTY720 for cancer therapy (review)</span> <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2571</span><span class="NLM_x">–</span> <span class="NLM_lpage">2578</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=24100923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFens7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=2571-2578&author=L.+Zhangauthor=H.+D.+Wangauthor=X.+J.+Jiauthor=Z.+X.+Congauthor=J.+H.+Zhuauthor=Y.+Zhou&title=FTY720+for+cancer+therapy+%28review%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720 for cancer therapy (review)</span></div><div class="casAuthors">Zhang, Li; Wang, Han-Dong; Ji, Xiang-Jun; Cong, Zi-Xiang; Zhu, Jian-Hong; Zhou, Yuan</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2571-2578</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  2-Amino-2-[2-(4-octylphenyl)]-1,3-propanediol hydrochloride (FTY720) is a potent immunosuppressant which has been approved by the Food and Drug Administration (FDA) as a new treatment for multiple sclerosis.  As an immunosuppressant, it displays its anti-multiple sclerosis, immunosuppressive effects by activating sphingosine-1-phosphate receptors (S1PRs).  In addn. to the immunosuppressive effects, FTY720 also shows preclin. antitumor efficacy in several cancer models.  In most cases, phosphorylation of FTY720 is not required for its cytotoxic effect, indicating the involvement of S1PR-independent mechanisms which are starkly different from the immunosuppressive property of FTY720.  In the present study, we reviewed the rapidly advancing field of FTY720 in cancer therapy as well as some mol. targets of the unphosphorylated form of FTY720.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoweV7s8B10rbVg90H21EOLACvtfcHk0liOnkU0WCxGFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFens7%252FN&md5=7d7ada798b3758ec9d0ac10291e575d1</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%2BD.%26aulast%3DJi%26aufirst%3DX.%2BJ.%26aulast%3DCong%26aufirst%3DZ.%2BX.%26aulast%3DZhu%26aufirst%3DJ.%2BH.%26aulast%3DZhou%26aufirst%3DY.%26atitle%3DFTY720%2520for%2520cancer%2520therapy%2520%2528review%2529%26jtitle%3DOncol.%2520Rep.%26date%3D2013%26volume%3D30%26spage%3D2571%26epage%3D2578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradhan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span> </span><span class="NLM_article-title">Fingolimod (FTY720): first approved oral therapy for multiple sclerosis</span> <span class="citation_source-journal">J. Pharmacol. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.4103%2F0976-500X.77118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A280%3ADC%252BC3Mnjt1Srtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=49-51&author=S.+Sharmaauthor=A.+G.+Mathurauthor=S.+Pradhanauthor=D.+B.+Singhauthor=S.+Gupta&title=Fingolimod+%28FTY720%29%3A+first+approved+oral+therapy+for+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720): First approved oral therapy for multiple sclerosis</span></div><div class="casAuthors">Sharma Sushil; Mathur A G; Pradhan Sapna; Singh D B; Gupta Sparsh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacology & pharmacotherapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ4qpZm1OlRojAyhZbj3lKdfW6udTcc2eahVByL5UyPkbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mnjt1Srtg%253D%253D&md5=424019d3e63ead4c6e6198ad3a9de9d7</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.4103%2F0976-500X.77118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F0976-500X.77118%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DMathur%26aufirst%3DA.%2BG.%26aulast%3DPradhan%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DD.%2BB.%26aulast%3DGupta%26aufirst%3DS.%26atitle%3DFingolimod%2520%2528FTY720%2529%253A%2520first%2520approved%2520oral%2520therapy%2520for%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Pharmacol.%2520Pharmacother.%26date%3D2011%26volume%3D2%26spage%3D49%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Parrill, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bautista, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brocklyn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorincz, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liliom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span> </span><span class="NLM_article-title">Identification of Edg1 receptor residues that recognize sphingosine 1-phosphate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">39379</span><span class="NLM_x">–</span> <span class="NLM_lpage">39384</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1074%2Fjbc.M007680200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=10982820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptFSrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=39379-39384&author=A.+L.+Parrillauthor=D.+Wangauthor=D.+L.+Bautistaauthor=J.+R.+Van+Brocklynauthor=Z.+Lorinczauthor=D.+J.+Fischerauthor=D.+L.+Bakerauthor=K.+Liliomauthor=S.+Spiegelauthor=G.+Tigyi&title=Identification+of+Edg1+receptor+residues+that+recognize+sphingosine+1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Edg1 receptor residues that recognize sphingosine 1-phosphate</span></div><div class="casAuthors">Parrill, Abby L.; Wang, De-An; Bautista, Debra L.; Van Brocklyn, James R.; Lorincz, Zsolt; Fischer, David J.; Baker, Daniel L.; Liliom, Karoly; Spiegel, Sarah; Tigyi, Gabor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">39379-39384</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Originating from its DNA sequence, a computational model of the Edg1 receptor has been developed that predicts crit. interactions with its ligand, sphingosine 1-phosphate.  The basic amino acids Arg120 and Arg292 ion pair with the phosphate, whereas the acidic Glu121 residue ion pairs with the ammonium moiety of sphingosine 1-phosphate.  The requirement of these interactions for specific ligand recognition has been confirmed through examn. of site-directed mutants by radioligand binding, ligand-induced [35S]GTPγS binding, and receptor internalization assays.  These ion-pairing interactions explain the ligand specificity of the Edg1 receptor and provide insight into ligand specificity differences within the Edg receptor family.  This computational map of the ligand binding pocket provides information necessary for understanding the mol. pharmacol. of this receptor, thus underlining the potential of the computational method in predicting ligand-receptor interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8bLS2jWZ-dbVg90H21EOLACvtfcHk0liLwVTbKIjF3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptFSrsbg%253D&md5=2ff5a71db88fab6ff901d4c07e02f26c</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M007680200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M007680200%26sid%3Dliteratum%253Aachs%26aulast%3DParrill%26aufirst%3DA.%2BL.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DBautista%26aufirst%3DD.%2BL.%26aulast%3DVan%2BBrocklyn%26aufirst%3DJ.%2BR.%26aulast%3DLorincz%26aufirst%3DZ.%26aulast%3DFischer%26aufirst%3DD.%2BJ.%26aulast%3DBaker%26aufirst%3DD.%2BL.%26aulast%3DLiliom%26aufirst%3DK.%26aulast%3DSpiegel%26aufirst%3DS.%26aulast%3DTigyi%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520Edg1%2520receptor%2520residues%2520that%2520recognize%2520sphingosine%25201-phosphate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D39379%26epage%3D39384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Deng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, S. A.</span><span> </span><span class="NLM_article-title">Identification of Leu276 of the S1P1 receptor and Phe263 of the S1P3 receptor in interaction with receptor specific agonists by molecular modeling, site-directed mutagenesis, and affinity studies</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">724</span><span class="NLM_x">–</span> <span class="NLM_lpage">735</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=724-735&author=Q.+Dengauthor=J.+A.+Clemasauthor=G.+Chrebetauthor=P.+Fischerauthor=J.+J.+Haleauthor=Z.+Liauthor=S.+G.+Millsauthor=J.+Bergstromauthor=S.+Mandalaauthor=R.+Mosleyauthor=S.+A.+Parent&title=Identification+of+Leu276+of+the+S1P1+receptor+and+Phe263+of+the+S1P3+receptor+in+interaction+with+receptor+specific+agonists+by+molecular+modeling%2C+site-directed+mutagenesis%2C+and+affinity+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DQ.%26aulast%3DClemas%26aufirst%3DJ.%2BA.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DFischer%26aufirst%3DP.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DMosley%26aufirst%3DR.%26aulast%3DParent%26aufirst%3DS.%2BA.%26atitle%3DIdentification%2520of%2520Leu276%2520of%2520the%2520S1P1%2520receptor%2520and%2520Phe263%2520of%2520the%2520S1P3%2520receptor%2520in%2520interaction%2520with%2520receptor%2520specific%2520agonists%2520by%2520molecular%2520modeling%252C%2520site-directed%2520mutagenesis%252C%2520and%2520affinity%2520studies%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D71%26spage%3D724%26epage%3D735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Lim, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, N. J.</span><span> </span><span class="NLM_article-title">FTY720 analogues as sphingosine kinase 1 inhibitors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">18633</span><span class="NLM_x">–</span> <span class="NLM_lpage">18640</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=18633-18640&author=K.+G.+Limauthor=F.+Tonelliauthor=Z.+Liauthor=X.+Luauthor=R.+Bittmanauthor=S.+Pyneauthor=N.+J.+Pyne&title=FTY720+analogues+as+sphingosine+kinase+1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DK.%2BG.%26aulast%3DTonelli%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26atitle%3DFTY720%2520analogues%2520as%2520sphingosine%2520kinase%25201%2520inhibitors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D18633%26epage%3D18640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Lim, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdyshev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorshkova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leclercq, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, N. J.</span><span> </span><span class="NLM_article-title">Inhibition kinetics and regulation of sphingosine kinase 1 expression in prostate cancer cells: functional differences between sphingosine kinase 1a and 1b</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1457</span><span class="NLM_x">–</span> <span class="NLM_lpage">1464</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2Fj.biocel.2012.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=22634604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVektbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2012&pages=1457-1464&author=K.+G.+Limauthor=F.+Tonelliauthor=E.+Berdyshevauthor=I.+Gorshkovaauthor=T.+Leclercqauthor=S.+M.+Pitsonauthor=R.+Bittmanauthor=S.+Pyneauthor=N.+J.+Pyne&title=Inhibition+kinetics+and+regulation+of+sphingosine+kinase+1+expression+in+prostate+cancer+cells%3A+functional+differences+between+sphingosine+kinase+1a+and+1b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition kinetics and regulation of sphingosine kinase 1 expression in prostate cancer cells: Functional differences between sphingosine kinase 1a and 1b</span></div><div class="casAuthors">Lim, Keng Gat; Tonelli, Francesca; Berdyshev, Evgeny; Gorshkova, Irina; Leclercq, Tamara; Pitson, Stuart M.; Bittman, Robert; Pyne, Susan; Pyne, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1457-1464</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Sphingosine kinase 1 catalyzes the formation of the bioactive lipid, sphingosine 1-phosphate and is a target for anti-cancer agents.  We demonstrate here that 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole (SKi, also referred to as SKI-II), FTY720 (Fingolimod), and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 activity with distinct kinetics, indicating that these compds. exhibit different binding modalities with sphingosine kinase 1.  Thus, SKi is a mixed inhibitor of sphingosine and ATP binding, whereas FTY720 is competitive with sphingosine and uncompetitive with ATP, and (S)-FTY720 vinylphosphonate is uncompetitive with sphingosine and is a mixed inhibitor with respect to ATP.  A novel see-saw' model is proposed for the binding of inhibitor to catalytic and allosteric sites, the latter dependent on substrate binding, that provides an explanation for the different inhibitor kinetics.  In addn., we demonstrate that the expression level and properties unique to an N-terminal 86 amino-acid isoform variant of sphingosine kinase 1 (SK1b) in prostate cancer cells reduce its sensitivity to SKi-induced proteasomal degrdn. in comparison to SK1a, i.e. these two N-terminal variants of sphingosine kinase 1 (SK1a and SK1b) have different properties.  The reduced sensitivity of SK1b to proteasomal degrdn. in response to SKi is translated into specific changes in ceramide and S1P levels that leads to apoptosis of androgen-sensitive but not androgen-independent LNCaP prostate cancer cells.  Therefore, our proposed see-saw' model might be usefully employed in the design of sphingosine kinase inhibitors to promote apoptosis of chemotherapeutic resistant cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1g1AAUtLNBLVg90H21EOLACvtfcHk0liLwVTbKIjF3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVektbnL&md5=3ffa9b6af3a1012c10150e297ffcf69c</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2012.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2012.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DK.%2BG.%26aulast%3DTonelli%26aufirst%3DF.%26aulast%3DBerdyshev%26aufirst%3DE.%26aulast%3DGorshkova%26aufirst%3DI.%26aulast%3DLeclercq%26aufirst%3DT.%26aulast%3DPitson%26aufirst%3DS.%2BM.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26atitle%3DInhibition%2520kinetics%2520and%2520regulation%2520of%2520sphingosine%2520kinase%25201%2520expression%2520in%2520prostate%2520cancer%2520cells%253A%2520functional%2520differences%2520between%2520sphingosine%2520kinase%25201a%2520and%25201b%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2012%26volume%3D44%26spage%3D1457%26epage%3D1464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Pyne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, N. J.</span><span> </span><span class="NLM_article-title">New perspectives on the role of sphingosine 1-phosphate in cancer</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">216</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1007%2F978-3-7091-1511-4_3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=23563651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKls73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=2013&pages=55-71&author=S.+Pyneauthor=N.+J.+Pyne&title=New+perspectives+on+the+role+of+sphingosine+1-phosphate+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">New perspectives on the role of sphingosine 1-phosphate in cancer</span></div><div class="casAuthors">Pyne, Susan; Pyne, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">216</span>
        (<span class="NLM_cas:issue">Sphingolipids in Disease</span>),
    <span class="NLM_cas:pages">55-71</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">In this chapter, we review the latest developments concerning the role of sphingosine 1-phosphate (S1P) in cancer.  Particular focus is paid to the role of sphingosine kinases 1 and 2, S1P lyase and S1P-dependent signalling networks in both solid tumors and haematol. cancer.  The potential of this S1P-dependent pathophysiol. as a therapeutic target for the treatment of cancer is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPNhVc8oIFGrVg90H21EOLACvtfcHk0li9Yled6oHcUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKls73F&md5=69036ae2d4279f36f45bb631fbe3feaf</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1007%2F978-3-7091-1511-4_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-7091-1511-4_3%26sid%3Dliteratum%253Aachs%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26atitle%3DNew%2520perspectives%2520on%2520the%2520role%2520of%2520sphingosine%25201-phosphate%2520in%2520cancer%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2013%26volume%3D216%26spage%3D55%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Pyne, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate signalling in cancer</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1042%2FBST20110602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=22260672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=94-100&author=N.+J.+Pyneauthor=F.+Tonelliauthor=K.+G.+Limauthor=J.+S.+Longauthor=J.+Edwardsauthor=S.+Pyne&title=Sphingosine+1-phosphate+signalling+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate signalling in cancer</span></div><div class="casAuthors">Pyne, Nigel J.; Tonelli, Francesca; Lim, Keng Gat; Long, Jaclyn S.; Edwards, Joanne; Pyne, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-100</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  There is an increasing body of evidence demonstrating a crit. role for the bioactive lipid S1P (sphingosine 1-phosphate) in cancer.  S1P is synthesized and metabolized by a no. of enzymes, including sphingosine kinase, S1P lyase and S1P phosphatases.  S1P binds to cell-surface G-protein-coupled receptors (S1P1-S1P5) to elicit cell responses and can also regulate, by direct binding, a no. of intracellular targets such as HDAC (histone deacetylase) 1/2 to induce epigenetic regulation.  S1P is involved in cancer progression including cell transformation/oncogenesis, cell survival/apoptosis, cell migration/metastasis and tumor microenvironment neovascularization.  In the present paper, we describe our research findings regarding the correlation of sphingosine kinase 1 and S1P receptor expression in tumors with clin. outcome and we define some of the mol. mechanisms underlying the involvement of sphingosine kinase 1 and S1P receptors in the formation of a cancer cell migratory phenotype.  The role of sphingosine kinase 1 in the acquisition of chemotherapeutic resistance and the interaction of S1P receptors with oncogenes such as HER2 is also reviewed.  We also discuss novel aspects of the use of small-mol. inhibitors of sphingosine kinase 1 in terms of allosterism, ubiquitin-proteasomal degrdn. of sphingosine kinase 1 and anticancer activity.  Finally, we describe how S1P receptor-modulating agents abrogate S1P receptor-receptor tyrosine kinase interactions, with potential to inhibit growth-factor-dependent cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryryplFV-76bVg90H21EOLACvtfcHk0li9Yled6oHcUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCqurc%253D&md5=e0f90be10095c1d682345caaf8cce2c0</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1042%2FBST20110602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20110602%26sid%3Dliteratum%253Aachs%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DTonelli%26aufirst%3DF.%26aulast%3DLim%26aufirst%3DK.%2BG.%26aulast%3DLong%26aufirst%3DJ.%2BS.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DPyne%26aufirst%3DS.%26atitle%3DSphingosine%25201-phosphate%2520signalling%2520in%2520cancer%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2012%26volume%3D40%26spage%3D94%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Kim, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsutake, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of sphingoid analogs as inhibitors of sphingosine kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3475</span><span class="NLM_x">–</span> <span class="NLM_lpage">3485</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=3475-3485&author=J.+W.+Kimauthor=Y.+W.+Kimauthor=Y.+Inagakiauthor=Y.+A.+Hwangauthor=S.+Mitsutakeauthor=Y.+W.+Ryuauthor=W.+K.+Leeauthor=H.+J.+Haauthor=C.+S.+Parkauthor=Y.+Igarashi&title=Synthesis+and+evaluation+of+sphingoid+analogs+as+inhibitors+of+sphingosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DKim%26aufirst%3DY.%2BW.%26aulast%3DInagaki%26aufirst%3DY.%26aulast%3DHwang%26aufirst%3DY.%2BA.%26aulast%3DMitsutake%26aufirst%3DS.%26aulast%3DRyu%26aufirst%3DY.%2BW.%26aulast%3DLee%26aufirst%3DW.%2BK.%26aulast%3DHa%26aufirst%3DH.%2BJ.%26aulast%3DPark%26aufirst%3DC.%2BS.%26aulast%3DIgarashi%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520sphingoid%2520analogs%2520as%2520inhibitors%2520of%2520sphingosine%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D3475%26epage%3D3485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Hara-Yokoyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terasawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirabayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagishita, M.</span><span> </span><span class="NLM_article-title">Sphingosine kinase 2 inhibitor accelerates Fas-mediated cell death progression in A2O/2J cells</span> <span class="citation_source-journal">Open Bioact. Compd. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.2174%2F1874847300801010022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFym" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2008&pages=22-27&author=M.+Hara-Yokoyamaauthor=K.+Terasawaauthor=A.+Kiharaauthor=J.+W.+Kimauthor=C.+S.+Parkauthor=Y.+Hirabayashiauthor=Y.+Igarashiauthor=M.+Yanagishita&title=Sphingosine+kinase+2+inhibitor+accelerates+Fas-mediated+cell+death+progression+in+A2O%2F2J+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine kinase 2 inhibitor accelerates Fas-mediated cell death progression in A20/2J cells</span></div><div class="casAuthors">Hara-Yokoyama, Miki; Terasawa, Kazue; Kihara, Akio; Kim, Jin-Wook; Park, Chan-Seo; Hirabayashi, Yoshio; Igarashi, Yasuyuki; Yanagishita, Masaki</div><div class="citationInfo"><span class="NLM_cas:title">Open Bioactive Compounds Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22-27</span>CODEN:
                <span class="NLM_cas:coden">OBCJAU</span>;
        ISSN:<span class="NLM_cas:issn">1874-8473</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A sphingosine kinase (SPHK) type 2 inhibitor, SG-12, inhibited the SPHK2 activity in A20/2J cells and promoted Fas-dependent cell death.  The effect of SG-12 on cell death was relieved by SPHK2 transfection but not by SPHK1 transfection.  The results suggest a SPHK2-specific suppression of Fas-dependent cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv9ZypgRQQc7Vg90H21EOLACvtfcHk0li9Yled6oHcUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFym&md5=6c49cc5f85613fcd73839322992cfbec</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.2174%2F1874847300801010022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1874847300801010022%26sid%3Dliteratum%253Aachs%26aulast%3DHara-Yokoyama%26aufirst%3DM.%26aulast%3DTerasawa%26aufirst%3DK.%26aulast%3DKihara%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DPark%26aufirst%3DC.%2BS.%26aulast%3DHirabayashi%26aufirst%3DY.%26aulast%3DIgarashi%26aufirst%3DY.%26aulast%3DYanagishita%26aufirst%3DM.%26atitle%3DSphingosine%2520kinase%25202%2520inhibitor%2520accelerates%2520Fas-mediated%2520cell%2520death%2520progression%2520in%2520A2O%252F2J%2520cells%26jtitle%3DOpen%2520Bioact.%2520Compd.%2520J.%26date%3D2008%26volume%3D1%26spage%3D22%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Hara-Yokoyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terasawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichinose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podyma-Inoue, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyoshi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagishita, M.</span><span> </span><span class="NLM_article-title">Sphingosine kinase 2 inhibitor SG-12 induces apoptosis via phosphorylation by sphingosine kinase 2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2220</span><span class="NLM_x">–</span> <span class="NLM_lpage">2224</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=2220-2224&author=M.+Hara-Yokoyamaauthor=K.+Terasawaauthor=S.+Ichinoseauthor=A.+Watanabeauthor=K.+A.+Podyma-Inoueauthor=K.+Akiyoshiauthor=Y.+Igarashiauthor=M.+Yanagishita&title=Sphingosine+kinase+2+inhibitor+SG-12+induces+apoptosis+via+phosphorylation+by+sphingosine+kinase+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHara-Yokoyama%26aufirst%3DM.%26aulast%3DTerasawa%26aufirst%3DK.%26aulast%3DIchinose%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DPodyma-Inoue%26aufirst%3DK.%2BA.%26aulast%3DAkiyoshi%26aufirst%3DK.%26aulast%3DIgarashi%26aufirst%3DY.%26aulast%3DYanagishita%26aufirst%3DM.%26atitle%3DSphingosine%2520kinase%25202%2520inhibitor%2520SG-12%2520induces%2520apoptosis%2520via%2520phosphorylation%2520by%2520sphingosine%2520kinase%25202%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D2220%26epage%3D2224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Nishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iio, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawase, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nara, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inaba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomisato, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimozato, T.</span><span> </span><span class="NLM_article-title">Discovery of CS-0777: a potent, selective, and orally active S1P1 agonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">368</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100301k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=368-372&author=T.+Nishiauthor=S.+Miyazakiauthor=T.+Takemotoauthor=K.+Suzukiauthor=Y.+Iioauthor=K.+Nakajimaauthor=T.+Ohnukiauthor=Y.+Kawaseauthor=F.+Naraauthor=S.+Inabaauthor=T.+Izumiauthor=H.+Yuitaauthor=K.+Oshimaauthor=H.+Doiauthor=R.+Inoueauthor=W.+Tomisatoauthor=T.+Kagariauthor=T.+Shimozato&title=Discovery+of+CS-0777%3A+a+potent%2C+selective%2C+and+orally+active+S1P1+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fml100301k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100301k%26sid%3Dliteratum%253Aachs%26aulast%3DNishi%26aufirst%3DT.%26aulast%3DMiyazaki%26aufirst%3DS.%26aulast%3DTakemoto%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DIio%26aufirst%3DY.%26aulast%3DNakajima%26aufirst%3DK.%26aulast%3DOhnuki%26aufirst%3DT.%26aulast%3DKawase%26aufirst%3DY.%26aulast%3DNara%26aufirst%3DF.%26aulast%3DInaba%26aufirst%3DS.%26aulast%3DIzumi%26aufirst%3DT.%26aulast%3DYuita%26aufirst%3DH.%26aulast%3DOshima%26aufirst%3DK.%26aulast%3DDoi%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DR.%26aulast%3DTomisato%26aufirst%3DW.%26aulast%3DKagari%26aufirst%3DT.%26aulast%3DShimozato%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520CS-0777%253A%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520S1P1%2520agonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D368%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Moberly, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truitt, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollmer, T. L.</span><span> </span><span class="NLM_article-title">Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: results from a 12-week, open-label pilot study in multiple sclerosis patients</span> <span class="citation_source-journal">J. Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">246</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2Fj.jneuroim.2012.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=22465063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvF2jtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=2012&pages=100-107&author=J.+B.+Moberlyauthor=D.+M.+Fordauthor=H.+Zahirauthor=S.+Chenauthor=T.+Mochizukiauthor=K.+E.+Truittauthor=T.+L.+Vollmer&title=Pharmacological+effects+of+CS-0777%2C+a+selective+sphingosine+1-phosphate+receptor-1+modulator%3A+results+from+a+12-week%2C+open-label+pilot+study+in+multiple+sclerosis+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: Results from a 12-week, open-label pilot study in multiple sclerosis patients</span></div><div class="casAuthors">Moberly, James B.; Ford, Daniel M.; Zahir, Hamim; Chen, Shuquan; Mochizuki, Takashi; Truitt, Kenneth E.; Vollmer, Timothy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">100-107</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">CS-0777 is a selective sphingosine 1-phosphate receptor-1 modulator under investigation for treatment of multiple sclerosis (MS).  We conducted an open-label, pilot study in 25 MS patients to assess the safety, pharmacokinetics, pharmacodynamics and exploratory efficacy of oral CS-0777 (0.1, 0.3 and 0.6 mg), administered once weekly or every other week for 12 wk.  CS-0777 resulted in a pronounced, dose-dependent decrease in lymphocytes and CD4 T cell subsets, which returned to baseline within 4 wk after the last dose.  Overall, CS-0777 was safe and well-tolerated.  These results require confirmation in a double-blind, placebo-controlled and adequately powered phase 2 study in MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnUDMmZ5gpHLVg90H21EOLACvtfcHk0lg63yr5Urryyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvF2jtbY%253D&md5=ce750c33bbfd69ba65304cb02f7c22f9</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2012.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2012.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DMoberly%26aufirst%3DJ.%2BB.%26aulast%3DFord%26aufirst%3DD.%2BM.%26aulast%3DZahir%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DMochizuki%26aufirst%3DT.%26aulast%3DTruitt%26aufirst%3DK.%2BE.%26aulast%3DVollmer%26aufirst%3DT.%2BL.%26atitle%3DPharmacological%2520effects%2520of%2520CS-0777%252C%2520a%2520selective%2520sphingosine%25201-phosphate%2520receptor-1%2520modulator%253A%2520results%2520from%2520a%252012-week%252C%2520open-label%2520pilot%2520study%2520in%2520multiple%2520sclerosis%2520patients%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2012%26volume%3D246%26spage%3D100%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Humpf, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmelz, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesper, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vales, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menaldino, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrill, A. H.,  Jr.</span><span> </span><span class="NLM_article-title">Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase. Formation of <i>N</i>-palmitoyl-aminopentol produces a toxic metabolite of hydrolyzed fumonisin, AP1, and a new category of ceramide synthase inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">19060</span><span class="NLM_x">–</span> <span class="NLM_lpage">19064</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=19060-19064&author=H.+U.+Humpfauthor=E.+M.+Schmelzauthor=F.+I.+Meredithauthor=H.+Vesperauthor=T.+R.+Valesauthor=E.+Wangauthor=D.+S.+Menaldinoauthor=D.+C.+Liottaauthor=A.+H.+Merrill&title=Acylation+of+naturally+occurring+and+synthetic+1-deoxysphinganines+by+ceramide+synthase.+Formation+of+N-palmitoyl-aminopentol+produces+a+toxic+metabolite+of+hydrolyzed+fumonisin%2C+AP1%2C+and+a+new+category+of+ceramide+synthase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHumpf%26aufirst%3DH.%2BU.%26aulast%3DSchmelz%26aufirst%3DE.%2BM.%26aulast%3DMeredith%26aufirst%3DF.%2BI.%26aulast%3DVesper%26aufirst%3DH.%26aulast%3DVales%26aufirst%3DT.%2BR.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DMenaldino%26aufirst%3DD.%2BS.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26atitle%3DAcylation%2520of%2520naturally%2520occurring%2520and%2520synthetic%25201-deoxysphinganines%2520by%2520ceramide%2520synthase.%2520Formation%2520of%2520N-palmitoyl-aminopentol%2520produces%2520a%2520toxic%2520metabolite%2520of%2520hydrolyzed%2520fumonisin%252C%2520AP1%252C%2520and%2520a%2520new%2520category%2520of%2520ceramide%2520synthase%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D19060%26epage%3D19064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Symolon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushnev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramaraju, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mays, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegood, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruett, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullards, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillehay, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrill, A. H.,  Jr.</span><span> </span><span class="NLM_article-title">Enigmol: a novel sphingolipid analogue with anticancer activity against cancer cell lines and in vivo models for intestinal and prostate cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">648</span><span class="NLM_x">–</span> <span class="NLM_lpage">657</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1158%2F1535-7163.MCT-10-0754" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=21398423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSrtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=648-657&author=H.+Symolonauthor=A.+Bushnevauthor=Q.+Pengauthor=H.+Ramarajuauthor=S.+G.+Maysauthor=J.+C.+Allegoodauthor=S.+T.+Pruettauthor=M.+C.+Sullardsauthor=D.+L.+Dillehayauthor=D.+C.+Liottaauthor=A.+H.+Merrill&title=Enigmol%3A+a+novel+sphingolipid+analogue+with+anticancer+activity+against+cancer+cell+lines+and+in+vivo+models+for+intestinal+and+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Enigmol: A Novel Sphingolipid Analogue with Anticancer Activity against Cancer Cell Lines and In vivo Models for Intestinal and Prostate Cancer</span></div><div class="casAuthors">Symolon, Holly; Bushnev, Anatoliy; Peng, Qiong; Ramaraju, Harsha; Mays, Suzanne G.; Allegood, Jeremy C.; Pruett, Sarah T.; Sullards, M. Cameron; Dillehay, Dirck L.; Liotta, Dennis C.; Merrill, Alfred H., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">648-657</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Sphingoid bases are cytotoxic for many cancer cell lines and are thought to contribute to suppression of intestinal tumorigenesis in vivo by ingested sphingolipids.  This study explored the behavior of a sphingoid base analog, (2S,3S,5S)-2-amino-3,5-dihydroxyoctadecane (Enigmol), that cannot be phosphorylated by sphingosine kinases and is slowly N-acylated and therefore is more persistent than natural sphingoid bases.  Enigmol had potential anticancer activity in a National Cancer Institute (NCI-60) cell line screen and was confirmed to be more cytotoxic and persistent than naturally occurring sphingoid bases using HT29 cells, a colon cancer cell line.  Although the mol. targets of sphingoid bases are not well delineated, Enigmol shared one of the mechanisms that has been found for naturally occurring sphingoid bases: normalization of the aberrant accumulation of β-catenin in the nucleus and cytoplasm of colon cancer cells due to defect(s) in the adenomatous polyposis coli (APC)/β-catenin regulatory system.  Enigmol also had antitumor efficacy when administered orally to Min mice, a mouse model with a truncated APC gene product (C57Bl/6JMin/+ mice), decreasing the no. of intestinal tumors by half at 0.025% of the diet (wt./wt.), with no evidence of host toxicity until higher dosages.  Enigmol was also tested against the prostate cancer cell lines DU145 and PC-3 in nude mouse xenografts and suppressed tumor growth in both.  Thus, Enigmol represents a novel category of sphingoid base analog that is orally bioavailable and has the potential to be effective against multiple types of cancer.  Mol Cancer Ther; 10(4); 648-57.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAT97RiH5ehrVg90H21EOLACvtfcHk0ljeEyvL4tjDlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSrtLo%253D&md5=ddfa116c8344f76b548d45a27081b0d1</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0754%26sid%3Dliteratum%253Aachs%26aulast%3DSymolon%26aufirst%3DH.%26aulast%3DBushnev%26aufirst%3DA.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DRamaraju%26aufirst%3DH.%26aulast%3DMays%26aufirst%3DS.%2BG.%26aulast%3DAllegood%26aufirst%3DJ.%2BC.%26aulast%3DPruett%26aufirst%3DS.%2BT.%26aulast%3DSullards%26aufirst%3DM.%2BC.%26aulast%3DDillehay%26aufirst%3DD.%2BL.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26atitle%3DEnigmol%253A%2520a%2520novel%2520sphingolipid%2520analogue%2520with%2520anticancer%2520activity%2520against%2520cancer%2520cell%2520lines%2520and%2520in%2520vivo%2520models%2520for%2520intestinal%2520and%2520prostate%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D648%26epage%3D657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Garnier-Amblard, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mays, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrendale, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushnev, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culver, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebeskind, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menaldino, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natchus, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petros, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramaraju, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span> </span><span class="NLM_article-title">Novel synthesis and biological evaluation of enigmols as therapeutic agents for treating prostate cancer</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">438</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml2000164" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=438-443&author=E.+C.+Garnier-Amblardauthor=S.+G.+Maysauthor=R.+F.+Arrendaleauthor=M.+T.+Baillieauthor=A.+S.+Bushnevauthor=D.+G.+Culverauthor=T.+J.+Eversauthor=J.+J.+Holtauthor=R.+B.+Howardauthor=L.+S.+Liebeskindauthor=D.+S.+Menaldinoauthor=M.+G.+Natchusauthor=J.+A.+Petrosauthor=H.+Ramarajuauthor=G.+P.+Reddyauthor=D.+C.+Liotta&title=Novel+synthesis+and+biological+evaluation+of+enigmols+as+therapeutic+agents+for+treating+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fml2000164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2000164%26sid%3Dliteratum%253Aachs%26aulast%3DGarnier-Amblard%26aufirst%3DE.%2BC.%26aulast%3DMays%26aufirst%3DS.%2BG.%26aulast%3DArrendale%26aufirst%3DR.%2BF.%26aulast%3DBaillie%26aufirst%3DM.%2BT.%26aulast%3DBushnev%26aufirst%3DA.%2BS.%26aulast%3DCulver%26aufirst%3DD.%2BG.%26aulast%3DEvers%26aufirst%3DT.%2BJ.%26aulast%3DHolt%26aufirst%3DJ.%2BJ.%26aulast%3DHoward%26aufirst%3DR.%2BB.%26aulast%3DLiebeskind%26aufirst%3DL.%2BS.%26aulast%3DMenaldino%26aufirst%3DD.%2BS.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DPetros%26aufirst%3DJ.%2BA.%26aulast%3DRamaraju%26aufirst%3DH.%26aulast%3DReddy%26aufirst%3DG.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26atitle%3DNovel%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520enigmols%2520as%2520therapeutic%2520agents%2520for%2520treating%2520prostate%2520cancer%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D438%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Mays, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushnev, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruett, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culver, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natchus, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrendale, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petros, J. A.</span><span> </span><span class="NLM_article-title">330 Fluorination of enigmol improves tissue uptake and effects in vivo prostate cancer efficacy</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">189</span><span class="NLM_x">, </span> <span class="NLM_fpage">e133</span><span class="NLM_x">–</span> <span class="NLM_lpage">e134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2013&pages=e133-e134&author=S.+G.+Maysauthor=M.+T.+Baillieauthor=E.+J.+Millerauthor=A.+S.+Bushnevauthor=S.+T.+Pruettauthor=D.+G.+Culverauthor=T.+J.+Eversauthor=J.+Gaoauthor=G.+P.+Reddyauthor=M.+G.+Natchusauthor=R.+F.+Arrendaleauthor=R.+B.+Howardauthor=D.+C.+Liottaauthor=J.+A.+Petros&title=330+Fluorination+of+enigmol+improves+tissue+uptake+and+effects+in+vivo+prostate+cancer+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMays%26aufirst%3DS.%2BG.%26aulast%3DBaillie%26aufirst%3DM.%2BT.%26aulast%3DMiller%26aufirst%3DE.%2BJ.%26aulast%3DBushnev%26aufirst%3DA.%2BS.%26aulast%3DPruett%26aufirst%3DS.%2BT.%26aulast%3DCulver%26aufirst%3DD.%2BG.%26aulast%3DEvers%26aufirst%3DT.%2BJ.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DReddy%26aufirst%3DG.%2BP.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DArrendale%26aufirst%3DR.%2BF.%26aulast%3DHoward%26aufirst%3DR.%2BB.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DPetros%26aufirst%3DJ.%2BA.%26atitle%3D330%2520Fluorination%2520of%2520enigmol%2520improves%2520tissue%2520uptake%2520and%2520effects%2520in%2520vivo%2520prostate%2520cancer%2520efficacy%26jtitle%3DJ.%2520Urol.%26date%3D2013%26volume%3D189%26spage%3De133%26epage%3De134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Foss, F. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okusa, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=663-677&author=F.+W.+Fossauthor=A.+H.+Snyderauthor=M.+D.+Davisauthor=M.+Rouseauthor=M.+D.+Okusaauthor=K.+R.+Lynchauthor=T.+L.+Macdonald&title=Synthesis+and+biological+evaluation+of+gamma-aminophosphonates+as+potent%2C+subtype-selective+sphingosine+1-phosphate+receptor+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoss%26aufirst%3DF.%2BW.%26aulast%3DSnyder%26aufirst%3DA.%2BH.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DRouse%26aufirst%3DM.%26aulast%3DOkusa%26aufirst%3DM.%2BD.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520gamma-aminophosphonates%2520as%2520potent%252C%2520subtype-selective%2520sphingosine%25201-phosphate%2520receptor%2520agonists%2520and%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D663%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Foss, F. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6123</span><span class="NLM_x">–</span> <span class="NLM_lpage">6136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2Fj.bmc.2009.04.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=19632123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1Crsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=6123-6136&author=F.+W.+Fossauthor=T.+P.+Mathewsauthor=Y.+Kharelauthor=P.+C.+Kennedyauthor=A.+H.+Snyderauthor=M.+D.+Davisauthor=K.+R.+Lynchauthor=T.+L.+Macdonald&title=Synthesis+and+biological+evaluation+of+sphingosine+kinase+substrates+as+sphingosine-1-phosphate+receptor+prodrugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs</span></div><div class="casAuthors">Foss, Frank W.; Mathews, Thomas P.; Kharel, Yugesh; Kennedy, Perry C.; Snyder, Ashley H.; Davis, Michael D.; Lynch, Kevin R.; MacDonald, Timothy L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6123-6136</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In the search for bioactive sphingosine 1-phosphate (S1P) receptor ligands, a series of 2-amino-2-heterocyclic-propanols were synthesized.  These mols. were discovered to be substrates of human-sphingosine kinases 1 and 2 (SPHK1 and SPHK2).  When phosphorylated, the resultant phosphates showed varied activities at the five sphingosine-1-phosphate (S1P) receptors (S1P1-5).  Agonism at S1P1 was displayed in vivo by induction of lymphopenia.  A stereochem. preference of the quaternary carbon was crucial for phosphorylation by the kinases and alters binding affinities at the S1P receptors.  Oxazole and oxadiazole compds. are superior kinase substrates to FTY720, the prototypical prodrug immunomodulator, fingolimod (FTY720).  The oxazole-derived structure was the most active for human SPHK2.  Imidazole analogs were less active substrates for SPHKs, but more potent and selective agonists of the S1P1 receptor; addnl., the imidazole class of compds. rendered mice lymphopenic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmuspJ6izmqbVg90H21EOLACvtfcHk0ljeEyvL4tjDlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1Crsbk%253D&md5=4756f9c22f4ba11c04e52b5e74adc630</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.04.015%26sid%3Dliteratum%253Aachs%26aulast%3DFoss%26aufirst%3DF.%2BW.%26aulast%3DMathews%26aufirst%3DT.%2BP.%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DKennedy%26aufirst%3DP.%2BC.%26aulast%3DSnyder%26aufirst%3DA.%2BH.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520sphingosine%2520kinase%2520substrates%2520as%2520sphingosine-1-phosphate%2520receptor%2520prodrugs%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D6123%26epage%3D6136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Mathews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoara, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunkara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wamhoff, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span> </span><span class="NLM_article-title">Discovery, biological evaluation, and structure–activity relationship of amidine based sphingosine kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2766</span><span class="NLM_x">–</span> <span class="NLM_lpage">2778</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901860h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2766-2778&author=T.+P.+Mathewsauthor=A.+J.+Kennedyauthor=Y.+Kharelauthor=P.+C.+Kennedyauthor=O.+Nicoaraauthor=M.+Sunkaraauthor=A.+J.+Morrisauthor=B.+R.+Wamhoffauthor=K.+R.+Lynchauthor=T.+L.+Macdonald&title=Discovery%2C+biological+evaluation%2C+and+structure%E2%80%93activity+relationship+of+amidine+based+sphingosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjm901860h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901860h%26sid%3Dliteratum%253Aachs%26aulast%3DMathews%26aufirst%3DT.%2BP.%26aulast%3DKennedy%26aufirst%3DA.%2BJ.%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DKennedy%26aufirst%3DP.%2BC.%26aulast%3DNicoara%26aufirst%3DO.%26aulast%3DSunkara%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DA.%2BJ.%26aulast%3DWamhoff%26aufirst%3DB.%2BR.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DDiscovery%252C%2520biological%2520evaluation%252C%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520amidine%2520based%2520sphingosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2766%26epage%3D2778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Kennedy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Field, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">East, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houck, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span> </span><span class="NLM_article-title">Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3524</span><span class="NLM_x">–</span> <span class="NLM_lpage">3548</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2001053" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVyhs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3524-3548&author=A.+J.+Kennedyauthor=T.+P.+Mathewsauthor=Y.+Kharelauthor=S.+D.+Fieldauthor=M.+L.+Moyerauthor=J.+E.+Eastauthor=J.+D.+Houckauthor=K.+R.+Lynchauthor=T.+L.+Macdonald&title=Development+of+amidine-based+sphingosine+kinase+1+nanomolar+inhibitors+and+reduction+of+sphingosine+1-phosphate+in+human+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Amidine-Based Sphingosine Kinase 1 Nanomolar Inhibitors and Reduction of Sphingosine 1-Phosphate in Human Leukemia Cells</span></div><div class="casAuthors">Kennedy, Andrew J.; Mathews, Thomas P.; Kharel, Yugesh; Field, Saundra D.; Moyer, Morgan L.; East, James E.; Houck, Joseph D.; Lynch, Kevin R.; MacDonald, Timothy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3524-3548</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a bioactive lipid that has been identified as an accelerant of cancer progression.  The sphingosine kinases (SphKs) are the sole producers of S1P, and thus, SphK inhibitors may prove effective in cancer mitigation and chemosensitization.  Of the two SphKs, SphK1 overexpression has been obsd. in a myriad of cancer cell lines and tissues and has been recognized as the presumptive target over that of the poorly characterized SphK2.  Herein, the authors present the design and synthesis of amidine-based nanomolar SphK1 subtype-selective inhibitors.  A homol. model of SphK1, trained with this library of amidine inhibitors, was then used to predict the activity of addnl., more potent, inhibitors.  Lastly, select amidine inhibitors were validated in human leukemia U937 cells, where they significantly reduced endogenous S1P levels at nanomolar concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiiQaZkSe6UrVg90H21EOLACvtfcHk0lirfyF3baaeHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVyhs7c%253D&md5=a8a72acfa6b5893deb75a91cec2e8938</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm2001053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2001053%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DA.%2BJ.%26aulast%3DMathews%26aufirst%3DT.%2BP.%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DField%26aufirst%3DS.%2BD.%26aulast%3DMoyer%26aufirst%3DM.%2BL.%26aulast%3DEast%26aufirst%3DJ.%2BE.%26aulast%3DHouck%26aufirst%3DJ.%2BD.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DDevelopment%2520of%2520amidine-based%2520sphingosine%2520kinase%25201%2520nanomolar%2520inhibitors%2520and%2520reduction%2520of%2520sphingosine%25201-phosphate%2520in%2520human%2520leukemia%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3524%26epage%3D3548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Kharel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellett, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomsig, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, W. L.</span><span> </span><span class="NLM_article-title">Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">447</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1042%2FBJ20120609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=22747486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlCjsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2012&pages=149-157&author=Y.+Kharelauthor=M.+Rajeauthor=M.+Gaoauthor=A.+M.+Gellettauthor=J.+L.+Tomsigauthor=K.+R.+Lynchauthor=W.+L.+Santos&title=Sphingosine+kinase+type+2+inhibition+elevates+circulating+sphingosine+1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate</span></div><div class="casAuthors">Kharel, Yugesh; Raje, Mithun; Gao, Ming; Gellett, Amanda M.; Tomsig, Jose L.; Lynch, Kevin R.; Santos, Webster L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">447</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">149-157</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">S1P (sphingosine 1-phosphate) is a pleiotropic lipid mediator involved in numerous cellular and physiol. functions.  Of note among these are cell survival and migration, as well as lymphocyte trafficking.  S1P, which exerts its effects via five GPCRs (G-protein-coupled receptors) (S1P1-S1P5), is formed by the action of two SphKs (sphingosine kinases).  Although SphK1 is the more intensively studied isotype, SphK2 is unique in it nuclear localization and has been reported to oppose some of the actions ascribed to SphK1.  Although several scaffolds of SphK1 inhibitors have been described, there is a scarcity of selective SphK2 inhibitors that are necessary to evaluate the downstream effects of inhibition of this isotype.  In the present paper we report a cationic amphiphilic small mol. that is a selective SphK2 inhibitor.  In the course of characterizing this compd. in wild-type and SphK-null mice, we discovered that administration of the inhibitor to wild-type mice resulted in a rapid increase in blood S1P, which is in contrast with our SphK1 inhibitor that drives circulating S1P levels down.  Using a cohort of F2 hybrid mice, we confirmed, compared with wild-type mice, that circulating S1P levels were higher in SphK2-null mice and lower in SphK1-null mice.  Thus both SphK1 and SphK2 inhibitors recapitulate the blood S1P levels obsd. in the corresponding null mice.  Moreover, circulating S1P levels mirror SphK2 inhibitor levels, providing a convenient biomarker of target engagement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKDtUfuqfG5bVg90H21EOLACvtfcHk0lirfyF3baaeHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlCjsLrE&md5=dbd6766a0d93b120155a2c0caa69ceda</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1042%2FBJ20120609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20120609%26sid%3Dliteratum%253Aachs%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DRaje%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DGellett%26aufirst%3DA.%2BM.%26aulast%3DTomsig%26aufirst%3DJ.%2BL.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DSantos%26aufirst%3DW.%2BL.%26atitle%3DSphingosine%2520kinase%2520type%25202%2520inhibition%2520elevates%2520circulating%2520sphingosine%25201-phosphate%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D447%26spage%3D149%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Liu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hait, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parikh, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellogg, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span> </span><span class="NLM_article-title">Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e56471</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1371%2Fjournal.pone.0056471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=23437140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsF2ju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e56471&author=K.+Liuauthor=T.+L.+Guoauthor=N.+C.+Haitauthor=J.+Allegoodauthor=H.+I.+Parikhauthor=W.+Xuauthor=G.+E.+Kelloggauthor=S.+Grantauthor=S.+Spiegelauthor=S.+Zhang&title=Biological+characterization+of+3-%282-amino-ethyl%29-5-%5B3-%284-butoxyl-phenyl%29-propylidene%5D-thiazolidine-2%2C4-dione+%28K145%29+as+a+selective+sphingosine+kinase-2+inhibitor+and+anticancer+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent</span></div><div class="casAuthors">Liu, Kai; Guo, Tai L.; Hait, Nitai C.; Allegood, Jeremy; Parikh, Hardik I.; Xu, Wenfang; Kellogg, Glen E.; Grant, Steven; Spiegel, Sarah; Zhang, Shijun</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e56471</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">In our effort to develop selective sphingosine kinase-2 (SphK2) inhibitors as pharmacol. tools, a thiazolidine-2,4-dione analog, 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione(K145), was synthesized and biol. characterized.  Biochem. assay results indicate that K145 is a selective SphK2 inhibitor.  Mol. modeling studies also support this notion.  In vitro studies using human leukemia U937 cells demonstrated that K145 accumulates in U937 cells, suppresses the S1P level, and inhibits SphK2.  K145 also exhibited inhibitory effects on the growth of U937 cells as well as apoptotic effects in U937 cells, and that these effects may be through the inhibition of down-stream ERK and Akt signaling pathways.  K145 also significantly inhibited the growth of U937 tumors in nude mice by both i.p. and oral administration, thus demonstrating its in vivo efficacy as a potential lead anticancer agent.  The antitumor activity of K145 was also confirmed in a syngeneic mouse model by implanting murine breast cancer JC cells in BALB/c mice.  Collectively, these results strongly encourage further optimization of K145 as a novel lead compd. for development of more potent and selective SphK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXIc2J15Fc-bVg90H21EOLACvtfcHk0liS-O3G839QNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsF2ju7s%253D&md5=bddb4fe0ce70a76f3b2adcdcd1cb9ec8</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0056471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0056471%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DGuo%26aufirst%3DT.%2BL.%26aulast%3DHait%26aufirst%3DN.%2BC.%26aulast%3DAllegood%26aufirst%3DJ.%26aulast%3DParikh%26aufirst%3DH.%2BI.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DKellogg%26aufirst%3DG.%2BE.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26atitle%3DBiological%2520characterization%2520of%25203-%25282-amino-ethyl%2529-5-%255B3-%25284-butoxyl-phenyl%2529-propylidene%255D-thiazolidine-2%252C4-dione%2520%2528K145%2529%2520as%2520a%2520selective%2520sphingosine%2520kinase-2%2520inhibitor%2520and%2520anticancer%2520agent%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De56471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">French, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. D.</span><span> </span><span class="NLM_article-title">Antitumor activity of sphingosine kinase inhibitors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">603</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1124%2Fjpet.106.101345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=16632640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD28XnslOlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2006&pages=596-603&author=K.+J.+Frenchauthor=J.+J.+Upsonauthor=S.+N.+Kellerauthor=Y.+Zhuangauthor=J.+K.+Yunauthor=C.+D.+Smith&title=Antitumor+activity+of+sphingosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of sphingosine kinase inhibitors</span></div><div class="casAuthors">French, Kevin J.; Upson, John J.; Keller, Staci N.; Zhuang, Yan; Yun, Jong K.; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">596-603</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingosine kinase (SK) is an oncogenic sphingolipid-metabolizing enzyme that catalyzes the formation of the mitogenic second messenger sphingosine-1-phosphate (S1P) at the expense of proapoptotic ceramide.  Thus, SK is an attractive target for cancer therapy because blockage of S1P formation leads to inhibition of proliferation, as well as the induction of apoptosis in cancer cells.  We have recently identified novel SK inhibitors with nanomolar to low micromolar potencies toward recombinant human SK.  This study describes the continuing anal. of these inhibitors through in vitro and in vivo expts.  All three structurally diverse SK inhibitors tested showed antitumor activity in mice without exhibiting toxicity.  Blood and tumor inhibitor concns. exceeded in vitro potency levels.  Cell signaling analyses in vitro revealed mixed inhibition of mitogen-activated protein kinase kinase and Akt phosphorylation by the SK inhibitors.  Importantly, 4-[4-(4-chloro-phenyl)-thiazol-2-ylamino]-phenol (SKI-II) is orally bioavailable, detected in the blood for at least 8 h, and showed a significant inhibition of tumor growth in mice.  These compds. are the first examples of nonlipid selective inhibitors of SK with in vivo antitumor activity and provide leads for further development of inhibitors of this important mol. target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOz-4ODWl8HbVg90H21EOLACvtfcHk0liS-O3G839QNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnslOlsLs%253D&md5=625e4f9f3c438f2ee00f9039ffb76690</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.101345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.101345%26sid%3Dliteratum%253Aachs%26aulast%3DFrench%26aufirst%3DK.%2BJ.%26aulast%3DUpson%26aufirst%3DJ.%2BJ.%26aulast%3DKeller%26aufirst%3DS.%2BN.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DYun%26aufirst%3DJ.%2BK.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DAntitumor%2520activity%2520of%2520sphingosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D318%26spage%3D596%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Leroux, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auzenne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hail, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spohn, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farquhar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klostergaard, J.</span><span> </span><span class="NLM_article-title">Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1699</span><span class="NLM_x">–</span> <span class="NLM_lpage">1717</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=1699-1717&author=M.+E.+Lerouxauthor=E.+Auzenneauthor=R.+Evansauthor=N.+Hailauthor=W.+Spohnauthor=S.+C.+Ghoshauthor=D.+Farquharauthor=T.+McDonnellauthor=J.+Klostergaard&title=Sphingolipids+and+the+sphingosine+kinase+inhibitor%2C+SKI+II%2C+induce+BCL-2-independent+apoptosis+in+human+prostatic+adenocarcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeroux%26aufirst%3DM.%2BE.%26aulast%3DAuzenne%26aufirst%3DE.%26aulast%3DEvans%26aufirst%3DR.%26aulast%3DHail%26aufirst%3DN.%26aulast%3DSpohn%26aufirst%3DW.%26aulast%3DGhosh%26aufirst%3DS.%2BC.%26aulast%3DFarquhar%26aufirst%3DD.%26aulast%3DMcDonnell%26aufirst%3DT.%26aulast%3DKlostergaard%26aufirst%3DJ.%26atitle%3DSphingolipids%2520and%2520the%2520sphingosine%2520kinase%2520inhibitor%252C%2520SKI%2520II%252C%2520induce%2520BCL-2-independent%2520apoptosis%2520in%2520human%2520prostatic%2520adenocarcinoma%2520cells%26jtitle%3DProstate%26date%3D2007%26volume%3D67%26spage%3D1699%26epage%3D1717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Bektas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poe, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H. S.</span><span> </span><span class="NLM_article-title">A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cells</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1053</span><span class="NLM_x">–</span> <span class="NLM_lpage">1058</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1007%2Fs00280-009-1063-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=19597728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSitLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2009&pages=1053-1058&author=M.+Bektasauthor=S.+P.+Johnsonauthor=W.+E.+Poeauthor=D.+D.+Bignerauthor=H.+S.+Friedman&title=A+sphingosine+kinase+inhibitor+induces+cell+death+in+temozolomide+resistant+glioblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cells</span></div><div class="casAuthors">Bektas, Meryem; Johnson, Stewart P.; Poe, William E.; Bigner, Darell D.; Friedman, Henry S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1053-1058</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Sphingosine kinase is an oncogene that is up-regulated in several solid tumors.  The product of the sphingosine kinase activity, sphingosine-1-phosphate is a potent mitogen involved in diverse cell processes such as cell survival and migration.  Current std. therapy in the treatment of glioblastoma multiforme (GBM) is a combination of surgery, radiation, and chemotherapy using the drug temozolomide (TMZ).  However, virtually all tumors become resistant to TMZ.  Therefore, new drug targets are necessary.  In this study, we investigated whether inhibiting sphingosine kinase could induce cell death in TMZ-resistant GBM cells.  Methods: To study TMZ resistance in vitro, we have generated TMZ-resistant cell lines from established GBM cells.  We used a potent inhibitor of sphingosine kinase to study its effect on colony formation and cell growth in GBM cells with a limited diln. and WST assay.  Moreover, cell death was detd. by measuring caspase-3 activity using flow cytometry.  Results: A sphingosine kinase inhibitor reduced cell colony formation and activated caspase-3 in both TMZ-sensitive and resistant GBM cells.  Conclusion: Addn. of a sphingosine kinase inhibitor to the std. chemotherapy regimen against GBM may be beneficial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofRTn3a_Tk57Vg90H21EOLACvtfcHk0liS-O3G839QNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSitLzO&md5=fd6dc751d0ae4ebd5380bbc6c6dd874c</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1007%2Fs00280-009-1063-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-009-1063-0%26sid%3Dliteratum%253Aachs%26aulast%3DBektas%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DS.%2BP.%26aulast%3DPoe%26aufirst%3DW.%2BE.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DFriedman%26aufirst%3DH.%2BS.%26atitle%3DA%2520sphingosine%2520kinase%2520inhibitor%2520induces%2520cell%2520death%2520in%2520temozolomide%2520resistant%2520glioblastoma%2520cells%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2009%26volume%3D64%26spage%3D1053%26epage%3D1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Loveridge, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leclercq, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdyshev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span> </span><span class="NLM_article-title">The sphingosine kinase 1 inhibitor 2-(<i>p</i>-hydroxyanilino)-4-(<i>p</i>-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">38841</span><span class="NLM_x">–</span> <span class="NLM_lpage">38852</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=38841-38852&author=C.+Loveridgeauthor=F.+Tonelliauthor=T.+Leclercqauthor=K.+G.+Limauthor=J.+S.+Longauthor=E.+Berdyshevauthor=R.+J.+Tateauthor=V.+Natarajanauthor=S.+M.+Pitsonauthor=N.+J.+Pyneauthor=S.+Pyne&title=The+sphingosine+kinase+1+inhibitor+2-%28p-hydroxyanilino%29-4-%28p-chlorophenyl%29thiazole+induces+proteasomal+degradation+of+sphingosine+kinase+1+in+mammalian+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLoveridge%26aufirst%3DC.%26aulast%3DTonelli%26aufirst%3DF.%26aulast%3DLeclercq%26aufirst%3DT.%26aulast%3DLim%26aufirst%3DK.%2BG.%26aulast%3DLong%26aufirst%3DJ.%2BS.%26aulast%3DBerdyshev%26aufirst%3DE.%26aulast%3DTate%26aufirst%3DR.%2BJ.%26aulast%3DNatarajan%26aufirst%3DV.%26aulast%3DPitson%26aufirst%3DS.%2BM.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DPyne%26aufirst%3DS.%26atitle%3DThe%2520sphingosine%2520kinase%25201%2520inhibitor%25202-%2528p-hydroxyanilino%2529-4-%2528p-chlorophenyl%2529thiazole%2520induces%2520proteasomal%2520degradation%2520of%2520sphingosine%2520kinase%25201%2520in%2520mammalian%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D38841%26epage%3D38852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Ren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeilschifter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huwiler, A.</span><span> </span><span class="NLM_article-title">A novel mode of action of the putative sphingosine kinase inhibitor 2-(<i>p</i>-hydroxyanilino)-4-(<i>p</i>-chlorophenyl) thiazole (SKI II): induction of lysosomal sphingosine kinase 1 degradation</span> <span class="citation_source-journal">Cell. Physiol. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1159%2F000315110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=20502009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVOms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=97-104&author=S.+Renauthor=C.+Xinauthor=J.+Pfeilschifterauthor=A.+Huwiler&title=A+novel+mode+of+action+of+the+putative+sphingosine+kinase+inhibitor+2-%28p-hydroxyanilino%29-4-%28p-chlorophenyl%29+thiazole+%28SKI+II%29%3A+induction+of+lysosomal+sphingosine+kinase+1+degradation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Mode of Action of the Putative Sphingosine Kinase Inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) Thiazole (SKI II): Induction of Lysosomal Sphingosine Kinase 1 Degradation</span></div><div class="casAuthors">Ren, Shuyu; Xin, Cuiyan; Pfeilschifter, Josef; Huwiler, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-104</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: Sphingosine kinase 1 (SK1) is a key enzyme in the generation of sphingosine 1-phosphate (S1P) which critically regulates a variety of important cell responses such as proliferation and migration.  Therefore, inhibition of SK-1 has been suggested to be an attractive approach to treat tumor growth and metastasis formation.  Results: We show here that the previously developed putative SK-1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole (SKI II) displays an addnl. facet of action complementary to the known inhibition of enzymic SK-1 activity.  In various human cell lines including glomerular podocytes and mesangial cells, the human endothelial cell line EA.hy 926, and the lung cancer cell line NCI H358, SKI II reduced TGFβ- and TPA-stimulated cellular SK-1 activity by downregulating SK-1 protein expression without affecting SK-1 mRNA expression.  By using cycloheximide to block the de novo protein synthesis, the protein expression of SK-1 under untreated conditions was stable over 24h.  Under SKI II treatment, the half-live drastically decreased to approx. 0.8h.  Mechanistically, this degrdn. occurred through a lysosomal pathway and involved cathepsin B since the general lysosomal inhibitor chloroquine and the specific cathepsin B inhibitor CA-074ME were able to reverse the effect of SKI II.  Surprisingly, in vitro SK-1 activity assays revealed only a very weak direct inhibitory effect of SKI II on SK-1 overexpressed HEK293 cell lysates.  Conclusion: These data show for the first time that the previously developed SK inhibitor SKI II hardly inhibits SK-1 directly but rather acts by triggering the lysosomal degrdn. of SK-1 in various cell types.  This finding discloses a new mode of action of SKI II and strongly suggests that addnl. direct targets of SKI II may exist other than SK-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp5euCa4C_ULVg90H21EOLACvtfcHk0liStK1EMcWRUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVOms78%253D&md5=8c9a34963bce0264bcc1fa13f066bd42</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1159%2F000315110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000315110%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DS.%26aulast%3DXin%26aufirst%3DC.%26aulast%3DPfeilschifter%26aufirst%3DJ.%26aulast%3DHuwiler%26aufirst%3DA.%26atitle%3DA%2520novel%2520mode%2520of%2520action%2520of%2520the%2520putative%2520sphingosine%2520kinase%2520inhibitor%25202-%2528p-hydroxyanilino%2529-4-%2528p-chlorophenyl%2529%2520thiazole%2520%2528SKI%2520II%2529%253A%2520induction%2520of%2520lysosomal%2520sphingosine%2520kinase%25201%2520degradation%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2010%26volume%3D26%26spage%3D97%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Antoon, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meacham, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bratton, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaughter, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashe, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burow, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckman, B. S.</span><span> </span><span class="NLM_article-title">Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer</span> <span class="citation_source-journal">J. Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1530%2FJME-10-0116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=21321095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovV2hsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=205-216&author=J.+W.+Antoonauthor=W.+D.+Meachamauthor=M.+R.+Brattonauthor=E.+M.+Slaughterauthor=L.+V.+Rhodesauthor=H.+B.+Asheauthor=T.+E.+Wieseauthor=M.+E.+Burowauthor=B.+S.+Beckman&title=Pharmacological+inhibition+of+sphingosine+kinase+isoforms+alters+estrogen+receptor+signaling+in+human+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer</span></div><div class="casAuthors">Antoon, James W.; Meacham, William D.; Bratton, Melyssa R.; Slaughter, Evelyn M.; Rhodes, Lyndsay V.; Ashe, Hasina B.; Wiese, Thomas E.; Burow, Matthew E.; Beckman, Barbara S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">205-216</span>CODEN:
                <span class="NLM_cas:coden">JMLEEI</span>;
        ISSN:<span class="NLM_cas:issn">0952-5041</span>.
    
            (<span class="NLM_cas:orgname">BioScientifica Ltd.</span>)
        </div><div class="casAbstract">Recently, crosstalk between sphingolipid signaling pathways and steroid hormones has been illuminated as a possible therapeutic target.  Sphingosine kinase (SK), the key enzyme metabolizing pro-apoptotic ceramide to pro-survival sphingosine-1-phosphate (S1P), is a promising therapeutic target for solid tumor cancers.  In this study, we examd. the ability of pharmacol. inhibition of S1P formation to block estrogen signaling as a targeted breast cancer therapy.  We found that the Sphk1/2 selective inhibitor (SK inhibitor (SKI))-II, blocked breast cancer viability, clonogenic survival and proliferation.  Furthermore, SKI-II dose-dependently decreased estrogen-stimulated estrogen response element transcriptional activity and diminished mRNA levels of the estrogen receptor (ER)-regulated genes progesterone receptor and steroid derived factor-1.  This inhibitor binds the ER directly in the antagonist ligand-binding domain.  Taken together, our results suggest that SKIs have the ability to act as novel ER signaling inhibitors in breast carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbB00lH8kWNbVg90H21EOLACvtfcHk0liStK1EMcWRUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovV2hsLo%253D&md5=1c5c38f99375e272468b1c567f25b156</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1530%2FJME-10-0116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252FJME-10-0116%26sid%3Dliteratum%253Aachs%26aulast%3DAntoon%26aufirst%3DJ.%2BW.%26aulast%3DMeacham%26aufirst%3DW.%2BD.%26aulast%3DBratton%26aufirst%3DM.%2BR.%26aulast%3DSlaughter%26aufirst%3DE.%2BM.%26aulast%3DRhodes%26aufirst%3DL.%2BV.%26aulast%3DAshe%26aufirst%3DH.%2BB.%26aulast%3DWiese%26aufirst%3DT.%2BE.%26aulast%3DBurow%26aufirst%3DM.%2BE.%26aulast%3DBeckman%26aufirst%3DB.%2BS.%26atitle%3DPharmacological%2520inhibition%2520of%2520sphingosine%2520kinase%2520isoforms%2520alters%2520estrogen%2520receptor%2520signaling%2520in%2520human%2520breast%2520cancer%26jtitle%3DJ.%2520Mol.%2520Endocrinol.%26date%3D2011%26volume%3D46%26spage%3D205%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Sharma, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sk, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimbor, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hengst, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amin, S.</span><span> </span><span class="NLM_article-title">Synthesis and bioactivity of sphingosine kinase inhibitors and their novel aspirinyl conjugated analogs</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4149</span><span class="NLM_x">–</span> <span class="NLM_lpage">4156</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=4149-4156&author=A.+K.+Sharmaauthor=U.+H.+Skauthor=M.+A.+Gimborauthor=J.+A.+Hengstauthor=X.+Wangauthor=J.+Yunauthor=S.+Amin&title=Synthesis+and+bioactivity+of+sphingosine+kinase+inhibitors+and+their+novel+aspirinyl+conjugated+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DSk%26aufirst%3DU.%2BH.%26aulast%3DGimbor%26aufirst%3DM.%2BA.%26aulast%3DHengst%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DYun%26aufirst%3DJ.%26aulast%3DAmin%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520bioactivity%2520of%2520sphingosine%2520kinase%2520inhibitors%2520and%2520their%2520novel%2520aspirinyl%2520conjugated%2520analogs%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D4149%26epage%3D4156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Hengst, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sk, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, J. K.</span><span> </span><span class="NLM_article-title">Development of a sphingosine kinase 1 specific small-molecule inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7498</span><span class="NLM_x">–</span> <span class="NLM_lpage">7502</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7498-7502&author=J.+A.+Hengstauthor=X.+Wangauthor=U.+H.+Skauthor=A.+K.+Sharmaauthor=S.+Aminauthor=J.+K.+Yun&title=Development+of+a+sphingosine+kinase+1+specific+small-molecule+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHengst%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSk%26aufirst%3DU.%2BH.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DYun%26aufirst%3DJ.%2BK.%26atitle%3DDevelopment%2520of%2520a%2520sphingosine%2520kinase%25201%2520specific%2520small-molecule%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7498%26epage%3D7502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">French, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maines, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beljanski, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. D.</span><span> </span><span class="NLM_article-title">Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1124%2Fjpet.109.163444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=20061445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFGktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=129-139&author=K.+J.+Frenchauthor=Y.+Zhuangauthor=L.+W.+Mainesauthor=P.+Gaoauthor=W.+Wangauthor=V.+Beljanskiauthor=J.+J.+Upsonauthor=C.+L.+Greenauthor=S.+N.+Kellerauthor=C.+D.+Smith&title=Pharmacology+and+antitumor+activity+of+ABC294640%2C+a+selective+inhibitor+of+sphingosine+kinase-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2</span></div><div class="casAuthors">French, Kevin J.; Zhuang, Yan; Maines, Lynn W.; Gao, Peng; Wang, Wenxue; Beljanski, Vladimir; Upson, John J.; Green, Cecelia L.; Keller, Staci N.; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-139</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingolipid-metabolizing enzymes control the dynamic balance of the cellular levels of important bioactive lipids, including the apoptotic compd. ceramide and the proliferative compd. sphingosine 1-phosphate (S1P).  Many growth factors and inflammatory cytokines promote the cleavage of sphingomyelin and ceramide leading to rapid elevation of S1P levels through the action of sphingosine kinases (SK1 and SK2).  SK1 and SK2 are overexpressed in a variety of human cancers, making these enzymes potential mol. targets for cancer therapy.  We have identified an aryladamantane compd., termed ABC294640 [3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide], that selectively inhibits SK2 activity in vitro, acting as a competitive inhibitor with respect to sphingosine with a Ki of 9.8 μM, and attenuates S1P formation in intact cells.  In tissue culture, ABC294640 suppresses the proliferation of a broad panel of tumor cell lines, and inhibits tumor cell migration concomitant with loss of microfilaments.  In vivo, ABC294640 has excellent oral bioavailability, and demonstrates a plasma clearance half-time of 4.5 h in mice.  Acute and chronic toxicol. studies indicate that ABC294640 induces a transient minor decrease in the hematocrit of rats and mice; however, this normalizes by 28 days of treatment.  No other changes in hematol. parameters, or gross or microscopic tissue pathol., result from treatment with ABC294640.  Oral administration of ABC294640 to mice bearing mammary adenocarcinoma xenografts results in dose-dependent antitumor activity assocd. with depletion of S1P levels in the tumors and progressive tumor cell apoptosis.  Therefore, this newly developed SK2 inhibitor provides an orally available drug candidate for the treatment of cancer and other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsJFYxYhWjhbVg90H21EOLACvtfcHk0livNhCKZxj4Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFGktro%253D&md5=63e0792b887d9ad70c76f209e577a693</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.163444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.163444%26sid%3Dliteratum%253Aachs%26aulast%3DFrench%26aufirst%3DK.%2BJ.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DMaines%26aufirst%3DL.%2BW.%26aulast%3DGao%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DBeljanski%26aufirst%3DV.%26aulast%3DUpson%26aufirst%3DJ.%2BJ.%26aulast%3DGreen%26aufirst%3DC.%2BL.%26aulast%3DKeller%26aufirst%3DS.%2BN.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DPharmacology%2520and%2520antitumor%2520activity%2520of%2520ABC294640%252C%2520a%2520selective%2520inhibitor%2520of%2520sphingosine%2520kinase-2%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D129%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Beljanski, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knaak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. D.</span><span> </span><span class="NLM_article-title">A novel sphingosine kinase inhibitor induces autophagy in tumor cells</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">454</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1124%2Fjpet.109.163337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=20179157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFKhtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=454-464&author=V.+Beljanskiauthor=C.+Knaakauthor=C.+D.+Smith&title=A+novel+sphingosine+kinase+inhibitor+induces+autophagy+in+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">A novel sphingosine kinase inhibitor induces autophagy in tumor cells</span></div><div class="casAuthors">Beljanski, Vladimir; Knaak, Christian; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">454-464</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The sphingolipids ceramide, sphingosine, and sphingosine 1-phosphate (S1P) regulate cell signaling, proliferation, apoptosis, and autophagy.  Sphingosine kinase-1 and -2 (SK1 and SK2) phosphorylate sphingosine to form S1P, shifting the balanced activity of these lipids toward cell proliferation.  We have previously reported that pharmacol. inhibition of SK activity delays tumor growth in vivo.  The present studies demonstrate that the SK2-selective inhibitor 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide (ABC294640) induces nonapoptotic cell death that is preceded by microtubule-assocd. protein light chain 3 cleavage, morphol. changes in lysosomes, formation of autophagosomes, and increases in acidic vesicles in A-498 kidney carcinoma cells.  ABC294640 caused similar autophagic responses in PC-3 prostate and MDA-MB-231 breast adenocarcinoma cells.  Simultaneous exposure of A-498 cells to ABC294640 and 3-methyladenine, an inhibitor of autophagy, switched the mechanism of toxicity to apoptosis, but decreased the potency of the SK2 inhibitor, indicating that autophagy is a major mechanism for tumor cell killing by this compd.  Induction of the unfolded protein response by the proteasome inhibitor N-(benzyloxycarbonyl)leucinylleucinylleucinal Z-Leu-Leu-Leu-al (MG-132) or the heat shock protein 90 inhibitor geldanamycin synergistically increased the cytotoxicity of ABC294640 in vitro.  In severe combined immunodeficient mice bearing A-498 xenografts, daily administration of ABC294640 delayed tumor growth and elevated autophagy markers, but did not increase terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling-pos. cells in the tumors.  These data suggest that ABC294640 promotes tumor cell autophagy, which ultimately results in nonapoptotic cell death and a delay of tumor growth in vivo.  Consequently, ABC294640 may effectively complement anticancer drugs that induce tumor cell apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKrohC6YQacrVg90H21EOLACvtfcHk0liKJQSRYlq1Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFKhtb4%253D&md5=5a3545b993705f7a1f16f9d3c9567061</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.163337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.163337%26sid%3Dliteratum%253Aachs%26aulast%3DBeljanski%26aufirst%3DV.%26aulast%3DKnaak%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DA%2520novel%2520sphingosine%2520kinase%2520inhibitor%2520induces%2520autophagy%2520in%2520tumor%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D454%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Antoon, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meacham, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaughter, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashe, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burow, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckman, B. S.</span><span> </span><span class="NLM_article-title">Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">5124</span><span class="NLM_x">–</span> <span class="NLM_lpage">5135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2010&pages=5124-5135&author=J.+W.+Antoonauthor=M.+D.+Whiteauthor=W.+D.+Meachamauthor=E.+M.+Slaughterauthor=S.+E.+Muirauthor=S.+Elliottauthor=L.+V.+Rhodesauthor=H.+B.+Asheauthor=T.+E.+Wieseauthor=C.+D.+Smithauthor=M.+E.+Burowauthor=B.+S.+Beckman&title=Antiestrogenic+effects+of+the+novel+sphingosine+kinase-2+inhibitor+ABC294640"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAntoon%26aufirst%3DJ.%2BW.%26aulast%3DWhite%26aufirst%3DM.%2BD.%26aulast%3DMeacham%26aufirst%3DW.%2BD.%26aulast%3DSlaughter%26aufirst%3DE.%2BM.%26aulast%3DMuir%26aufirst%3DS.%2BE.%26aulast%3DElliott%26aufirst%3DS.%26aulast%3DRhodes%26aufirst%3DL.%2BV.%26aulast%3DAshe%26aufirst%3DH.%2BB.%26aulast%3DWiese%26aufirst%3DT.%2BE.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26aulast%3DBurow%26aufirst%3DM.%2BE.%26aulast%3DBeckman%26aufirst%3DB.%2BS.%26atitle%3DAntiestrogenic%2520effects%2520of%2520the%2520novel%2520sphingosine%2520kinase-2%2520inhibitor%2520ABC294640%26jtitle%3DEndocrinology%26date%3D2010%26volume%3D151%26spage%3D5124%26epage%3D5135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Antoon, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaughter, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driver, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khalili, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burow, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckman, B. S.</span><span> </span><span class="NLM_article-title">Targeting NFkB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">678</span><span class="NLM_x">–</span> <span class="NLM_lpage">689</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.4161%2Fcbt.11.7.14903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=21307639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlslKqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=678-689&author=J.+W.+Antoonauthor=M.+D.+Whiteauthor=E.+M.+Slaughterauthor=J.+L.+Driverauthor=H.+S.+Khaliliauthor=S.+Elliottauthor=C.+D.+Smithauthor=M.+E.+Burowauthor=B.+S.+Beckman&title=Targeting+NFkB+mediated+breast+cancer+chemoresistance+through+selective+inhibition+of+sphingosine+kinase-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting NFκB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2</span></div><div class="casAuthors">Antoon, James W.; White, Martin D.; Slaughter, Evelyn M.; Driver, Jennifer L.; Khalili, Hafez S.; Elliott, Steven; Smith, Charles D.; Burow, Matthew E.; Beckman, Barbara S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">678-689</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Resistance to chemotherapy remains a significant obstacle in the treatment of hormone-independent breast cancer.  Recent evidence suggests that altered sphingolipid signaling through increased sphingosine kinase activity may be an important mediator of breast cancer drug resistance.  Sphingosine kinase-1 (Sphk1) is a proposed key regulator of breast cancer tumorigenesis, proliferation and resistance.  There is, however, conflicting data on the role of sphingosine kinase-2 (Sphk2) in cancer biol. and resistance, with some suggesting that Sphk2 has an opposing role to that of Sphk1.  Here, we studied the effects of the novel selective Sphk2 inhibitor, ABC294640 (3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl) amide), on human breast cancer.  ABC294640 blocked both viability and survival at low micromolar IC50 concns. in the endocrine therapy-resistant MDA-MB-231 and chemoresistant MCF-7TN-R cell systems.  Treatment with the inhibitor significantly reduced proliferation, as seen in immunofluorescence staining of Ki-67 in vitro.  Interestingly, pharmacol. inhibition of Sphk2 induced apoptosis through the intrinsic programmed cell death pathway.  Furthermore, ABC294640 also diminished NFκB survival signaling, through decreased activation of the Ser536 phosphorylation site on the p65 subunit.  Xenografts of MCF-7TN-R cells growing in immunocompromised mice were utilized to validate the therapeutic efficacy of the sphingosine kinase-2 inhibitor.  Treatment with 50 mg of ABC294640/kg completely blocked tumor vol. in this model.  These results indicate that pharmacol. inhibition of Sphk2 with the orally bioavailable selective inhibitor, ABC294640, has therapeutic potential in the treatment of chemo- and endocrine therapy-resistant breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_Xeo_aYQALrVg90H21EOLACvtfcHk0liKJQSRYlq1Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlslKqtbc%253D&md5=998f07f58fad7fb0852fc972e5ecf445</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.4161%2Fcbt.11.7.14903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.11.7.14903%26sid%3Dliteratum%253Aachs%26aulast%3DAntoon%26aufirst%3DJ.%2BW.%26aulast%3DWhite%26aufirst%3DM.%2BD.%26aulast%3DSlaughter%26aufirst%3DE.%2BM.%26aulast%3DDriver%26aufirst%3DJ.%2BL.%26aulast%3DKhalili%26aufirst%3DH.%2BS.%26aulast%3DElliott%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26aulast%3DBurow%26aufirst%3DM.%2BE.%26aulast%3DBeckman%26aufirst%3DB.%2BS.%26atitle%3DTargeting%2520NFkB%2520mediated%2520breast%2520cancer%2520chemoresistance%2520through%2520selective%2520inhibition%2520of%2520sphingosine%2520kinase-2%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2011%26volume%3D11%26spage%3D678%26epage%3D689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Beljanski, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knaak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. D.</span><span> </span><span class="NLM_article-title">Combined anticancer effects of sphingosine kinase inhibitors and sorafenib</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1132</span><span class="NLM_x">–</span> <span class="NLM_lpage">1142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1132-1142&author=V.+Beljanskiauthor=C.+Knaakauthor=Y.+Zhuangauthor=C.+D.+Smith&title=Combined+anticancer+effects+of+sphingosine+kinase+inhibitors+and+sorafenib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeljanski%26aufirst%3DV.%26aulast%3DKnaak%26aufirst%3DC.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DCombined%2520anticancer%2520effects%2520of%2520sphingosine%2520kinase%2520inhibitors%2520and%2520sorafenib%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2011%26volume%3D29%26spage%3D1132%26epage%3D1142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Gao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. D.</span><span> </span><span class="NLM_article-title">Characterization of isoenzyme-selective inhibitors of human sphingosine kinases</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e44543</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e44543&author=P.+Gaoauthor=Y.+K.+Petersonauthor=R.+A.+Smithauthor=C.+D.+Smith&title=Characterization+of+isoenzyme-selective+inhibitors+of+human+sphingosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DP.%26aulast%3DPeterson%26aufirst%3DY.%2BK.%26aulast%3DSmith%26aufirst%3DR.%2BA.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DCharacterization%2520of%2520isoenzyme-selective%2520inhibitors%2520of%2520human%2520sphingosine%2520kinases%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De44543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, K. K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickrell, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frohn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanman, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElvain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnett, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cee, V. J.</span><span> </span><span class="NLM_article-title">4-Methoxy-<i>N</i>-[2-(trifluoromethyl)biphenyl-4-ylcarbamoyl]nicotinamide: a potent and selective agonist of S1P1</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">752</span><span class="NLM_x">–</span> <span class="NLM_lpage">757</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml2001399" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=752-757&author=L.+D.+Penningtonauthor=K.+K.+C.+Shamauthor=A.+J.+Pickrellauthor=P.+E.+Harringtonauthor=M.+J.+Frohnauthor=B.+A.+Lanmanauthor=A.+B.+Reedauthor=M.+D.+Croghanauthor=M.+R.+Leeauthor=H.+Xuauthor=M.+McElvainauthor=Y.+Xuauthor=X.+Zhangauthor=M.+Fiorinoauthor=M.+Hornerauthor=H.+G.+Morrisonauthor=H.+A.+Arnettauthor=C.+Fotschauthor=M.+Wongauthor=V.+J.+Cee&title=4-Methoxy-N-%5B2-%28trifluoromethyl%29biphenyl-4-ylcarbamoyl%5Dnicotinamide%3A+a+potent+and+selective+agonist+of+S1P1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fml2001399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2001399%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DSham%26aufirst%3DK.%2BK.%2BC.%26aulast%3DPickrell%26aufirst%3DA.%2BJ.%26aulast%3DHarrington%26aufirst%3DP.%2BE.%26aulast%3DFrohn%26aufirst%3DM.%2BJ.%26aulast%3DLanman%26aufirst%3DB.%2BA.%26aulast%3DReed%26aufirst%3DA.%2BB.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DMcElvain%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DFiorino%26aufirst%3DM.%26aulast%3DHorner%26aufirst%3DM.%26aulast%3DMorrison%26aufirst%3DH.%2BG.%26aulast%3DArnett%26aufirst%3DH.%2BA.%26aulast%3DFotsch%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26atitle%3D4-Methoxy-N-%255B2-%2528trifluoromethyl%2529biphenyl-4-ylcarbamoyl%255Dnicotinamide%253A%2520a%2520potent%2520and%2520selective%2520agonist%2520of%2520S1P1%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D752%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Kurata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shioya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habashita, H.</span><span> </span><span class="NLM_article-title">Discovery of S1P agonists with a dihydronaphthalene scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3885</span><span class="NLM_x">–</span> <span class="NLM_lpage">3889</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3885-3889&author=H.+Kurataauthor=K.+Kusumiauthor=K.+Otsukiauthor=R.+Suzukiauthor=M.+Kuronoauthor=Y.+Takadaauthor=H.+Shioyaauthor=T.+Komiyaauthor=H.+Mizunoauthor=T.+Onoauthor=H.+Hagiyaauthor=M.+Minamiauthor=S.+Nakadeauthor=H.+Habashita&title=Discovery+of+S1P+agonists+with+a+dihydronaphthalene+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DKusumi%26aufirst%3DK.%26aulast%3DOtsuki%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DKurono%26aufirst%3DM.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DShioya%26aufirst%3DH.%26aulast%3DKomiya%26aufirst%3DT.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DT.%26aulast%3DHagiya%26aufirst%3DH.%26aulast%3DMinami%26aufirst%3DM.%26aulast%3DNakade%26aufirst%3DS.%26aulast%3DHabashita%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520S1P%2520agonists%2520with%2520a%2520dihydronaphthalene%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3885%26epage%3D3889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Kurata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shioya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habashita, H.</span><span> </span><span class="NLM_article-title">Structure–activity relationship studies of S1P agonists with a dihydronaphthalene scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=144-148&author=H.+Kurataauthor=K.+Kusumiauthor=K.+Otsukiauthor=R.+Suzukiauthor=M.+Kuronoauthor=N.+Tokudaauthor=Y.+Takadaauthor=H.+Shioyaauthor=H.+Mizunoauthor=T.+Komiyaauthor=T.+Onoauthor=H.+Hagiyaauthor=M.+Minamiauthor=S.+Nakadeauthor=H.+Habashita&title=Structure%E2%80%93activity+relationship+studies+of+S1P+agonists+with+a+dihydronaphthalene+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DKusumi%26aufirst%3DK.%26aulast%3DOtsuki%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DKurono%26aufirst%3DM.%26aulast%3DTokuda%26aufirst%3DN.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DShioya%26aufirst%3DH.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DKomiya%26aufirst%3DT.%26aulast%3DOno%26aufirst%3DT.%26aulast%3DHagiya%26aufirst%3DH.%26aulast%3DMinami%26aufirst%3DM.%26aulast%3DNakade%26aufirst%3DS.%26aulast%3DHabashita%26aufirst%3DH.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520studies%2520of%2520S1P%2520agonists%2520with%2520a%2520dihydronaphthalene%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D144%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Kurata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terakado, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habashita, H.</span><span> </span><span class="NLM_article-title">Structure–activity relationship studies of sphingosine-1-phosphate receptor agonists with <i>N</i>-cinnamyl-beta-alanine moiety</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1390</span><span class="NLM_x">–</span> <span class="NLM_lpage">1393</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1390-1393&author=H.+Kurataauthor=K.+Otsukiauthor=K.+Kusumiauthor=M.+Kuronoauthor=M.+Terakadoauthor=T.+Sekoauthor=H.+Mizunoauthor=T.+Onoauthor=H.+Hagiyaauthor=M.+Minamiauthor=S.+Nakadeauthor=H.+Habashita&title=Structure%E2%80%93activity+relationship+studies+of+sphingosine-1-phosphate+receptor+agonists+with+N-cinnamyl-beta-alanine+moiety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DOtsuki%26aufirst%3DK.%26aulast%3DKusumi%26aufirst%3DK.%26aulast%3DKurono%26aufirst%3DM.%26aulast%3DTerakado%26aufirst%3DM.%26aulast%3DSeko%26aufirst%3DT.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DT.%26aulast%3DHagiya%26aufirst%3DH.%26aulast%3DMinami%26aufirst%3DM.%26aulast%3DNakade%26aufirst%3DS.%26aulast%3DHabashita%26aufirst%3DH.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520studies%2520of%2520sphingosine-1-phosphate%2520receptor%2520agonists%2520with%2520N-cinnamyl-beta-alanine%2520moiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1390%26epage%3D1393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.+Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0lhTMuqicwNOow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.%2BY.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Sanada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizushima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uejima, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span> </span><span class="NLM_article-title">Therapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e23933</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e23933&author=Y.+Sanadaauthor=T.+Mizushimaauthor=Y.+Kaiauthor=J.+Nishimuraauthor=H.+Hagiyaauthor=H.+Kurataauthor=H.+Mizunoauthor=E.+Uejimaauthor=T.+Ito&title=Therapeutic+effects+of+novel+sphingosine-1-phosphate+receptor+agonist+W-061+in+murine+DSS+colitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanada%26aufirst%3DY.%26aulast%3DMizushima%26aufirst%3DT.%26aulast%3DKai%26aufirst%3DY.%26aulast%3DNishimura%26aufirst%3DJ.%26aulast%3DHagiya%26aufirst%3DH.%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DUejima%26aufirst%3DE.%26aulast%3DIto%26aufirst%3DT.%26atitle%3DTherapeutic%2520effects%2520of%2520novel%2520sphingosine-1-phosphate%2520receptor%2520agonist%2520W-061%2520in%2520murine%2520DSS%2520colitis%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De23933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Kotelevets, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huwiler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zangemeister-Wittke, U.</span><span> </span><span class="NLM_article-title">Targeting sphingosine kinase 1 in carcinoma cells decreases proliferation and survival by compromising PKC activity and cytokinesis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e39209</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e39209&author=N.+Kotelevetsauthor=D.+Fabbroauthor=A.+Huwilerauthor=U.+Zangemeister-Wittke&title=Targeting+sphingosine+kinase+1+in+carcinoma+cells+decreases+proliferation+and+survival+by+compromising+PKC+activity+and+cytokinesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKotelevets%26aufirst%3DN.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DHuwiler%26aufirst%3DA.%26aulast%3DZangemeister-Wittke%26aufirst%3DU.%26atitle%3DTargeting%2520sphingosine%2520kinase%25201%2520in%2520carcinoma%2520cells%2520decreases%2520proliferation%2520and%2520survival%2520by%2520compromising%2520PKC%2520activity%2520and%2520cytokinesis%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De39209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Cragg, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snader, K. M.</span><span> </span><span class="NLM_article-title">Natural products in drug discovery and development</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks">[<a href="/doi/10.1021/np9604893" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADyaK2sXitVOiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1997&pages=52-60&author=G.+M.+Craggauthor=D.+J.+Newmanauthor=K.+M.+Snader&title=Natural+products+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products in Drug Discovery and Development</span></div><div class="casAuthors">Cragg, Gordon M.; Newman, David J.; Snader, Kenneth M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-60</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, with 38 refs., highlighting the invaluable role that natural products have played, and continue to play, in the drug discovery process, particularly in the areas of cancer and infectious diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrydB_TVNym8rVg90H21EOLACvtfcHk0lgjD6CDQxwO2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitVOiug%253D%253D&md5=944832f883f1b8f3e54f2abe8cdc851e</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1021%2Fnp9604893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp9604893%26sid%3Dliteratum%253Aachs%26aulast%3DCragg%26aufirst%3DG.%2BM.%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DSnader%26aufirst%3DK.%2BM.%26atitle%3DNatural%2520products%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1997%26volume%3D60%26spage%3D52%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Kuroda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtani, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichiba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gravalos, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higa, T.</span><span> </span><span class="NLM_article-title">Pachastrissamine, a cytotoxic anhydrophytosphingosine from a marine sponge, <i>Pachastrissa</i> sp</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1505</span><span class="NLM_x">–</span> <span class="NLM_lpage">1506</span></span><div class="citationLinks">[<a href="/doi/10.1021/np010659y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2002&pages=1505-1506&author=I.+Kurodaauthor=M.+Musmanauthor=I.+I.+Ohtaniauthor=T.+Ichibaauthor=J.+Tanakaauthor=D.+G.+Gravalosauthor=T.+Higa&title=Pachastrissamine%2C+a+cytotoxic+anhydrophytosphingosine+from+a+marine+sponge%2C+Pachastrissa+sp"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fnp010659y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp010659y%26sid%3Dliteratum%253Aachs%26aulast%3DKuroda%26aufirst%3DI.%26aulast%3DMusman%26aufirst%3DM.%26aulast%3DOhtani%26aufirst%3DI.%2BI.%26aulast%3DIchiba%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DJ.%26aulast%3DGravalos%26aufirst%3DD.%2BG.%26aulast%3DHiga%26aufirst%3DT.%26atitle%3DPachastrissamine%252C%2520a%2520cytotoxic%2520anhydrophytosphingosine%2520from%2520a%2520marine%2520sponge%252C%2520Pachastrissa%2520sp%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2002%26volume%3D65%26spage%3D1505%26epage%3D1506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Ballereau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baltas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genisson, Y.</span><span> </span><span class="NLM_article-title">Sphingolipids cyclic derivatives: occurrence, biological relevance and synthetic approaches</span> <span class="citation_source-journal">Curr. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">986</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.2174%2F138527211794785127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslajsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=953-986&author=S.+Ballereauauthor=M.+Baltasauthor=Y.+Genisson&title=Sphingolipids+cyclic+derivatives%3A+occurrence%2C+biological+relevance+and+synthetic+approaches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipids cyclic derivatives: occurrence, biological relevance and synthetic approaches</span></div><div class="casAuthors">Ballereau, Stephanie; Baltas, Michel; Genisson, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Current Organic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">953-986</span>CODEN:
                <span class="NLM_cas:coden">CORCFE</span>;
        ISSN:<span class="NLM_cas:issn">1385-2728</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids (SLs) are ubiquitous membrane constituents that have emerged as essential lipid mediators involved in signal transduction and cancer development.  Due to the implication of SLs in the alteration of cell proliferation, adhesion or migration, their metab. has been targeted in search for novel anti-cancer therapeutic approaches.  In this context, much attention has been directed towards SLs analogs interfering with these complex signalization pathways as well as the immune system.  A general structural modulation of the basic sphingosine backbone of SLs concerns its cyclization into various types of conformationally constrained derivs.  Different series of both natural and synthetic compds. can be considered according to this common structural feature.  The present review article lists these naturally occurring sphingolipids cyclic derivs. including anhydrophytosphingosine-type marine products pachastrissamine (jaspine B), penaresidine/penazetidine, broussonetine, prosopine/prosopinine/prosophylline derivs., as well as conceptually related synthetic products.  A brief statement of their biol. activity is presented.  Detailed informations concerning the org. synthetic aspects are given with emphasize on the natural azetidine, pyrrolidine and synthetic analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7RgSbMAIUX7Vg90H21EOLACvtfcHk0lgw39YoWdi94Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslajsLY%253D&md5=e68deca66265b3572ed01fd8e5f629b8</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.2174%2F138527211794785127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138527211794785127%26sid%3Dliteratum%253Aachs%26aulast%3DBallereau%26aufirst%3DS.%26aulast%3DBaltas%26aufirst%3DM.%26aulast%3DGenisson%26aufirst%3DY.%26atitle%3DSphingolipids%2520cyclic%2520derivatives%253A%2520occurrence%252C%2520biological%2520relevance%2520and%2520synthetic%2520approaches%26jtitle%3DCurr.%2520Org.%2520Chem.%26date%3D2011%26volume%3D15%26spage%3D953%26epage%3D986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Yoshimitsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span> </span><span class="NLM_article-title">Pachastrissamine (jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5402</span><span class="NLM_x">–</span> <span class="NLM_lpage">5408</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=5402-5408&author=Y.+Yoshimitsuauthor=S.+Oishiauthor=J.+Miyagakiauthor=S.+Inukiauthor=H.+Ohnoauthor=N.+Fujii&title=Pachastrissamine+%28jaspine+B%29+and+its+stereoisomers+inhibit+sphingosine+kinases+and+atypical+protein+kinase+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimitsu%26aufirst%3DY.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DMiyagaki%26aufirst%3DJ.%26aulast%3DInuki%26aufirst%3DS.%26aulast%3DOhno%26aufirst%3DH.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DPachastrissamine%2520%2528jaspine%2520B%2529%2520and%2520its%2520stereoisomers%2520inhibit%2520sphingosine%2520kinases%2520and%2520atypical%2520protein%2520kinase%2520C%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D5402%26epage%3D5408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Ledroit, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debitus, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavaud, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massiot, G.</span><span> </span><span class="NLM_article-title">Jaspines A and B: two new cytotoxic sphingosine derivatives from the marine sponge Jaspis sp</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=225-228&author=V.+Ledroitauthor=C.+Debitusauthor=C.+Lavaudauthor=G.+Massiot&title=Jaspines+A+and+B%3A+two+new+cytotoxic+sphingosine+derivatives+from+the+marine+sponge+Jaspis+sp"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLedroit%26aufirst%3DV.%26aulast%3DDebitus%26aufirst%3DC.%26aulast%3DLavaud%26aufirst%3DC.%26aulast%3DMassiot%26aufirst%3DG.%26atitle%3DJaspines%2520A%2520and%2520B%253A%2520two%2520new%2520cytotoxic%2520sphingosine%2520derivatives%2520from%2520the%2520marine%2520sponge%2520Jaspis%2520sp%26jtitle%3DTetrahedron%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D225%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Salma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therville, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpentier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnafe, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levade, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genisson, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrieu-Abadie, N.</span><span> </span><span class="NLM_article-title">The natural marine anhydrophytosphingosine, Jaspine B, induces apoptosis in melanoma cells by interfering with ceramide metabolism</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">485</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=477-485&author=Y.+Salmaauthor=E.+Lafontauthor=N.+Thervilleauthor=S.+Carpentierauthor=M.+J.+Bonnafeauthor=T.+Levadeauthor=Y.+Genissonauthor=N.+Andrieu-Abadie&title=The+natural+marine+anhydrophytosphingosine%2C+Jaspine+B%2C+induces+apoptosis+in+melanoma+cells+by+interfering+with+ceramide+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalma%26aufirst%3DY.%26aulast%3DLafont%26aufirst%3DE.%26aulast%3DTherville%26aufirst%3DN.%26aulast%3DCarpentier%26aufirst%3DS.%26aulast%3DBonnafe%26aufirst%3DM.%2BJ.%26aulast%3DLevade%26aufirst%3DT.%26aulast%3DGenisson%26aufirst%3DY.%26aulast%3DAndrieu-Abadie%26aufirst%3DN.%26atitle%3DThe%2520natural%2520marine%2520anhydrophytosphingosine%252C%2520Jaspine%2520B%252C%2520induces%2520apoptosis%2520in%2520melanoma%2520cells%2520by%2520interfering%2520with%2520ceramide%2520metabolism%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D477%26epage%3D485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Yoo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. Y.</span><span> </span><span class="NLM_article-title">Pachastrissamine from <i>Pachastrissa</i> sp. inhibits melanoma cell growth by dual inhibition of Cdk2 and ERK-mediated FOXO3 downregulation</span> <span class="citation_source-journal">Phytother. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1927</span><span class="NLM_x">–</span> <span class="NLM_lpage">1933</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1002%2Fptr.4673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=22451302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVeksL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=1927-1933&author=H.+Yooauthor=Y.+S.+Leeauthor=S.+Leeauthor=S.+Kimauthor=T.+Y.+Kim&title=Pachastrissamine+from+Pachastrissa+sp.+inhibits+melanoma+cell+growth+by+dual+inhibition+of+Cdk2+and+ERK-mediated+FOXO3+downregulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Pachastrissamine from Pachastrissa sp. Inhibits Melanoma Cell Growth by Dual Inhibition of Cdk2 and ERK-mediated FOXO3 Downregulation</span></div><div class="casAuthors">Yoo, Hyun; Lee, Yun Sang; Lee, Sukjin; Kim, Sanghee; Kim, Tae-Yoon</div><div class="citationInfo"><span class="NLM_cas:title">Phytotherapy Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1927-1933</span>CODEN:
                <span class="NLM_cas:coden">PHYREH</span>;
        ISSN:<span class="NLM_cas:issn">0951-418X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Melanoma cells are relatively resistant to apoptosis compared with other tumor cell types, and thus, chemotherapy, radiotherapy and immunotherapy are not effective in treating melanoma.  Pachastrissamine (PA) exhibits cytotoxic activity and promotes apoptosis in several cancer cells.  However, its specific mol. mechanisms have not been characterized fully.  This study investigated the antimelanoma effect of PA, an anhydrophytosphingosine derived from marine sponge, and its underlying mol. mechanisms.  The data demonstrated that treatment with PA inhibited the phosphorylation of ERK and subsequent ERK-mediated FOXO3 phosphorylation in melanoma cells.  Interestingly, PA did not inhibit AKT-mediated FOXO3 phosphorylation.  Therefore, it appears that PA-induced apoptosis results from the inhibition of ERK.  Furthermore, i.v. administration of PA was found to suppress melanoma cell growth in a C57BL6 mouse without causing side effects.  Addnl., PA inhibited the prodn. of Cdk2, which is involved in cell cycle regulation.  Taken together, inhibition of melanoma cell growth by PA is a result of the inhibition of ERK-mediated FOXO3 downregulation and decreased Cdk2 levels.  The results of this study imply that dual inhibition of the ERK pathway and cell cycle progression could be an effective approach to control the growth of melanoma cells.  Copyright © 2012 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbHwUVmNKcnbVg90H21EOLACvtfcHk0lgaMUI3oKSOCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVeksL7L&md5=0c6ea84a0623f7b85752c7f793590b51</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1002%2Fptr.4673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fptr.4673%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DT.%2BY.%26atitle%3DPachastrissamine%2520from%2520Pachastrissa%2520sp.%2520inhibits%2520melanoma%2520cell%2520growth%2520by%2520dual%2520inhibition%2520of%2520Cdk2%2520and%2520ERK-mediated%2520FOXO3%2520downregulation%26jtitle%3DPhytother.%2520Res.%26date%3D2012%26volume%3D26%26spage%3D1927%26epage%3D1933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Canals, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mormeneo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabrias, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llebaria, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, A.</span><span> </span><span class="NLM_article-title">Synthesis and biological properties of pachastrissamine (jaspine B) and diastereoisomeric jaspines</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=235-241&author=D.+Canalsauthor=D.+Mormeneoauthor=G.+Fabriasauthor=A.+Llebariaauthor=J.+Casasauthor=A.+Delgado&title=Synthesis+and+biological+properties+of+pachastrissamine+%28jaspine+B%29+and+diastereoisomeric+jaspines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCanals%26aufirst%3DD.%26aulast%3DMormeneo%26aufirst%3DD.%26aulast%3DFabrias%26aufirst%3DG.%26aulast%3DLlebaria%26aufirst%3DA.%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DDelgado%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520biological%2520properties%2520of%2520pachastrissamine%2520%2528jaspine%2520B%2529%2520and%2520diastereoisomeric%2520jaspines%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D235%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Jeon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baek, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span> </span><span class="NLM_article-title">Syntheses of sulfur and selenium analogues of pachastrissamine via double displacements of cyclic sulfate</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">7237</span><span class="NLM_x">–</span> <span class="NLM_lpage">7242</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=7237-7242&author=H.+Jeonauthor=H.+Baeauthor=D.+J.+Baekauthor=Y.+S.+Kwakauthor=D.+Kimauthor=S.+Kim&title=Syntheses+of+sulfur+and+selenium+analogues+of+pachastrissamine+via+double+displacements+of+cyclic+sulfate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJeon%26aufirst%3DH.%26aulast%3DBae%26aufirst%3DH.%26aulast%3DBaek%26aufirst%3DD.%2BJ.%26aulast%3DKwak%26aufirst%3DY.%2BS.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DS.%26atitle%3DSyntheses%2520of%2520sulfur%2520and%2520selenium%2520analogues%2520of%2520pachastrissamine%2520via%2520double%2520displacements%2520of%2520cyclic%2520sulfate%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2011%26volume%3D9%26spage%3D7237%26epage%3D7242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Salma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballereau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maaliki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladeira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrieu-Abadie, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genisson, Y.</span><span> </span><span class="NLM_article-title">Flexible and enantioselective access to jaspine B and biologically active chain-modified analogues thereof</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">3227</span><span class="NLM_x">–</span> <span class="NLM_lpage">3243</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=3227-3243&author=Y.+Salmaauthor=S.+Ballereauauthor=C.+Maalikiauthor=S.+Ladeiraauthor=N.+Andrieu-Abadieauthor=Y.+Genisson&title=Flexible+and+enantioselective+access+to+jaspine+B+and+biologically+active+chain-modified+analogues+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalma%26aufirst%3DY.%26aulast%3DBallereau%26aufirst%3DS.%26aulast%3DMaaliki%26aufirst%3DC.%26aulast%3DLadeira%26aufirst%3DS.%26aulast%3DAndrieu-Abadie%26aufirst%3DN.%26aulast%3DGenisson%26aufirst%3DY.%26atitle%3DFlexible%2520and%2520enantioselective%2520access%2520to%2520jaspine%2520B%2520and%2520biologically%2520active%2520chain-modified%2520analogues%2520thereof%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2010%26volume%3D8%26spage%3D3227%26epage%3D3243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Rives, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladeira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levade, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrieu-Abadie, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genisson, Y.</span><span> </span><span class="NLM_article-title">Synthesis of cytotoxic aza analogues of jaspine B</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=18&author=A.+Rivesauthor=S.+Ladeiraauthor=T.+Levadeauthor=N.+Andrieu-Abadieauthor=Y.+Genisson&title=Synthesis+of+cytotoxic+aza+analogues+of+jaspine+B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRives%26aufirst%3DA.%26aulast%3DLadeira%26aufirst%3DS.%26aulast%3DLevade%26aufirst%3DT.%26aulast%3DAndrieu-Abadie%26aufirst%3DN.%26aulast%3DGenisson%26aufirst%3DY.%26atitle%3DSynthesis%2520of%2520cytotoxic%2520aza%2520analogues%2520of%2520jaspine%2520B%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Kono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohama, T.</span><span> </span><span class="NLM_article-title">B-535a, b and c, new sphingosine kinase inhibitors, produced by a marine bacterium; taxonomy, fermentation, isolation, physico-chemical properties and structure determination</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">758</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2000&pages=753-758&author=K.+Konoauthor=M.+Tanakaauthor=T.+Mizunoauthor=K.+Kodamaauthor=T.+Ogitaauthor=T.+Kohama&title=B-535a%2C+b+and+c%2C+new+sphingosine+kinase+inhibitors%2C+produced+by+a+marine+bacterium%3B+taxonomy%2C+fermentation%2C+isolation%2C+physico-chemical+properties+and+structure+determination"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKono%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DMizuno%26aufirst%3DT.%26aulast%3DKodama%26aufirst%3DK.%26aulast%3DOgita%26aufirst%3DT.%26aulast%3DKohama%26aufirst%3DT.%26atitle%3DB-535a%252C%2520b%2520and%2520c%252C%2520new%2520sphingosine%2520kinase%2520inhibitors%252C%2520produced%2520by%2520a%2520marine%2520bacterium%253B%2520taxonomy%252C%2520fermentation%252C%2520isolation%252C%2520physico-chemical%2520properties%2520and%2520structure%2520determination%26jtitle%3DJ.%2520Antibiot.%26date%3D2000%26volume%3D53%26spage%3D753%26epage%3D758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Kono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohama, T.</span><span> </span><span class="NLM_article-title">Characterization of B-5354c, a new sphingosine kinase inhibitor, produced by a marine bacterium</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2000&pages=759-764&author=K.+Konoauthor=M.+Tanakaauthor=T.+Ogitaauthor=T.+Kohama&title=Characterization+of+B-5354c%2C+a+new+sphingosine+kinase+inhibitor%2C+produced+by+a+marine+bacterium"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKono%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DOgita%26aufirst%3DT.%26aulast%3DKohama%26aufirst%3DT.%26atitle%3DCharacterization%2520of%2520B-5354c%252C%2520a%2520new%2520sphingosine%2520kinase%2520inhibitor%252C%2520produced%2520by%2520a%2520marine%2520bacterium%26jtitle%3DJ.%2520Antibiot.%26date%3D2000%26volume%3D53%26spage%3D759%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nava, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edsall, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">19513</span><span class="NLM_x">–</span> <span class="NLM_lpage">19520</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=19513-19520&author=H.+Liuauthor=M.+Sugiuraauthor=V.+E.+Navaauthor=L.+C.+Edsallauthor=K.+Konoauthor=S.+Poultonauthor=S.+Milstienauthor=T.+Kohamaauthor=S.+Spiegel&title=Molecular+cloning+and+functional+characterization+of+a+novel+mammalian+sphingosine+kinase+type+2+isoform"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DSugiura%26aufirst%3DM.%26aulast%3DNava%26aufirst%3DV.%2BE.%26aulast%3DEdsall%26aufirst%3DL.%2BC.%26aulast%3DKono%26aufirst%3DK.%26aulast%3DPoulton%26aufirst%3DS.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DKohama%26aufirst%3DT.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DMolecular%2520cloning%2520and%2520functional%2520characterization%2520of%2520a%2520novel%2520mammalian%2520sphingosine%2520kinase%2520type%25202%2520isoform%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D19513%26epage%3D19520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Park, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span> </span><span class="NLM_article-title">Phytosphingosine induces apoptotic cell death via caspase 8 activation and Bax translocation in human cancer cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">878</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=12576463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVKktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=878-885&author=M.+T.+Parkauthor=J.+A.+Kangauthor=J.+A.+Choiauthor=C.+M.+Kangauthor=T.+H.+Kimauthor=S.+Baeauthor=S.+Kangauthor=S.+Kimauthor=W.+I.+Choiauthor=C.+K.+Choauthor=H.+Y.+Chungauthor=Y.+S.+Leeauthor=S.+J.+Lee&title=Phytosphingosine+induces+apoptotic+cell+death+via+caspase+8+activation+and+Bax+translocation+in+human+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Phytosphingosine Induces Apoptotic Cell Death via Caspase 8 Activation and Bax Translocation in Human Cancer Cells</span></div><div class="casAuthors">Park, Moon-Taek; Kang, Jung A.; Choi, Jung-A.; Kang, Chang-Mo; Kim, Tae-Hwan; Bae, Sangwoo; Kang, Seongman; Kim, Sujong; Choi, Weon-Ik; Cho, Chul-Koo; Chung, Hee-Yong; Lee, Yun-Sil; Lee, Su-Jae</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">878-885</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Sphingolipid metabolites, such as sphingosine and ceramide, are highly bioactive compds. and are involved in diverse cell processes, including cell-cell interaction, cell proliferation, differentiation, and apoptosis.  However, the physiol. roles of phytosphingosine are poorly understood.  In this study, we report that phytosphingosine can potently induce apoptotic cell death in human cancer cells via caspase activation and caspase-independent cytochrome c release.  Phytosphingosine-induced apoptosis was detd. by Hoechst 33258 staining, flow cytometric anal., and DNA fragmentation assay.  Involvement of caspases was detd. by immunoblot anal. and cell death detection assays after treatment with synthetic inhibitor z-Val-Ala-Asp-fluoromethyl ketone, z-DEVD-fmk, or z-IETD-fmk.  Death receptor (DR) dependency was analyzed by examg. expression of DRs (Fas, DR4, DR5, TNFR1, and R2), and interaction of Fas-assocd. death domain and caspase 8.  Involvement of the mitochondria pathway was examd. by monitoring of the mitochondria membrane potential, cytochrome c release, and Bax translocation.  Phytosphingosine-treated cells displayed several features of apoptosis, including increase of sub-G1 population, DNA fragmentation, and poly(ADP-ribose) polymerase cleavage.  We obsd. that phytosphingosine cause activation of caspase 8 in a DR-independent fashion.  Phytosphingosine also induced activation of caspase 9 and 3, loss of mitochondrial membrane potential, and the cytochrome c release from mitochondria.  However, we failed to detect Bid cleavage.  Moreover, caspase 8 inhibitor z-IETD-fmk did not affect phytosphingosine-induced cytochrome c release and caspase 9 activation, suggesting that phytosphingosine-induced cytochrome c release is caused by caspase 8-independent manner.  Phytosphingosine induced mitochondrial translocation of Bax from the cytosol without changes in the protein levels of Bcl-2, Bcl-xL, and Bax.  In addn., Bcl-2/Bax interaction was diminished after addn. of phytosphingosine.  These findings indicate that phytosphingosine induces apoptotic cell death in human cancer cells by direct activation of caspase 8, and by mitochondrial translocation of Bax and subsequent release of cytochrome c into cytoplasm, providing a potential mechanism for the anticancer activity of phytosphingosine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRvCcH_z38drVg90H21EOLACvtfcHk0lhFPCx_zQOAZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVKktrg%253D&md5=c060d9f013b765775d6d8479cc4c851c</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DM.%2BT.%26aulast%3DKang%26aufirst%3DJ.%2BA.%26aulast%3DChoi%26aufirst%3DJ.%2BA.%26aulast%3DKang%26aufirst%3DC.%2BM.%26aulast%3DKim%26aufirst%3DT.%2BH.%26aulast%3DBae%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DW.%2BI.%26aulast%3DCho%26aufirst%3DC.%2BK.%26aulast%3DChung%26aufirst%3DH.%2BY.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26atitle%3DPhytosphingosine%2520induces%2520apoptotic%2520cell%2520death%2520via%2520caspase%25208%2520activation%2520and%2520Bax%2520translocation%2520in%2520human%2520cancer%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D878%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Nagahara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinomiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikekita, M.</span><span> </span><span class="NLM_article-title">Phytosphingosine induced mitochondria-involved apoptosis</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1111%2Fj.1349-7006.2005.00012.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=15723652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislOhs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2005&pages=83-92&author=Y.+Nagaharaauthor=T.+Shinomiyaauthor=S.+Kurodaauthor=N.+Kanekoauthor=R.+Nishioauthor=M.+Ikekita&title=Phytosphingosine+induced+mitochondria-involved+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Phytosphingosine induced mitochondria-involved apoptosis</span></div><div class="casAuthors">Nagahara, Yukitoshi; Shinomiya, Takahisa; Kuroda, Sachiko; Kaneko, Naoki; Nishio, Reiji; Ikekita, Masahiko</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-92</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">Sphingolipids are putative intracellular signal mediators in cell differentiation, growth inhibition, and apoptosis.  Sphingosine, sphinganine, and phytosphingosine are structural analogs of sphingolipids and are classified as long-chain sphingoid bases.  Sphingosine and sphinganine are known to play important roles in apoptosis.  In the present study, the authors examd. the phytosphingosine-induced apoptosis mechanism, focusing on mitochondria in human T-cell lymphoma Jurkat cells.  Phytosphingosine significantly induced chromatin DNA fragmentation, which is a hallmark of apoptosis.  Enzymic activity measurements of caspases revealed that caspase-3 and caspase-9 are activated in phytosphingosine-induced apoptosis, but there is little activation of caspase-8 suggesting that phytosphingosine influences mitochondrial functions.  In agreement with this hypothesis, a decrease in ΔΨm and the release of cytochrome c to the cytosol were obsd. upon phytosphingosine treatment.  Furthermore, overexpression of mitochondria-localized anti-apoptotic protein Bcl-2 prevented phytosphingosine apoptotic stimuli.  Western blot assays revealed that phytosphingosine decreases phosphorylated Akt and p70S6k.  Dephosphorylation of Akt was partially inhibited by protein phosphatase inhibitor OA and OA attenuated phytosphingosine-induced apoptosis.  Moreover, using a cell-free system, phytosphingosine directly reduced ΔΨm.  These results indicate that phytosphingosine perturbs mitochondria both directly and indirectly to induce apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQWdaUUnvNQrVg90H21EOLACvtfcHk0lin9Q5Q-RUT9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislOhs70%253D&md5=9c17dfd6d2770da9b61e6190d1d120f1</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2005.00012.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2005.00012.x%26sid%3Dliteratum%253Aachs%26aulast%3DNagahara%26aufirst%3DY.%26aulast%3DShinomiya%26aufirst%3DT.%26aulast%3DKuroda%26aufirst%3DS.%26aulast%3DKaneko%26aufirst%3DN.%26aulast%3DNishio%26aufirst%3DR.%26aulast%3DIkekita%26aufirst%3DM.%26atitle%3DPhytosphingosine%2520induced%2520mitochondria-involved%2520apoptosis%26jtitle%3DCancer%2520Sci.%26date%3D2005%26volume%3D96%26spage%3D83%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Choi, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, Y. J.</span><span> </span><span class="NLM_article-title">Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5</span> <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=17143496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFagtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=175-184&author=S.+Y.+Choiauthor=M.+J.+Kimauthor=H.+Y.+Chungauthor=S.+J.+Leeauthor=Y.+J.+Jang&title=Phytosphingosine+in+combination+with+TRAIL+sensitizes+cancer+cells+to+TRAIL+through+synergistic+up-regulation+of+DR4+and+DR5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5</span></div><div class="casAuthors">Choi, Soon-Young; Kim, Min-Jung; Chung, Hee Yong; Lee, Su-Jae; Jang, Young-Ju</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-184</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Oncology Reports</span>)
        </div><div class="casAbstract">Sensitization of cancer cells to TRAIL could improve the effectiveness of TRAIL as an anticancer agent.  We explored whether TRAIL in combination with phytosphingosine could sensitize cancer cells to TRAIL.  The combined treatment enhanced synergistic apoptotic cell death of Jurkat T cells, compared to TRAIL or phytosphingosine alone.  Enhanced apoptosis in response to the combination treatment was assocd. with caspase-8 activation-mediated Bax and Bak activation and mitochondrial dysfunction.  The combination treatment also resulted in synergistic up-regulation of TRAIL receptor R1 (DR4) and R2 (DR5).  SiRNA targeting of DR5 significantly attenuated the combination treatment-induced caspase-8 activation, mitochondrial dysfunction, and apoptotic cell death.  Upon stimulation of cells with the combination treatment, NF-κB was activated.  Moreover, siRNA targeting of NF-κB significantly attenuated the combination treatment-induced DR4 and DR5 expression and receptor-mediated caspase-8 activation.  These results indicate that phytosphingosine sensitizes cancer cells to TRAIL through the synergistic up-regulation of DR4 and DR5 in an NF-κB-dependent fashion resulting in caspase-8 activation and subsequent mitochondrial dysfunction.  These findings support the potential application of combination treatment with TRAIL and phytosphingosine in the treatment of cancers that are less sensitive to TRAIL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiZZwDEfXm0rVg90H21EOLACvtfcHk0lin9Q5Q-RUT9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFagtLc%253D&md5=229ed07e322960d2a2001ffbe6d7c955</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DChung%26aufirst%3DH.%2BY.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DJang%26aufirst%3DY.%2BJ.%26atitle%3DPhytosphingosine%2520in%2520combination%2520with%2520TRAIL%2520sensitizes%2520cancer%2520cells%2520to%2520TRAIL%2520through%2520synergistic%2520up-regulation%2520of%2520DR4%2520and%2520DR5%26jtitle%3DOncol.%2520Rep.%26date%3D2007%26volume%3D17%26spage%3D175%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Park, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span> </span><span class="NLM_article-title">Phytosphingosine in combination with ionizing radiation enhances apoptotic cell death in radiation-resistant cancer cells through ROS-dependent and -independent AIF release</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1724</span><span class="NLM_x">–</span> <span class="NLM_lpage">1733</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=1724-1733&author=M.+T.+Parkauthor=M.+J.+Kimauthor=Y.+H.+Kangauthor=S.+Y.+Choiauthor=J.+H.+Leeauthor=J.+A.+Choiauthor=C.+M.+Kangauthor=C.+K.+Choauthor=S.+Kangauthor=S.+Baeauthor=Y.+S.+Leeauthor=H.+Y.+Chungauthor=S.+J.+Lee&title=Phytosphingosine+in+combination+with+ionizing+radiation+enhances+apoptotic+cell+death+in+radiation-resistant+cancer+cells+through+ROS-dependent+and+-independent+AIF+release"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DM.%2BT.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DKang%26aufirst%3DY.%2BH.%26aulast%3DChoi%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DChoi%26aufirst%3DJ.%2BA.%26aulast%3DKang%26aufirst%3DC.%2BM.%26aulast%3DCho%26aufirst%3DC.%2BK.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DBae%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DChung%26aufirst%3DH.%2BY.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26atitle%3DPhytosphingosine%2520in%2520combination%2520with%2520ionizing%2520radiation%2520enhances%2520apoptotic%2520cell%2520death%2520in%2520radiation-resistant%2520cancer%2520cells%2520through%2520ROS-dependent%2520and%2520-independent%2520AIF%2520release%26jtitle%3DBlood%26date%3D2005%26volume%3D105%26spage%3D1724%26epage%3D1733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Kim, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S. H.</span><span> </span><span class="NLM_article-title"><i>N</i>,<i>N</i>-Dimethyl phytosphingosine induces caspase-8-dependent cytochrome c release and apoptosis through ROS generation in human leukemia cells</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">239</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2Fj.taap.2009.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=19481559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVCisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=239&publication_year=2009&pages=87-97&author=B.+M.+Kimauthor=Y.+J.+Choiauthor=Y.+Hanauthor=Y.+S.+Yunauthor=S.+H.+Hong&title=N%2CN-Dimethyl+phytosphingosine+induces+caspase-8-dependent+cytochrome+c+release+and+apoptosis+through+ROS+generation+in+human+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">N,N-dimethyl phytosphingosine induces caspase-8-dependent cytochrome c release and apoptosis through ROS generation in human leukemia cells</span></div><div class="casAuthors">Kim, Byeong Mo; Choi, Yun Jung; Han, Youngsoo; Yun, Yeon-Sook; Hong, Sung Hee</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">239</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-97</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N,N-di-Me phytosphingosine (DMPS) blocks the conversion of sphingosine to sphingosine-1-phosphate (S1P) by the enzyme sphingosine kinase (SK).  In this study, we elucidated the apoptotic mechanisms of DMPS action on a human leukemia cell line using functional pharmacol. and genetic approaches.  First, we demonstrated that DMPS-induced apoptosis is evidenced by nuclear morphol. change, distinct internucleosomal DNA fragmentation, and an increased sub-G1 cell population.  DMPS treatment led to the activation of caspase-9 and caspase-3, accompanied by the cleavage of poly(ADP-ribose) polymerase (PARP) and led to cytochrome c release, depolarization of the mitochondrial membrane potential, and downregulation of the anti-apoptotic members of the bcl-2 family.  Ectopic expression of bcl-2 and bcl-xL conferred resistance of HL-60 cells to DMPS-induced cell death, suggesting that DMPS-induced apoptosis occurs predominantly through the activation of the intrinsic mitochondrial pathway.  We also obsd. that DMPS activated the caspase-8-Bid-Bax pathway and that the inhibition of caspase-8 by z-IETD-fmk or small interfering RNA suppressed the cleavage of Bid, cytochrome c release, caspase-3 activation, and apoptotic cell death.  In addn., cells subjected to DMPS exhibited significantly increased reactive oxygen species (ROS) generation, and ROS scavengers, such as quercetin and Tiron, but not N-acetylcysteine (NAC), inhibited DMPS-induced activations of caspase-8, -3 and subsequent apoptotic cell death, indicating the role of ROS in caspase-8-mediated apoptosis.  Taken together, these results indicate that caspase-8 acts upstream of caspase-3, and that the caspase-8-mediated mitochondrial pathway is important in DMPS-induced apoptosis.  Our results also suggest that ROS are crit. regulators of caspase-8-mediated apoptosis in DMPS-treated leukemia cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow6fzN5zQBGLVg90H21EOLACvtfcHk0lh9N47UUrXnwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVCisr0%253D&md5=07d5a68ecb65dd901f9afad19ccc99ff</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2009.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2009.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DB.%2BM.%26aulast%3DChoi%26aufirst%3DY.%2BJ.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DYun%26aufirst%3DY.%2BS.%26aulast%3DHong%26aufirst%3DS.%2BH.%26atitle%3DN%252CN-Dimethyl%2520phytosphingosine%2520induces%2520caspase-8-dependent%2520cytochrome%2520c%2520release%2520and%2520apoptosis%2520through%2520ROS%2520generation%2520in%2520human%2520leukemia%2520cells%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2009%26volume%3D239%26spage%3D87%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Park, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S.</span><span> </span><span class="NLM_article-title">Cytotoxic effects of novel phytosphingosine derivatives, including <i>N</i>,<i>N</i>-dimethylphytosphingosine and <i>N</i>-monomethylphytosphingosine, in human leukemia cell line HL60</span> <span class="citation_source-journal">Leuk. Lymphoma</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.3109%2F10428190903383419" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=20001229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlyqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=132-145&author=S.+R.+Parkauthor=H.+J.+Choauthor=K.+J.+Moonauthor=K.+H.+Chunauthor=S.+Y.+Kongauthor=S.+S.+Yoonauthor=J.+S.+Leeauthor=S.+Park&title=Cytotoxic+effects+of+novel+phytosphingosine+derivatives%2C+including+N%2CN-dimethylphytosphingosine+and+N-monomethylphytosphingosine%2C+in+human+leukemia+cell+line+HL60"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic effects of novel phytosphingosine derivatives, including N,N-dimethylphytosphingosine and N-monomethylphytosphingosine, in human leukemia cell line HL60</span></div><div class="casAuthors">Park, Sook Ryun; Cho, Hyo Jin; Moon, Kyung Jin; Chun, Kyung-Hee; Kong, Sun-Young; Yoon, Sung-Soo; Lee, Jong Seok; Park, Seonyang</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">132-145</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1042-8194</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Novel phytosphingosine derivs. have been developed based on the inhibition of sphingosine kinase, which has been implicated in cell growth and inhibition of ceramide-mediated apoptosis.  This study evaluated the cytotoxic effects and underlying mechanisms of action of novel phytosphingosine derivs., including N-monomethylphytosphingosine (MMPH) and N,N-dimethylphytosphingosine (DMPH) and the pegylated forms MMPH-PEG and DMPH-PEG, in human leukemia HL60 cells.  In viability and proliferation assays using WST-1, all four drugs induced suppression of cell growth and viability in a concn.-dependent manner.  Among them, DMPH had the highest antileukemic activity and induced apoptosis via caspase-8, caspase-3, and caspase-9 activation.  The apoptotic effect was also assocd. with Fas/FasL upregulation, Bid cleavage, Bcl-2 downregulation, Bax upregulation, mitochondrial membrane depolarization, and cytochrome c release.  DMPH decreased the phosphorylation of ERK and inhibited daunorubicin-induced ERK activation.  Furthermore, DMPH displayed synergistic cytotoxicity with daunorubicin in a sequence-dependent manner.  Our findings indicate that DMPH has potential as an effective cytotoxic agent for leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5Gx5UhAeIT7Vg90H21EOLACvtfcHk0lh9N47UUrXnwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlyqsg%253D%253D&md5=9782638e152920cfa74991ad577e0750</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.3109%2F10428190903383419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10428190903383419%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BR.%26aulast%3DCho%26aufirst%3DH.%2BJ.%26aulast%3DMoon%26aufirst%3DK.%2BJ.%26aulast%3DChun%26aufirst%3DK.%2BH.%26aulast%3DKong%26aufirst%3DS.%2BY.%26aulast%3DYoon%26aufirst%3DS.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DPark%26aufirst%3DS.%26atitle%3DCytotoxic%2520effects%2520of%2520novel%2520phytosphingosine%2520derivatives%252C%2520including%2520N%252CN-dimethylphytosphingosine%2520and%2520N-monomethylphytosphingosine%252C%2520in%2520human%2520leukemia%2520cell%2520line%2520HL60%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2010%26volume%3D51%26spage%3D132%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Moon, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheon, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span> </span><span class="NLM_article-title">Synthesis of novel phytosphingosine derivatives and their preliminary biological evaluation for enhancing radiation therapy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6643</span><span class="NLM_x">–</span> <span class="NLM_lpage">6646</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6643-6646&author=B.+S.+Moonauthor=M.+T.+Parkauthor=J.+H.+Parkauthor=S.+W.+Kimauthor=K.+C.+Leeauthor=G.+I.+Anauthor=S.+D.+Yangauthor=D.+Y.+Chiauthor=G.+J.+Cheonauthor=S.+J.+Lee&title=Synthesis+of+novel+phytosphingosine+derivatives+and+their+preliminary+biological+evaluation+for+enhancing+radiation+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DB.%2BS.%26aulast%3DPark%26aufirst%3DM.%2BT.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DK.%2BC.%26aulast%3DAn%26aufirst%3DG.%2BI.%26aulast%3DYang%26aufirst%3DS.%2BD.%26aulast%3DChi%26aufirst%3DD.%2BY.%26aulast%3DCheon%26aufirst%3DG.%2BJ.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26atitle%3DSynthesis%2520of%2520novel%2520phytosphingosine%2520derivatives%2520and%2520their%2520preliminary%2520biological%2520evaluation%2520for%2520enhancing%2520radiation%2520therapy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6643%26epage%3D6646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Kono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohama, T.</span><span> </span><span class="NLM_article-title">F-12509A, a new sphingosine kinase inhibitor, produced by a discomycete</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2000&pages=459-466&author=K.+Konoauthor=M.+Tanakaauthor=T.+Ogitaauthor=T.+Hosoyaauthor=T.+Kohama&title=F-12509A%2C+a+new+sphingosine+kinase+inhibitor%2C+produced+by+a+discomycete"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKono%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DOgita%26aufirst%3DT.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DKohama%26aufirst%3DT.%26atitle%3DF-12509A%252C%2520a%2520new%2520sphingosine%2520kinase%2520inhibitor%252C%2520produced%2520by%2520a%2520discomycete%26jtitle%3DJ.%2520Antibiot.%26date%3D2000%26volume%3D53%26spage%3D459%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Maezawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuichi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsumura, S.</span><span> </span><span class="NLM_article-title">Synthesis of a novel sphingosine kinase inhibitor (−)-F-12509A and determination of its absolute configuration</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4865</span><span class="NLM_x">–</span> <span class="NLM_lpage">4867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=4865-4867&author=N.+Maezawaauthor=N.+Furuichiauthor=H.+Tsuchikawaauthor=S.+Katsumura&title=Synthesis+of+a+novel+sphingosine+kinase+inhibitor+%28%E2%88%92%29-F-12509A+and+determination+of+its+absolute+configuration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaezawa%26aufirst%3DN.%26aulast%3DFuruichi%26aufirst%3DN.%26aulast%3DTsuchikawa%26aufirst%3DH.%26aulast%3DKatsumura%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520a%2520novel%2520sphingosine%2520kinase%2520inhibitor%2520%2528%25E2%2588%2592%2529-F-12509A%2520and%2520determination%2520of%2520its%2520absolute%2520configuration%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D4865%26epage%3D4867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Bonhoure, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pchejetski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aouali, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morjani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levade, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuvillier, O.</span><span> </span><span class="NLM_article-title">Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=95-102&author=E.+Bonhoureauthor=D.+Pchejetskiauthor=N.+Aoualiauthor=H.+Morjaniauthor=T.+Levadeauthor=T.+Kohamaauthor=O.+Cuvillier&title=Overcoming+MDR-associated+chemoresistance+in+HL-60+acute+myeloid+leukemia+cells+by+targeting+sphingosine+kinase-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonhoure%26aufirst%3DE.%26aulast%3DPchejetski%26aufirst%3DD.%26aulast%3DAouali%26aufirst%3DN.%26aulast%3DMorjani%26aufirst%3DH.%26aulast%3DLevade%26aufirst%3DT.%26aulast%3DKohama%26aufirst%3DT.%26aulast%3DCuvillier%26aufirst%3DO.%26atitle%3DOvercoming%2520MDR-associated%2520chemoresistance%2520in%2520HL-60%2520acute%2520myeloid%2520leukemia%2520cells%2520by%2520targeting%2520sphingosine%2520kinase-1%26jtitle%3DLeukemia%26date%3D2006%26volume%3D20%26spage%3D95%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Bonhoure, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauret, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malavaud, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melo, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuvillier, O.</span><span> </span><span class="NLM_article-title">Sphingosine kinase-1 is a downstream regulator of imatinib-induced apoptosis in chronic myeloid leukemia cells</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">979</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=971-979&author=E.+Bonhoureauthor=A.+Lauretauthor=D.+J.+Barnesauthor=C.+Martinauthor=B.+Malavaudauthor=T.+Kohamaauthor=J.+V.+Meloauthor=O.+Cuvillier&title=Sphingosine+kinase-1+is+a+downstream+regulator+of+imatinib-induced+apoptosis+in+chronic+myeloid+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonhoure%26aufirst%3DE.%26aulast%3DLauret%26aufirst%3DA.%26aulast%3DBarnes%26aufirst%3DD.%2BJ.%26aulast%3DMartin%26aufirst%3DC.%26aulast%3DMalavaud%26aufirst%3DB.%26aulast%3DKohama%26aufirst%3DT.%26aulast%3DMelo%26aufirst%3DJ.%2BV.%26aulast%3DCuvillier%26aufirst%3DO.%26atitle%3DSphingosine%2520kinase-1%2520is%2520a%2520downstream%2520regulator%2520of%2520imatinib-induced%2520apoptosis%2520in%2520chronic%2520myeloid%2520leukemia%2520cells%26jtitle%3DLeukemia%26date%3D2008%26volume%3D22%26spage%3D971%26epage%3D979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Brizuela, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doumerc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ader, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golzio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izard, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malavaud, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuvillier, O.</span><span> </span><span class="NLM_article-title">The sphingosine kinase-1 survival pathway is a molecular target for the tumor-suppressive tea and wine polyphenols in prostate cancer</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">3882</span><span class="NLM_x">–</span> <span class="NLM_lpage">3894</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=3882-3894&author=L.+Brizuelaauthor=A.+Dayonauthor=N.+Doumercauthor=I.+Aderauthor=M.+Golzioauthor=J.+C.+Izardauthor=Y.+Haraauthor=B.+Malavaudauthor=O.+Cuvillier&title=The+sphingosine+kinase-1+survival+pathway+is+a+molecular+target+for+the+tumor-suppressive+tea+and+wine+polyphenols+in+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrizuela%26aufirst%3DL.%26aulast%3DDayon%26aufirst%3DA.%26aulast%3DDoumerc%26aufirst%3DN.%26aulast%3DAder%26aufirst%3DI.%26aulast%3DGolzio%26aufirst%3DM.%26aulast%3DIzard%26aufirst%3DJ.%2BC.%26aulast%3DHara%26aufirst%3DY.%26aulast%3DMalavaud%26aufirst%3DB.%26aulast%3DCuvillier%26aufirst%3DO.%26atitle%3DThe%2520sphingosine%2520kinase-1%2520survival%2520pathway%2520is%2520a%2520molecular%2520target%2520for%2520the%2520tumor-suppressive%2520tea%2520and%2520wine%2520polyphenols%2520in%2520prostate%2520cancer%26jtitle%3DFASEB%2520J.%26date%3D2010%26volume%3D24%26spage%3D3882%26epage%3D3894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Zu Heringdorf, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihlefeld, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeilschifter, J.</span><span> </span><span class="NLM_article-title">Pharmacology of the sphingosine-1-phosphate signalling system</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">215</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1007%2F978-3-7091-1368-4_13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=23579459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2htL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2013&pages=239-253&author=D.+M.+Zu+Heringdorfauthor=K.+Ihlefeldauthor=J.+Pfeilschifter&title=Pharmacology+of+the+sphingosine-1-phosphate+signalling+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of the sphingosine-1-phosphate signalling system</span></div><div class="casAuthors">zu Heringdorf, Dagmar Meyer; Ihlefeld, Katja; Pfeilschifter, Josef</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">Sphingolipids: Basic Science and Drug Development</span>),
    <span class="NLM_cas:pages">239-253</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  The recent success of FTY720 (Fingolimod, Gilenya), which has been approved for the treatment of relapsing-remitting multiple sclerosis and is the first-in-class sphingosine-1-phosphate (S1P) receptor modulating drug, has boosted the interest in further drug development in this area.  Several selective S1P1 receptor-modulating drugs are being investigated in clin. trials for the treatment of diverse autoimmune disorders.  Sphingosine kinase inhibitors are under development for the treatment of cancer, aberrant angiogenesis and inflammatory diseases; an inhibitor of SK2 with relatively low affinity is being analyzed in patients with advanced solid tumors.  While an indirect S1P lyase inhibitor has just failed the proof of concept in patients with rheumatoid arthritis, S1P lyase is still a promising target for the treatment of inflammatory and autoimmune diseases.  Another approach is the development of S1P-scavenging or -clearing agents, including a monoclonal S1P antibody that has successfully passed phase I clin. trials and will be further developed for age-related macular degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL_KbFggq0WbVg90H21EOLACvtfcHk0lgckO4CuzLX2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2htL%252FO&md5=a448f07ec75327d721973b9cc77ba7e0</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1007%2F978-3-7091-1368-4_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-7091-1368-4_13%26sid%3Dliteratum%253Aachs%26aulast%3DZu%2BHeringdorf%26aufirst%3DD.%2BM.%26aulast%3DIhlefeld%26aufirst%3DK.%26aulast%3DPfeilschifter%26aufirst%3DJ.%26atitle%3DPharmacology%2520of%2520the%2520sphingosine-1-phosphate%2520signalling%2520system%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2013%26volume%3D215%26spage%3D239%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Edmonds, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Development of small-molecule inhibitors of sphingosine-1-phosphate signaling</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2Fj.pharmthera.2011.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=21906625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtl2ntrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2011&pages=352-360&author=Y.+Edmondsauthor=S.+Milstienauthor=S.+Spiegel&title=Development+of+small-molecule+inhibitors+of+sphingosine-1-phosphate+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Development of small-molecule inhibitors of sphingosine-1-phosphate signaling</span></div><div class="casAuthors">Edmonds, Yvette; Milstien, Sheldon; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">352-360</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The pleiotropic sphingolipid mediator, sphingosine-1-phosphate, produced in cells by two sphingosine kinase isoenzymes, SphK1 and SphK2, regulates many cellular and physiol. processes important for homeostasis and development and pathophysiol.  Many of the actions of S1P are mediated by a family of five specific cell surface receptors that are ubiquitously and specifically expressed, although important direct intracellular targets of S1P have also recently been identified.  S1P, SphK1, and or S1P receptors have been linked to onset and progression of numerous diseases, including many types of cancer, and esp. inflammatory disorders, such as multiple sclerosis, asthma, rheumatoid arthritis, inflammatory bowel disease, and sepsis.  S1P formation and signaling are attractive targets for development of new therapeutics.  The effects of a no. of inhibitors of SphKs and S1PRs have been examd. in animal models of human diseases.  The effectiveness of the immunosuppressant FTY720 (known as Fingolimod or Gilenya), recently approved for the treatment of multiple sclerosis, whose actions are mediated by downregulation of S1PR1, has become the gold std. for S1P-centric drugs.  Here, we review S1P biol. and signaling with an emphasis on potential therapeutic benefits of specific interventions and discuss recent development of small mol. antagonists and agonists that target specific subtypes of S1P receptors as well as inhibitors of SphKs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6EDQC_6khNrVg90H21EOLACvtfcHk0ljbo7xzcAoj3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtl2ntrzL&md5=2a265498dfa77a25a0ef9e6199fcbbc8</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2011.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2011.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DEdmonds%26aufirst%3DY.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DDevelopment%2520of%2520small-molecule%2520inhibitors%2520of%2520sphingosine-1-phosphate%2520signaling%26jtitle%3DPharmacol.%2520Ther.%26date%3D2011%26volume%3D132%26spage%3D352%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Song, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span> </span><span class="NLM_article-title">Prevention of GVHD and graft rejection by a new S1P receptor agonist, W-061, in rat small bowel transplantation</span> <span class="citation_source-journal">Transpl. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2Fj.trim.2011.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=22210496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVChu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=163-170&author=J.+Songauthor=H.+Hagiyaauthor=H.+Kurataauthor=H.+Mizunoauthor=T.+Ito&title=Prevention+of+GVHD+and+graft+rejection+by+a+new+S1P+receptor+agonist%2C+W-061%2C+in+rat+small+bowel+transplantation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of GVHD and graft rejection by a new S1P receptor agonist, W-061, in rat small bowel transplantation</span></div><div class="casAuthors">Song, Jinghai; Hagiya, Hiroshi; Kurata, Haruto; Mizuno, Hirotaka; Ito, Toshinori</div><div class="citationInfo"><span class="NLM_cas:title">Transplant Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">163-170</span>CODEN:
                <span class="NLM_cas:coden">TRIME2</span>;
        ISSN:<span class="NLM_cas:issn">0966-3274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Background: In small bowel transplantation (SBTx), inhibition of both graft-vs.-host disease (GVHD) and allograft rejection is necessary.  Methods: We investigated the potency of a new sphingosine-1-phosphate receptor agonist, W-061, for these two immune responses in SBTx.  W-061 has a completely different mol. structure from FTY720.  Heterotopic SBTx was performed from Wistar-Furth (WF) into (WF × ACI) F1 rats as a GVHD model or F1 to WF rats as a rejection model.  Recipients were orally given 3 mg/kg/day W-061 for 14 days after SBTx.  Recipient survival, body wt., histopathol., lymphocyte subpopulations, and the cytokine profile were evaluated.  Results: W-061 treatment significantly prolonged graft survival over 100 days in four out of six recipients in the GVHD group and over 60 days in three out of six recipients in the rejection group.  W-061 strongly inhibited GVHD and rejection as seen histopathol. in comparison with untreated control rats.  W-061 caused a significant redn. in donor-derived T cells in target organs and infiltrating T cells in allografts by promoting these cells to home into the secondary lymphoid tissues and sequestrating those cells there.  W-061 significantly decreased prodn. of interferon-γ in target organs and allografts.  Conclusion: Therefore, these data suggest that W-061 has considerable potential as a new therapeutic immunosuppressant in patients with SBTx.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPmIrYa6ttSbVg90H21EOLACvtfcHk0ljbo7xzcAoj3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVChu70%253D&md5=1cbafd0f401b5984e81798f527391ac5</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2Fj.trim.2011.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trim.2011.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DHagiya%26aufirst%3DH.%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DT.%26atitle%3DPrevention%2520of%2520GVHD%2520and%2520graft%2520rejection%2520by%2520a%2520new%2520S1P%2520receptor%2520agonist%252C%2520W-061%252C%2520in%2520rat%2520small%2520bowel%2520transplantation%26jtitle%3DTranspl.%2520Immunol.%26date%3D2012%26volume%3D26%26spage%3D163%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Lauer, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghori, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haldar, K.</span><span> </span><span class="NLM_article-title">Sphingolipid synthesis as a target for chemotherapy against malaria parasites</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">9181</span><span class="NLM_x">–</span> <span class="NLM_lpage">9185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=9181-9185&author=S.+A.+Lauerauthor=N.+Ghoriauthor=K.+Haldar&title=Sphingolipid+synthesis+as+a+target+for+chemotherapy+against+malaria+parasites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLauer%26aufirst%3DS.%2BA.%26aulast%3DGhori%26aufirst%3DN.%26aulast%3DHaldar%26aufirst%3DK.%26atitle%3DSphingolipid%2520synthesis%2520as%2520a%2520target%2520for%2520chemotherapy%2520against%2520malaria%2520parasites%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1995%26volume%3D92%26spage%3D9181%26epage%3D9185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Meyer, E. V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballie, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushnev, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menaldino, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrendale, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culver, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galinski, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natchus, M. G.</span><span> </span><span class="NLM_article-title">Sphingolipid analogues inhibit development of malaria parasites</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=43-47&author=E.+V.+S.+Meyerauthor=J.+J.+Holtauthor=K.+R.+Girardauthor=M.+T.+Ballieauthor=A.+S.+Bushnevauthor=S.+Lappauthor=D.+S.+Menaldinoauthor=R.+F.+Arrendaleauthor=G.+P.+Reddyauthor=T.+J.+Eversauthor=R.+B.+Howardauthor=D.+G.+Culverauthor=D.+C.+Liottaauthor=M.+R.+Galinskiauthor=M.+G.+Natchus&title=Sphingolipid+analogues+inhibit+development+of+malaria+parasites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DE.%2BV.%2BS.%26aulast%3DHolt%26aufirst%3DJ.%2BJ.%26aulast%3DGirard%26aufirst%3DK.%2BR.%26aulast%3DBallie%26aufirst%3DM.%2BT.%26aulast%3DBushnev%26aufirst%3DA.%2BS.%26aulast%3DLapp%26aufirst%3DS.%26aulast%3DMenaldino%26aufirst%3DD.%2BS.%26aulast%3DArrendale%26aufirst%3DR.%2BF.%26aulast%3DReddy%26aufirst%3DG.%2BP.%26aulast%3DEvers%26aufirst%3DT.%2BJ.%26aulast%3DHoward%26aufirst%3DR.%2BB.%26aulast%3DCulver%26aufirst%3DD.%2BG.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DGalinski%26aufirst%3DM.%2BR.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26atitle%3DSphingolipid%2520analogues%2520inhibit%2520development%2520of%2520malaria%2520parasites%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D3%26spage%3D43%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Alexander, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swatson, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, H.</span><span> </span><span class="NLM_article-title">Pharmacogenetics of resistance to cisplatin and other anticancer drugs and the role of sphingolipid metabolism</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">983</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1007%2F978-1-62703-302-2_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=23494308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A280%3ADC%252BC3svntVWjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=983&publication_year=2013&pages=185-204&author=S.+Alexanderauthor=W.+S.+Swatsonauthor=H.+Alexander&title=Pharmacogenetics+of+resistance+to+cisplatin+and+other+anticancer+drugs+and+the+role+of+sphingolipid+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacogenetics of resistance to Cisplatin and other anticancer drugs and the role of sphingolipid metabolism</span></div><div class="casAuthors">Alexander Stephen; Swatson William S; Alexander Hannah</div><div class="citationInfo"><span class="NLM_cas:title">Methods in molecular biology (Clifton, N.J.)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">983</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">185-204</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dictyostelium discoideum has proven to be a useful lead genetic system for identifying novel genes and pathways responsible for the regulation of sensitivity to the widely used anticancer drug cisplatin.  Resistance to cisplatin is a major factor limiting the efficacy of the drug in treating many types of cancer.  Studies using unbiased insertional mutagenesis in D. discoideum have identified the pathway of sphingolipid metabolism as a key regulator in controlling sensitivity to cisplatin.  Using the genetic tools including directed homologous recombination and ectopic gene expression available with D. discoideum has shown how pharmacological modulation of this pathway can increase sensitivity to cisplatin, and these results have been extensively translated to, and validated in, human cells.  Strategies, experimental conditions, and methods are presented to enable further study of resistance to cisplatin as well as other important drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQYO-J6ygKsqM25P7XSLhESfW6udTcc2eYjt2ResY42nLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svntVWjuw%253D%253D&md5=d8039cec3b2ea4007e72741087ceb881</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1007%2F978-1-62703-302-2_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-62703-302-2_10%26sid%3Dliteratum%253Aachs%26aulast%3DAlexander%26aufirst%3DS.%26aulast%3DSwatson%26aufirst%3DW.%2BS.%26aulast%3DAlexander%26aufirst%3DH.%26atitle%3DPharmacogenetics%2520of%2520resistance%2520to%2520cisplatin%2520and%2520other%2520anticancer%2520drugs%2520and%2520the%2520role%2520of%2520sphingolipid%2520metabolism%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2013%26volume%3D983%26spage%3D185%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Salas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponnusamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senkal, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers-Needham, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selvam, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saddoughi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apohan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentelle, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gault, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeid, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Shewy, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oaks, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhanam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuart, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrotti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogretmen, B.</span><span> </span><span class="NLM_article-title">Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">5941</span><span class="NLM_x">–</span> <span class="NLM_lpage">5952</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=5941-5952&author=A.+Salasauthor=S.+Ponnusamyauthor=C.+E.+Senkalauthor=M.+Meyers-Needhamauthor=S.+P.+Selvamauthor=S.+A.+Saddoughiauthor=E.+Apohanauthor=R.+D.+Sentelleauthor=C.+Smithauthor=C.+R.+Gaultauthor=L.+M.+Obeidauthor=H.+M.+El-Shewyauthor=J.+Oaksauthor=R.+Santhanamauthor=G.+Marcucciauthor=Y.+Baranauthor=S.+Mahajanauthor=D.+Fernandesauthor=R.+Stuartauthor=D.+Perrottiauthor=B.+Ogretmen&title=Sphingosine+kinase-1+and+sphingosine+1-phosphate+receptor+2+mediate+Bcr-Abl1+stability+and+drug+resistance+by+modulation+of+protein+phosphatase+2A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalas%26aufirst%3DA.%26aulast%3DPonnusamy%26aufirst%3DS.%26aulast%3DSenkal%26aufirst%3DC.%2BE.%26aulast%3DMeyers-Needham%26aufirst%3DM.%26aulast%3DSelvam%26aufirst%3DS.%2BP.%26aulast%3DSaddoughi%26aufirst%3DS.%2BA.%26aulast%3DApohan%26aufirst%3DE.%26aulast%3DSentelle%26aufirst%3DR.%2BD.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DGault%26aufirst%3DC.%2BR.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26aulast%3DEl-Shewy%26aufirst%3DH.%2BM.%26aulast%3DOaks%26aufirst%3DJ.%26aulast%3DSanthanam%26aufirst%3DR.%26aulast%3DMarcucci%26aufirst%3DG.%26aulast%3DBaran%26aufirst%3DY.%26aulast%3DMahajan%26aufirst%3DS.%26aulast%3DFernandes%26aufirst%3DD.%26aulast%3DStuart%26aufirst%3DR.%26aulast%3DPerrotti%26aufirst%3DD.%26aulast%3DOgretmen%26aufirst%3DB.%26atitle%3DSphingosine%2520kinase-1%2520and%2520sphingosine%25201-phosphate%2520receptor%25202%2520mediate%2520Bcr-Abl1%2520stability%2520and%2520drug%2520resistance%2520by%2520modulation%2520of%2520protein%2520phosphatase%25202A%26jtitle%3DBlood%26date%3D2011%26volume%3D117%26spage%3D5941%26epage%3D5952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Schnitzer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brune, B.</span><span> </span><span class="NLM_article-title">Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1158%2F1541-7786.MCR-08-0156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=19240180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtF2js7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=393-401&author=S.+E.+Schnitzerauthor=A.+Weigertauthor=J.+Zhouauthor=B.+Brune&title=Hypoxia+enhances+sphingosine+kinase+2+activity+and+provokes+sphingosine-1-phosphate-mediated+chemoresistance+in+A549+lung+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia Enhances Sphingosine Kinase 2 Activity and Provokes Sphingosine-1-Phosphate-Mediated Chemoresistance in A549 Lung Cancer Cells</span></div><div class="casAuthors">Schnitzer, Steffen E.; Weigert, Andreas; Zhou, Jie; Bruene, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">393-401</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hypoxia and signaling via hypoxia-inducible factor-1 (HIF-1) is a key feature of solid tumors and is related to tumor progression as well as treatment failure.  Although it is generally accepted that HIF-1 provokes tumor cell survival and induces chemoresistance under hypoxia, HIF-1-independent mechanisms operate as well.  We present evidence that conditioned medium obtained from A549 cells, incubated for 24 h under hypoxia, protected naive A549 cells from etoposide-induced cell death.  Lipid exts. generated from hypoxia-conditioned medium still rescued cells from apoptosis induced by etoposide.  Specifically, the bioactive lipid sphingosine-1-phosphate (S1P) not only was essential for cell viability of A549 cells but also protected cells from apoptosis.  We noticed an increase in sphingosine kinase 2 (SphK2) protein level and enzymic activity under hypoxia, which correlated with the release of S1P into the medium.  Knockdown of SphK2 using specific small interfering RNA relieved chemoresistance of A549 cells under hypoxia and conditioned medium obtained from SphK2 knockdown cells was only partially protective.  Coincubations of conditioned medium with VPC23019, a S1P1/S1P3 antagonist, reduced protection of conditioned medium, with the further notion that p42/44 mitogen-activated protein kinase transmits autocrine or paracrine survival signaling downstream of S1P1/S1P3 receptors.  Our data suggest that hypoxia activates SphK2 to promote the synthesis and release of S1P, which in turn binds to S1P1/S1P3 receptors, thus activating p42/44 mitogen-activated protein kinase to convey autocrine or paracrine protection of A549 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLBtrq0j1xzrVg90H21EOLACvtfcHk0lijCCglBdFPKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtF2js7c%253D&md5=c2b24fd14e4cab36c4b9c076aaeaafab</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-08-0156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-08-0156%26sid%3Dliteratum%253Aachs%26aulast%3DSchnitzer%26aufirst%3DS.%2BE.%26aulast%3DWeigert%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DBrune%26aufirst%3DB.%26atitle%3DHypoxia%2520enhances%2520sphingosine%2520kinase%25202%2520activity%2520and%2520provokes%2520sphingosine-1-phosphate-mediated%2520chemoresistance%2520in%2520A549%2520lung%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2009%26volume%3D7%26spage%3D393%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Gustin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connors, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffries, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franks, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesche, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">Structure guided design of a series of sphingosine kinase (SphK) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4608</span><span class="NLM_x">–</span> <span class="NLM_lpage">4616</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2Fj.bmcl.2013.06.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=23845219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2lsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4608-4616&author=D.+J.+Gustinauthor=Y.+Liauthor=M.+L.+Brownauthor=X.+Minauthor=M.+J.+Schmittauthor=M.+Wanskaauthor=X.+Wangauthor=R.+Connorsauthor=S.+Johnstoneauthor=M.+Cardozoauthor=A.+C.+Chengauthor=S.+Jeffriesauthor=B.+Franksauthor=S.+Liauthor=S.+Shenauthor=M.+Wongauthor=H.+Wescheauthor=G.+Xuauthor=T.+J.+Carlsonauthor=M.+Plantauthor=K.+Morgensternauthor=K.+Rexauthor=J.+Schmittauthor=A.+Coxonauthor=N.+Walkerauthor=F.+Kayserauthor=Z.+Wang&title=Structure+guided+design+of+a+series+of+sphingosine+kinase+%28SphK%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Structure guided design of a series of sphingosine kinase (SphK) inhibitors</span></div><div class="casAuthors">Gustin, Darin J.; Li, Yihong; Brown, Matthew L.; Min, Xiaoshan; Schmitt, Mike J.; Wanska, Malgorzata; Wang, Xiaodong; Connors, Richard; Johnstone, Sheere; Cardozo, Mario; Cheng, Alan C.; Jeffries, Shawn; Franks, Brendon; Li, Shyun; Shen, Shanling; Wong, Mariwil; Wesche, Holger; Xu, Guifen; Carlson, Timothy J.; Plant, Matthew; Morgenstern, Kurt; Rex, Karen; Schmitt, Joanna; Coxon, Angela; Walker, Nigel; Kayser, Frank; Wang, Zhulun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4608-4616</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sphingosine-1-phosphate (S1P) signaling plays a vital role in mitogenesis, cell migration and angiogenesis.  Sphingosine kinases (SphKs) catalyze a key step in sphingomyelin metab. that leads to the prodn. of S1P.  There are two isoforms of SphK and observations made with SphK deficient mice show the two isoforms can compensate for each other's loss.  Thus, inhibition of both isoforms is likely required to block SphK dependent angiogenesis.  A structure based approach was used to design and synthesize a series of SphK inhibitors resulting in the identification of the first potent inhibitors of both isoforms of human SphK.  Addnl., to our knowledge, this series of inhibitors contains the only sufficiently potent inhibitors of murine SphK1 with suitable physico-chem. properties to pharmacol. interrogate the role of SphK1 in rodent models and to reproduce the phenotype of SphK1 (-/-) mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovzWgmT5jALrVg90H21EOLACvtfcHk0lijCCglBdFPKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2lsb%252FN&md5=42c7f013299278232f62a9f70bccd08c</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.030%26sid%3Dliteratum%253Aachs%26aulast%3DGustin%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DSchmitt%26aufirst%3DM.%2BJ.%26aulast%3DWanska%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DConnors%26aufirst%3DR.%26aulast%3DJohnstone%26aufirst%3DS.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DJeffries%26aufirst%3DS.%26aulast%3DFranks%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DWesche%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DCarlson%26aufirst%3DT.%2BJ.%26aulast%3DPlant%26aufirst%3DM.%26aulast%3DMorgenstern%26aufirst%3DK.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DWalker%26aufirst%3DN.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DStructure%2520guided%2520design%2520of%2520a%2520series%2520of%2520sphingosine%2520kinase%2520%2528SphK%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4608%26epage%3D4616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Neubauer, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitson, S. M.</span><span> </span><span class="NLM_article-title">Roles, regulation and inhibitors of sphingosine kinase 2</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">5317</span><span class="NLM_x">–</span> <span class="NLM_lpage">5336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=5317-5336&author=H.+A.+Neubauerauthor=S.+M.+Pitson&title=Roles%2C+regulation+and+inhibitors+of+sphingosine+kinase+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeubauer%26aufirst%3DH.%2BA.%26aulast%3DPitson%26aufirst%3DS.%2BM.%26atitle%3DRoles%252C%2520regulation%2520and%2520inhibitors%2520of%2520sphingosine%2520kinase%25202%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D5317%26epage%3D5336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Urbano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, E.</span><span> </span><span class="NLM_article-title">Modulators of the sphingosine 1-phosphate receptor 1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6377</span><span class="NLM_x">–</span> <span class="NLM_lpage">6389</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6377-6389&author=M.+Urbanoauthor=M.+Guerreroauthor=H.+Rosenauthor=E.+Roberts&title=Modulators+of+the+sphingosine+1-phosphate+receptor+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUrbano%26aufirst%3DM.%26aulast%3DGuerrero%26aufirst%3DM.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DRoberts%26aufirst%3DE.%26atitle%3DModulators%2520of%2520the%2520sphingosine%25201-phosphate%2520receptor%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6377%26epage%3D6389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffries, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fajardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassner, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruefli-Brasse, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swearingen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickramasinghe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesche, H.</span><span> </span><span class="NLM_article-title">Sphingosine kinase activity is not required for tumor cell viability</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e68328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e68328&author=K.+Rexauthor=S.+Jeffriesauthor=M.+L.+Brownauthor=T.+Carlsonauthor=A.+Coxonauthor=F.+Fajardoauthor=B.+Frankauthor=D.+Gustinauthor=A.+Kambauthor=P.+D.+Kassnerauthor=S.+Liauthor=Y.+Liauthor=K.+Morgensternauthor=M.+Plantauthor=K.+Quonauthor=A.+Ruefli-Brasseauthor=J.+Schmidtauthor=E.+Swearingenauthor=N.+Walkerauthor=Z.+Wangauthor=J.+E.+V.+Watsonauthor=D.+Wickramasingheauthor=M.+Wongauthor=G.+Xuauthor=H.+Wesche&title=Sphingosine+kinase+activity+is+not+required+for+tumor+cell+viability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRex%26aufirst%3DK.%26aulast%3DJeffries%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DCarlson%26aufirst%3DT.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DFajardo%26aufirst%3DF.%26aulast%3DFrank%26aufirst%3DB.%26aulast%3DGustin%26aufirst%3DD.%26aulast%3DKamb%26aufirst%3DA.%26aulast%3DKassner%26aufirst%3DP.%2BD.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMorgenstern%26aufirst%3DK.%26aulast%3DPlant%26aufirst%3DM.%26aulast%3DQuon%26aufirst%3DK.%26aulast%3DRuefli-Brasse%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DSwearingen%26aufirst%3DE.%26aulast%3DWalker%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWatson%26aufirst%3DJ.%2BE.%2BV.%26aulast%3DWickramasinghe%26aufirst%3DD.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DWesche%26aufirst%3DH.%26atitle%3DSphingosine%2520kinase%2520activity%2520is%2520not%2520required%2520for%2520tumor%2520cell%2520viability%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De68328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Beljanski, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. D.</span><span> </span><span class="NLM_article-title">Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">524</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.4161%2Fcbt.11.5.14677" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=21258214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktl2ms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=524-534&author=V.+Beljanskiauthor=C.+S.+Lewisauthor=C.+D.+Smith&title=Antitumor+activity+of+sphingosine+kinase+2+inhibitor+ABC294640+and+sorafenib+in+hepatocellular+carcinoma+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts</span></div><div class="casAuthors">Beljanski, Vladimir; Lewis, Clayton S.; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">524-534</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">The balance between the pro-apoptotic lipids ceramide and sphingosine and the pro-survival lipid sphingosine 1-phosphate (S1P) is termed the "sphingosine rheostat".  Two isoenzymes, sphingosine kinase 1 and 2 (SK1 and SK2), are responsible for phosphorylation of pro-apoptotic sphingosine to form pro-survival S1P.  We have previously reported the antitumor properties of an SK2 selective inhibitor, ABC294640, alone or in combination with the multikinase inhibitor sorafenib in mouse models of kidney carcinoma and pancreatic adenocarcinoma.  Here, we evaluated the combined antitumor effects of the aforementioned drug combination in two mouse models of hepatocellular carcinoma.  Although combining the SK2 inhibitor, ABC294640 and sorafenib in vitro only afforded additive drug-drug effects, their combined antitumor properties in the mouse model bearing HepG2 cells mirrored effects previously obsd. in animals bearing kidney carcinoma and pancreatic adenocarcinoma cells.  Combining ABC294640 and sorafenib led to a decrease in the levels of phosphorylated ERK in SK-HEP-1 cells, indicating that the antitumor effect of this drug combination is likely mediated through a suppression of the MAPK pathway in hepatocellular models.  We also measured levels of S1P in the plasma of mice treated with two different doses of ABC294640 and sorafenib.  We found decreases in the levels of S1P in plasma of mice treated daily with 100 mg/kg of ABC294640 for 5 wk, and this decrease was not affected by co-administration of sorafenib.  Taken together, these data support combining ABC294640 and sorafenib in clin. trials in HCC patients.  Furthermore, monitoring levels of S1P may provide a pharmacodynamic marker of ABC294640 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVXNclr6Hb-LVg90H21EOLACvtfcHk0lj9_NxZy0guiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktl2ms70%253D&md5=a4ddc2eb4b02d27365db41f57be7172c</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.4161%2Fcbt.11.5.14677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.11.5.14677%26sid%3Dliteratum%253Aachs%26aulast%3DBeljanski%26aufirst%3DV.%26aulast%3DLewis%26aufirst%3DC.%2BS.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DAntitumor%2520activity%2520of%2520sphingosine%2520kinase%25202%2520inhibitor%2520ABC294640%2520and%2520sorafenib%2520in%2520hepatocellular%2520carcinoma%2520xenografts%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2011%26volume%3D11%26spage%3D524%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Li, Q. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. S.</span><span> </span><span class="NLM_article-title">Bortezomib and sphingosine kinase inhibitor interact synergistically to induces apoptosis in BCR/ABl+ cells sensitive and resistant to STI571 through down-regulation Mcl-1</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">405</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2011&pages=31-36&author=Q.+F.+Liauthor=J.+Yanauthor=K.+Zhangauthor=Y.+F.+Yangauthor=F.+J.+Xiaoauthor=C.+T.+Wuauthor=H.+Wangauthor=L.+S.+Wang&title=Bortezomib+and+sphingosine+kinase+inhibitor+interact+synergistically+to+induces+apoptosis+in+BCR%2FABl%2B+cells+sensitive+and+resistant+to+STI571+through+down-regulation+Mcl-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%2BF.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DY.%2BF.%26aulast%3DXiao%26aufirst%3DF.%2BJ.%26aulast%3DWu%26aufirst%3DC.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%2BS.%26atitle%3DBortezomib%2520and%2520sphingosine%2520kinase%2520inhibitor%2520interact%2520synergistically%2520to%2520induces%2520apoptosis%2520in%2520BCR%252FABl%252B%2520cells%2520sensitive%2520and%2520resistant%2520to%2520STI571%2520through%2520down-regulation%2520Mcl-1%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2011%26volume%3D405%26spage%3D31%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Chatzakos, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rundlof, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Verdier, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flygare, J.</span><span> </span><span class="NLM_article-title">Inhibition of sphingosine kinase 1 enhances cytotoxicity, ceramide levels and ROS formation in liver cancer cells treated with selenite</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=712-721&author=V.+Chatzakosauthor=A.+K.+Rundlofauthor=D.+Ahmedauthor=P.+J.+de+Verdierauthor=J.+Flygare&title=Inhibition+of+sphingosine+kinase+1+enhances+cytotoxicity%2C+ceramide+levels+and+ROS+formation+in+liver+cancer+cells+treated+with+selenite"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChatzakos%26aufirst%3DV.%26aulast%3DRundlof%26aufirst%3DA.%2BK.%26aulast%3DAhmed%26aufirst%3DD.%26aulast%3Dde%2BVerdier%26aufirst%3DP.%2BJ.%26aulast%3DFlygare%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520sphingosine%2520kinase%25201%2520enhances%2520cytotoxicity%252C%2520ceramide%2520levels%2520and%2520ROS%2520formation%2520in%2520liver%2520cancer%2520cells%2520treated%2520with%2520selenite%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26spage%3D712%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 66 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Sonam Roy, Taj Mohammad, Preeti Gupta, Rashmi Dahiya, Shahnaz Parveen, Suaib Luqman, Gulam Mustafa Hasan, <span class="NLM_string-name hlFld-ContribAuthor">Md. Imtaiyaz Hassan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (34)
                                     , 21550-21560. <a href="https://doi.org/10.1021/acsomega.0c02165" title="DOI URL">https://doi.org/10.1021/acsomega.0c02165</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c02165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c02165%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DDiscovery%252Bof%252BHarmaline%252Bas%252Ba%252BPotent%252BInhibitor%252Bof%252BSphingosine%252BKinase-1%25253A%252BA%252BChemopreventive%252BRole%252Bin%252BLung%252BCancer%26aulast%3DRoy%26aufirst%3DSonam%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09052020%26date%3D10082020%26date%3D20082020%26volume%3D5%26issue%3D34%26spage%3D21550%26epage%3D21560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Luca Dellafiora, Gianni Galaverna, <span class="NLM_string-name hlFld-ContribAuthor">Chiara Dall’Asta</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanisms of Fumonisin B1 Toxicity: A Computational Perspective beyond the Ceramide Synthases Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2018,</strong> <em>31 </em>
                                    (11)
                                     , 1203-1212. <a href="https://doi.org/10.1021/acs.chemrestox.8b00188" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.8b00188</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.8b00188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.8b00188%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DMechanisms%252Bof%252BFumonisin%252BB1%252BToxicity%25253A%252BA%252BComputational%252BPerspective%252Bbeyond%252Bthe%252BCeramide%252BSynthases%252BInhibition%26aulast%3DDellafiora%26aufirst%3DLuca%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D13072018%26date%3D02112018%26date%3D22102018%26volume%3D31%26issue%3D11%26spage%3D1203%26epage%3D1212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth S.  Childress</span>, <span class="hlFld-ContribAuthor ">Yugesh  Kharel</span>, <span class="hlFld-ContribAuthor ">Anne M.  Brown</span>, <span class="hlFld-ContribAuthor ">David R.  Bevan</span>, <span class="hlFld-ContribAuthor ">Kevin R.  Lynch</span>, and <span class="hlFld-ContribAuthor ">Webster L.  Santos</span>  . </span><span class="cited-content_cbyCitation_article-title">Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 3933-3957. <a href="https://doi.org/10.1021/acs.jmedchem.7b00233" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00233</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00233%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTransforming%252BSphingosine%252BKinase%252B1%252BInhibitors%252Binto%252BDual%252Band%252BSphingosine%252BKinase%252B2%252BSelective%252BInhibitors%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252Bin%252BVivo%252BActivity%26aulast%3DChildress%26aufirst%3DElizabeth%2BS.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D10022017%26date%3D25042017%26date%3D11052017%26date%3D13042017%26volume%3D60%26issue%3D9%26spage%3D3933%26epage%3D3957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark E.  Schnute</span>, <span class="hlFld-ContribAuthor ">Matthew D.  McReynolds</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Carroll</span>, <span class="hlFld-ContribAuthor ">Jill  Chrencik</span>, <span class="hlFld-ContribAuthor ">Maureen K.  Highkin</span>, <span class="hlFld-ContribAuthor ">Kaliapan  Iyanar</span>, <span class="hlFld-ContribAuthor ">Gina  Jerome</span>, <span class="hlFld-ContribAuthor ">John W.  Rains</span>, <span class="hlFld-ContribAuthor ">Matthew  Saabye</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Scholten</span>, <span class="hlFld-ContribAuthor ">Matthew  Yates</span>, and <span class="hlFld-ContribAuthor ">Marek M.  Nagiec</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent and Selective Sphingosine Kinase 1 Inhibitor through the Molecular Combination of Chemotype-Distinct Screening Hits. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (6)
                                     , 2562-2572. <a href="https://doi.org/10.1021/acs.jmedchem.7b00070" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00070%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252Band%252BSelective%252BSphingosine%252BKinase%252B1%252BInhibitor%252Bthrough%252Bthe%252BMolecular%252BCombination%252Bof%252BChemotype-Distinct%252BScreening%252BHits%26aulast%3DSchnute%26aufirst%3DMark%2BE.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D14012017%26date%3D06032017%26date%3D23032017%26date%3D23022017%26volume%3D60%26issue%3D6%26spage%3D2562%26epage%3D2572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam J.  Rosenberg</span>, <span class="hlFld-ContribAuthor ">Hui  Liu</span>, <span class="hlFld-ContribAuthor ">Hongjun  Jin</span>, <span class="hlFld-ContribAuthor ">Xuyi  Yue</span>, <span class="hlFld-ContribAuthor ">Sean  Riley</span>, <span class="hlFld-ContribAuthor ">Steven J.  Brown</span>, and <span class="hlFld-ContribAuthor ">Zhude  Tu</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and In Vitro and In Vivo Evaluation of an 18F-Labeled Sphingosine 1-Phosphate Receptor 1 (S1P1) PET Tracer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (13)
                                     , 6201-6220. <a href="https://doi.org/10.1021/acs.jmedchem.6b00390" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00390</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00390%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BIn%252BVitro%252Band%252BIn%252BVivo%252BEvaluation%252Bof%252Ban%252B18F-Labeled%252BSphingosine%252B1-Phosphate%252BReceptor%252B1%252B%252528S1P1%252529%252BPET%252BTracer%26aulast%3DRosenberg%26aufirst%3DAdam%2BJ.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D15032016%26date%3D22062016%26date%3D14072016%26date%3D09062016%26volume%3D59%26issue%3D13%26spage%3D6201%26epage%3D6220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph D.  Houck</span>, <span class="hlFld-ContribAuthor ">Thomas K.  Dawson</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Kennedy</span>, <span class="hlFld-ContribAuthor ">Yugesh  Kharel</span>, <span class="hlFld-ContribAuthor ">Niels D.  Naimon</span>, <span class="hlFld-ContribAuthor ">Saundra D.  Field</span>, <span class="hlFld-ContribAuthor ">Kevin R.  Lynch</span>, and <span class="hlFld-ContribAuthor ">Timothy L.  Macdonald</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural Requirements and Docking Analysis of Amidine-Based Sphingosine Kinase 1 Inhibitors Containing Oxadiazoles. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (5)
                                     , 487-492. <a href="https://doi.org/10.1021/acsmedchemlett.6b00002" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00002%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructural%252BRequirements%252Band%252BDocking%252BAnalysis%252Bof%252BAmidine-Based%252BSphingosine%252BKinase%252B1%252BInhibitors%252BContaining%252BOxadiazoles%26aulast%3DHouck%26aufirst%3DJoseph%2BD.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D04012016%26date%3D01032016%26date%3D09032016%26date%3D12052016%26date%3D01032016%26volume%3D7%26issue%3D5%26spage%3D487%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric J.  Miller</span>, <span class="hlFld-ContribAuthor ">Suzanne G.  Mays</span>, <span class="hlFld-ContribAuthor ">Mark T.  Baillie</span>, <span class="hlFld-ContribAuthor ">Randy B.  Howard</span>, <span class="hlFld-ContribAuthor ">Deborah G.  Culver</span>, <span class="hlFld-ContribAuthor ">Manohar  Saindane</span>, <span class="hlFld-ContribAuthor ">Sarah T.  Pruett</span>, <span class="hlFld-ContribAuthor ">Jason J.  Holt</span>, <span class="hlFld-ContribAuthor ">David S.  Menaldino</span>, <span class="hlFld-ContribAuthor ">Taylor J.  Evers</span>, <span class="hlFld-ContribAuthor ">G. Prabhakar  Reddy</span>, <span class="hlFld-ContribAuthor ">Richard F.  Arrendale</span>, <span class="hlFld-ContribAuthor ">Michael G.  Natchus</span>, <span class="hlFld-ContribAuthor ">John A.  Petros</span>, and <span class="hlFld-ContribAuthor ">Dennis C.  Liotta</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Fluorinated Enigmol Analog with Enhanced in Vivo Pharmacokinetic and Anti-Tumor Properties. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (5)
                                     , 537-542. <a href="https://doi.org/10.1021/acsmedchemlett.6b00113" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00113%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BFluorinated%252BEnigmol%252BAnalog%252Bwith%252BEnhanced%252Bin%252BVivo%252BPharmacokinetic%252Band%252BAnti-Tumor%252BProperties%26aulast%3DMiller%26aufirst%3DEric%2BJ.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D14032016%26date%3D21032016%26date%3D23032016%26date%3D12052016%26date%3D21032016%26volume%3D7%26issue%3D5%26spage%3D537%26epage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Molly D.  Congdon</span>, <span class="hlFld-ContribAuthor ">Yugesh  Kharel</span>, <span class="hlFld-ContribAuthor ">Anne M.  Brown</span>, <span class="hlFld-ContribAuthor ">Stephanie N.  Lewis</span>, <span class="hlFld-ContribAuthor ">David R.  Bevan</span>, <span class="hlFld-ContribAuthor ">Kevin R.  Lynch</span>, and <span class="hlFld-ContribAuthor ">Webster L.  Santos</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationship Studies and Molecular Modeling of Naphthalene-Based Sphingosine Kinase 2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (3)
                                     , 229-234. <a href="https://doi.org/10.1021/acsmedchemlett.5b00304" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00304</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00304%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationship%252BStudies%252Band%252BMolecular%252BModeling%252Bof%252BNaphthalene-Based%252BSphingosine%252BKinase%252B2%252BInhibitors%26aulast%3DCongdon%26aufirst%3DMolly%2BD.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D31072015%26date%3D02022016%26date%3D08022016%26date%3D10032016%26date%3D02022016%26volume%3D7%26issue%3D3%26spage%3D229%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luigi  Aurelio</span>, <span class="hlFld-ContribAuthor ">Carmen V.  Scullino</span>, <span class="hlFld-ContribAuthor ">Melissa R.  Pitman</span>, <span class="hlFld-ContribAuthor ">Anna  Sexton</span>, <span class="hlFld-ContribAuthor ">Victoria  Oliver</span>, <span class="hlFld-ContribAuthor ">Lorena  Davies</span>, <span class="hlFld-ContribAuthor ">Richard J.  Rebello</span>, <span class="hlFld-ContribAuthor ">Luc  Furic</span>, <span class="hlFld-ContribAuthor ">Darren J.  Creek</span>, <span class="hlFld-ContribAuthor ">Stuart M.  Pitson</span>, and <span class="hlFld-ContribAuthor ">Bernard L.  Flynn</span>  . </span><span class="cited-content_cbyCitation_article-title">From Sphingosine Kinase to Dihydroceramide Desaturase: A Structure–Activity Relationship (SAR) Study of the Enzyme Inhibitory and Anticancer Activity of 4-((4-(4-Chlorophenyl)thiazol-2-yl)amino)phenol (SKI-II). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (3)
                                     , 965-984. <a href="https://doi.org/10.1021/acs.jmedchem.5b01439" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01439</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01439%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFrom%252BSphingosine%252BKinase%252Bto%252BDihydroceramide%252BDesaturase%25253A%252BA%252BStructure%2525E2%252580%252593Activity%252BRelationship%252B%252528SAR%252529%252BStudy%252Bof%252Bthe%252BEnzyme%252BInhibitory%252Band%252BAnticancer%252BActivity%252Bof%252B4-%252528%2525284-%2525284-Chlorophenyl%252529thiazol-2-yl%252529amino%252529phenol%252B%252528SKI-II%252529%26aulast%3DAurelio%26aufirst%3DLuigi%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D16092015%26date%3D03022016%26date%3D11022016%26date%3D18012016%26volume%3D59%26issue%3D3%26spage%3D965%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neeraj N.  Patwardhan</span>, <span class="hlFld-ContribAuthor ">Emily A.  Morris</span>, <span class="hlFld-ContribAuthor ">Yugesh  Kharel</span>, <span class="hlFld-ContribAuthor ">Mithun R.  Raje</span>, <span class="hlFld-ContribAuthor ">Ming  Gao</span>, <span class="hlFld-ContribAuthor ">Jose L.  Tomsig</span>, <span class="hlFld-ContribAuthor ">Kevin R.  Lynch</span>, and <span class="hlFld-ContribAuthor ">Webster L.  Santos</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure−Activity Relationship Studies and in Vivo Activity of Guanidine-Based Sphingosine Kinase Inhibitors: Discovery of SphK1- and SphK2-Selective Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (4)
                                     , 1879-1899. <a href="https://doi.org/10.1021/jm501760d" title="DOI URL">https://doi.org/10.1021/jm501760d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501760d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501760d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252588%252592Activity%252BRelationship%252BStudies%252Band%252Bin%252BVivo%252BActivity%252Bof%252BGuanidine-Based%252BSphingosine%252BKinase%252BInhibitors%25253A%252BDiscovery%252Bof%252BSphK1-%252Band%252BSphK2-Selective%252BInhibitors%26aulast%3DPatwardhan%26aufirst%3DNeeraj%2BN.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D13112014%26date%3D13022015%26date%3D26022015%26date%3D02022015%26volume%3D58%26issue%3D4%26spage%3D1879%26epage%3D1899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Webster L.  Santos</span> and <span class="hlFld-ContribAuthor ">Kevin R.  Lynch</span>  . </span><span class="cited-content_cbyCitation_article-title">Drugging Sphingosine Kinases. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2015,</strong> <em>10 </em>
                                    (1)
                                     , 225-233. <a href="https://doi.org/10.1021/cb5008426" title="DOI URL">https://doi.org/10.1021/cb5008426</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb5008426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb5008426%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DDrugging%252BSphingosine%252BKinases%26aulast%3DSantos%26aufirst%3DWebster%2BL.%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D17102014%26date%3D10112014%26date%3D19112014%26date%3D16012015%26date%3D10112014%26volume%3D10%26issue%3D1%26spage%3D225%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Nigel J.  Pyne</span>, <span class="hlFld-ContribAuthor ">Susan  Pyne</span>, and <span class="hlFld-ContribAuthor ">Jonathan M.  Elkins</span>  . </span><span class="cited-content_cbyCitation_article-title">Crystal Structure of Sphingosine Kinase 1 with PF-543. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (12)
                                     , 1329-1333. <a href="https://doi.org/10.1021/ml5004074" title="DOI URL">https://doi.org/10.1021/ml5004074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml5004074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml5004074%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCrystal%252BStructure%252Bof%252BSphingosine%252BKinase%252B1%252Bwith%252BPF-543%26aulast%3DWang%26aufirst%3DJing%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D05102014%26date%3D27102014%26date%3D31102014%26date%3D11122014%26date%3D27102014%26volume%3D5%26issue%3D12%26spage%3D1329%26epage%3D1333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shadia A.  Galal</span>, <span class="hlFld-ContribAuthor ">Mohamed A.  Omar</span>, <span class="hlFld-ContribAuthor ">Sarah H. M.  Khairat</span>, <span class="hlFld-ContribAuthor ">Fatma A. F.  Ragab</span>, <span class="hlFld-ContribAuthor ">Sonam  Roy</span>, <span class="hlFld-ContribAuthor ">Ahmad Abu Turab  Naqvi</span>, <span class="hlFld-ContribAuthor ">Md. Imtaiyaz  Hassan</span>, <span class="hlFld-ContribAuthor ">Hoda I.  El Diwani</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of new pyrazolylbenzimidazoles as sphingosine kinase-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.1007/s00044-021-02760-3" title="DOI URL">https://doi.org/10.1007/s00044-021-02760-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-021-02760-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-021-02760-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnew%252Bpyrazolylbenzimidazoles%252Bas%252Bsphingosine%252Bkinase-1%252Binhibitors%26aulast%3DGalal%26aufirst%3DShadia%2BA.%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah H. M.  Khairat</span>, <span class="hlFld-ContribAuthor ">Mohamed A.  Omar</span>, <span class="hlFld-ContribAuthor ">Fatma A. F.  Ragab</span>, <span class="hlFld-ContribAuthor ">Sonam  Roy</span>, <span class="hlFld-ContribAuthor ">Ahmad A.  Turab Naqvi</span>, <span class="hlFld-ContribAuthor ">Ahmed S.  Abdelsamie</span>, <span class="hlFld-ContribAuthor ">Anna K. H.  Hirsch</span>, <span class="hlFld-ContribAuthor ">Shadia A.  Galal</span>, <span class="hlFld-ContribAuthor ">Md. Imtaiyaz  Hassan</span>, <span class="hlFld-ContribAuthor ">Hoda I.  El Diwani</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of novel benzimidazole derivatives as sphingosine kinase 1 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.1002/ardp.202100080" title="DOI URL">https://doi.org/10.1002/ardp.202100080</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.202100080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.202100080%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bbenzimidazole%252Bderivatives%252Bas%252Bsphingosine%252Bkinase%252B1%252Binhibitor%26aulast%3DKhairat%26aufirst%3DSarah%2BH.%2BM.%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tiandi  Ding</span>, <span class="hlFld-ContribAuthor ">Ying  Zhi</span>, <span class="hlFld-ContribAuthor ">Weilin  Xie</span>, <span class="hlFld-ContribAuthor ">Qingqiang  Yao</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design of SphK inhibitors using crystal structures aided by computer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113164. <a href="https://doi.org/10.1016/j.ejmech.2021.113164" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113164</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113164%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bdesign%252Bof%252BSphK%252Binhibitors%252Busing%252Bcrystal%252Bstructures%252Baided%252Bby%252Bcomputer%26aulast%3DDing%26aufirst%3DTiandi%26date%3D2021%26volume%3D213%26spage%3D113164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo  Xie</span>, <span class="hlFld-ContribAuthor ">Haojie  Lu</span>, <span class="hlFld-ContribAuthor ">Jinhui  Xu</span>, <span class="hlFld-ContribAuthor ">Haixin  Luo</span>, <span class="hlFld-ContribAuthor ">Yebei  Hu</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Qingwei  Geng</span>, <span class="hlFld-ContribAuthor ">Xiuzu  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Targets of hydroxychloroquine in the treatment of rheumatoid arthritis. A network pharmacology study. </span><span class="cited-content_cbyCitation_journal-name">Joint Bone Spine</span><span> <strong>2021,</strong> <em>88 </em>
                                    (2)
                                     , 105099. <a href="https://doi.org/10.1016/j.jbspin.2020.105099" title="DOI URL">https://doi.org/10.1016/j.jbspin.2020.105099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jbspin.2020.105099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jbspin.2020.105099%26sid%3Dliteratum%253Aachs%26jtitle%3DJoint%2520Bone%2520Spine%26atitle%3DTargets%252Bof%252Bhydroxychloroquine%252Bin%252Bthe%252Btreatment%252Bof%252Brheumatoid%252Barthritis.%252BA%252Bnetwork%252Bpharmacology%252Bstudy%26aulast%3DXie%26aufirst%3DBo%26date%3D2021%26volume%3D88%26issue%3D2%26spage%3D105099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sonam  Roy</span>, <span class="hlFld-ContribAuthor ">Shama  Khan</span>, <span class="hlFld-ContribAuthor ">Deeba Shamim  Jairajpuri</span>, <span class="hlFld-ContribAuthor ">Afzal  Hussain</span>, <span class="hlFld-ContribAuthor ">Mohamed F.  Alajmi</span>, <span class="hlFld-ContribAuthor ">Asimul  Islam</span>, <span class="hlFld-ContribAuthor ">Suaib  Luqman</span>, <span class="hlFld-ContribAuthor ">Suhel  Parvez</span>, <span class="hlFld-ContribAuthor ">Md. Imtaiyaz  Hassan</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of sphingosine kinase 1 inhibitory potential of cinchonine and colcemid targeting anticancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>8 </em>, 1-13. <a href="https://doi.org/10.1080/07391102.2021.1882341" title="DOI URL">https://doi.org/10.1080/07391102.2021.1882341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1882341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1882341%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DInvestigation%252Bof%252Bsphingosine%252Bkinase%252B1%252Binhibitory%252Bpotential%252Bof%252Bcinchonine%252Band%252Bcolcemid%252Btargeting%252Banticancer%252Btherapy%26aulast%3DRoy%26aufirst%3DSonam%26date%3D2021%26date%3D2021%26volume%3D8%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Molly  Congdon</span>, <span class="hlFld-ContribAuthor ">Russell G.  Fritzemeier</span>, <span class="hlFld-ContribAuthor ">Yugesh  Kharel</span>, <span class="hlFld-ContribAuthor ">Anne M.  Brown</span>, <span class="hlFld-ContribAuthor ">Vlad  Serbulea</span>, <span class="hlFld-ContribAuthor ">David R.  Bevan</span>, <span class="hlFld-ContribAuthor ">Kevin R.  Lynch</span>, <span class="hlFld-ContribAuthor ">Webster L.  Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Probing the substitution pattern of indole-based scaffold reveals potent and selective sphingosine kinase 2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 113121. <a href="https://doi.org/10.1016/j.ejmech.2020.113121" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113121%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProbing%252Bthe%252Bsubstitution%252Bpattern%252Bof%252Bindole-based%252Bscaffold%252Breveals%252Bpotent%252Band%252Bselective%252Bsphingosine%252Bkinase%252B2%252Binhibitors%26aulast%3DCongdon%26aufirst%3DMolly%26date%3D2021%26volume%3D212%26spage%3D113121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yichao  Wan</span>, <span class="hlFld-ContribAuthor ">Jiabing  Long</span>, <span class="hlFld-ContribAuthor ">Han  Gao</span>, <span class="hlFld-ContribAuthor ">Zilong  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">2-Aminothiazole: A privileged scaffold for the discovery of anti-cancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 112953. <a href="https://doi.org/10.1016/j.ejmech.2020.112953" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112953</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112953%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2-Aminothiazole%25253A%252BA%252Bprivileged%252Bscaffold%252Bfor%252Bthe%252Bdiscovery%252Bof%252Banti-cancer%252Bagents%26aulast%3DWan%26aufirst%3DYichao%26date%3D2021%26volume%3D210%26spage%3D112953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ákos  Bajtel</span>, <span class="hlFld-ContribAuthor ">Mounir  Raji</span>, <span class="hlFld-ContribAuthor ">Matti  Haukka</span>, <span class="hlFld-ContribAuthor ">Ferenc  Fülöp</span>, <span class="hlFld-ContribAuthor ">Zsolt  Szakonyi</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoselective synthesis and transformation of pinane-based 2-amino-1,3-diols. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>17 </em>, 983-990. <a href="https://doi.org/10.3762/bjoc.17.80" title="DOI URL">https://doi.org/10.3762/bjoc.17.80</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.17.80&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.17.80%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStereoselective%252Bsynthesis%252Band%252Btransformation%252Bof%252Bpinane-based%252B2-amino-1%25252C3-diols%26aulast%3DBajtel%26aufirst%3D%25C3%2581kos%26date%3D2021%26date%3D2021%26volume%3D17%26spage%3D983%26epage%3D990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keqi  Song</span>, <span class="hlFld-ContribAuthor ">Lan  Dai</span>, <span class="hlFld-ContribAuthor ">Xiaoran  Long</span>, <span class="hlFld-ContribAuthor ">Wenjing  Wang</span>, <span class="hlFld-ContribAuthor ">Wen  Di</span>. </span><span class="cited-content_cbyCitation_article-title">Follicle-stimulating hormone promotes the proliferation of epithelial ovarian cancer cells by activating sphingosine kinase. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-70896-0" title="DOI URL">https://doi.org/10.1038/s41598-020-70896-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-70896-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-70896-0%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DFollicle-stimulating%252Bhormone%2525C2%2525A0promotes%252Bthe%252Bproliferation%252Bof%2525C2%2525A0epithelial%252Bovarian%252Bcancer%2525C2%2525A0cells%252Bby%252Bactivating%252Bsphingosine%252Bkinase%26aulast%3DSong%26aufirst%3DKeqi%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vijai Kumar Reddy  Tangadanchu</span>, <span class="hlFld-ContribAuthor ">Hao  Jiang</span>, <span class="hlFld-ContribAuthor ">Yanbo  Yu</span>, <span class="hlFld-ContribAuthor ">Thomas J.A.  Graham</span>, <span class="hlFld-ContribAuthor ">Hui  Liu</span>, <span class="hlFld-ContribAuthor ">Buck E.  Rogers</span>, <span class="hlFld-ContribAuthor ">Robert  Gropler</span>, <span class="hlFld-ContribAuthor ">Joel  Perlmutter</span>, <span class="hlFld-ContribAuthor ">Zhude  Tu</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationship studies and bioactivity evaluation of 1,2,3-triazole containing analogues as a selective sphingosine kinase-2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>206 </em>, 112713. <a href="https://doi.org/10.1016/j.ejmech.2020.112713" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112713</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112713%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-activity%252Brelationship%252Bstudies%252Band%252Bbioactivity%252Bevaluation%252Bof%252B1%25252C2%25252C3-triazole%252Bcontaining%252Banalogues%252Bas%252Ba%252Bselective%252Bsphingosine%252Bkinase-2%252Binhibitors%26aulast%3DTangadanchu%26aufirst%3DVijai%2BKumar%2BReddy%26date%3D2020%26volume%3D206%26spage%3D112713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeremy A.  Hengst</span>, <span class="hlFld-ContribAuthor ">Taryn E.  Dick</span>, <span class="hlFld-ContribAuthor ">Charles D.  Smith</span>, <span class="hlFld-ContribAuthor ">Jong K.  Yun</span>. </span><span class="cited-content_cbyCitation_article-title">Analysis of selective target engagement by small-molecule sphingosine kinase inhibitors using the Cellular Thermal Shift Assay (CETSA). </span><span class="cited-content_cbyCitation_journal-name">Cancer Biology & Therapy</span><span> <strong>2020,</strong> <em>21 </em>
                                    (9)
                                     , 841-852. <a href="https://doi.org/10.1080/15384047.2020.1798696" title="DOI URL">https://doi.org/10.1080/15384047.2020.1798696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/15384047.2020.1798696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F15384047.2020.1798696%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Biology%2520%2526%2520Therapy%26atitle%3DAnalysis%252Bof%252Bselective%252Btarget%252Bengagement%252Bby%252Bsmall-molecule%252Bsphingosine%252Bkinase%252Binhibitors%252Busing%252Bthe%252BCellular%252BThermal%252BShift%252BAssay%252B%252528CETSA%252529%26aulast%3DHengst%26aufirst%3DJeremy%2BA.%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D9%26spage%3D841%26epage%3D852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhijie  Chen</span>, <span class="hlFld-ContribAuthor ">Bingxiong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Sphk1 participates in malignant progression of breast cancer by regulating epithelial-mesenchymal transition and stem cell characteristics. </span><span class="cited-content_cbyCitation_journal-name">Tissue and Cell</span><span> <strong>2020,</strong> <em>65 </em>, 101380. <a href="https://doi.org/10.1016/j.tice.2020.101380" title="DOI URL">https://doi.org/10.1016/j.tice.2020.101380</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tice.2020.101380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tice.2020.101380%26sid%3Dliteratum%253Aachs%26jtitle%3DTissue%2520and%2520Cell%26atitle%3DSphk1%252Bparticipates%252Bin%252Bmalignant%252Bprogression%252Bof%252Bbreast%252Bcancer%252Bby%252Bregulating%252Bepithelial-mesenchymal%252Btransition%252Band%252Bstem%252Bcell%252Bcharacteristics%26aulast%3DChen%26aufirst%3DZhijie%26date%3D2020%26volume%3D65%26spage%3D101380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiwei  Shi</span>, <span class="hlFld-ContribAuthor ">Shan  Zhang</span>, <span class="hlFld-ContribAuthor ">Ding  Ma</span>, <span class="hlFld-ContribAuthor ">Dongliang  Yan</span>, <span class="hlFld-ContribAuthor ">Guang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yin  Cao</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Wang</span>, <span class="hlFld-ContribAuthor ">Junhua  Wu</span>, <span class="hlFld-ContribAuthor ">Chunping  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting SphK2 Reverses Acquired Resistance of Regorafenib in Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fonc.2020.00694" title="DOI URL">https://doi.org/10.3389/fonc.2020.00694</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2020.00694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2020.00694%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DTargeting%252BSphK2%252BReverses%252BAcquired%252BResistance%252Bof%252BRegorafenib%252Bin%252BHepatocellular%252BCarcinoma%26aulast%3DShi%26aufirst%3DWeiwei%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seyede Tahereh  Hosseini</span>, <span class="hlFld-ContribAuthor ">Heidar  Raissi</span>, <span class="hlFld-ContribAuthor ">Majid  Pakdel</span>. </span><span class="cited-content_cbyCitation_article-title">High-performance carbon dioxide capture and storage by multi-functional sphingosine kinase inhibitors through a CO
              2
              -philic membrane. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (19)
                                     , 7771-7779. <a href="https://doi.org/10.1039/D0NJ01231A" title="DOI URL">https://doi.org/10.1039/D0NJ01231A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ01231A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ01231A%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DHigh-performance%252Bcarbon%252Bdioxide%252Bcapture%252Band%252Bstorage%252Bby%252Bmulti-functional%252Bsphingosine%252Bkinase%252Binhibitors%252Bthrough%252Ba%252BCO%252B2%252B-philic%252Bmembrane%26aulast%3DHosseini%26aufirst%3DSeyede%2BTahereh%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D19%26spage%3D7771%26epage%3D7779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min-Koo  Choi</span>, <span class="hlFld-ContribAuthor ">Im-Sook  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the formulation of sphingolipid anticancer therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical Investigation</span><span> <strong>2020,</strong> <em>50 </em>
                                    (3)
                                     , 295-307. <a href="https://doi.org/10.1007/s40005-020-00475-y" title="DOI URL">https://doi.org/10.1007/s40005-020-00475-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40005-020-00475-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40005-020-00475-y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520Investigation%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bformulation%252Bof%252Bsphingolipid%252Banticancer%252Btherapeutics%26aulast%3DChoi%26aufirst%3DMin-Koo%26date%3D2020%26date%3D2020%26volume%3D50%26issue%3D3%26spage%3D295%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haoran  Yang</span>, <span class="hlFld-ContribAuthor ">Ying  Li</span>, <span class="hlFld-ContribAuthor ">Huining  Chai</span>, <span class="hlFld-ContribAuthor ">Takayuki  Yakura</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Qingqiang  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 2-epi-jaspine B analogs as selective sphingosine kinase 1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>98 </em>, 103369. <a href="https://doi.org/10.1016/j.bioorg.2019.103369" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103369</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103369%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B2-epi-jaspine%252BB%252Banalogs%252Bas%252Bselective%252Bsphingosine%252Bkinase%252B1%252Binhibitors%26aulast%3DYang%26aufirst%3DHaoran%26date%3D2020%26volume%3D98%26spage%3D103369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinmiao  Zhang</span>, <span class="hlFld-ContribAuthor ">Maoyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Jinying  Yu</span>, <span class="hlFld-ContribAuthor ">Yanguo  Shang</span>, <span class="hlFld-ContribAuthor ">Kaixuan  Jiang</span>, <span class="hlFld-ContribAuthor ">Yihe  Jia</span>, <span class="hlFld-ContribAuthor ">Jinxin  Wang</span>, <span class="hlFld-ContribAuthor ">Kan  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Investigating the binding mechanism of sphingosine kinase 1/2 inhibitors: Insights into subtype selectivity by homology modeling, molecular dynamics simulation and free energy calculation studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1208 </em>, 127900. <a href="https://doi.org/10.1016/j.molstruc.2020.127900" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.127900</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.127900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.127900%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DInvestigating%252Bthe%252Bbinding%252Bmechanism%252Bof%252Bsphingosine%252Bkinase%252B1%25252F2%252Binhibitors%25253A%252BInsights%252Binto%252Bsubtype%252Bselectivity%252Bby%252Bhomology%252Bmodeling%25252C%252Bmolecular%252Bdynamics%252Bsimulation%252Band%252Bfree%252Benergy%252Bcalculation%252Bstudies%26aulast%3DZhang%26aufirst%3DJinmiao%26date%3D2020%26volume%3D1208%26spage%3D127900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heba  Alshaker</span>, <span class="hlFld-ContribAuthor ">Hannah  Thrower</span>, <span class="hlFld-ContribAuthor ">Dmitri  Pchejetski</span>. </span><span class="cited-content_cbyCitation_article-title">Sphingosine Kinase 1 in Breast Cancer—A New Molecular Marker and a Therapy Target. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fonc.2020.00289" title="DOI URL">https://doi.org/10.3389/fonc.2020.00289</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2020.00289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2020.00289%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DSphingosine%252BKinase%252B1%252Bin%252BBreast%252BCancer%2525E2%252580%252594A%252BNew%252BMolecular%252BMarker%252Band%252Ba%252BTherapy%252BTarget%26aulast%3DAlshaker%26aufirst%3DHeba%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Faez Iqbal  Khan</span>, <span class="hlFld-ContribAuthor ">Dakun  Lai</span>, <span class="hlFld-ContribAuthor ">Razique  Anwer</span>, <span class="hlFld-ContribAuthor ">Iffat  Azim</span>, <span class="hlFld-ContribAuthor ">Mohd Kalim Ahmad  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">Identifying novel sphingosine kinase 1 inhibitors as therapeutics against breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 172-186. <a href="https://doi.org/10.1080/14756366.2019.1692828" title="DOI URL">https://doi.org/10.1080/14756366.2019.1692828</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2019.1692828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2019.1692828%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DIdentifying%252Bnovel%252Bsphingosine%252Bkinase%252B1%252Binhibitors%252Bas%252Btherapeutics%252Bagainst%252Bbreast%252Bcancer%26aulast%3DKhan%26aufirst%3DFaez%2BIqbal%26date%3D2020%26date%3D2019%26volume%3D35%26issue%3D1%26spage%3D172%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shrestha</span>, <span class="hlFld-ContribAuthor ">Hwang</span>, <span class="hlFld-ContribAuthor ">Lee</span>, <span class="hlFld-ContribAuthor ">Kim</span>, <span class="hlFld-ContribAuthor ">Oh</span>, <span class="hlFld-ContribAuthor ">Kwon</span>, <span class="hlFld-ContribAuthor ">Hong</span>, <span class="hlFld-ContribAuthor ">Kim</span>, <span class="hlFld-ContribAuthor ">Moon</span>, <span class="hlFld-ContribAuthor ">Baek</span>, <span class="hlFld-ContribAuthor ">Park</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of BODIPY-PF-543. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (23)
                                     , 4408. <a href="https://doi.org/10.3390/molecules24234408" title="DOI URL">https://doi.org/10.3390/molecules24234408</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24234408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24234408%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BBODIPY-PF-543%26aulast%3DShrestha%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D23%26spage%3D4408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miroslava  Martinková</span>, <span class="hlFld-ContribAuthor ">Jozef  Gonda</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic analogues of marine cytotoxic jaspine B and its stereoisomers. </span><span class="cited-content_cbyCitation_journal-name">Carbohydrate Research</span><span> <strong>2019,</strong> <em>482 </em>, 107737. <a href="https://doi.org/10.1016/j.carres.2019.06.016" title="DOI URL">https://doi.org/10.1016/j.carres.2019.06.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.carres.2019.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.carres.2019.06.016%26sid%3Dliteratum%253Aachs%26jtitle%3DCarbohydrate%2520Research%26atitle%3DSynthetic%252Banalogues%252Bof%252Bmarine%252Bcytotoxic%252Bjaspine%252BB%252Band%252Bits%252Bstereoisomers%26aulast%3DMartinkov%25C3%25A1%26aufirst%3DMiroslava%26date%3D2019%26volume%3D482%26spage%3D107737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leili  Hasanifard</span>, <span class="hlFld-ContribAuthor ">Roghayeh  Sheervalilou</span>, <span class="hlFld-ContribAuthor ">Maryam  Majidinia</span>, <span class="hlFld-ContribAuthor ">Bahman  Yousefi</span>. </span><span class="cited-content_cbyCitation_article-title">New insights into the roles and regulation of SphK2 as a therapeutic target in cancer chemoresistance. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Physiology</span><span> <strong>2019,</strong> <em>234 </em>
                                    (6)
                                     , 8162-8181. <a href="https://doi.org/10.1002/jcp.27612" title="DOI URL">https://doi.org/10.1002/jcp.27612</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcp.27612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcp.27612%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Physiology%26atitle%3DNew%252Binsights%252Binto%252Bthe%252Broles%252Band%252Bregulation%252Bof%252BSphK2%252Bas%252Ba%252Btherapeutic%252Btarget%252Bin%252Bcancer%252Bchemoresistance%26aulast%3DHasanifard%26aufirst%3DLeili%26date%3D2019%26date%3D2018%26volume%3D234%26issue%3D6%26spage%3D8162%26epage%3D8181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcela  Vettorazzi</span>, <span class="hlFld-ContribAuthor ">Laura  Vila</span>, <span class="hlFld-ContribAuthor ">Santiago  Lima</span>, <span class="hlFld-ContribAuthor ">Lina  Acosta</span>, <span class="hlFld-ContribAuthor ">Felipe  Yépes</span>, <span class="hlFld-ContribAuthor ">Alirio  Palma</span>, <span class="hlFld-ContribAuthor ">Justo  Cobo</span>, <span class="hlFld-ContribAuthor ">Jan  Tengler</span>, <span class="hlFld-ContribAuthor ">Ivan  Malik</span>, <span class="hlFld-ContribAuthor ">Sergio  Alvarez</span>, <span class="hlFld-ContribAuthor ">Patrice  Marqués</span>, <span class="hlFld-ContribAuthor ">Nuria  Cabedo</span>, <span class="hlFld-ContribAuthor ">María J.  Sanz</span>, <span class="hlFld-ContribAuthor ">Josef  Jampilek</span>, <span class="hlFld-ContribAuthor ">Sarah  Spiegel</span>, <span class="hlFld-ContribAuthor ">Ricardo D.  Enriz</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of sphingosine kinase 2 inhibitors with anti-inflammatory activity. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2019,</strong> <em>352 </em>
                                    (3)
                                     , 1800298. <a href="https://doi.org/10.1002/ardp.201800298" title="DOI URL">https://doi.org/10.1002/ardp.201800298</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201800298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201800298%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bsphingosine%252Bkinase%252B2%252Binhibitors%252Bwith%252Banti-inflammatory%252Bactivity%26aulast%3DVettorazzi%26aufirst%3DMarcela%26date%3D2019%26date%3D2019%26volume%3D352%26issue%3D3%26spage%3D1800298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangjin  Zheng</span>, <span class="hlFld-ContribAuthor ">Wan  Li</span>, <span class="hlFld-ContribAuthor ">Liwen  Ren</span>, <span class="hlFld-ContribAuthor ">Jinyi  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaocong  Pang</span>, <span class="hlFld-ContribAuthor ">Xiuping  Chen</span>, <span class="hlFld-ContribAuthor ">De  Kang</span>, <span class="hlFld-ContribAuthor ">Jinhua  Wang</span>, <span class="hlFld-ContribAuthor ">Guanhua  Du</span>. </span><span class="cited-content_cbyCitation_article-title">The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2019,</strong> <em>195 </em>, 85-99. <a href="https://doi.org/10.1016/j.pharmthera.2018.10.011" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2018.10.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2018.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2018.10.011%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DThe%252Bsphingosine%252Bkinase-1%25252Fsphingosine-1-phosphate%252Baxis%252Bin%252Bcancer%25253A%252BPotential%252Btarget%252Bfor%252Banticancer%252Btherapy%26aulast%3DZheng%26aufirst%3DXiangjin%26date%3D2019%26volume%3D195%26spage%3D85%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun-Yi  Wu</span>, <span class="hlFld-ContribAuthor ">An-Lai  Ji</span>, <span class="hlFld-ContribAuthor ">Zhong-xia  Wang</span>, <span class="hlFld-ContribAuthor ">Guang-Hui  Qiang</span>, <span class="hlFld-ContribAuthor ">Zhen  Qu</span>, <span class="hlFld-ContribAuthor ">Jun-Hua  Wu</span>, <span class="hlFld-ContribAuthor ">Chun-Ping  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Exosome-Mimetic Nanovesicles from Hepatocytes promote hepatocyte proliferation in vitro and liver regeneration in vivo. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-20505-y" title="DOI URL">https://doi.org/10.1038/s41598-018-20505-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-20505-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-20505-y%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DExosome-Mimetic%252BNanovesicles%252Bfrom%252BHepatocytes%252Bpromote%252Bhepatocyte%252Bproliferation%252Bin%252Bvitro%252Band%252Bliver%252Bregeneration%252Bin%252Bvivo%26aulast%3DWu%26aufirst%3DJun-Yi%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giusi  Barra</span>, <span class="hlFld-ContribAuthor ">Alessio  Lepore</span>, <span class="hlFld-ContribAuthor ">Miriam  Gagliardi</span>, <span class="hlFld-ContribAuthor ">Domenico  Somma</span>, <span class="hlFld-ContribAuthor ">Maria Rosaria  Matarazzo</span>, <span class="hlFld-ContribAuthor ">Francesca  Costabile</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Pasquale</span>, <span class="hlFld-ContribAuthor ">Alessio  Mazzoni</span>, <span class="hlFld-ContribAuthor ">Carmela  Gallo</span>, <span class="hlFld-ContribAuthor ">Genoveffa  Nuzzo</span>, <span class="hlFld-ContribAuthor ">Francesco  Annunziato</span>, <span class="hlFld-ContribAuthor ">Angelo  Fontana</span>, <span class="hlFld-ContribAuthor ">Antonio  Leonardi</span>, <span class="hlFld-ContribAuthor ">Raffaele  De Palma</span>. </span><span class="cited-content_cbyCitation_article-title">Sphingosine Kinases promote IL-17 expression in human T lymphocytes. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-31666-1" title="DOI URL">https://doi.org/10.1038/s41598-018-31666-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-31666-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-31666-1%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DSphingosine%252BKinases%252Bpromote%252BIL-17%252Bexpression%252Bin%252Bhuman%252BT%252Blymphocytes%26aulast%3DBarra%26aufirst%3DGiusi%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Margarita  Escudero-Casao</span>, <span class="hlFld-ContribAuthor ">Adrià  Cardona</span>, <span class="hlFld-ContribAuthor ">Raúl  Beltrán-Debón</span>, <span class="hlFld-ContribAuthor ">Yolanda  Díaz</span>, <span class="hlFld-ContribAuthor ">M. Isabel  Matheu</span>, <span class="hlFld-ContribAuthor ">Sergio  Castillón</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorinated triazole-containing sphingosine analogues. Syntheses and
              in vitro
              evaluation as SPHK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (39)
                                     , 7230-7235. <a href="https://doi.org/10.1039/C8OB01867G" title="DOI URL">https://doi.org/10.1039/C8OB01867G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB01867G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB01867G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DFluorinated%252Btriazole-containing%252Bsphingosine%252Banalogues.%252BSyntheses%252Band%252Bin%252Bvitro%252Bevaluation%252Bas%252BSPHK%252Binhibitors%26aulast%3DEscudero-Casao%26aufirst%3DMargarita%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D39%26spage%3D7230%26epage%3D7235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shinsuke  Inuki</span>, <span class="hlFld-ContribAuthor ">Takashi  Miyagawa</span>, <span class="hlFld-ContribAuthor ">Shinya  Oishi</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Ohno</span>. </span><span class="cited-content_cbyCitation_article-title">Introduction of a Polar Functional Group to the Lipid Tail of 4-epi-Jaspine B Affects Sphingosine Kinase Isoform Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Chemical and Pharmaceutical Bulletin</span><span> <strong>2018,</strong> <em>66 </em>
                                    (9)
                                     , 866-872. <a href="https://doi.org/10.1248/cpb.c18-00366" title="DOI URL">https://doi.org/10.1248/cpb.c18-00366</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c18-00366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c18-00366%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DIntroduction%252Bof%252Ba%252BPolar%252BFunctional%252BGroup%252Bto%252Bthe%252BLipid%252BTail%252Bof%252B4-epi-Jaspine%252BB%252BAffects%252BSphingosine%252BKinase%252BIsoform%252BSelectivity%26aulast%3DInuki%26aufirst%3DShinsuke%26date%3D2018%26volume%3D66%26issue%3D9%26spage%3D866%26epage%3D872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">İlhami  Gulçin</span>, <span class="hlFld-ContribAuthor ">Parham  Taslimi</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfonamide inhibitors: a patent review 2013-present. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2018,</strong> <em>28 </em>
                                    (7)
                                     , 541-549. <a href="https://doi.org/10.1080/13543776.2018.1487400" title="DOI URL">https://doi.org/10.1080/13543776.2018.1487400</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2018.1487400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2018.1487400%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSulfonamide%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B2013-present%26aulast%3DGul%25C3%25A7in%26aufirst%3D%25C4%25B0lhami%26date%3D2018%26date%3D2018%26volume%3D28%26issue%3D7%26spage%3D541%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michele  Dei Cas</span>, <span class="hlFld-ContribAuthor ">Riccardo  Ghidoni</span>. </span><span class="cited-content_cbyCitation_article-title">Cancer Prevention and Therapy with Polyphenols: Sphingolipid-Mediated Mechanisms. </span><span class="cited-content_cbyCitation_journal-name">Nutrients</span><span> <strong>2018,</strong> <em>10 </em>
                                    (7)
                                     , 940. <a href="https://doi.org/10.3390/nu10070940" title="DOI URL">https://doi.org/10.3390/nu10070940</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/nu10070940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fnu10070940%26sid%3Dliteratum%253Aachs%26jtitle%3DNutrients%26atitle%3DCancer%252BPrevention%252Band%252BTherapy%252Bwith%252BPolyphenols%25253A%252BSphingolipid-Mediated%252BMechanisms%26aulast%3DDei%2BCas%26aufirst%3DMichele%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D7%26spage%3D940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takashi  Miyagawa</span>, <span class="hlFld-ContribAuthor ">Shinsuke  Inuki</span>, <span class="hlFld-ContribAuthor ">Maho  Honda</span>, <span class="hlFld-ContribAuthor ">Shinya  Nakamura</span>, <span class="hlFld-ContribAuthor ">Isao  Nakanishi</span>, <span class="hlFld-ContribAuthor ">Nobutaka  Fujii</span>, <span class="hlFld-ContribAuthor ">Shinya  Oishi</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Ohno</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of jaspine B regioisomers through palladium-catalyzed stereoselective tetrahydrofuran formation: Insight into the ligand recognition of sphingosine kinases. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (15)
                                     , 1802-1809. <a href="https://doi.org/10.1016/j.tet.2018.02.042" title="DOI URL">https://doi.org/10.1016/j.tet.2018.02.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.02.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.02.042%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bjaspine%252BB%252Bregioisomers%252Bthrough%252Bpalladium-catalyzed%252Bstereoselective%252Btetrahydrofuran%252Bformation%25253A%252BInsight%252Binto%252Bthe%252Bligand%252Brecognition%252Bof%252Bsphingosine%252Bkinases%26aulast%3DMiyagawa%26aufirst%3DTakashi%26date%3D2018%26volume%3D74%26issue%3D15%26spage%3D1802%26epage%3D1809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mengda  Cao</span>, <span class="hlFld-ContribAuthor ">Chunmei  Ji</span>, <span class="hlFld-ContribAuthor ">Yanjun  Zhou</span>, <span class="hlFld-ContribAuthor ">Wen  Huang</span>, <span class="hlFld-ContribAuthor ">Weiwei  Ni</span>, <span class="hlFld-ContribAuthor ">Xunliang  Tong</span>, <span class="hlFld-ContribAuthor ">Ji-Fu  Wei</span>. </span><span class="cited-content_cbyCitation_article-title">Sphingosine kinase inhibitors: A patent review. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Medicine</span><span> <strong>2018,</strong> <em> </em><a href="https://doi.org/10.3892/ijmm.2018.3505" title="DOI URL">https://doi.org/10.3892/ijmm.2018.3505</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ijmm.2018.3505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fijmm.2018.3505%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Medicine%26atitle%3DSphingosine%252Bkinase%252Binhibitors%25253A%252BA%252Bpatent%252Breview%26aulast%3DCao%26aufirst%3DMengda%26date%3D2018%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clayton S.  Lewis</span>, <span class="hlFld-ContribAuthor ">Christina  Voelkel-Johnson</span>, <span class="hlFld-ContribAuthor ">Charles D.  Smith</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Sphingosine Kinases for the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 295-325. <a href="https://doi.org/10.1016/bs.acr.2018.04.015" title="DOI URL">https://doi.org/10.1016/bs.acr.2018.04.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.acr.2018.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.acr.2018.04.015%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BSphingosine%252BKinases%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DLewis%26aufirst%3DClayton%2BS.%26date%3D2018%26spage%3D295%26epage%3D325%26pub%3DElsevier%26atitle%3DSphingolipids%252Bin%252BCancer%26date%3D2018%26volume%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui-Zhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Long  Zhao</span>, <span class="hlFld-ContribAuthor ">Cheng-He  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advance in oxazole-based medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>144 </em>, 444-492. <a href="https://doi.org/10.1016/j.ejmech.2017.12.044" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.12.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.12.044%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvance%252Bin%252Boxazole-based%252Bmedicinal%252Bchemistry%26aulast%3DZhang%26aufirst%3DHui-Zhen%26date%3D2018%26volume%3D144%26spage%3D444%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanan  Shi</span>, <span class="hlFld-ContribAuthor ">Jiayun  Qiao</span>, <span class="hlFld-ContribAuthor ">Biao  Mu</span>, <span class="hlFld-ContribAuthor ">Bingfeng  Zuo</span>, <span class="hlFld-ContribAuthor ">Jihong  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) ameliorated dexamethasone induced hepatic gluconeogenesis through activation of Akt/FoxO1 pathway. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2017,</strong> <em>493 </em>
                                    (1)
                                     , 286-290. <a href="https://doi.org/10.1016/j.bbrc.2017.09.029" title="DOI URL">https://doi.org/10.1016/j.bbrc.2017.09.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2017.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2017.09.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3D3-%2525282-amino-ethyl%252529-5-%25255B3-%2525284-butoxyl-phenyl%252529-propylidene%25255D-thiazolidine-2%25252C4-dione%252B%252528K145%252529%252Bameliorated%252Bdexamethasone%252Binduced%252Bhepatic%252Bgluconeogenesis%252Bthrough%252Bactivation%252Bof%252BAkt%25252FFoxO1%252Bpathway%26aulast%3DShi%26aufirst%3DYanan%26date%3D2017%26volume%3D493%26issue%3D1%26spage%3D286%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angela  Corvino</span>, <span class="hlFld-ContribAuthor ">Roberta  Rosa</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Incisivo</span>, <span class="hlFld-ContribAuthor ">Ferdinando  Fiorino</span>, <span class="hlFld-ContribAuthor ">Francesco  Frecentese</span>, <span class="hlFld-ContribAuthor ">Elisa  Magli</span>, <span class="hlFld-ContribAuthor ">Elisa  Perissutti</span>, <span class="hlFld-ContribAuthor ">Irene  Saccone</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Santagada</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Cirino</span>, <span class="hlFld-ContribAuthor ">Maria  Riemma</span>, <span class="hlFld-ContribAuthor ">Piero  Temussi</span>, <span class="hlFld-ContribAuthor ">Paola  Ciciola</span>, <span class="hlFld-ContribAuthor ">Roberto  Bianco</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Caliendo</span>, <span class="hlFld-ContribAuthor ">Fiorentina  Roviezzo</span>, <span class="hlFld-ContribAuthor ">Beatrice  Severino</span>. </span><span class="cited-content_cbyCitation_article-title">Development of 1,2,3-Triazole-Based Sphingosine Kinase Inhibitors and Their Evaluation as Antiproliferative Agents. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2017,</strong> <em>18 </em>
                                    (11)
                                     , 2332. <a href="https://doi.org/10.3390/ijms18112332" title="DOI URL">https://doi.org/10.3390/ijms18112332</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms18112332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms18112332%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDevelopment%252Bof%252B1%25252C2%25252C3-Triazole-Based%252BSphingosine%252BKinase%252BInhibitors%252Band%252BTheir%252BEvaluation%252Bas%252BAntiproliferative%252BAgents%26aulast%3DCorvino%26aufirst%3DAngela%26date%3D2017%26date%3D2017%26volume%3D18%26issue%3D11%26spage%3D2332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carolyn D.  Britten</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Garrett-Mayer</span>, <span class="hlFld-ContribAuthor ">Steven H.  Chin</span>, <span class="hlFld-ContribAuthor ">Keisuke  Shirai</span>, <span class="hlFld-ContribAuthor ">Besim  Ogretmen</span>, <span class="hlFld-ContribAuthor ">Tricia A.  Bentz</span>, <span class="hlFld-ContribAuthor ">Alan  Brisendine</span>, <span class="hlFld-ContribAuthor ">Kate  Anderton</span>, <span class="hlFld-ContribAuthor ">Susan L.  Cusack</span>, <span class="hlFld-ContribAuthor ">Lynn W.  Maines</span>, <span class="hlFld-ContribAuthor ">Yan  Zhuang</span>, <span class="hlFld-ContribAuthor ">Charles D.  Smith</span>, <span class="hlFld-ContribAuthor ">Melanie B.  Thomas</span>. </span><span class="cited-content_cbyCitation_article-title">A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2017,</strong> <em>23 </em>
                                    (16)
                                     , 4642-4650. <a href="https://doi.org/10.1158/1078-0432.CCR-16-2363" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-16-2363</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-16-2363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-16-2363%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DA%252BPhase%252BI%252BStudy%252Bof%252BABC294640%25252C%252Ba%252BFirst-in-Class%252BSphingosine%252BKinase-2%252BInhibitor%25252C%252Bin%252BPatients%252Bwith%252BAdvanced%252BSolid%252BTumors%26aulast%3DBritten%26aufirst%3DCarolyn%2BD.%26date%3D2017%26date%3D2017%26volume%3D23%26issue%3D16%26spage%3D4642%26epage%3D4650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroaki  Ohno</span>, <span class="hlFld-ContribAuthor ">Maho  Honda</span>, <span class="hlFld-ContribAuthor ">Naoka  Hamada</span>, <span class="hlFld-ContribAuthor ">Jun  Miyagaki</span>, <span class="hlFld-ContribAuthor ">Akira  Iwata</span>, <span class="hlFld-ContribAuthor ">Kazuhiro  Otsuki</span>, <span class="hlFld-ContribAuthor ">Toru  Maruyama</span>, <span class="hlFld-ContribAuthor ">Shinya  Nakamura</span>, <span class="hlFld-ContribAuthor ">Isao  Nakanishi</span>, <span class="hlFld-ContribAuthor ">Shinsuke  Inuki</span>, <span class="hlFld-ContribAuthor ">Nobutaka  Fujii</span>, <span class="hlFld-ContribAuthor ">Shinya  Oishi</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of selective inhibitors of sphingosine kinases 1 and 2 through a structure–activity relationship study of 4- epi -jaspine B. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (12)
                                     , 3046-3052. <a href="https://doi.org/10.1016/j.bmc.2017.03.059" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.03.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.03.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.03.059%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bselective%252Binhibitors%252Bof%252Bsphingosine%252Bkinases%252B1%252Band%252B2%252Bthrough%252Ba%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bstudy%252Bof%252B4-%252Bepi%252B-jaspine%252BB%26aulast%3DOhno%26aufirst%3DHiroaki%26date%3D2017%26volume%3D25%26issue%3D12%26spage%3D3046%26epage%3D3052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuka  Aoyama</span>, <span class="hlFld-ContribAuthor ">Sayaka  Sobue</span>, <span class="hlFld-ContribAuthor ">Naoki  Mizutani</span>, <span class="hlFld-ContribAuthor ">Chisato  Inoue</span>, <span class="hlFld-ContribAuthor ">Yoshiyuki  Kawamoto</span>, <span class="hlFld-ContribAuthor ">Yuji  Nishizawa</span>, <span class="hlFld-ContribAuthor ">Masatoshi  Ichihara</span>, <span class="hlFld-ContribAuthor ">Mamoru  Kyogashima</span>, <span class="hlFld-ContribAuthor ">Motoshi  Suzuki</span>, <span class="hlFld-ContribAuthor ">Yoshinoti  Nozawa</span>, <span class="hlFld-ContribAuthor ">Takashi  Murate</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of the sphingolipid rheostat is involved in paclitaxel resistance of the human prostate cancer cell line PC3-PR. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2017,</strong> <em>486 </em>
                                    (2)
                                     , 551-557. <a href="https://doi.org/10.1016/j.bbrc.2017.03.084" title="DOI URL">https://doi.org/10.1016/j.bbrc.2017.03.084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2017.03.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2017.03.084%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DModulation%252Bof%252Bthe%252Bsphingolipid%252Brheostat%252Bis%252Binvolved%252Bin%252Bpaclitaxel%252Bresistance%252Bof%252Bthe%252Bhuman%252Bprostate%252Bcancer%252Bcell%252Bline%252BPC3-PR%26aulast%3DAoyama%26aufirst%3DYuka%26date%3D2017%26volume%3D486%26issue%3D2%26spage%3D551%26epage%3D557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dominik  Vogt</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2017,</strong> <em>37 </em>
                                    (1)
                                     , 3-51. <a href="https://doi.org/10.1002/med.21402" title="DOI URL">https://doi.org/10.1002/med.21402</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21402%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DTherapeutic%252BStrategies%252Band%252BPharmacological%252BTools%252BInfluencing%252BS1P%252BSignaling%252Band%252BMetabolism%26aulast%3DVogt%26aufirst%3DDominik%26date%3D2017%26date%3D2016%26volume%3D37%26issue%3D1%26spage%3D3%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katia  Urso</span>, <span class="hlFld-ContribAuthor ">David  Alvarez</span>, <span class="hlFld-ContribAuthor ">Viviana  Cremasco</span>, <span class="hlFld-ContribAuthor ">Kelly  Tsang</span>, <span class="hlFld-ContribAuthor ">Angelo  Grauel</span>, <span class="hlFld-ContribAuthor ">Robert  Lafyatis</span>, <span class="hlFld-ContribAuthor ">Ulrich H.  von Andrian</span>, <span class="hlFld-ContribAuthor ">Joerg  Ermann</span>, <span class="hlFld-ContribAuthor ">Antonios O.  Aliprantis</span>. </span><span class="cited-content_cbyCitation_article-title">IL4RA on lymphatic endothelial cells promotes T cell egress during sclerodermatous graft versus host disease. </span><span class="cited-content_cbyCitation_journal-name">JCI Insight</span><span> <strong>2016,</strong> <em>1 </em>
                                    (12)
                                     <a href="https://doi.org/10.1172/jci.insight.88057" title="DOI URL">https://doi.org/10.1172/jci.insight.88057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/jci.insight.88057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2Fjci.insight.88057%26sid%3Dliteratum%253Aachs%26jtitle%3DJCI%2520Insight%26atitle%3DIL4RA%252Bon%252Blymphatic%252Bendothelial%252Bcells%252Bpromotes%252BT%252Bcell%252Begress%252Bduring%252Bsclerodermatous%252Bgraft%252Bversus%252Bhost%252Bdisease%26aulast%3DUrso%26aufirst%3DKatia%26date%3D2016%26volume%3D1%26issue%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meiyang  Xi</span>, <span class="hlFld-ContribAuthor ">Jun  Ge</span>, <span class="hlFld-ContribAuthor ">Xiaojian  Wang</span>, <span class="hlFld-ContribAuthor ">Chenbin  Sun</span>, <span class="hlFld-ContribAuthor ">Tianqi  Liu</span>, <span class="hlFld-ContribAuthor ">Liang  Fang</span>, <span class="hlFld-ContribAuthor ">Qiong  Xiao</span>, <span class="hlFld-ContribAuthor ">Dali  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Development of hydroxy-based sphingosine kinase inhibitors and anti-inflammation in dextran sodium sulfate induced colitis in mice. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (14)
                                     , 3218-3230. <a href="https://doi.org/10.1016/j.bmc.2016.05.047" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.05.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.05.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.05.047%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Bhydroxy-based%252Bsphingosine%252Bkinase%252Binhibitors%252Band%252Banti-inflammation%252Bin%252Bdextran%252Bsodium%252Bsulfate%252Binduced%252Bcolitis%252Bin%252Bmice%26aulast%3DXi%26aufirst%3DMeiyang%26date%3D2016%26volume%3D24%26issue%3D14%26spage%3D3218%26epage%3D3230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pol  Sanllehí</span>, <span class="hlFld-ContribAuthor ">José-Luis  Abad</span>, <span class="hlFld-ContribAuthor ">Josefina  Casas</span>, <span class="hlFld-ContribAuthor ">Antonio  Delgado</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of sphingosine-1-phosphate metabolism (sphingosine kinases and sphingosine-1-phosphate lyase). </span><span class="cited-content_cbyCitation_journal-name">Chemistry and Physics of Lipids</span><span> <strong>2016,</strong> <em>197 </em>, 69-81. <a href="https://doi.org/10.1016/j.chemphyslip.2015.07.007" title="DOI URL">https://doi.org/10.1016/j.chemphyslip.2015.07.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chemphyslip.2015.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chemphyslip.2015.07.007%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520and%2520Physics%2520of%2520Lipids%26atitle%3DInhibitors%252Bof%252Bsphingosine-1-phosphate%252Bmetabolism%252B%252528sphingosine%252Bkinases%252Band%252Bsphingosine-1-phosphate%252Blyase%252529%26aulast%3DSanlleh%25C3%25AD%26aufirst%3DPol%26date%3D2016%26volume%3D197%26spage%3D69%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammed A.  Kashem</span>, <span class="hlFld-ContribAuthor ">Charles A.  Kennedy</span>, <span class="hlFld-ContribAuthor ">Kylie E.  Fogarty</span>, <span class="hlFld-ContribAuthor ">Janice R.  Dimock</span>, <span class="hlFld-ContribAuthor ">Yunlong  Zhang</span>, <span class="hlFld-ContribAuthor ">Mary L.  Sanville-Ross</span>, <span class="hlFld-ContribAuthor ">Donna J.  Skow</span>, <span class="hlFld-ContribAuthor ">Steven R.  Brunette</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Swantek</span>, <span class="hlFld-ContribAuthor ">Heidi S.  Hummel</span>, <span class="hlFld-ContribAuthor ">John  Swindle</span>, <span class="hlFld-ContribAuthor ">Richard M.  Nelson</span>. </span><span class="cited-content_cbyCitation_article-title">A High-Throughput Genetic Complementation Assay in Yeast Cells Identified Selective Inhibitors of Sphingosine Kinase 1 Not Found Using a Cell-Free Enzyme Assay. </span><span class="cited-content_cbyCitation_journal-name">ASSAY and Drug Development Technologies</span><span> <strong>2016,</strong> <em>14 </em>
                                    (1)
                                     , 39-49. <a href="https://doi.org/10.1089/adt.2015.671" title="DOI URL">https://doi.org/10.1089/adt.2015.671</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/adt.2015.671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fadt.2015.671%26sid%3Dliteratum%253Aachs%26jtitle%3DASSAY%2520and%2520Drug%2520Development%2520Technologies%26atitle%3DA%252BHigh-Throughput%252BGenetic%252BComplementation%252BAssay%252Bin%252BYeast%252BCells%252BIdentified%252BSelective%252BInhibitors%252Bof%252BSphingosine%252BKinase%252B1%252BNot%252BFound%252BUsing%252Ba%252BCell-Free%252BEnzyme%252BAssay%26aulast%3DKashem%26aufirst%3DMohammed%2BA.%26date%3D2016%26volume%3D14%26issue%3D1%26spage%3D39%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Braddock</span>. </span><span class="cited-content_cbyCitation_article-title">Methods for Testing Immunological Factors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 2091-2203. <a href="https://doi.org/10.1007/978-3-319-05392-9_45" title="DOI URL">https://doi.org/10.1007/978-3-319-05392-9_45</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-05392-9_45&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-05392-9_45%26sid%3Dliteratum%253Aachs%26atitle%3DMethods%252Bfor%252BTesting%252BImmunological%252BFactors%26aulast%3DBraddock%26aufirst%3DMartin%26date%3D2016%26spage%3D2091%26epage%3D2203%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DDrug%252BDiscovery%252Band%252BEvaluation%25253A%252BPharmacological%252BAssays%26aulast%3DHock%26aufirst%3DFranz%2BJ.%26date%3D2016%26volume%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Fang</span>, <span class="hlFld-ContribAuthor ">Xiaojian  Wang</span>, <span class="hlFld-ContribAuthor ">Meiyang  Xi</span>, <span class="hlFld-ContribAuthor ">Tianqi  Liu</span>, <span class="hlFld-ContribAuthor ">Dali  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Assessing the ligand selectivity of sphingosine kinases using molecular dynamics and MM-PBSA binding free energy calculations. </span><span class="cited-content_cbyCitation_journal-name">Molecular BioSystems</span><span> <strong>2016,</strong> <em>12 </em>
                                    (4)
                                     , 1174-1182. <a href="https://doi.org/10.1039/C6MB00067C" title="DOI URL">https://doi.org/10.1039/C6MB00067C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MB00067C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MB00067C%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520BioSystems%26atitle%3DAssessing%252Bthe%252Bligand%252Bselectivity%252Bof%252Bsphingosine%252Bkinases%252Busing%252Bmolecular%252Bdynamics%252Band%252BMM-PBSA%252Bbinding%252Bfree%252Benergy%252Bcalculations%26aulast%3DFang%26aufirst%3DLiang%26date%3D2016%26date%3D2016%26volume%3D12%26issue%3D4%26spage%3D1174%26epage%3D1182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francis R  LeBlanc</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Jeremy  Hengst</span>, <span class="hlFld-ContribAuthor ">Todd  Fox</span>, <span class="hlFld-ContribAuthor ">Valerie  Calvert</span>, <span class="hlFld-ContribAuthor ">Emanuel F  Petricoin</span>, <span class="hlFld-ContribAuthor ">Jong  Yun</span>, <span class="hlFld-ContribAuthor ">David J  Feith</span>, <span class="hlFld-ContribAuthor ">Thomas P  Loughran</span>. </span><span class="cited-content_cbyCitation_article-title">Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia. </span><span class="cited-content_cbyCitation_journal-name">Cancer Biology & Therapy</span><span> <strong>2015,</strong> <em>16 </em>
                                    (12)
                                     , 1830-1840. <a href="https://doi.org/10.1080/15384047.2015.1078949" title="DOI URL">https://doi.org/10.1080/15384047.2015.1078949</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/15384047.2015.1078949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F15384047.2015.1078949%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Biology%2520%2526%2520Therapy%26atitle%3DSphingosine%252Bkinase%252Binhibitors%252Bdecrease%252Bviability%252Band%252Binduce%252Bcell%252Bdeath%252Bin%252Bnatural%252Bkiller-large%252Bgranular%252Blymphocyte%252Bleukemia%26aulast%3DLeBlanc%26aufirst%3DFrancis%2BR%26date%3D2015%26date%3D2015%26volume%3D16%26issue%3D12%26spage%3D1830%26epage%3D1840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Molly D.  Congdon</span>, <span class="hlFld-ContribAuthor ">Elizabeth S.  Childress</span>, <span class="hlFld-ContribAuthor ">Neeraj N.  Patwardhan</span>, <span class="hlFld-ContribAuthor ">James  Gumkowski</span>, <span class="hlFld-ContribAuthor ">Emily A.  Morris</span>, <span class="hlFld-ContribAuthor ">Yugesh  Kharel</span>, <span class="hlFld-ContribAuthor ">Kevin R.  Lynch</span>, <span class="hlFld-ContribAuthor ">Webster L.  Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–activity relationship studies of the lipophilic tail region of sphingosine kinase 2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (21)
                                     , 4956-4960. <a href="https://doi.org/10.1016/j.bmcl.2015.03.041" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.03.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.03.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.03.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593activity%252Brelationship%252Bstudies%252Bof%252Bthe%252Blipophilic%252Btail%252Bregion%252Bof%252Bsphingosine%252Bkinase%252B2%252Binhibitors%26aulast%3DCongdon%26aufirst%3DMolly%2BD.%26date%3D2015%26volume%3D25%26issue%3D21%26spage%3D4956%26epage%3D4960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samy A.F.  Morad</span>, <span class="hlFld-ContribAuthor ">Myles C.  Cabot</span>. </span><span class="cited-content_cbyCitation_article-title">Tamoxifen regulation of sphingolipid metabolism—Therapeutic implications. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids</span><span> <strong>2015,</strong> <em>1851 </em>
                                    (9)
                                     , 1134-1145. <a href="https://doi.org/10.1016/j.bbalip.2015.05.001" title="DOI URL">https://doi.org/10.1016/j.bbalip.2015.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbalip.2015.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbalip.2015.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520and%2520Cell%2520Biology%2520of%2520Lipids%26atitle%3DTamoxifen%252Bregulation%252Bof%252Bsphingolipid%252Bmetabolism%2525E2%252580%252594Therapeutic%252Bimplications%26aulast%3DMorad%26aufirst%3DSamy%2BA.F.%26date%3D2015%26volume%3D1851%26issue%3D9%26spage%3D1134%26epage%3D1145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joyce  Lee</span>, <span class="hlFld-ContribAuthor ">Behzad  Yeganeh</span>, <span class="hlFld-ContribAuthor ">Leonardo  Ermini</span>, <span class="hlFld-ContribAuthor ">Martin  Post</span>. </span><span class="cited-content_cbyCitation_article-title">Sphingolipids as cell fate regulators in lung development and disease. </span><span class="cited-content_cbyCitation_journal-name">Apoptosis</span><span> <strong>2015,</strong> <em>20 </em>
                                    (5)
                                     , 740-757. <a href="https://doi.org/10.1007/s10495-015-1112-6" title="DOI URL">https://doi.org/10.1007/s10495-015-1112-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10495-015-1112-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10495-015-1112-6%26sid%3Dliteratum%253Aachs%26jtitle%3DApoptosis%26atitle%3DSphingolipids%252Bas%252Bcell%252Bfate%252Bregulators%252Bin%252Blung%252Bdevelopment%252Band%252Bdisease%26aulast%3DLee%26aufirst%3DJoyce%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D5%26spage%3D740%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J. Bernd  Helms</span>, <span class="hlFld-ContribAuthor ">Dora V.  Kaloyanova</span>, <span class="hlFld-ContribAuthor ">Jeroen R. P.  Strating</span>, <span class="hlFld-ContribAuthor ">Jaap J.  van Hellemond</span>, <span class="hlFld-ContribAuthor ">Hilde M.  van der Schaar</span>, <span class="hlFld-ContribAuthor ">Aloysius G. M.  Tielens</span>, <span class="hlFld-ContribAuthor ">Frank J. M.  van Kuppeveld</span>, <span class="hlFld-ContribAuthor ">Jos F.  Brouwers</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting of the Hydrophobic Metabolome by Pathogens. </span><span class="cited-content_cbyCitation_journal-name">Traffic</span><span> <strong>2015,</strong> <em>16 </em>
                                    (5)
                                     , 439-460. <a href="https://doi.org/10.1111/tra.12280" title="DOI URL">https://doi.org/10.1111/tra.12280</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/tra.12280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ftra.12280%26sid%3Dliteratum%253Aachs%26jtitle%3DTraffic%26atitle%3DTargeting%252Bof%252Bthe%252BHydrophobic%252BMetabolome%252Bby%252BPathogens%26aulast%3DHelms%26aufirst%3DJ.%2BBernd%26date%3D2015%26date%3D2015%26volume%3D16%26issue%3D5%26spage%3D439%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaojian  Wang</span>, <span class="hlFld-ContribAuthor ">Chenbin  Sun</span>, <span class="hlFld-ContribAuthor ">Liang  Fang</span>, <span class="hlFld-ContribAuthor ">Dali  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel sphingosine kinase 1 inhibitors
              via
              structure-based hierarchical virtual screening. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (3)
                                     , 413-417. <a href="https://doi.org/10.1039/C4MD00312H" title="DOI URL">https://doi.org/10.1039/C4MD00312H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MD00312H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MD00312H%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDiscovery%252Bof%252Bnovel%252Bsphingosine%252Bkinase%252B1%252Binhibitors%252Bvia%252Bstructure-based%252Bhierarchical%252Bvirtual%252Bscreening%26aulast%3DWang%26aufirst%3DXiaojian%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D3%26spage%3D413%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Braddock</span>. </span><span class="cited-content_cbyCitation_article-title">Methods for Testing Immunological Factors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 1-131. <a href="https://doi.org/10.1007/978-3-642-27728-3_45-1" title="DOI URL">https://doi.org/10.1007/978-3-642-27728-3_45-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-642-27728-3_45-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-642-27728-3_45-1%26sid%3Dliteratum%253Aachs%26atitle%3DMethods%252Bfor%252BTesting%252BImmunological%252BFactors%26aulast%3DBraddock%26aufirst%3DMartin%26date%3D2015%26date%3D2015%26spage%3D1%26epage%3D131%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DDrug%252BDiscovery%252Band%252BEvaluation%25253A%252BPharmacological%252BAssays%26aulast%3DHock%26aufirst%3DFranz%2BJ.%26date%3D2014%26volume%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jarrod  Barnes</span>, <span class="hlFld-ContribAuthor ">Raed A.  Dweik</span>. </span><span class="cited-content_cbyCitation_article-title">Is Pulmonary Hypertension a Metabolic Disease?. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Respiratory and Critical Care Medicine</span><span> <strong>2014,</strong> <em>190 </em>
                                    (9)
                                     , 973-975. <a href="https://doi.org/10.1164/rccm.201409-1702ED" title="DOI URL">https://doi.org/10.1164/rccm.201409-1702ED</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1164/rccm.201409-1702ED&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1164%2Frccm.201409-1702ED%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Respiratory%2520and%2520Critical%2520Care%2520Medicine%26atitle%3DIs%252BPulmonary%252BHypertension%252Ba%252BMetabolic%252BDisease%25253F%26aulast%3DBarnes%26aufirst%3DJarrod%26date%3D2014%26volume%3D190%26issue%3D9%26spage%3D973%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0012.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Cartoon representation of the crystal structure of SphK1 in three different orientations (adapted from Protein Data Bank, PDB reference <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VZB">3VZB</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Role of SphK1/2 in Cer/S1P rheostat: effects on cancer cells and therapeutic intervention by SKIs treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Sphingosine structure and its key chemical regions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Chemical structures of sphingosine-based SKIs grouped by the various modifications carried out over the sphingosine structure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of <b>1</b> and its analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of amidine derivatives obtained after various chemical modulations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Chemical structures of nolipidic small molecule SphK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of nonlipidic small molecule SphK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Chemical structures of <b>28</b> and its analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/medium/jm-2013-011687_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of the SKIs obtained from different natural sources.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm4011687/production/images/large/jm-2013-011687_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011687&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i20">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88586" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88586" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 144 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Signorelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghidoni, R.</span><span> </span><span class="NLM_article-title">Breast cancer and sphingolipid signalling</span> <span class="citation_source-journal">J. Dairy Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1017%2FS0022029905001238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=16180715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFaisbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2005&pages=5-13&author=P.+Signorelliauthor=R.+Ghidoni&title=Breast+cancer+and+sphingolipid+signalling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Breast cancer and sphingolipid signalling</span></div><div class="casAuthors">Signorelli, Paola; Ghidoni, Riccardo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Dairy Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">Spec. Issue</span>),
    <span class="NLM_cas:pages">5-13</span>CODEN:
                <span class="NLM_cas:coden">JDRSAN</span>;
        ISSN:<span class="NLM_cas:issn">0022-0299</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review on the role of sphingolipid signaling in breast cancer.  Evidence of the alteration of sphingolipid metab. and signaling is discussed in breast cancer prevention and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokCuUJCGwfDbVg90H21EOLACvtfcHk0liZd-mAyto46Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFaisbvE&md5=ac9ba7fb4f3d6bb22ef01084904ff385</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1017%2FS0022029905001238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0022029905001238%26sid%3Dliteratum%253Aachs%26aulast%3DSignorelli%26aufirst%3DP.%26aulast%3DGhidoni%26aufirst%3DR.%26atitle%3DBreast%2520cancer%2520and%2520sphingolipid%2520signalling%26jtitle%3DJ.%2520Dairy%2520Res.%26date%3D2005%26volume%3D72%26spage%3D5%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Huwiler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zangemeister-Wittke, U.</span><span> </span><span class="NLM_article-title">Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy</span> <span class="citation_source-journal">Crit. Rev. Oncol. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2Fj.critrevonc.2007.04.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=17560117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A280%3ADC%252BD2szoslynsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=150-159&author=A.+Huwilerauthor=U.+Zangemeister-Wittke&title=Targeting+the+conversion+of+ceramide+to+sphingosine+1-phosphate+as+a+novel+strategy+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy</span></div><div class="casAuthors">Huwiler Andrea; Zangemeister-Wittke Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">150-9</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">Sphingolipids not only function as structural components of cell membranes but also act as signaling molecules to regulate fundamental cellular responses, such as cell death and differentiation, proliferation and certain types of inflammation.  Particularly the cellular balance between ceramide and sphingosine 1-phosphate seems to be crucial for a cell's decision to either undergo apoptosis or proliferate, two events which are implicated in tumor development and growth.  Whereas ceramide possesses proapoptotic capacity in many cell types, sphingosine 1-phosphate acts as a counterplayer able to induce cell proliferation and protect cells from undergoing apoptosis.  Therefore, tipping the balance in favour of ceramide production, i.e. by inhibiting ceramidase or sphingosine kinase activities has potential to support its proapoptotic action and hence represents a promising rational approach to effective cancer therapy.  This review highlights most recent data on the regulation of cellular sphingolipid formation and their potential implication in tumor development, and provides perspectives for their use as targets in molecular intervention therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHzG4u3UWGahBrI9DTGjC0fW6udTcc2ebcEDZceAgpq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szoslynsg%253D%253D&md5=8f500fe7c676f103b50657e925bd9f11</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2007.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2007.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DHuwiler%26aufirst%3DA.%26aulast%3DZangemeister-Wittke%26aufirst%3DU.%26atitle%3DTargeting%2520the%2520conversion%2520of%2520ceramide%2520to%2520sphingosine%25201-phosphate%2520as%2520a%2520novel%2520strategy%2520for%2520cancer%2520therapy%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D2007%26volume%3D63%26spage%3D150%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Taha, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannun, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeid, L. M.</span><span> </span><span class="NLM_article-title">Sphingosine kinase: biochemical and cellular regulation and role in disease</span> <span class="citation_source-journal">J. Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.5483%2FBMBRep.2006.39.2.113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=16584625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsVCnsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2006&pages=113-131&author=T.+A.+Tahaauthor=Y.+A.+Hannunauthor=L.+M.+Obeid&title=Sphingosine+kinase%3A+biochemical+and+cellular+regulation+and+role+in+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine kinase: biochemical and cellular regulation and role in disease</span></div><div class="casAuthors">Taha, Tarek Assad; Hannun, Yusuf Awni; Obeid, Lina Marie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-131</span>CODEN:
                <span class="NLM_cas:coden">JBMBE5</span>;
        ISSN:<span class="NLM_cas:issn">1225-8687</span>.
    
            (<span class="NLM_cas:orgname">Korean Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Sphingolipids have emerged as mols. whose metab. is regulated leading to generation of bioactive products including ceramide, sphingosine, and sphingosine 1-phosphate (S1P).  The balance between the cellular levels of these bioactive products is increasingly recognized to be crit. to cell regulation, whereby ceramide and sphingosine cause apoptosis and growth arrest phenotypes and S1P mediates proliferative and angiogenic responses.  Sphingosine kinase (SK) is a key enzyme in modulating the levels of these lipids and is emerging as an important and regulated enzyme.  This review is directed toward mechanisms of regulation of SK and the emergence of its role in disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-KLKLbTMS1LVg90H21EOLACvtfcHk0lgePqyvBkYLlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsVCnsbk%253D&md5=339350005fee5edb245f8b1f8703f26f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.5483%2FBMBRep.2006.39.2.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5483%252FBMBRep.2006.39.2.113%26sid%3Dliteratum%253Aachs%26aulast%3DTaha%26aufirst%3DT.%2BA.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26atitle%3DSphingosine%2520kinase%253A%2520biochemical%2520and%2520cellular%2520regulation%2520and%2520role%2520in%2520disease%26jtitle%3DJ.%2520Biochem.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D39%26spage%3D113%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Cuvillier, O.</span><span> </span><span class="NLM_article-title">Sphingosine kinase-1—a potential therapeutic target in cancer</span> <span class="citation_source-journal">Anti-Cancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=105-110&author=O.+Cuvillier&title=Sphingosine+kinase-1%E2%80%94a+potential+therapeutic+target+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuvillier%26aufirst%3DO.%26atitle%3DSphingosine%2520kinase-1%25E2%2580%2594a%2520potential%2520therapeutic%2520target%2520in%2520cancer%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2007%26volume%3D18%26spage%3D105%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Xia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamble, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wattenberg, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Andrea, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vadas, M. A.</span><span> </span><span class="NLM_article-title">An oncogenic role of sphingosine kinase</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1527</span><span class="NLM_x">–</span> <span class="NLM_lpage">1530</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2FS0960-9822%2800%2900834-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=11114522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD3cXoslGmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1527-1530&author=P.+Xiaauthor=J.+R.+Gambleauthor=L.+Wangauthor=S.+M.+Pitsonauthor=P.+A.+Morettiauthor=B.+W.+Wattenbergauthor=R.+J.+D%E2%80%99Andreaauthor=M.+A.+Vadas&title=An+oncogenic+role+of+sphingosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">An oncogenic role of sphingosine kinase</span></div><div class="casAuthors">Xia, P.; Gamble, J. R.; Wang, L.; Pitson, S. M.; Moretti, P. A. B.; Wattenberg, B. W.; D'Andrea, R. J.; Vadas, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">1527-1530</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Sphingosine kinase (SphK) is a highly conserved lipid kinase that phosphorylates sphingosine to form sphingosine-1-phosphate (S1P).  S1P/SphK has been implicated as a signaling pathway to regulate diverse cellular functions, including cell growth, proliferation and survival.  The authors report that cells overexpressing SphK have increased enzymic activity and acquire the transformed phenotype, as detd. by focus formation, colony growth in soft agar and the ability to form tumors in NOD/SCID mice.  This is the first demonstration that a wild-type lipid kinase gene acts as an oncogene.  Using a chem. inhibitor of SphK, or an SphK mutant that inhibits enzyme activation, the authors found that SphK activity is involved in oncogenic H-Ras-mediated transformation, suggesting a novel signaling pathway for Ras activation.  The findings not only point to a new signaling pathway in transformation but also to the potential of SphK inhibitors in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvWSPdMxVm3LVg90H21EOLACvtfcHk0lgePqyvBkYLlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXoslGmsr4%253D&md5=edce66ee4b3aa1c6f071de8bdc59689e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0960-9822%2800%2900834-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-9822%252800%252900834-4%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DP.%26aulast%3DGamble%26aufirst%3DJ.%2BR.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DPitson%26aufirst%3DS.%2BM.%26aulast%3DMoretti%26aufirst%3DP.%2BA.%26aulast%3DWattenberg%26aufirst%3DB.%2BW.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DR.%2BJ.%26aulast%3DVadas%26aufirst%3DM.%2BA.%26atitle%3DAn%2520oncogenic%2520role%2520of%2520sphingosine%2520kinase%26jtitle%3DCurr.%2520Biol.%26date%3D2000%26volume%3D10%26spage%3D1527%26epage%3D1530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Alshaker, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottaviani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivats, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pchejetski, D.</span><span> </span><span class="NLM_article-title">Therapeutic potential of targeting SK1 in human cancers</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2013&pages=143-200&author=H.+Alshakerauthor=L.+Sauerauthor=D.+Monteilauthor=S.+Ottavianiauthor=S.+Srivatsauthor=T.+Bohlerauthor=D.+Pchejetski&title=Therapeutic+potential+of+targeting+SK1+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlshaker%26aufirst%3DH.%26aulast%3DSauer%26aufirst%3DL.%26aulast%3DMonteil%26aufirst%3DD.%26aulast%3DOttaviani%26aufirst%3DS.%26aulast%3DSrivats%26aufirst%3DS.%26aulast%3DBohler%26aufirst%3DT.%26aulast%3DPchejetski%26aufirst%3DD.%26atitle%3DTherapeutic%2520potential%2520of%2520targeting%2520SK1%2520in%2520human%2520cancers%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2013%26volume%3D117%26spage%3D143%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Heffernan-Stroud, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeid, L. M.</span><span> </span><span class="NLM_article-title">Sphingosine kinase 1 in cancer</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2013&pages=201-235&author=L.+A.+Heffernan-Stroudauthor=L.+M.+Obeid&title=Sphingosine+kinase+1+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeffernan-Stroud%26aufirst%3DL.%2BA.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26atitle%3DSphingosine%2520kinase%25201%2520in%2520cancer%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2013%26volume%3D117%26spage%3D201%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, G. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L. B.</span><span> </span><span class="NLM_article-title">Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1393</span><span class="NLM_x">–</span> <span class="NLM_lpage">1399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1158%2F1078-0432.CCR-08-1158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=19228740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitVOkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=1393-1399&author=W.+Liauthor=C.+P.+Yuauthor=J.+T.+Xiaauthor=L.+Zhangauthor=G.+X.+Wengauthor=H.+Q.+Zhengauthor=Q.+L.+Kongauthor=L.+J.+Huauthor=M.+S.+Zengauthor=Y.+X.+Zengauthor=M.+Liauthor=J.+Liauthor=L.+B.+Song&title=Sphingosine+kinase+1+is+associated+with+gastric+cancer+progression+and+poor+survival+of+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine Kinase 1 Is Associated with Gastric Cancer Progression and Poor Survival of Patients</span></div><div class="casAuthors">Li, Wen; Yu, Chun-Ping; Xia, Jin-tang; Zhang, Ling; Weng, Gui-Xiang; Zheng, Hai-qing; Kong, Qing-li; Hu, Li-juan; Zeng, Mu-Sheng; Zeng, Yi-xin; Li, Mengfeng; Li, Jun; Song, Li-Bing</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1393-1399</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The present study was to investigate the clin. significance of sphingosine kinase 1 (SPHK1), an oncoenzyme, in the development and progression of gastric cancer.  mRNA and protein levels of SPHK1 expression in normal gastric epithelial cells, gastric cancer cell lines, and paired gastric cancer lesions and the adjacent noncancerous tissues were examd. using reverse transcription-PCR and Western blotting.  Immunohistochem. was employed to analyze SPHK1 expression in 175 clinicopathol. characterized gastric cancer cases.  Statistical analyses were applied to derive prognostic and diagnostic assocns.  Levels of SPHK1 mRNA and protein were higher in gastric cancer cell lines than in normal gastric epithelial cells.  SPHK1 protein level was up-regulated in gastric cancer lesions compared with that in the paired adjacent noncancerous tissues.  Gastric cancer tissues from 115 of 175 (65.7%) patients revealed high level of SPHK1 protein expression in contrast to the undetectable or marginally detectable expression of SPHK1 in the adjacent noncancerous gastric tissues.  Significantly different expression levels of SPHK1 were found in patients at different clin. stages (P = 0.003), T classification (P = 0.035), and M classification (P = 0.020).  Patients with higher SPHK1 expression had shorter overall survival time, whereas those with lower SPHK1 expression survived longer.  Further multivariate anal. suggested that SPHK1 up-regulation was an independent prognostic indicator for the disease.  SPHK1 protein could be a useful marker for the prognosis of gastric cancer.  Further study on the potential use of SPHK1 as a therapeutic target is also warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6a-utjUoS77Vg90H21EOLACvtfcHk0lgePqyvBkYLlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitVOkt7k%253D&md5=5d65096d0960a7f58e68b82246439414</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-1158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-1158%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DC.%2BP.%26aulast%3DXia%26aufirst%3DJ.%2BT.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWeng%26aufirst%3DG.%2BX.%26aulast%3DZheng%26aufirst%3DH.%2BQ.%26aulast%3DKong%26aufirst%3DQ.%2BL.%26aulast%3DHu%26aufirst%3DL.%2BJ.%26aulast%3DZeng%26aufirst%3DM.%2BS.%26aulast%3DZeng%26aufirst%3DY.%2BX.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%2BB.%26atitle%3DSphingosine%2520kinase%25201%2520is%2520associated%2520with%2520gastric%2520cancer%2520progression%2520and%2520poor%2520survival%2520of%2520patients%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D1393%26epage%3D1399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span> </span><span class="NLM_article-title">Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy</span> <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=495&author=G.+Liuauthor=H.+Zhengauthor=Z.+Zhangauthor=Z.+Wuauthor=H.+Xiongauthor=J.+Liauthor=L.+Song&title=Overexpression+of+sphingosine+kinase+1+is+associated+with+salivary+gland+carcinoma+progression+and+might+be+a+novel+predictive+marker+for+adjuvant+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DXiong%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%26atitle%3DOverexpression%2520of%2520sphingosine%2520kinase%25201%2520is%2520associated%2520with%2520salivary%2520gland%2520carcinoma%2520progression%2520and%2520might%2520be%2520a%2520novel%2520predictive%2520marker%2520for%2520adjuvant%2520therapy%26jtitle%3DBMC%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span> </span><span class="NLM_article-title">Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6996</span><span class="NLM_x">–</span> <span class="NLM_lpage">7003</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1158%2F1078-0432.CCR-08-0754" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=18980995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlens7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=6996-7003&author=J.+Liauthor=H.+Y.+Guanauthor=L.+Y.+Gongauthor=L.+B.+Songauthor=N.+Zhangauthor=J.+Wuauthor=J.+Yuanauthor=Y.+J.+Zhengauthor=Z.+S.+Huangauthor=M.+Li&title=Clinical+significance+of+sphingosine+kinase-1+expression+in+human+astrocytomas+progression+and+overall+patient+survival"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Significance of Sphingosine Kinase-1 Expression in Human Astrocytomas Progression and Overall Patient Survival</span></div><div class="casAuthors">Li, Jun; Guan, Hong-Yu; Gong, Li-Yun; Song, Li-Bing; Zhang, Nu; Wu, Jueheng; Yuan, Jie; Zheng, Yi-Jie; Huang, Zheng-Song; Li, Mengfeng</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6996-7003</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: To characterize the expression of sphingosine kinase-1 (SPHK1) in human astrocytomas and to investigate the assocn. between SPHK1 expression and progression of astrocytomas.  Exptl. Design: The expression of SPHK1 in normal human astrocytes, astrocytoma cell lines, and four pairs of matched astrocytoma tissues and their adjacent normal brain tissues were detected by quant. reverse transcription-PCR and Western blot.  In addn., SPHK1 protein expression was examd. in 243 cases of histol. characterized astrocytomas by immunohistochem.  Statistical analyses were applied to test for prognostic and diagnostic assocns.  RESULTS: SPHK1 in astrocytoma cell lines was elevated at both mRNA and protein levels, and the SPHK1 mRNA and protein were significantly up-regulated by up to 6.8- and 40-fold, resp., in primary astrocytomas compared with those in the adjacent noncancerous brain tissues.  Immunohistochem. anal. showed that 100 of 243 (41.2%) paraffin-embedded archival astrocytoma biopsies exhibited high expression of SPHK1.  Statistical anal. suggested that the up-regulation of SPHK1 was significantly correlated with the histol. grade of astrocytoma (P = 0.000) and that patients with high SPHK1 level exhibited shorter survival time (P < 0.001).  Multivariate anal. revealed that SPHK1 up-regulation might be an independent prognostic indicator for the survival of patients with astrocytoma.  CONCLUSIONS: SPHK1 might represent a novel and useful prognostic marker for astrocytoma and play a role during the development and progression of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj1r4G3W_Fr7Vg90H21EOLACvtfcHk0ljP_7Bpq0eXrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlens7bK&md5=670030678fc952a28cdc711de723e96b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0754%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGuan%26aufirst%3DH.%2BY.%26aulast%3DGong%26aufirst%3DL.%2BY.%26aulast%3DSong%26aufirst%3DL.%2BB.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DY.%2BJ.%26aulast%3DHuang%26aufirst%3DZ.%2BS.%26aulast%3DLi%26aufirst%3DM.%26atitle%3DClinical%2520significance%2520of%2520sphingosine%2520kinase-1%2520expression%2520in%2520human%2520astrocytomas%2520progression%2520and%2520overall%2520patient%2520survival%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D6996%26epage%3D7003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Guan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span> </span><span class="NLM_article-title">Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e19946</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e19946&author=H.+Guanauthor=L.+Songauthor=J.+Caiauthor=Y.+Huangauthor=J.+Wuauthor=J.+Yuanauthor=J.+Liauthor=M.+Li&title=Sphingosine+kinase+1+regulates+the+Akt%2FFOXO3a%2FBim+pathway+and+contributes+to+apoptosis+resistance+in+glioma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DH.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DM.%26atitle%3DSphingosine%2520kinase%25201%2520regulates%2520the%2520Akt%252FFOXO3a%252FBim%2520pathway%2520and%2520contributes%2520to%2520apoptosis%2520resistance%2520in%2520glioma%2520cells%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De19946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Kapitonov, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegood, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hait, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almenara, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zipkin, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kordula, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">6915</span><span class="NLM_x">–</span> <span class="NLM_lpage">6923</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=6915-6923&author=D.+Kapitonovauthor=J.+C.+Allegoodauthor=C.+Mitchellauthor=N.+C.+Haitauthor=J.+A.+Almenaraauthor=J.+K.+Adamsauthor=R.+E.+Zipkinauthor=P.+Dentauthor=T.+Kordulaauthor=S.+Milstienauthor=S.+Spiegel&title=Targeting+sphingosine+kinase+1+inhibits+Akt+signaling%2C+induces+apoptosis%2C+and+suppresses+growth+of+human+glioblastoma+cells+and+xenografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKapitonov%26aufirst%3DD.%26aulast%3DAllegood%26aufirst%3DJ.%2BC.%26aulast%3DMitchell%26aufirst%3DC.%26aulast%3DHait%26aufirst%3DN.%2BC.%26aulast%3DAlmenara%26aufirst%3DJ.%2BA.%26aulast%3DAdams%26aufirst%3DJ.%2BK.%26aulast%3DZipkin%26aufirst%3DR.%2BE.%26aulast%3DDent%26aufirst%3DP.%26aulast%3DKordula%26aufirst%3DT.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DTargeting%2520sphingosine%2520kinase%25201%2520inhibits%2520Akt%2520signaling%252C%2520induces%2520apoptosis%252C%2520and%2520suppresses%2520growth%2520of%2520human%2520glioblastoma%2520cells%2520and%2520xenografts%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D6915%26epage%3D6923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Rosa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marciano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malapelle, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formisano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nappi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amato, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amato, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marfe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Vecchio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zannetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Stefano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlomagno, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veneziani, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troncone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Placido, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianco, R.</span><span> </span><span class="NLM_article-title">Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1158%2F1078-0432.CCR-12-1050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=23166225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFGhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=138-147&author=R.+Rosaauthor=R.+Marcianoauthor=U.+Malapelleauthor=L.+Formisanoauthor=L.+Nappiauthor=C.+D%E2%80%99Amatoauthor=V.+D%E2%80%99Amatoauthor=V.+Damianoauthor=G.+Marfeauthor=S.+Del+Vecchioauthor=A.+Zannettiauthor=A.+Grecoauthor=A.+De+Stefanoauthor=C.+Carlomagnoauthor=B.+M.+Venezianiauthor=G.+Tronconeauthor=S.+De+Placidoauthor=R.+Bianco&title=Sphingosine+kinase+1+overexpression+contributes+to+cetuximab+resistance+in+human+colorectal+cancer+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models</span></div><div class="casAuthors">Rosa, Roberta; Marciano, Roberta; Malapelle, Umberto; Formisano, Luigi; Nappi, Lucia; D'Amato, Claudia; D'Amato, Valentina; Damiano, Vincenzo; Marfe, Gabriella; Del Vecchio, Silvana; Zannetti, Antonella; Greco, Adelaide; De Stefano, Alfonso; Carlomagno, Chiara; Veneziani, Bianca Maria; Troncone, Giancarlo; De Placido, Sabino; Bianco, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">138-147</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Although the anti-EGF receptor (EGFR) monoclonal antibody cetuximab is an effective strategy in colorectal cancer therapy, its clin. use is limited by intrinsic or acquired resistance.  Alterations in the "sphingolipid rheostat"-the balance between the proapoptotic mol. ceramide and the mitogenic factor sphingosine-1-phosphate (S1P)-due to sphingosine kinase 1 (SphK1) overactivation have been involved in resistance to anticancer-targeted agents.  Moreover, cross-talks between SphK1 and EGFR-dependent signaling pathways have been described.  Exptl. design: We investigated SphK1 contribution to cetuximab resistance in colorectal cancer, in preclin. in vitro/in vivo models, and in tumor specimens from patients.  Results: SphK1 was found overexpressed and overactivated in colorectal cancer cells with intrinsic or acquired resistance to cetuximab.  SphK1 contribution to resistance was supported by the demonstration that SphK1 inhibition by N,N-dimethyl-sphingosine or silencing via siRNA in resistant cells restores sensitivity to cetuximab, whereas exogenous SphK1 overexpression in sensitive cells confers resistance to these agents.  Moreover, treatment of resistant cells with fingolimod (FTY720), a S1P receptor (S1PR) antagonist, resulted in resensitization to cetuximab both in vitro and in vivo, with inhibition of tumor growth, interference with signal transduction, induction of cancer cells apoptosis, and prolongation of mice survival.  Finally, a correlation between SphK1 expression and cetuximab response was found in colorectal cancer patients.  Clin Cancer Res; 19(1); 138-47. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYEnt3BNcDsrVg90H21EOLACvtfcHk0ljqLeId6IYW6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFGhsg%253D%253D&md5=e8c6c153aeca808201d5d583f368821d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-1050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-1050%26sid%3Dliteratum%253Aachs%26aulast%3DRosa%26aufirst%3DR.%26aulast%3DMarciano%26aufirst%3DR.%26aulast%3DMalapelle%26aufirst%3DU.%26aulast%3DFormisano%26aufirst%3DL.%26aulast%3DNappi%26aufirst%3DL.%26aulast%3DD%25E2%2580%2599Amato%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Amato%26aufirst%3DV.%26aulast%3DDamiano%26aufirst%3DV.%26aulast%3DMarfe%26aufirst%3DG.%26aulast%3DDel%2BVecchio%26aufirst%3DS.%26aulast%3DZannetti%26aufirst%3DA.%26aulast%3DGreco%26aufirst%3DA.%26aulast%3DDe%2BStefano%26aufirst%3DA.%26aulast%3DCarlomagno%26aufirst%3DC.%26aulast%3DVeneziani%26aufirst%3DB.%2BM.%26aulast%3DTroncone%26aufirst%3DG.%26aulast%3DDe%2BPlacido%26aufirst%3DS.%26aulast%3DBianco%26aufirst%3DR.%26atitle%3DSphingosine%2520kinase%25201%2520overexpression%2520contributes%2520to%2520cetuximab%2520resistance%2520in%2520human%2520colorectal%2520cancer%2520models%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D138%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Cuvillier, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ader, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouquerel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brizuela, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gstalder, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malavaud, B.</span><span> </span><span class="NLM_article-title">Hypoxia, therapeutic resistance, and sphingosine 1-phosphate</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2013&pages=117-141&author=O.+Cuvillierauthor=I.+Aderauthor=P.+Bouquerelauthor=L.+Brizuelaauthor=C.+Gstalderauthor=B.+Malavaud&title=Hypoxia%2C+therapeutic+resistance%2C+and+sphingosine+1-phosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuvillier%26aufirst%3DO.%26aulast%3DAder%26aufirst%3DI.%26aulast%3DBouquerel%26aufirst%3DP.%26aulast%3DBrizuela%26aufirst%3DL.%26aulast%3DGstalder%26aufirst%3DC.%26aulast%3DMalavaud%26aufirst%3DB.%26atitle%3DHypoxia%252C%2520therapeutic%2520resistance%252C%2520and%2520sphingosine%25201-phosphate%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2013%26volume%3D117%26spage%3D117%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Pchejetski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doumerc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golzio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naymark, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teissie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waxman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malavaud, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuvillier, O.</span><span> </span><span class="NLM_article-title">Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1836</span><span class="NLM_x">–</span> <span class="NLM_lpage">1845</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1158%2F1535-7163.MCT-07-2322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=18644996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCgtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1836-1845&author=D.+Pchejetskiauthor=N.+Doumercauthor=M.+Golzioauthor=M.+Naymarkauthor=J.+Teissieauthor=T.+Kohamaauthor=J.+Waxmanauthor=B.+Malavaudauthor=O.+Cuvillier&title=Chemosensitizing+effects+of+sphingosine+kinase-1+inhibition+in+prostate+cancer+cell+and+animal+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models</span></div><div class="casAuthors">Pchejetski, Dimitri; Doumerc, Nicolas; Golzio, Muriel; Naymark, Maria; Teissie, Justin; Kohama, Takafumi; Waxman, Jonathan; Malavaud, Bernard; Cuvillier, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1836-1845</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We have previously reported that, in prostate cancer, inhibition of the oncogenic sphingosine kinase-1/sphingosine 1-phosphate (SphK1/S1P) pathway is a key element in chemotherapy-induced apoptosis.  Here, we show that selective pharmacol. inhibition of SphK1 triggers apoptosis in LNCaP and PC-3 prostate cancer cells, an effect that is reversed by SphK1 enforced expression.  More importantly, we show for the first time that the up-regulation of the SphK1/S1P pathway plays a crucial role in the resistance of prostate cancer cells to chemotherapy.  Importantly, pharmacol. SphK1 inhibition with the B-5354c compd. sensitizes LNCaP and PC-3 cells to docetaxel and camptothecin, resp.  In vivo, camptothecin and B-5354c alone display a limited effect on tumor growth in PC-3 cells, whereas in combination there is a synergy of effect on tumor size with a significant increase in the ceramide to S1P sphingolipid ratio.  To conclude, our study highlights the notion that drugs specifically designed to inhibit SphK1 could provide a means of enhancing the effects of conventional treatment through the prosurvival antiapoptotic SphK1/S1P pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxORZv-9TsMrVg90H21EOLACvtfcHk0ljqLeId6IYW6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCgtLY%253D&md5=80c4217f39039e683331008a3ad54c31</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-2322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-2322%26sid%3Dliteratum%253Aachs%26aulast%3DPchejetski%26aufirst%3DD.%26aulast%3DDoumerc%26aufirst%3DN.%26aulast%3DGolzio%26aufirst%3DM.%26aulast%3DNaymark%26aufirst%3DM.%26aulast%3DTeissie%26aufirst%3DJ.%26aulast%3DKohama%26aufirst%3DT.%26aulast%3DWaxman%26aufirst%3DJ.%26aulast%3DMalavaud%26aufirst%3DB.%26aulast%3DCuvillier%26aufirst%3DO.%26atitle%3DChemosensitizing%2520effects%2520of%2520sphingosine%2520kinase-1%2520inhibition%2520in%2520prostate%2520cancer%2520cell%2520and%2520animal%2520models%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1836%26epage%3D1845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macritchie, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittman, R.</span><span> </span><span class="NLM_article-title">Synthesis of (S)-FTY720 vinylphosphonate analogues and evaluation of their potential as sphingosine kinase 1 inhibitors and activators</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2503</span><span class="NLM_x">–</span> <span class="NLM_lpage">2510</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=2503-2510&author=Z.+Liuauthor=N.+Macritchieauthor=S.+Pyneauthor=N.+J.+Pyneauthor=R.+Bittman&title=Synthesis+of+%28S%29-FTY720+vinylphosphonate+analogues+and+evaluation+of+their+potential+as+sphingosine+kinase+1+inhibitors+and+activators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DMacritchie%26aufirst%3DN.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DBittman%26aufirst%3DR.%26atitle%3DSynthesis%2520of%2520%2528S%2529-FTY720%2520vinylphosphonate%2520analogues%2520and%2520evaluation%2520of%2520their%2520potential%2520as%2520sphingosine%2520kinase%25201%2520inhibitors%2520and%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D2503%26epage%3D2510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Baek, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacRitchie, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittman, R.</span><span> </span><span class="NLM_article-title">Synthesis of selective inhibitors of sphingosine kinase 1</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2136</span><span class="NLM_x">–</span> <span class="NLM_lpage">2138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=2136-2138&author=D.+J.+Baekauthor=N.+MacRitchieauthor=N.+J.+Pyneauthor=S.+Pyneauthor=R.+Bittman&title=Synthesis+of+selective+inhibitors+of+sphingosine+kinase+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaek%26aufirst%3DD.%2BJ.%26aulast%3DMacRitchie%26aufirst%3DN.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DBittman%26aufirst%3DR.%26atitle%3DSynthesis%2520of%2520selective%2520inhibitors%2520of%2520sphingosine%2520kinase%25201%26jtitle%3DChem.%2520Commun.%26date%3D2013%26volume%3D49%26spage%3D2136%26epage%3D2138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Mei, T.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, X.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span> </span><span class="NLM_article-title">Suzuki coupling based synthesis and in vitro cytotoxic evaluation of fingolimod and analogues</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">2927</span><span class="NLM_x">–</span> <span class="NLM_lpage">2932</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=2927-2932&author=T.-W.+Meiauthor=Y.+Luoauthor=X.-J.+Fengauthor=W.+Luauthor=B.+Yang&title=Suzuki+coupling+based+synthesis+and+in+vitro+cytotoxic+evaluation+of+fingolimod+and+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMei%26aufirst%3DT.-W.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFeng%26aufirst%3DX.-J.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DB.%26atitle%3DSuzuki%2520coupling%2520based%2520synthesis%2520and%2520in%2520vitro%2520cytotoxic%2520evaluation%2520of%2520fingolimod%2520and%2520analogues%26jtitle%3DTetrahedron%26date%3D2013%26volume%3D69%26spage%3D2927%26epage%3D2932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">French, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrecengost, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberly, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. D.</span><span> </span><span class="NLM_article-title">Discovery and evaluation of inhibitors of human sphingosine kinase</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">5962</span><span class="NLM_x">–</span> <span class="NLM_lpage">5969</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=14522923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvVSisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=5962-5969&author=K.+J.+Frenchauthor=R.+S.+Schrecengostauthor=B.+D.+Leeauthor=Y.+Zhuangauthor=S.+N.+Smithauthor=J.+L.+Eberlyauthor=J.+K.+Yunauthor=C.+D.+Smith&title=Discovery+and+evaluation+of+inhibitors+of+human+sphingosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Evaluation of Inhibitors of Human Sphingosine Kinase</span></div><div class="casAuthors">French, Kevin J.; Schrecengost, Randy S.; Lee, Brian D.; Zhuang, Yan; Smith, Staci N.; Eberly, Justin L.; Yun, Jong K.; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5962-5969</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Sphingolipid-metabolizing enzymes control the dynamic balance of the cellular levels of bioactive lipids, including the proapoptotic compd. ceramide and the proliferative compd. sphingosine 1-phosphate.  Accumulating evidence indicates that sphingosine kinase (SK) plays a pivotal role in regulating tumor growth and that SK can act as an oncogene.  Despite the importance of SK for cell proliferation, pharmacol. inhibition of SK is an untested means of treating cancer because of the current lack of nonlipid inhibitors of this enzyme.  To further assess the involvement of SK in human tumors, levels of RNA for SK in paired samples of cDNA prepd. from tumors and normal adjacent tissue were analyzed.  Expression of SK RNA was significantly elevated in a variety of solid tumors, compared with normal tissue from the same patient.  To identify and evaluate inhibitors of SK, a medium throughput assay for recombinant human SK fused to glutathione S-transferase was developed, validated, and used to screen a library of synthetic compds.  A no. of novel inhibitors of human SK were identified, and several representative compds. were characterized in detail.  These compds. demonstrated activity at sub- to micromolar concns., making them more potent than any other reported SK inhibitor, and were selective toward SK compared with a panel of human lipid and protein kinases.  Kinetic studies revealed that the compds. were not competitive inhibitors of the ATP-binding site of SK.  The SK inhibitors were antiproliferative toward a panel of tumor cell lines, including lines with the multidrug resistance phenotype because of overexpression of either P-glycoprotein or multidrug resistance phenotype 1, and were shown to inhibit endogenous human SK activity in intact cells.  Furthermore, each inhibitor induced apoptosis concomitant with tumor cell cytotoxicity.  Methods for the synthesis of a series of aurone inhibitors of SK were established, and a prototypical dihydroxyaurone was found to have moderate antitumor activity in vivo in the absence of overt toxicity to the mice.  These compds. are the first examples of nonlipid inhibitors of SK with in vivo antitumor activity and so provide leads for addnl. development of inhibitors of this important mol. target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbSJdFV0GwMLVg90H21EOLACvtfcHk0ljoO2wFv9K7JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvVSisLk%253D&md5=7740d8beec597ce818711a61a4652f85</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrench%26aufirst%3DK.%2BJ.%26aulast%3DSchrecengost%26aufirst%3DR.%2BS.%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DS.%2BN.%26aulast%3DEberly%26aufirst%3DJ.%2BL.%26aulast%3DYun%26aufirst%3DJ.%2BK.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DDiscovery%2520and%2520evaluation%2520of%2520inhibitors%2520of%2520human%2520sphingosine%2520kinase%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D5962%26epage%3D5969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romanow, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meininger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, N.</span><span> </span><span class="NLM_article-title">Molecular basis of sphingosine kinase 1 substrate recognition and catalysis</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">798</span><span class="NLM_x">–</span> <span class="NLM_lpage">809</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2Fj.str.2013.02.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=23602659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Cmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=798-809&author=Z.+Wangauthor=X.+Minauthor=S.+H.+Xiaoauthor=S.+Johnstoneauthor=W.+Romanowauthor=D.+Meiningerauthor=H.+Xuauthor=J.+Liuauthor=J.+Daiauthor=S.+Anauthor=S.+Thibaultauthor=N.+Walker&title=Molecular+basis+of+sphingosine+kinase+1+substrate+recognition+and+catalysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Basis of Sphingosine Kinase 1 Substrate Recognition and Catalysis</span></div><div class="casAuthors">Wang, Zhulun; Min, Xiaoshan; Xiao, Shou-Hua; Johnstone, Sheree; Romanow, William; Meininger, David; Xu, Haoda; Liu, Jinsong; Dai, Jessica; An, Songzhu; Thibault, Stephen; Walker, Nigel</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">798-809</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Sphingosine kinase 1 (SphK1) is a lipid kinase that catalyzes the conversion of sphingosine to sphingosine-1-phosphate (S1P), which has been shown to play a role in lymphocyte trafficking, angiogenesis, and response to apoptotic stimuli.  As a central enzyme in modulating the S1P levels in cells, SphK1 emerges as an important regulator for diverse cellular functions and a potential target for drug discovery.  Here, the authors present the crystal structures of human SphK1 in the apo form and in complexes with a substrate sphingosine-like lipid, ADP, and an inhibitor at 2.0-2.3 Å resoln.  The SphK1 structures reveal a two-domain architecture in which its catalytic site is located in the cleft between the two domains and a hydrophobic lipid-binding pocket is buried in the C-terminal domain.  Comparative anal. of these structures with mutagenesis and kinetic studies provides insight into how SphK1 recognizes the lipid substrate and catalyzes ATP-dependent phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGhuSYFEdxbrVg90H21EOLACvtfcHk0ljoO2wFv9K7JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Cmsr8%253D&md5=61b387e356ae18e0420be5e543f2187e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2013.02.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2013.02.025%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DXiao%26aufirst%3DS.%2BH.%26aulast%3DJohnstone%26aufirst%3DS.%26aulast%3DRomanow%26aufirst%3DW.%26aulast%3DMeininger%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DAn%26aufirst%3DS.%26aulast%3DThibault%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DN.%26atitle%3DMolecular%2520basis%2520of%2520sphingosine%2520kinase%25201%2520substrate%2520recognition%2520and%2520catalysis%26jtitle%3DStructure%26date%3D2013%26volume%3D21%26spage%3D798%26epage%3D809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Selvam, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogretmen, B.</span><span> </span><span class="NLM_article-title">Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">216</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1007%2F978-3-7091-1511-4_1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=23563649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKls73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=2013&pages=3-27&author=S.+P.+Selvamauthor=B.+Ogretmen&title=Sphingosine+kinase%2Fsphingosine+1-phosphate+signaling+in+cancer+therapeutics+and+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance</span></div><div class="casAuthors">Selvam, Shanmugam Panneer; Ogretmen, Besim</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">216</span>
        (<span class="NLM_cas:issue">Sphingolipids in Disease</span>),
    <span class="NLM_cas:pages">3-27</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  In this chapter, roles of bioactive sphingolipids, specifically sphingosine kinase 1 (SK1) and 2 (SK2) and their product-sphingosine 1-phosphate (S1P)-will be reviewed with respect to regulation of cancer growth, metastasis, chemotherapeutics, and drug resistance.  Sphingolipids are known to be key bioeffector mols. that regulate cancer proliferation, angiogenesis, and cell death.  Sphingolipid mols. such as ceramide and S1P have been shown to control cancer cell death and proliferation, resp.  Roles of S1P have been described with respect to their intracellular and extracellular pro-survival and drug resistance functions mostly through S1P receptor (S1PR1-5) engagement.  Identification of novel intracellular SK/S1P targets has broadened the existing complex regulatory roles of bioactive sphingolipids in cancer pathogenesis and therapeutics.  Thus, deciphering the biochem. and mol. regulation of SK/S1P/S1PR signaling could permit development of novel therapeutic interventions to improve cancer therapy and/or overcome drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDlCQuZSOmH7Vg90H21EOLACvtfcHk0ljoO2wFv9K7JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKls73L&md5=63b61d0ab607548f512e9157336611b1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2F978-3-7091-1511-4_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-7091-1511-4_1%26sid%3Dliteratum%253Aachs%26aulast%3DSelvam%26aufirst%3DS.%2BP.%26aulast%3DOgretmen%26aufirst%3DB.%26atitle%3DSphingosine%2520kinase%252Fsphingosine%25201-phosphate%2520signaling%2520in%2520cancer%2520therapeutics%2520and%2520drug%2520resistance%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2013%26volume%3D216%26spage%3D3%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Hannun, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeid, L. M.</span><span> </span><span class="NLM_article-title">Principles of bioactive lipid signalling: lessons from sphingolipids</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1038%2Fnrm2329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=18216770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFOntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=139-150&author=Y.+A.+Hannunauthor=L.+M.+Obeid&title=Principles+of+bioactive+lipid+signalling%3A+lessons+from+sphingolipids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Principles of bioactive lipid signalling: lessons from sphingolipids</span></div><div class="casAuthors">Hannun, Yusuf A.; Obeid, Lina M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-150</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  It has become increasingly difficult to find an area of cell biol. in which lipids do not have important, if not key, roles as signaling and regulatory mols.  The rapidly expanding field of bioactive lipids is exemplified by many sphingolipids, such as ceramide, sphingosine, sphingosine-1-phosphate (S1P), ceramide-1-phosphate, and lyso-sphingomyelin, which have roles in the regulation of cell growth, death, senescence, adhesion, migration, inflammation, angiogenesis, and intracellular trafficking.  Deciphering the mechanisms of these varied cell functions necessitates an understanding of the complex pathways of sphingolipid metab. and the mechanisms that regulate lipid generation and lipid action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrJi0iM1f277Vg90H21EOLACvtfcHk0liiDaOslVjw5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFOntg%253D%253D&md5=0bee4e560d083ef4c43f7d0b591a0997</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnrm2329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2329%26sid%3Dliteratum%253Aachs%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26atitle%3DPrinciples%2520of%2520bioactive%2520lipid%2520signalling%253A%2520lessons%2520from%2520sphingolipids%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2008%26volume%3D9%26spage%3D139%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Morad, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabot, M. C.</span><span> </span><span class="NLM_article-title">Ceramide-orchestrated signalling in cancer cells</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1038%2Fnrc3398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=23235911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVais7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=51-65&author=S.+A.+Moradauthor=M.+C.+Cabot&title=Ceramide-orchestrated+signalling+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide-orchestrated signalling in cancer cells</span></div><div class="casAuthors">Morad, Samy A. F.; Cabot, Myles C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-65</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  One crucial barrier to progress in the treatment of cancer has been the inability to control the balance between cell proliferation and apoptosis: enter ceramide.  Discoveries over the past 15 years have elevated this sphingolipid to the lofty position of a regulator of cell fate.  Ceramide, it turns out, is a powerful tumor suppressor, potentiating signalling events that drive apoptosis, autophagic responses and cell cycle arrest.  However, defects in ceramide generation and metab. in cancer cells contribute to tumor cell survival and resistance to chemotherapy.  This Review focuses on ceramide signalling and the targeting of specific metabolic junctures to amplify the tumor suppressive activities of ceramide.  The potential of ceramide-based therapeutics in the treatment of cancer is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo76pxQVHiNu7Vg90H21EOLACvtfcHk0liiDaOslVjw5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVais7vL&md5=ad6eb1da2465b3db6298e747bd7d3f58</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnrc3398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3398%26sid%3Dliteratum%253Aachs%26aulast%3DMorad%26aufirst%3DS.%2BA.%26aulast%3DCabot%26aufirst%3DM.%2BC.%26atitle%3DCeramide-orchestrated%2520signalling%2520in%2520cancer%2520cells%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2013%26volume%3D13%26spage%3D51%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Orr Gandy, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeid, L. M.</span><span> </span><span class="NLM_article-title">Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2013&pages=157-166&author=K.+A.+Orr+Gandyauthor=L.+M.+Obeid&title=Targeting+the+sphingosine+kinase%2Fsphingosine+1-phosphate+pathway+in+disease%3A+review+of+sphingosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrr%2BGandy%26aufirst%3DK.%2BA.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26atitle%3DTargeting%2520the%2520sphingosine%2520kinase%252Fsphingosine%25201-phosphate%2520pathway%2520in%2520disease%253A%2520review%2520of%2520sphingosine%2520kinase%2520inhibitors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2013%26volume%3D1%26spage%3D157%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Chalfant, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">4605</span><span class="NLM_x">–</span> <span class="NLM_lpage">4612</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1242%2Fjcs.02637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=16219683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1CnurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2005&pages=4605-4612&author=C.+E.+Chalfantauthor=S.+Spiegel&title=Sphingosine+1-phosphate+and+ceramide+1-phosphate%3A+expanding+roles+in+cell+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling</span></div><div class="casAuthors">Chalfant, Charles E.; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4605-4612</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  The phosphorylated sphingolipid metabolites sphingosine 1-phosphate (S1P) and ceramide 1-phosphate (C1P) have emerged as potent bioactive agents.  Recent studies have begun to define new biol. functions for these lipids.  Generated by sphingosine kinases and ceramide kinase, they control numerous aspects of cell physiol., including cell survival and mammalian inflammatory responses.  Interestingly, S1P is involved in cyclooxygenase-2 induction and C1P is required for the activation and translocation of cPLA2.  This suggests that these two sphingolipid metabolites may act in concert to regulate prodn. of eicosanoids, important inflammatory mediators.  Whereas S1P functions mainly via G-protein-coupled receptors, C1P appears to bind directly to targets such as cPLA2 and protein phosphatase 1/2A.  S1P probably also has intracellular targets, and in plants it appears to directly regulate the G protein α subunit GPA1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQGTlv0qGkXLVg90H21EOLACvtfcHk0liiDaOslVjw5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1CnurzP&md5=423d9f0836f031e20c92d3fd654f16ab</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1242%2Fjcs.02637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.02637%26sid%3Dliteratum%253Aachs%26aulast%3DChalfant%26aufirst%3DC.%2BE.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine%25201-phosphate%2520and%2520ceramide%25201-phosphate%253A%2520expanding%2520roles%2520in%2520cell%2520signaling%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2005%26volume%3D118%26spage%3D4605%26epage%3D4612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Cuvillier, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirianov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleuser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanek, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coso, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutkind, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">381</span><span class="NLM_x">, </span> <span class="NLM_fpage">800</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1038%2F381800a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=8657285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADyaK28XjvVKnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=1996&pages=800-803&author=O.+Cuvillierauthor=G.+Pirianovauthor=B.+Kleuserauthor=P.+G.+Vanekauthor=O.+A.+Cosoauthor=S.+Gutkindauthor=S.+Spiegel&title=Suppression+of+ceramide-mediated+programmed+cell+death+by+sphingosine-1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate</span></div><div class="casAuthors">Cuvillier, Olivier; Pirianov, Grisha; Kleuser, Burkhard; Vanek, Philip G.; Coso, Omar A.; Gutkind, J. Silvio; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">381</span>
        (<span class="NLM_cas:issue">6585</span>),
    <span class="NLM_cas:pages">800-803</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Ceramide is an important regulatory participant of programmed cell death (apoptosis) induced by tumor-necrosis factor (TMF)-α and Fas ligand, members of the TNF superfamily.  Conversely, sphingosine and sphingosine-1-phosphate, which are metabolites of ceramide, induce mitogenesis and have been implicated as second messengers in cellular proliferation induced by platelet-derived growth factor and serum.  Here we report that sphingosine-1-phosphate prevents the appearance of the key features of apoptosis, namely intranucleosomal DNA fragmentation and morphol. changes, which result from increased concns. of ceramide.  Furthermore, inhibition of ceramide-mediated apoptosis by activation of protein kinase C results from stimulation of sphingosine kinase and the concomitant increase in intracellular sphingosine-1-phosphate.  Finally sphingosine-1-phosphate not only stimulates the extracellular signal-regulated kinase (ERK) pathway, it counteracts the ceramide-induced activation of stress-activated protein kinase of ceramide and sphingosine-1-phosphate and their regulatory effects on different family members of mitogen-activated protein kinases dets. the fate of the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3xEuzICMjarVg90H21EOLACvtfcHk0liiDaOslVjw5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvVKnsro%253D&md5=50d91e59dc03600594fd0a236ecc2838</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2F381800a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F381800a0%26sid%3Dliteratum%253Aachs%26aulast%3DCuvillier%26aufirst%3DO.%26aulast%3DPirianov%26aufirst%3DG.%26aulast%3DKleuser%26aufirst%3DB.%26aulast%3DVanek%26aufirst%3DP.%2BG.%26aulast%3DCoso%26aufirst%3DO.%2BA.%26aulast%3DGutkind%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSuppression%2520of%2520ceramide-mediated%2520programmed%2520cell%2520death%2520by%2520sphingosine-1-phosphate%26jtitle%3DNature%26date%3D1996%26volume%3D381%26spage%3D800%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Ponnusamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers-Needham, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senkal, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saddoughi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentelle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selvam, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogretmen, B.</span><span> </span><span class="NLM_article-title">Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance</span> <span class="citation_source-journal">Future Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1603</span><span class="NLM_x">–</span> <span class="NLM_lpage">1624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.2217%2Ffon.10.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=21062159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2rsbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=1603-1624&author=S.+Ponnusamyauthor=M.+Meyers-Needhamauthor=C.+E.+Senkalauthor=S.+A.+Saddoughiauthor=D.+Sentelleauthor=S.+P.+Selvamauthor=A.+Salasauthor=B.+Ogretmen&title=Sphingolipids+and+cancer%3A+ceramide+and+sphingosine-1-phosphate+in+the+regulation+of+cell+death+and+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance</span></div><div class="casAuthors">Ponnusamy, Suriyan; Meyers-Needham, Marisa; Senkal, Can E.; Saddoughi, Sahar A.; Sentelle, David; Selvam, Shanmugam Panneer; Salas, Arelis; Ogretmen, Besim</div><div class="citationInfo"><span class="NLM_cas:title">Future Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1603-1624</span>CODEN:
                <span class="NLM_cas:coden">FOUNBN</span>;
        ISSN:<span class="NLM_cas:issn">1479-6694</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids have emerged as bioeffector mols., controlling various aspects of cell growth and proliferation in cancer, which is becoming the deadliest disease in the world.  These lipid mols. have also been implicated in the mechanism of action of cancer chemotherapeutics.  Ceramide, the central mol. of sphingolipid metab., generally mediates antiproliferative responses, such as cell growth inhibition, apoptosis induction, senescence modulation, endoplasmic reticulum stress responses and/or autophagy.  Interestingly, recent studies suggest de novo-generated ceramides may have distinct and opposing roles in the promotion/suppression of tumors, and that these activities are based on their fatty acid chain lengths, subcellular localization and/or direct downstream targets.  For example, in head and neck cancer cells, ceramide synthase 6/C16-ceramide addiction was revealed, and this was assocd. with increased tumor growth, whereas downregulation of its synthesis resulted in ER stress-induced apoptosis.  By contrast, ceramide synthase 1-generated C18-ceramide has been shown to suppress tumor growth in various cancer models, both in situ and in vivo.  In addn., ceramide metab. to generate sphingosine-1-phosphate (S1P) by sphingosine kinases 1 and 2 mediates, with or without the involvement of G-protein-coupled S1P receptor signaling, prosurvival, angiogenesis, metastasis and/or resistance to drug-induced apoptosis.  Importantly, recent findings regarding the mechanisms by which sphingolipid metab. and signaling regulate tumor growth and progression, such as identifying direct intracellular protein targets of sphingolipids, have been key for the development of new chemotherapeutic strategies.  Thus, in this article, we will present conclusions of recent studies that describe opposing roles of de novo-generated ceramides by ceramide synthases and/or S1P in the regulation of cancer pathogenesis, as well as the development of sphingolipid-based cancer therapeutics and drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo16aaSjjevSLVg90H21EOLACvtfcHk0lgKPy4YIxhgRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2rsbjJ&md5=8f65136dd6ed29f852181b7140ddde6f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2217%2Ffon.10.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffon.10.116%26sid%3Dliteratum%253Aachs%26aulast%3DPonnusamy%26aufirst%3DS.%26aulast%3DMeyers-Needham%26aufirst%3DM.%26aulast%3DSenkal%26aufirst%3DC.%2BE.%26aulast%3DSaddoughi%26aufirst%3DS.%2BA.%26aulast%3DSentelle%26aufirst%3DD.%26aulast%3DSelvam%26aufirst%3DS.%2BP.%26aulast%3DSalas%26aufirst%3DA.%26aulast%3DOgretmen%26aufirst%3DB.%26atitle%3DSphingolipids%2520and%2520cancer%253A%2520ceramide%2520and%2520sphingosine-1-phosphate%2520in%2520the%2520regulation%2520of%2520cell%2520death%2520and%2520drug%2520resistance%26jtitle%3DFuture%2520Oncol.%26date%3D2010%26volume%3D6%26spage%3D1603%26epage%3D1624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Johnson, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crellin, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogretmen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boylan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harley, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeid, L. M.</span><span> </span><span class="NLM_article-title">Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue</span> <span class="citation_source-journal">J. Histochem. Cytochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1159</span><span class="NLM_x">–</span> <span class="NLM_lpage">1166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1369%2Fjhc.4A6606.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=15923363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVersbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2005&pages=1159-1166&author=K.+R.+Johnsonauthor=K.+Y.+Johnsonauthor=H.+G.+Crellinauthor=B.+Ogretmenauthor=A.+M.+Boylanauthor=R.+A.+Harleyauthor=L.+M.+Obeid&title=Immunohistochemical+distribution+of+sphingosine+kinase+1+in+normal+and+tumor+lung+tissue"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue</span></div><div class="casAuthors">Johnson, Korey R.; Johnson, Kristy Y.; Crellin, Heather G.; Ogretmen, Besim; Boylan, Alice M.; Harley, Russell A.; Obeid, Lina M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1159-1166</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">Sphingosine kinase 1 (SK1) is a key enzyme crit. to the sphingolipid metabolic pathway responsible for catalyzing the formation of the bioactive lipid sphingosine-1-phosphate.  SK1-mediated prodn. of sphingosine-1-phosphate has been shown to stimulate such biol. processes as cell growth, differentiation, migration, angiogenesis, and inhibition of apoptosis.  In this study, cell type-specific immunolocalization of SK1 was examd. in the bronchus/terminal bronchiole of the lung.  Strong immunopos. staining was evident at the apical surface of pseudostratified epithelial cells of the bronchus and underlying smooth muscle cells, submucosal serous glands, immature chondrocytes, type II alveolar cells, foamy macrophages, endothelial cells of blood vessels, and neural bundles.  Immunohistochem. screening for SK1 expression was performed in 25 samples of normal/tumor patient matched non-small-cell lung cancer tissue and found that 25 of 25 tumor samples (carcinoid [5 samples], squamous [10 samples], and adenocarcinoma tumors [10 samples]), exhibited overwhelmingly pos. immunostaining for SK1 as compared with patient-matched normal tissue.  In addn., an approx. 2-fold elevation of SK1 mRNA expression was obsd. in lung cancer tissue vs. normal tissue, as well as in several other solid tumors.  Taken together, these findings define the localization of SK1 in lung and provide clues as to how SK1 may play a role in normal lung physiol. and the pathophysiol. of lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc9RJ87kecebVg90H21EOLACvtfcHk0lgKPy4YIxhgRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVersbrP&md5=4b68bb0bcd702b0f2e87cd49dd38fe9f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1369%2Fjhc.4A6606.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1369%252Fjhc.4A6606.2005%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DK.%2BR.%26aulast%3DJohnson%26aufirst%3DK.%2BY.%26aulast%3DCrellin%26aufirst%3DH.%2BG.%26aulast%3DOgretmen%26aufirst%3DB.%26aulast%3DBoylan%26aufirst%3DA.%2BM.%26aulast%3DHarley%26aufirst%3DR.%2BA.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26atitle%3DImmunohistochemical%2520distribution%2520of%2520sphingosine%2520kinase%25201%2520in%2520normal%2520and%2520tumor%2520lung%2520tissue%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2005%26volume%3D53%26spage%3D1159%26epage%3D1166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Kharel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellett, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomsig, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2011&pages=345-353&author=Y.+Kharelauthor=T.+P.+Mathewsauthor=A.+M.+Gellettauthor=J.+L.+Tomsigauthor=P.+C.+Kennedyauthor=M.+L.+Moyerauthor=T.+L.+Macdonaldauthor=K.+R.+Lynch&title=Sphingosine+kinase+type+1+inhibition+reveals+rapid+turnover+of+circulating+sphingosine+1-phosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DMathews%26aufirst%3DT.%2BP.%26aulast%3DGellett%26aufirst%3DA.%2BM.%26aulast%3DTomsig%26aufirst%3DJ.%2BL.%26aulast%3DKennedy%26aufirst%3DP.%2BC.%26aulast%3DMoyer%26aufirst%3DM.%2BL.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DSphingosine%2520kinase%2520type%25201%2520inhibition%2520reveals%2520rapid%2520turnover%2520of%2520circulating%2520sphingosine%25201-phosphate%26jtitle%3DBiochem.%2520J.%26date%3D2011%26volume%3D440%26spage%3D345%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Schnute, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McReynolds, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasten, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerome, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rains, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrencik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronin, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saabye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Highkin, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cukyne, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawadzke, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterkin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyanar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholten, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemirovskiy, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittwer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagiec, M. M.</span><span> </span><span class="NLM_article-title">Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">444</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1042%2FBJ20111929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=22397330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Kltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2012&pages=79-88&author=M.+E.+Schnuteauthor=M.+D.+McReynoldsauthor=T.+Kastenauthor=M.+Yatesauthor=G.+Jeromeauthor=J.+W.+Rainsauthor=T.+Hallauthor=J.+Chrencikauthor=M.+Krausauthor=C.+N.+Croninauthor=M.+Saabyeauthor=M.+K.+Highkinauthor=R.+Broadusauthor=S.+Ogawaauthor=K.+Cukyneauthor=L.+E.+Zawadzkeauthor=V.+Peterkinauthor=K.+Iyanarauthor=J.+A.+Scholtenauthor=J.+Wendlingauthor=H.+Fujiwaraauthor=O.+Nemirovskiyauthor=A.+J.+Wittwerauthor=M.+M.+Nagiec&title=Modulation+of+cellular+S1P+levels+with+a+novel%2C+potent+and+specific+inhibitor+of+sphingosine+kinase-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1</span></div><div class="casAuthors">Schnute, Mark E.; McReynolds, Matthew D.; Kasten, Tom; Yates, Matthew; Jerome, Gina; Rains, John W.; Hall, Troii; Chrencik, Jill; Kraus, Michelle; Cronin, Ciaran N.; Saabye, Matthew; Highkin, Maureen K.; Broadus, Richard; Ogawa, Shinji; Cukyne, Kristin; Zawadzke, Laura E.; Peterkin, Vincent; Iyanar, Kaliapan; Scholten, Jeffrey A.; Wendling, Jay; Fujiwara, Hideji; Nemirovskiy, Olga; Wittwer, Arthur J.; Nagiec, Marek M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">444</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-88</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">SphK (sphingosine kinase) is the major source of the bioactive lipid and GPCR (G-protein-coupled receptor) agonist S1P (sphingosine 1-phosphate).  S1P promotes cell growth, survival and migration, and is a key regulator of lymphocyte trafficking.  Inhibition of S1P signalling has been proposed as a strategy for treatment of inflammatory diseases and cancer.  In the present paper we describe the discovery and characterization of PF-543, a novel cell-permeant inhibitor of SphK1.  PF-543 inhibits SphK1 with a Ki of 3.6 nM, is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform.  In 1483 head and neck carcinoma cells, which are characterized by high levels of SphK1 expression and an unusually high rate of S1P prodn., PF-543 decreased the level of endogenous S1P 10-fold with a proportional increase in the level of sphingosine.  In contrast with past reports that show that the growth of many cancer cell lines is SphK1-dependent, specific inhibition of SphK1 had no effect on the proliferation and survival of 1483 cells, despite a dramatic change in the cellular S1P/sphingosine ratio.  PF-543 was effective as a potent inhibitor of S1P formation in whole blood, indicating that the SphK1 isoform of sphingosine kinase is the major source of S1P in human blood.  PF-543 is the most potent inhibitor of SphK1 described to date and it will be useful for dissecting specific roles of SphK1-driven S1P signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrenMsEAHJOo7Vg90H21EOLACvtfcHk0ligd6WRlz3DMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Kltrw%253D&md5=7615a3b0e28e4f798e30bf27998dbad0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1042%2FBJ20111929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20111929%26sid%3Dliteratum%253Aachs%26aulast%3DSchnute%26aufirst%3DM.%2BE.%26aulast%3DMcReynolds%26aufirst%3DM.%2BD.%26aulast%3DKasten%26aufirst%3DT.%26aulast%3DYates%26aufirst%3DM.%26aulast%3DJerome%26aufirst%3DG.%26aulast%3DRains%26aufirst%3DJ.%2BW.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DChrencik%26aufirst%3DJ.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DCronin%26aufirst%3DC.%2BN.%26aulast%3DSaabye%26aufirst%3DM.%26aulast%3DHighkin%26aufirst%3DM.%2BK.%26aulast%3DBroadus%26aufirst%3DR.%26aulast%3DOgawa%26aufirst%3DS.%26aulast%3DCukyne%26aufirst%3DK.%26aulast%3DZawadzke%26aufirst%3DL.%2BE.%26aulast%3DPeterkin%26aufirst%3DV.%26aulast%3DIyanar%26aufirst%3DK.%26aulast%3DScholten%26aufirst%3DJ.%2BA.%26aulast%3DWendling%26aufirst%3DJ.%26aulast%3DFujiwara%26aufirst%3DH.%26aulast%3DNemirovskiy%26aufirst%3DO.%26aulast%3DWittwer%26aufirst%3DA.%2BJ.%26aulast%3DNagiec%26aufirst%3DM.%2BM.%26atitle%3DModulation%2520of%2520cellular%2520S1P%2520levels%2520with%2520a%2520novel%252C%2520potent%2520and%2520specific%2520inhibitor%2520of%2520sphingosine%2520kinase-1%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D444%26spage%3D79%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Buehrer, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, R. M.</span><span> </span><span class="NLM_article-title">Inhibition of sphingosine kinase in vitro and in platelets. Implications for signal transduction pathways</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">3154</span><span class="NLM_x">–</span> <span class="NLM_lpage">3159</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=3154-3159&author=B.+M.+Buehrerauthor=R.+M.+Bell&title=Inhibition+of+sphingosine+kinase+in+vitro+and+in+platelets.+Implications+for+signal+transduction+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuehrer%26aufirst%3DB.%2BM.%26aulast%3DBell%26aufirst%3DR.%2BM.%26atitle%3DInhibition%2520of%2520sphingosine%2520kinase%2520in%2520vitro%2520and%2520in%2520platelets.%2520Implications%2520for%2520signal%2520transduction%2520pathways%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D3154%26epage%3D3159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Hamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakazawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yura, Y.</span><span> </span><span class="NLM_article-title">Induction of endonuclease G-mediated apopotosis in human oral squamous cell carcinoma cells by protein kinase C inhibitor safingol</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=47-56&author=M.+Hamadaauthor=T.+Sumiauthor=S.+Iwaiauthor=M.+Nakazawaauthor=Y.+Yura&title=Induction+of+endonuclease+G-mediated+apopotosis+in+human+oral+squamous+cell+carcinoma+cells+by+protein+kinase+C+inhibitor+safingol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHamada%26aufirst%3DM.%26aulast%3DSumi%26aufirst%3DT.%26aulast%3DIwai%26aufirst%3DS.%26aulast%3DNakazawa%26aufirst%3DM.%26aulast%3DYura%26aufirst%3DY.%26atitle%3DInduction%2520of%2520endonuclease%2520G-mediated%2520apopotosis%2520in%2520human%2520oral%2520squamous%2520cell%2520carcinoma%2520cells%2520by%2520protein%2520kinase%2520C%2520inhibitor%2520safingol%26jtitle%3DApoptosis%26date%3D2006%26volume%3D11%26spage%3D47%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Coward, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrosini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truman, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haimovitz-Friedman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegood, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrill, A. H.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span> </span><span class="NLM_article-title">Safingol (<span class="smallcaps smallerCapital">l</span>-threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=184-193&author=J.+Cowardauthor=G.+Ambrosiniauthor=E.+Musiauthor=J.+P.+Trumanauthor=A.+Haimovitz-Friedmanauthor=J.+C.+Allegoodauthor=E.+Wangauthor=A.+H.+Merrillauthor=G.+K.+Schwartz&title=Safingol+%28l-threo-sphinganine%29+induces+autophagy+in+solid+tumor+cells+through+inhibition+of+PKC+and+the+PI3-kinase+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoward%26aufirst%3DJ.%26aulast%3DAmbrosini%26aufirst%3DG.%26aulast%3DMusi%26aufirst%3DE.%26aulast%3DTruman%26aufirst%3DJ.%2BP.%26aulast%3DHaimovitz-Friedman%26aufirst%3DA.%26aulast%3DAllegood%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26atitle%3DSafingol%2520%2528l-threo-sphinganine%2529%2520induces%2520autophagy%2520in%2520solid%2520tumor%2520cells%2520through%2520inhibition%2520of%2520PKC%2520and%2520the%2520PI3-kinase%2520pathway%26jtitle%3DAutophagy%26date%3D2009%26volume%3D5%26spage%3D184%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Ling, L. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, G. N.</span><span> </span><span class="NLM_article-title">The role of reactive oxygen species and autophagy in safingol-induced cell death</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">e129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1038%2Fcddis.2011.12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=21390063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFeis74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=e129&author=L.+U.+Lingauthor=K.+B.+Tanauthor=H.+Linauthor=G.+N.+Chiu&title=The+role+of+reactive+oxygen+species+and+autophagy+in+safingol-induced+cell+death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The role of reactive oxygen species and autophagy in safingol-induced cell death</span></div><div class="casAuthors">Ling, L.-U.; Tan, K.-B.; Lin, H.; Chiu, G. N. C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">March</span>),
    <span class="NLM_cas:pages">e129/1-e129/12</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Safingol is a sphingolipid with promising anticancer potential, which is currently in phase I clin. trial.  Yet, the underlying mechanisms of its action remain largely unknown.  We reported here that safingol-induced primarily accidental necrotic cell death in MDA-MB-231 and HT-29 cells, as shown by the increase in the percentage of cells stained pos. for 7-aminoactinomycin D, collapse of mitochondria membrane potential and depletion of intracellular ATP.  Importantly, safingol treatment produced time- and concn.-dependent reactive oxygen species (ROS) generation.  Autophagy was triggered following safingol treatment, as reflected by the formation of autophagosomes, acidic vacuoles, increased light chain 3-II and Atg biomarkers expression.  Interestingly, scavenging ROS with N-acetyl-L-cysteine could prevent the autophagic features and reverse safingol-induced necrosis.  Our data also suggested that autophagy was a cell repair mechanism, as suppression of autophagy by 3-methyladenine or bafilomycin A1 significantly augmented cell death on 2-5 μM safingol treatment.  In addn., Bcl-xL and Bax might be involved in the regulation of safingol-induced autophagy.  Finally, glucose uptake was shown to be inhibited by safingol treatment, which was assocd. with an increase in p-AMPK expression.  Taken together, our data suggested that ROS was the mediator of safingol-induced cancer cell death, and autophagy is likely to be a mechanism triggered to repair damages from ROS generation on safingol treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnXFKfBZe5NbVg90H21EOLACvtfcHk0ligd6WRlz3DMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFeis74%253D&md5=8c2777ffe9de16f269e756300acf8d66</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2011.12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2011.12%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DL.%2BU.%26aulast%3DTan%26aufirst%3DK.%2BB.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DChiu%26aufirst%3DG.%2BN.%26atitle%3DThe%2520role%2520of%2520reactive%2520oxygen%2520species%2520and%2520autophagy%2520in%2520safingol-induced%2520cell%2520death%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2011%26volume%3D2%26spage%3De129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Schwartz, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casper, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodworth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venuti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zervos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storniolo, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelsen, D. P.</span><span> </span><span class="NLM_article-title">A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">543</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=9815717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADyaK2sXislGitLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=537-543&author=G.+K.+Schwartzauthor=D.+Wardauthor=L.+Saltzauthor=E.+S.+Casperauthor=T.+Spiessauthor=E.+Mullenauthor=J.+Woodworthauthor=R.+Venutiauthor=P.+Zervosauthor=A.+M.+Stornioloauthor=D.+P.+Kelsen&title=A+pilot+clinical%2Fpharmacological+study+of+the+protein+kinase+C-specific+inhibitor+safingol+alone+and+in+combination+with+doxorubicin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin</span></div><div class="casAuthors">Schwartz, Gary K.; Ward, David; Saltz, Leonard; Casper, Ephraim S.; Spiess, Tara; Mullen, Eillen; Woodworth, Jim; Venuti, Robert; Zervos, Peter; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">537-543</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We performed a pilot clin. trial with safingol (L-threo-dihydrosphingosine), a protein kinase C-specific inhibitor that potentiates the effect of doxorubicin (DOX) in tumor-bearing animals.  Safingol was initially administered as a 1-h infusion at escalating doses.  Fourteen days later, patients received the same dose of safingol in combination with a fixed dose of DOX.  The combination was repeated at 3-wk intervals.  Safingol dose levels ranged from 15 to 120 mg/m2.  The plasma levels achieved at the final dose level were comparable to those assocd. with potentiation of DOX in animals.  The mean Cmax and area under the curve for safingol at the 120 mg/m2 dose level were 1040 ± 196 ng/mL and 1251 ± 317 mg × h/mL, resp.  The mean plasma half-life for safingol was 3.97 ± 2.51 h, the mean estd. clearance was 3140 ± 765 mL/min, and the mean vol. of distribution was of 995 ± 421 L.  Coadministration of a fixed dose of DOX did not significantly change the pharmacokinetics of safingol, nor did increasing doses of safingol significantly affect the pharmacokinetics of DOX.  Minor responses were obsd. in three patients with pancreatic cancer and one patient with angiosarcoma of the scalp.  This pilot Phase I study indicates that the protein kinase C inhibitor safingol can be given safely with 45 mg/m2 of DOX at a dose that is potentially pharmacol. active without dose-limiting toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpZj2Ku7dLqrVg90H21EOLACvtfcHk0ljBjNuv46yTFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXislGitLc%253D&md5=dab6b7b4e13b06881a87f6b4a733f148</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26aulast%3DWard%26aufirst%3DD.%26aulast%3DSaltz%26aufirst%3DL.%26aulast%3DCasper%26aufirst%3DE.%2BS.%26aulast%3DSpiess%26aufirst%3DT.%26aulast%3DMullen%26aufirst%3DE.%26aulast%3DWoodworth%26aufirst%3DJ.%26aulast%3DVenuti%26aufirst%3DR.%26aulast%3DZervos%26aufirst%3DP.%26aulast%3DStorniolo%26aufirst%3DA.%2BM.%26aulast%3DKelsen%26aufirst%3DD.%2BP.%26atitle%3DA%2520pilot%2520clinical%252Fpharmacological%2520study%2520of%2520the%2520protein%2520kinase%2520C-specific%2520inhibitor%2520safingol%2520alone%2520and%2520in%2520combination%2520with%2520doxorubicin%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1997%26volume%3D3%26spage%3D537%26epage%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Ling, L. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, G. N.</span><span> </span><span class="NLM_article-title">The role of protein kinase C in the synergistic interaction of safingol and irinotecan in colon cancer cells</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1463</span><span class="NLM_x">–</span> <span class="NLM_lpage">1471</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=19885570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWksrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2009&pages=1463-1471&author=L.+U.+Lingauthor=H.+Linauthor=K.+B.+Tanauthor=G.+N.+Chiu&title=The+role+of+protein+kinase+C+in+the+synergistic+interaction+of+safingol+and+irinotecan+in+colon+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The role of protein kinase C in the synergistic interaction of safingol and irinotecan in colon cancer cells</span></div><div class="casAuthors">Ling, Leong-Uung; Lin, Huimin; Tan, Kuan-Boone; Chiu, Gigi N. C.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1463-1471</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Colon cancer represents one of the most common solid tumors in adults.  Although 5-fluorouracil (5-FU) and irinotecan have been frequently administered in colon cancer patients, low response rates to these single drug therapies were reported.  It is therefore imperative to search for new targeted combination therapies that are effective.  In this study, we investigated the anti-cancer effect of safingol as a single agent or in combination with irinotecan using HT-29 and LS-174T colon cancer cells as our in vitro models.  As a single agent, safingol was more potent than irinotecan and 5-FU, with IC50 values of 2.5±1.1 μM and 3.4±1.0 μM achieved in HT-29 and LS-174T cells, resp.  However, protein kinase C (PKC) was not inhibited with concns. of safingol which could induce substantial cell kill.  The combination of safingol/irinotecan at 1:1 molar ratio was found to be additive in HT-29 cells (CI=0.94) and synergistic in LS-174T cells (CI=0.68), and resulted in concn.- and time-dependent down-regulation of p-PKC and p-MARCKS.  The drug effect of the safingol/irinotecan combination was further modulated in the presence of a PKC stimulator (phorbol 12-myristate 13-acetate) or a PKC inhibitor (staurosporine).  Furthermore, the 1:1 safingol/irinotecan combination inhibited the adhesion of colon cancer cells to the extracellular matrix 4-h post-treatment.  Taken together, modulation of the PKC pathway could be a possible mol. basis for the obsd. synergism of the safingol/irinotecan combination, and these results demonstrate the therapeutic potential of this drug combination in colon cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Xiev9mnD77Vg90H21EOLACvtfcHk0ljBjNuv46yTFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWksrjI&md5=6a23c5f461d5e64ed5a19157013c7f49</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DL.%2BU.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DK.%2BB.%26aulast%3DChiu%26aufirst%3DG.%2BN.%26atitle%3DThe%2520role%2520of%2520protein%2520kinase%2520C%2520in%2520the%2520synergistic%2520interaction%2520of%2520safingol%2520and%2520irinotecan%2520in%2520colon%2520cancer%2520cells%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2009%26volume%3D35%26spage%3D1463%26epage%3D1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Kedderis, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bozigian, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleeman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Susick, R. L.,  Jr.</span><span> </span><span class="NLM_article-title">Toxicity of the protein kinase C inhibitor safingol administered alone and in combination with chemotherapeutic agents</span> <span class="citation_source-journal">Fundam. Appl. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1006%2Ffaat.1995.1056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=7665004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADyaK2MXmslehu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1995&pages=201-217&author=L.+B.+Kedderisauthor=H.+P.+Bozigianauthor=J.+M.+Kleemanauthor=R.+L.+Hallauthor=T.+E.+Palmerauthor=S.+D.+Harrisonauthor=R.+L.+Susick&title=Toxicity+of+the+protein+kinase+C+inhibitor+safingol+administered+alone+and+in+combination+with+chemotherapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity of the protein kinase C inhibitor safingol administered alone and in combination with chemotherapeutic agents</span></div><div class="casAuthors">Kedderis, Lorrene Buckley; Bozigian, Haig P.; Kleeman, James M.; Hall, Robert L.; Palmer, Thomas E.; Harrison, Steadman D., Jr.; Susick, Robert L., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental and Applied Toxicology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-17</span>CODEN:
                <span class="NLM_cas:coden">FAATDF</span>;
        ISSN:<span class="NLM_cas:issn">0272-0590</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Safingol [(2S,3S)-2-amino-1,3-octadecanediol] potentiates the toxicity of doxorubicin (DOX) and cisplatin (CIS) against tumor cells in vitro and in vivo.  The present studies were conducted in rats and dog to evaluate safingol toxicity when administered i.v. as a single agent and to evaluate safingol's ability to potentiate the toxicity of established chemotherapeutic agents to normal tissues in vivo.  In an escalating dose study, dogs were administered safingol i.v. at 5, 10, 20, 30, 40, and 75 mg/kg on Days 1 through 6.  Necropsies were performed on Day 7.  Red urine was obsd. at 10 mg/kg and higher.  Icterus was obsd. following 40 mg/kg with addnl. signs of hypoactivity and anorexia occurring after 75 mg/kg.  Clin. and microscopic pathol. revealed marked hepatotoxicity, venous degeneration and necrosis at injection sites, and evidence of intravascular hemolysis.  Doses of 5, 20, or 40 mg safingol/kg were utilized in single i.v. dose rat and dog studies.  No evidence of adverse systemic toxicity was seen ≤20 mg/kg in either species [for rats: Cmax = 12,600 (males) or 17,133 (females) ng/mL, AUC = 3853 (males) or 4365 (females) ng × h/mL (no sex differences)].  Local effects of venous irritation or intravascular hemolysis were obsd. at all doses in rats and at 20 and 40 mg/kg in dogs.  A dose of 40 mg/kg [for rats: Cmax = 31,233 (males) or 91,300 (females) ng/mL, AUC = 11,519 (males) or 18,620 (females) ng × h/mL; for dogs: Cmax = 9033 ng/mL, AUC = 11,094 ng × h/mL (combined sex)] was assocd. with clin. pathol. and renal histomorphol. changes considered consequent to intravascular hemolysis in both species, lethality and testicular toxicity in rats, and clin. biochem. changes indicative of hepatobiliary injury in dogs.  Studies indicated that hemolysis occurred during infusion, was not caused by circulating levels of safingol, and was a function of dose concn. and vein of delivery.  Safingol at 10 or 20 mg/kg was administered i.v. to rats 30-60 min prior to myelosuppressive i.v. doses of DOX, CIS, or cyclophosphamide (CYP).  Hematol., plus renal function and morphol. for CIS-treated animals, was assessed 4 and 14 days later.  Safingol did not potentiate DOX-, CIS-, or CYP-mediated leukopenia/thrombocytopenia.  A minimal enhancement of CIS-mediated decrease in GFR and increase in creatinine was obsd. at 20 mg safingol/kg.  Dogs were administered 20 mg safingol/kg i.v. followed 60 min later by 0.5 or 1.25 mg DOX/kg or 0.75 or 2.0 mg CIS/kg.  A complete toxicol. assessment 4 and 29 days postdose failed to show potentiation of DOX toxicity by safingol or vice versa.  A renal lesion was inferred in dogs administered 20 mg/kg safingol and 2 mg/kg CIS based on minimal to slight renal tubular regeneration obsd. 4 wk post-treatment.  There were no effects of safingol on the pharmacokinetic profiles of DOX or CIS or vice versa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdr-m28OPeYLVg90H21EOLACvtfcHk0ljBjNuv46yTFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmslehu70%253D&md5=0f8d01c8ee17cba0db23e00caf1a217f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1006%2Ffaat.1995.1056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Ffaat.1995.1056%26sid%3Dliteratum%253Aachs%26aulast%3DKedderis%26aufirst%3DL.%2BB.%26aulast%3DBozigian%26aufirst%3DH.%2BP.%26aulast%3DKleeman%26aufirst%3DJ.%2BM.%26aulast%3DHall%26aufirst%3DR.%2BL.%26aulast%3DPalmer%26aufirst%3DT.%2BE.%26aulast%3DHarrison%26aufirst%3DS.%2BD.%26aulast%3DSusick%26aufirst%3DR.%2BL.%26atitle%3DToxicity%2520of%2520the%2520protein%2520kinase%2520C%2520inhibitor%2520safingol%2520administered%2520alone%2520and%2520in%2520combination%2520with%2520chemotherapeutic%2520agents%26jtitle%3DFundam.%2520Appl.%2520Toxicol.%26date%3D1995%26volume%3D25%26spage%3D201%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Schwartz, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haimovitz-Friedman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhupar, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehleiter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maslak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loganzo, F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelsen, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuks, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albino, A. P.</span><span> </span><span class="NLM_article-title">Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">1394</span><span class="NLM_x">–</span> <span class="NLM_lpage">1399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1093%2Fjnci%2F87.18.1394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=7658500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADyaK2MXoslKiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1995&pages=1394-1399&author=G.+K.+Schwartzauthor=A.+Haimovitz-Friedmanauthor=S.+K.+Dhuparauthor=D.+Ehleiterauthor=P.+Maslakauthor=L.+Laiauthor=F.+Loganzoauthor=D.+P.+Kelsenauthor=Z.+Fuksauthor=A.+P.+Albino&title=Potentiation+of+apoptosis+by+treatment+with+the+protein+kinase+C-specific+inhibitor+safingol+in+mitomycin+C-treated+gastric+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells</span></div><div class="casAuthors">Schwartz, Gary K.; Haimovitz-Friedman, Adriana; Dhupar, Scott K.; Ehleiter, Desiree; Maslak, Peter; Lai, Lawrence; Loganzo, Frank Jr.; Kelsen, David P.; Fuks, Zvi; Albino, Anthony P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1394-9</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">National Cancer Institute</span>)
        </div><div class="casAbstract">Background: Protein kinase C (PKC) is a family of enzymes that function in processes relevant to carcinogenesis, tumor cell metastasis, and apoptosis.  Safingol, an optical isomer (the L-threo enantiomer) of dihydrosphingosine, is a specific inhibitor of PKC and might represent a novel agent for anticancer therapy.  Preclin. animal studies show that safingol alone has a minimal effect on tumor cell growth, but combining this compd. with conventional chemotherapy agents dramatically potentiates their antitumor effects.  It has been suggested that many chemotherapeutic agents exert their antitumor effects by inducing apoptosis.  Purpose: We wanted to det. the extent to which safingol, alone or in combination with a std. chemotherapeutic agent (mitomycin C [MMC]), would promote apoptosis in gastric cancer cells in vitro.  Furthermore, we investigated whether the induction of apoptosis in the treated cells was affected by their p53 tumor suppressor status or their drug-resistance status.  Method: SK-GT-5 (p53-deficient and MMC-resistant) and MKN-74 (p53 wild-type and MMC-sensitive) gastric cancer cells were exposed to either no drug, safingol (50 μM) alone, MMC (5 μg/mL) alone, or a combination of safingol (50 μM) and MMC (5 μg/mL).  In some expts., cells were exposed simultaneously to safingol and the PKC activator, 3-phorbol 12-myristate 13-acetate (PMA), prior to treatment with MMC.  Apoptosis was measured by two methods: (1) quant. fluorescence microscopy of nuclear chromatin condensation in cells stained with the dye, bisbenzamide trihydrochloride (Hoechst-33258), and (2) terminal deoxynucleotidyl transferase (TdT) labeling of the 3'-OH ends of DNA fragments produced in apoptotic cells.  Results: As detd. by quant. fluorescence microscopy, exposure of SK-GT-5 cells to safingol alone induced apoptosis in 2% (mean) of the cells, and MMC alone increased that level to 18%.  However, the combination of safingol and MMC induced apoptosis in 39% of the cells (for the drug combination vs. MMC alone).  With MKN-74 cells, safingol alone induced apoptosis in 8% of the cells, whereas MMC alone induced apoptosis in 40% of treated cells and the combination of safingol and MMC induced apoptosis in 83% of the cells.  Similar results were obtained with the TdT assay.  Simultaneous exposure of cells to safingol and PMA abrogated the safingol-mediated enhancement of MMC-induced apoptosis.  Conclusions: The PKC inhibitor safingol enhances the cytotoxic effect of the chemotherapeutic agent MMC in gastric cancer cells by promoting drug-induced apoptosis.  The induction of apoptosis occurs regardless of the p53 status or the drug-resistance status of the cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDxzSlEEQqV7Vg90H21EOLACvtfcHk0lgb5mosSjwhEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslKiu7s%253D&md5=55abbac0383b98f9e90a684dba523a87</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F87.18.1394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F87.18.1394%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26aulast%3DHaimovitz-Friedman%26aufirst%3DA.%26aulast%3DDhupar%26aufirst%3DS.%2BK.%26aulast%3DEhleiter%26aufirst%3DD.%26aulast%3DMaslak%26aufirst%3DP.%26aulast%3DLai%26aufirst%3DL.%26aulast%3DLoganzo%26aufirst%3DF.%26aulast%3DKelsen%26aufirst%3DD.%2BP.%26aulast%3DFuks%26aufirst%3DZ.%26aulast%3DAlbino%26aufirst%3DA.%2BP.%26atitle%3DPotentiation%2520of%2520apoptosis%2520by%2520treatment%2520with%2520the%2520protein%2520kinase%2520C-specific%2520inhibitor%2520safingol%2520in%2520mitomycin%2520C-treated%2520gastric%2520cancer%2520cells%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1995%26volume%3D87%26spage%3D1394%26epage%3D1399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Dickson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvajal, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrill, A. H.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cane, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span> </span><span class="NLM_article-title">A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2484</span><span class="NLM_x">–</span> <span class="NLM_lpage">2492</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1158%2F1078-0432.CCR-10-2323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=21257722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslCgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=2484-2492&author=M.+A.+Dicksonauthor=R.+D.+Carvajalauthor=A.+H.+Merrillauthor=M.+Gonenauthor=L.+M.+Caneauthor=G.+K.+Schwartz&title=A+phase+I+clinical+trial+of+safingol+in+combination+with+cisplatin+in+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase I Clinical Trial of Safingol in Combination with Cisplatin in Advanced Solid Tumors</span></div><div class="casAuthors">Dickson, Mark A.; Carvajal, Richard D.; Merrill, Alfred H., Jr.; Gonen, Mithat; Cane, Lauren M.; Schwartz, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2484-2492</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is an important mediator of cancer cell growth and proliferation.  Prodn. of S1P is catalyzed by sphingosine kinase 1 (SphK).  Safingol, (L-threo-dihydrosphingosine) is a putative inhibitor of SphK.  We conducted a phase I trial of safingol (S) alone and in combination with cisplatin (C).  A 3 + 3 dose escalation was used.  For safety, S was given alone 1 wk before the combination.  S + C were then administered every 3 wk.  S was given over 60 to 120 min, depending on dose.  Sixty minutes later, C was given over 60 min.  The C dose of 75 mg/m2 was reduced in cohort 4 to 60 mg/m2 due to excessive fatigue.  Forty-three patients were treated, 41 were evaluable for toxicity, and 37 for response.  The max. tolerated dose (MTD) was S 840 mg/m2 over 120 min C 60 mg/m2, every 3 wk.  Dose-limiting toxicity (DLT) attributed to cisplatin included fatigue and hyponatremia.  DLT from S was hepatic enzyme elevation.  S pharmacokinetic parameters were linear throughout the dose range with no significant interaction with C. Patients treated at or near the MTD achieved S levels of more than 20 μmol/L and maintained levels greater than and equal to 5 μmol/L for 4 h.  The best response was stable disease in 6 patients for on av. 3.3 mo (range 1.8-7.2 m).  One patient with adrenal cortical cancer had significant regression of liver and lung metastases and another had prolonged stable disease.  S was assocd. with a dose-dependent redn. in S1P in plasma.  Safingol, the first putative SphK inhibitor to enter clin. trials, can be safely administered in combination with cisplatin.  Reversible dose-dependent hepatic toxicity was seen, as expected from preclin. data.  Target inhibition was achieved with downregulation of S1P.  The recommended phase II dose is S 840 mg/m2 and C 60 mg/m2, every 3 wk.  Clin Cancer Res; 17(8); 2484-92.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-0rFxPBZYBLVg90H21EOLACvtfcHk0lgb5mosSjwhEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslCgt7g%253D&md5=fb09e8c3a4903928616a53f942b7a6b9</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-10-2323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-10-2323%26sid%3Dliteratum%253Aachs%26aulast%3DDickson%26aufirst%3DM.%2BA.%26aulast%3DCarvajal%26aufirst%3DR.%2BD.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26aulast%3DGonen%26aufirst%3DM.%26aulast%3DCane%26aufirst%3DL.%2BM.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26atitle%3DA%2520phase%2520I%2520clinical%2520trial%2520of%2520safingol%2520in%2520combination%2520with%2520cisplatin%2520in%2520advanced%2520solid%2520tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D2484%26epage%3D2492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Sachs, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safa, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, R. L.</span><span> </span><span class="NLM_article-title">Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">26639</span><span class="NLM_x">–</span> <span class="NLM_lpage">26648</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=26639-26648&author=C.+W.+Sachsauthor=A.+R.+Safaauthor=S.+D.+Harrisonauthor=R.+L.+Fine&title=Partial+inhibition+of+multidrug+resistance+by+safingol+is+independent+of+modulation+of+P-glycoprotein+substrate+activities+and+correlated+with+inhibition+of+protein+kinase+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSachs%26aufirst%3DC.%2BW.%26aulast%3DSafa%26aufirst%3DA.%2BR.%26aulast%3DHarrison%26aufirst%3DS.%2BD.%26aulast%3DFine%26aufirst%3DR.%2BL.%26atitle%3DPartial%2520inhibition%2520of%2520multidrug%2520resistance%2520by%2520safingol%2520is%2520independent%2520of%2520modulation%2520of%2520P-glycoprotein%2520substrate%2520activities%2520and%2520correlated%2520with%2520inhibition%2520of%2520protein%2520kinase%2520C%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D26639%26epage%3D26648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Tan, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, L. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunte, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chng, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, G. N.</span><span> </span><span class="NLM_article-title">In vivo efficacy of a novel liposomal formulation of safingol in the treatment of acute myeloid leukemia</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2012&pages=290-298&author=K.+B.+Tanauthor=L.+U.+Lingauthor=R.+M.+Bunteauthor=W.+J.+Chngauthor=G.+N.+Chiu&title=In+vivo+efficacy+of+a+novel+liposomal+formulation+of+safingol+in+the+treatment+of+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DK.%2BB.%26aulast%3DLing%26aufirst%3DL.%2BU.%26aulast%3DBunte%26aufirst%3DR.%2BM.%26aulast%3DChng%26aufirst%3DW.%2BJ.%26aulast%3DChiu%26aufirst%3DG.%2BN.%26atitle%3DIn%2520vivo%2520efficacy%2520of%2520a%2520novel%2520liposomal%2520formulation%2520of%2520safingol%2520in%2520the%2520treatment%2520of%2520acute%2520myeloid%2520leukemia%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2012%26volume%3D160%26spage%3D290%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Sweeney, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakakura, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirahama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masamune, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakomori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span> </span><span class="NLM_article-title">Sphingosine and its methylated derivative <i>N</i>,<i>N</i>-dimethylsphingosine (DMS) induce apoptosis in a variety of human cancer cell lines</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1002%2F%28SICI%291097-0215%2819960503%2966%3A3%3C358%3A%3AAID-IJC16%3E3.0.CO%3B2-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=8621258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADyaK28XjtVGqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1996&pages=358-366&author=E.+A.+Sweeneyauthor=C.+Sakakuraauthor=T.+Shirahamaauthor=A.+Masamuneauthor=H.+Ohtaauthor=S.+Hakomoriauthor=Y.+Igarashi&title=Sphingosine+and+its+methylated+derivative+N%2CN-dimethylsphingosine+%28DMS%29+induce+apoptosis+in+a+variety+of+human+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine and its methylated derivative N,N-dimethylsphingosine (DMS) induce apoptosis in a variety of human cancer cell lines</span></div><div class="casAuthors">Sweeney, Elizabeth A.; Sakakura, Chouhei; Shirahama, Tsutomu; Masamune, Atsushi; Ohta, Hideki; Hakomori, Sen-itiroh; Igarashi, Yasuyuki</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">358-366</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss</span>)
        </div><div class="casAbstract">In the study of apoptosis initiated by various signals including ligands binding to cell membrane receptors such as Fas and TNFRI, the sphingomyelin pathway and its resulting metabolites, the sphingolipids, have been suggested to be involved in the signaling pathway.  In earlier studies we presented data which indicated that sphingosine (Sph) itself was increased during apoptosis induced by phorbol myristate acetate (PMA) in HL60 cells and tumor necrosis factor (TNF) in neutrophils, and when added exogenously was able to induce apoptosis.  We report here that Sph and its methylated deriv. N,N,-dimethylsphingosine (DMS) are able to induce apoptosis in cancer cells of both hematopoietic and carcinoma origin.  In human leukemic cell lines CMK-7, HL60 and U937, treatment with 20 μM Sph for 6 h caused apoptosis in up to 90% of cells.  Human colonic carcinoma cells HT29, HRT18, MKN74 and COLO205 were shown to be more susceptible to apoptosis upon addn. of DMS (>50%) than of Sph (<50%), yet were weakly or not sensitive to N,N,N-trimethylysphingosine (TMS).  Under the same conditions, in the presence of serum, neither Sph-1-phosphate nor ceramide analogs C2-, C6- or C8-ceramide were able to induce apoptosis in any cell lines.  However, in the absence of serum, ceramide analogs induced apoptosis in leukemia cell lines after 18 h, yet much less so than Sph or DMS.  Furthermore, apoptosis induced by Sph or DMS could not be inhibited by the ceramide synthase inhibitor fumonisin BI.  Apoptosis was not induced by sphingolipids in primary culture cells, such as HUVEC or rat mesangial cells, but was apparent in transformed rat mesangial cells.  Addnl., apoptosis induced by Sph, DMS or C2Cer was inhibited by protease inhibitors.  Our data further support the evidence that the catabolic pathway of sphingomyelin involving Sph and other metabolites is an integral part of the apoptosis pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWSI61qE-VTLVg90H21EOLACvtfcHk0lgb5mosSjwhEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtVGqsbg%253D&md5=de7edea7f4af6f79f95cbc46737409e9</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2819960503%2966%3A3%3C358%3A%3AAID-IJC16%3E3.0.CO%3B2-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252819960503%252966%253A3%253C358%253A%253AAID-IJC16%253E3.0.CO%253B2-7%26sid%3Dliteratum%253Aachs%26aulast%3DSweeney%26aufirst%3DE.%2BA.%26aulast%3DSakakura%26aufirst%3DC.%26aulast%3DShirahama%26aufirst%3DT.%26aulast%3DMasamune%26aufirst%3DA.%26aulast%3DOhta%26aufirst%3DH.%26aulast%3DHakomori%26aufirst%3DS.%26aulast%3DIgarashi%26aufirst%3DY.%26atitle%3DSphingosine%2520and%2520its%2520methylated%2520derivative%2520N%252CN-dimethylsphingosine%2520%2528DMS%2529%2520induce%2520apoptosis%2520in%2520a%2520variety%2520of%2520human%2520cancer%2520cell%2520lines%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1996%26volume%3D66%26spage%3D358%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Shirahama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakakura, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singhal, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakomori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span> </span><span class="NLM_article-title">In vitro and in vivo induction of apoptosis by sphingosine and <i>N</i>,<i>N</i>-dimethylsphingosine in human epidermoid carcinoma KB-3-1 and its multidrug-resistant cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=9815681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADyaK2sXhsVOmtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=257-264&author=T.+Shirahamaauthor=E.+A.+Sweeneyauthor=C.+Sakakuraauthor=A.+K.+Singhalauthor=K.+Nishiyamaauthor=S.+Akiyamaauthor=S.+Hakomoriauthor=Y.+Igarashi&title=In+vitro+and+in+vivo+induction+of+apoptosis+by+sphingosine+and+N%2CN-dimethylsphingosine+in+human+epidermoid+carcinoma+KB-3-1+and+its+multidrug-resistant+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo induction of apoptosis by sphingosine and N,N-dimethylsphingosine in human epidermoid carcinoma KB-3-1 and its multidrug-resistant cells</span></div><div class="casAuthors">Shirahama, Tsutomu; Sweeney, Elizabeth A.; Sakakura, Chouhei; Singhal, Anil K.; Nishiyama, Kenryu; Akiyama, Shin-Ichi; Hakomori, Sen-Itiroh; Igarashi, Yasuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">257-264</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Sphingolipid breakdown products, including ceramide and sphingosine, regulate cell growth, cell differentiation, and apoptosis.  We examd. the effect of various agents, including sphingolipids, on apoptosis induction in human epidermoid carcinoma KB-3-1 and its multidrug-resistant (MDR) subclone KB-C2 cells which express P-glycoprotein.  Adriamycin (ADM) induced apoptosis in KB-3-1 cells but not in KB-C2 MDR cells at the concn. of 50 μg/mL.  On the other hand, 15 μM sphingosine or its methylated deriv. N,N-demethylsphingosine (DMS) induced apoptosis in both cell types in vitro.  These results suggested that KB-C2 MDR cells were resistant to apoptosis induction by ADM but sensitive to that by sphingosine and DMS.  Ceramide and sphingosine-1-phosphate, the initial metabolites of sphingosine, failed to induce apoptosis under the same exptl. condition as sphingosine/DMS.  The protein kinase C (PKC) inhibitors H7 and staurosporine did not induce apoptosis in either cell line, suggesting that PKC-independent signaling is involved in apoptosis induced by sphingosine and DMS, although both sphingosine and DMS have been shown to down-regulate PKC.  Furthermore, DMS significantly inhibited the growth of KB-3-1 as well as KB-C2 MDR tumors in vivo, with evidence of increased apoptosis.  The intracellular level of exogenously added [3H]sphingosine or [14C]ADM did not differ between the KB-3-1 parent cell line and its MDR subclone KB-C2, whereas that of [14C]ADM was reduced in KB-C2 MDR cells compared to KB-3-1 cells.  These results suggest that P-glycoprotein acts as a transporter for ADM but not for sphingosine or DMS.  Furthermore, DMS at the concns. which induce apoptosis in KB-C2 cells did not affect the level of [14C]ADM.  Because sphingosine and DMS induce apoptosis regardless of P-glycoprotein expression, they may provide a new strategy and a promising approach to the treatment of anticancer drug-resistant cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVLz_ArPmHSLVg90H21EOLACvtfcHk0liVn_z0OSX9BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsVOmtrw%253D&md5=6379fe541c2139e8579428f2f29f16e7</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShirahama%26aufirst%3DT.%26aulast%3DSweeney%26aufirst%3DE.%2BA.%26aulast%3DSakakura%26aufirst%3DC.%26aulast%3DSinghal%26aufirst%3DA.%2BK.%26aulast%3DNishiyama%26aufirst%3DK.%26aulast%3DAkiyama%26aufirst%3DS.%26aulast%3DHakomori%26aufirst%3DS.%26aulast%3DIgarashi%26aufirst%3DY.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520induction%2520of%2520apoptosis%2520by%2520sphingosine%2520and%2520N%252CN-dimethylsphingosine%2520in%2520human%2520epidermoid%2520carcinoma%2520KB-3-1%2520and%2520its%2520multidrug-resistant%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1997%26volume%3D3%26spage%3D257%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegood, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symolon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrill, A. H.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaze-Andersson, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabot, M. C.</span><span> </span><span class="NLM_article-title"><i>N</i>-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2967</span><span class="NLM_x">–</span> <span class="NLM_lpage">2976</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1158%2F1535-7163.MCT-08-0549" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=18790777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=2967-2976&author=H.+Wangauthor=B.+J.+Maurerauthor=Y.+Y.+Liuauthor=E.+Wangauthor=J.+C.+Allegoodauthor=S.+Kellyauthor=H.+Symolonauthor=Y.+Liuauthor=A.+H.+Merrillauthor=V.+Gouaze-Anderssonauthor=J.+Y.+Yuauthor=A.+E.+Giulianoauthor=M.+C.+Cabot&title=N-%284-Hydroxyphenyl%29retinamide+increases+dihydroceramide+and+synergizes+with+dimethylsphingosine+to+enhance+cancer+cell+killing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing</span></div><div class="casAuthors">Wang, Hongtao; Maurer, Barry J.; Liu, Yong-Yu; Wang, Elaine; Allegood, Jeremy C.; Kelly, Samuel; Symolon, Holly; Liu, Ying; Merrill, Alfred H., Jr.; Gouaze-Andersson, Valerie; Yu, Jing Yuan; Giuliano, Armando E.; Cabot, Myles C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2967-2976</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Fenretinide [N-(4-hydroxyphenyl)retinamide (4-HPR)] is cytotoxic in many cancer cell types.  Studies have shown that elevation of ceramide species plays a role in 4-HPR cytotoxicity.  To det. 4-HPR activity in a multidrug-resistant cancer cell line as well as to study ceramide metab., MCF-7/AdrR cells (redesignated NCI/ADR-RES) were treated with 4-HPR and sphingolipids were analyzed.  TLC anal. of cells radiolabeled with [3H]palmitic acid showed that 4-HPR elicited a dose-responsive increase in radioactivity migrating in the ceramide region of the chromatogram and a decrease in cell viability.  Results from liq. chromatog./electrospray tandem mass spectrometry revealed large elevations in dihydroceramides (N-acylsphinganines), but not desatd. ceramides, and large increases in complex dihydrosphingolipids (dihydrosphingomyelins, monohexosyldihydroceramides), sphinganine, and sphinganine 1-phosphate.  To test the hypothesis that elevation of sphinganine participates in the cytotoxicity of 4-HPR, cells were treated with the sphingosine kinase inhibitor D-erythro-N,N-dimethylsphingosine (DMS), with and without 4-HPR.  After 24 h, the 4-HPR/DMS combination caused a 9-fold increase in sphinganine that was sustained through +48 h, decreased sphinganine 1-phosphate, and increased cytotoxicity.  Increased dihydrosphingolipids and sphinganine were also found in HL-60 leukemia cells and HT-29 colon cancer cells treated with 4-HPR.  The 4-HPR/DMS combination elicited increased apoptosis in all three cell lines.  We propose that a mechanism of 4-HPR-induced cytotoxicity involves increases in dihydrosphingolipids, and that the synergy between 4-HPR and DMS is assocd. with large increases in cellular sphinganine.  These studies suggest that enhanced clin. efficacy of 4-HPR may be realized through regimens contg. agents that modulate sphingoid base metab. [Mol Cancer Ther 2008;7(9):2967-76].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdweYx84viqLVg90H21EOLACvtfcHk0liVn_z0OSX9BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsL7P&md5=7b7fd8cf6ac930a7864f80c634cc999c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0549%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DMaurer%26aufirst%3DB.%2BJ.%26aulast%3DLiu%26aufirst%3DY.%2BY.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DAllegood%26aufirst%3DJ.%2BC.%26aulast%3DKelly%26aufirst%3DS.%26aulast%3DSymolon%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26aulast%3DGouaze-Andersson%26aufirst%3DV.%26aulast%3DYu%26aufirst%3DJ.%2BY.%26aulast%3DGiuliano%26aufirst%3DA.%2BE.%26aulast%3DCabot%26aufirst%3DM.%2BC.%26atitle%3DN-%25284-Hydroxyphenyl%2529retinamide%2520increases%2520dihydroceramide%2520and%2520synergizes%2520with%2520dimethylsphingosine%2520to%2520enhance%2520cancer%2520cell%2520killing%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D2967%26epage%3D2976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Ghosh, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auzenne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farquhar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klostergaard, J.</span><span> </span><span class="NLM_article-title"><i>N</i>,<i>N</i>-Dimethylsphingosine-coumarin: synthesis, chemical characterization, and biological evaluation</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">735</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc060285q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1SisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=731-735&author=S.+C.+Ghoshauthor=E.+Auzenneauthor=D.+Farquharauthor=J.+Klostergaard&title=N%2CN-Dimethylsphingosine-coumarin%3A+synthesis%2C+chemical+characterization%2C+and+biological+evaluation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">N,N-Dimethylsphingosine-Coumarin: Synthesis, Chemical Characterization, and Biological Evaluation</span></div><div class="casAuthors">Ghosh, Sukhen C.; Auzenne, Edmond; Farquhar, David; Klostergaard, Jim</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">731-735</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Coumarin derivs. of N,N-dimethylsphingosine (DMSP) were prepd. and chem. characterized.  They were apparently biol. equiv. to DMSP in terms of tumor cell cytotoxicity and were used to establish the rapid mitochondrial localization of this sphingolipid in tumor cells, followed closely by its marked redn. of mitochondrial membrane potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLeyQEpM489LVg90H21EOLACvtfcHk0lgmflU2Cg54xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1SisLo%253D&md5=659f957e3b8842c294f69c8cd96b63d9</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fbc060285q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc060285q%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DS.%2BC.%26aulast%3DAuzenne%26aufirst%3DE.%26aulast%3DFarquhar%26aufirst%3DD.%26aulast%3DKlostergaard%26aufirst%3DJ.%26atitle%3DN%252CN-Dimethylsphingosine-coumarin%253A%2520synthesis%252C%2520chemical%2520characterization%252C%2520and%2520biological%2520evaluation%26jtitle%3DBioconjugate%2520Chem.%26date%3D2007%26volume%3D18%26spage%3D731%26epage%3D735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">De Jonghe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Overmeire, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Calenbergh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Keukeleire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herdewijn, P.</span><span> </span><span class="NLM_article-title">Structure–activity relationship of short-chain sphingoid bases as inhibitors of sphingosine kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">3175</span><span class="NLM_x">–</span> <span class="NLM_lpage">3180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=3175-3180&author=S.+De+Jongheauthor=I.+Van+Overmeireauthor=S.+Poultonauthor=C.+Hendrixauthor=R.+Bussonauthor=S.+Van+Calenberghauthor=D.+De+Keukeleireauthor=S.+Spiegelauthor=P.+Herdewijn&title=Structure%E2%80%93activity+relationship+of+short-chain+sphingoid+bases+as+inhibitors+of+sphingosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BJonghe%26aufirst%3DS.%26aulast%3DVan%2BOvermeire%26aufirst%3DI.%26aulast%3DPoulton%26aufirst%3DS.%26aulast%3DHendrix%26aufirst%3DC.%26aulast%3DBusson%26aufirst%3DR.%26aulast%3DVan%2BCalenbergh%26aufirst%3DS.%26aulast%3DDe%2BKeukeleire%26aufirst%3DD.%26aulast%3DSpiegel%26aufirst%3DS.%26aulast%3DHerdewijn%26aufirst%3DP.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520of%2520short-chain%2520sphingoid%2520bases%2520as%2520inhibitors%2520of%2520sphingosine%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D3175%26epage%3D3180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Johnson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvis, W. D.</span><span> </span><span class="NLM_article-title">Intrinsic cytotoxicity and chemomodulatory actions of novel phenethylisothiocyanate sphingoid base derivatives in HL-60 human promyelocytic leukemia cells</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">452</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1124%2Fjpet.103.060665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=14724218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1yhtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=452-461&author=C.+R.+Johnsonauthor=J.+Chunauthor=R.+Bittmanauthor=W.+D.+Jarvis&title=Intrinsic+cytotoxicity+and+chemomodulatory+actions+of+novel+phenethylisothiocyanate+sphingoid+base+derivatives+in+HL-60+human+promyelocytic+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Intrinsic cytotoxicity and chemomodulatory actions of novel phenethylisothiocyanate sphingoid base derivatives in HL-60 human promyelocytic leukemia cells</span></div><div class="casAuthors">Johnson, Charlene R.; Chun, Jiong; Bittman, Robert; Jarvis, W. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">452-461</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The protein kinase C (PKC) isoenzyme superfamily represents a popular target in pharmacol. interventions designed to elicit apoptosis directly in tumor cells or to potentiate the lethal effects of antineoplastic agents.  Numerous observations support the clin. utility of PKC inhibition by exptl. sphingolipid derivs. such as safingol.  The present studies document the cytotoxicity and chemomodulatory capacity of phenethylisothiocyanate derivs. of sphinganine and sphingosine (PEITC-Sa and PEITC-So) in the human myeloid leukemia cell line HL-60.  The biol. actions of these novel derivs. were compared directly with those of the parent compds. sphinganine and sphingosine.  Exposure to natural and modified sphingoid bases promoted extensive apoptotic cell death.  The PEITC-sphingoid base derivs. exhibited higher cytotoxicity than their natural counterparts and were also distinctly superior to the clin. relevant sphingoid base analog safingol.  In each instance, lethality was shown to correlate with inhibition of conventional and novel PKC isoforms and downstream loss of extracellular signal-regulated kinase (ERK)1/ERK2.  The involvement of these signaling systems in potentiating the lethal actions of 1-(β-D-arabinofuranosyl)cytosine (araC) was also examd. with regard to the differential actions of PEITC-Sa and PEITC-So to that of the parent compds. as well as safingol.  Exposure to araC alone rapidly increased PKC activity.  In the presence of PEITC-Sa or PEITC-So, the therapeutic efficacy of araC increased markedly; moreover, potentiation was directly related to the loss of araC-stimulated PKC activity.  These findings demonstrate that PEITC-substituted sphingoid base analogs exert potent antineoplastic effects in human leukemia cells.  We suggest that these synthetic lipids represent potentially useful agents in the development of conventional PKC/novel PKC-directed chemotherapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq-bD5W5tmEbVg90H21EOLACvtfcHk0lgmflU2Cg54xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1yhtLY%253D&md5=b710e421e795d81adfebd363920bf531</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.060665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.060665%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BR.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DJarvis%26aufirst%3DW.%2BD.%26atitle%3DIntrinsic%2520cytotoxicity%2520and%2520chemomodulatory%2520actions%2520of%2520novel%2520phenethylisothiocyanate%2520sphingoid%2520base%2520derivatives%2520in%2520HL-60%2520human%2520promyelocytic%2520leukemia%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D452%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Sharma, A. K.</span><span> </span><span class="NLM_article-title">Sphingo-guanidines and their use as inhibitors of sphingosine kinase (WO2010078247)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">807</span><span class="NLM_x">–</span> <span class="NLM_lpage">812</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1517%2F13543776.2011.573787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvFant7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=807-812&author=A.+K.+Sharma&title=Sphingo-guanidines+and+their+use+as+inhibitors+of+sphingosine+kinase+%28WO2010078247%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingo-guanidines and their use as inhibitors of sphingosine kinase (WO2010078247)</span></div><div class="casAuthors">Sharma, Arun K.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">807-812</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The sphingolipid metabolic pathway controls the balance of bioactive lipids including apoptotic ceramide and proliferative sphingosine 1-phosphate and, therefore, represents a potential source of new therapeutic targets for numerous diseases.  Targets, such as sphingosine kinases (SphK), have been extensively studied, and numerous strategies have been used to develop inhibitors against these enzymes.  The WO2010078247 patent application shows the development of some novel sphingo-guanidines, including their water sol. salts, as inhibitors of SphK, and for use in treating and/or preventing diseases and disorders related to undesirable ceramidase, ceramidase-related or SphK activity, including cancer and other proliferative diseases.  The synthesis of two agents D-erythro-2-N-(1''-carboxamidino)sphingosine hydrochloride (LCL146) and L-erythro-2-N-(1''-carboxamidino)sphingosine hydrochloride (LCL351) is described and they have been shown to inhibit SphK activity, be cytotoxic to cancer cells and decrease the migration rate of human prostate (DU145) cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBfjfoEioO3LVg90H21EOLACvtfcHk0lhrIInKU16WVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvFant7s%253D&md5=7781d42d080ae55a9b237b4fb797d16c</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.573787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.573787%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DA.%2BK.%26atitle%3DSphingo-guanidines%2520and%2520their%2520use%2520as%2520inhibitors%2520of%2520sphingosine%2520kinase%2520%2528WO2010078247%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D807%26epage%3D812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Paugh, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paugh, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahmani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapitonov, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almenara, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kordula, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zipkin, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">1382</span><span class="NLM_x">–</span> <span class="NLM_lpage">1391</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2008&pages=1382-1391&author=S.+W.+Paughauthor=B.+S.+Paughauthor=M.+Rahmaniauthor=D.+Kapitonovauthor=J.+A.+Almenaraauthor=T.+Kordulaauthor=S.+Milstienauthor=J.+K.+Adamsauthor=R.+E.+Zipkinauthor=S.+Grantauthor=S.+Spiegel&title=A+selective+sphingosine+kinase+1+inhibitor+integrates+multiple+molecular+therapeutic+targets+in+human+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaugh%26aufirst%3DS.%2BW.%26aulast%3DPaugh%26aufirst%3DB.%2BS.%26aulast%3DRahmani%26aufirst%3DM.%26aulast%3DKapitonov%26aufirst%3DD.%26aulast%3DAlmenara%26aufirst%3DJ.%2BA.%26aulast%3DKordula%26aufirst%3DT.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BK.%26aulast%3DZipkin%26aufirst%3DR.%2BE.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DA%2520selective%2520sphingosine%2520kinase%25201%2520inhibitor%2520integrates%2520multiple%2520molecular%2520therapeutic%2520targets%2520in%2520human%2520leukemia%26jtitle%3DBlood%26date%3D2008%26volume%3D112%26spage%3D1382%26epage%3D1391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, H. P.</span><span> </span><span class="NLM_article-title">Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=91-101&author=J.+Chunauthor=H.+P.+Hartung&title=Mechanism+of+action+of+oral+fingolimod+%28FTY720%29+in+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DHartung%26aufirst%3DH.%2BP.%26atitle%3DMechanism%2520of%2520action%2520of%2520oral%2520fingolimod%2520%2528FTY720%2529%2520in%2520multiple%2520sclerosis%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2010%26volume%3D33%26spage%3D91%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieschl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zollinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">21453</span><span class="NLM_x">–</span> <span class="NLM_lpage">21457</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1074%2Fjbc.C200176200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=11967257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=21453-21457&author=V.+Brinkmannauthor=M.+D.+Davisauthor=C.+E.+Heiseauthor=R.+Albertauthor=S.+Cottensauthor=R.+Hofauthor=C.+Brunsauthor=E.+Prieschlauthor=T.+Baumrukerauthor=P.+Hiestandauthor=C.+A.+Fosterauthor=M.+Zollingerauthor=K.+R.+Lynch&title=The+immune+modulator+FTY720+targets+sphingosine+1-phosphate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span></div><div class="casAuthors">Brinkmann, Volker; Davis, Michael D.; Heise, Christopher E.; Albert, Rainer; Cottens, Sylvain; Hof, Robert; Bruns, Christian; Prieschl, Eva; Baumruker, Thomas; Hiestand, Peter; Foster, Carolyn A.; Zollinger, Markus; Lynch, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21453-21457</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Immunosuppressant drugs such as cyclosporin have allowed widespread organ transplantation, but their utility remains limited by toxicities, and they are ineffective in chronic management of autoimmune diseases such as multiple sclerosis.  In contrast, the immune modulating drug FTY720 is efficacious in a variety of transplant and autoimmune models without inducing a generalized immunosuppressed state and is effective in human kidney transplantation.  FTY720 elicits a lymphopenia resulting from a reversible redistribution of lymphocytes from circulation to secondary lymphoid tissues by unknown mechanisms.  Using FTY720 and several analogs, we show now that FTY720 is phosphorylated by sphingosine kinase; the phosphorylated compd. is a potent agonist at four sphingosine 1-phosphate receptors and represents the therapeutic principle in a rodent model of multiple sclerosis.  Our results suggest that FTY720, after phosphorylation, acts through sphingosine 1-phosphate signaling pathways to modulate chemotactic responses and lymphocyte trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6zyZnHOYNbVg90H21EOLACvtfcHk0lhrIInKU16WVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D&md5=b59856fffa9ebae7fb8182d18daa025f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200176200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200176200%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DHof%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPrieschl%26aufirst%3DE.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DThe%2520immune%2520modulator%2520FTY720%2520targets%2520sphingosine%25201-phosphate%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D21453%26epage%3D21457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=346-349&author=S.+Mandalaauthor=R.+Hajduauthor=J.+Bergstromauthor=E.+Quackenbushauthor=J.+Xieauthor=J.+Milliganauthor=R.+Thorntonauthor=G.+J.+Sheiauthor=D.+Cardauthor=C.+Keohaneauthor=M.+Rosenbachauthor=J.+Haleauthor=C.+L.+Lynchauthor=K.+Rupprechtauthor=W.+Parsonsauthor=H.+Rosen&title=Alteration+of+lymphocyte+trafficking+by+sphingosine-1-phosphate+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DShei%26aufirst%3DG.%2BJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DRupprecht%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520lymphocyte%2520trafficking%2520by%2520sphingosine-1-phosphate%2520receptor%2520agonists%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D346%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Azuma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimaru, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukui, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshiga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuoka, Y.</span><span> </span><span class="NLM_article-title">Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1410</span><span class="NLM_x">–</span> <span class="NLM_lpage">1419</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=11888913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD38Xit1Khur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=1410-1419&author=H.+Azumaauthor=S.+Takaharaauthor=N.+Ichimaruauthor=J.+D.+Wangauthor=Y.+Itohauthor=Y.+Otsukiauthor=J.+Morimotoauthor=R.+Fukuiauthor=M.+Hoshigaauthor=T.+Ishiharaauthor=N.+Nonomuraauthor=S.+Suzukiauthor=A.+Okuyamaauthor=Y.+Katsuoka&title=Marked+prevention+of+tumor+growth+and+metastasis+by+a+novel+immunosuppressive+agent%2C+FTY720%2C+in+mouse+breast+cancer+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models</span></div><div class="casAuthors">Azuma, Haruhito; Takahara, Shiro; Ichimaru, Naotsugu; Wang, Jing Ding; Itoh, Yuko; Otsuki, Yoshinori; Morimoto, Junji; Fukui, Ryosuke; Hoshiga, Masaaki; Ishihara, Tadashi; Nonomura, Norio; Suzuki, Seiichi; Okuyama, Akihiko; Katsuoka, Yoji</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1410-1419</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">In vitro treatment with FTY720 induced dramatic apoptosis in a mouse breast cancer cell line, JygMC(A).  Electron microscopy revealed distinct changes on the cell surface with decreased filopodias and microvilli in cancer cells treated with FTY720 at 2 μM and clear evidence of apoptosis at 10 μM.  The effect of FTY720 was significantly less in normal fibroblasts than in the cancer cells, indicating greater susceptibility of cancer cells to the agent.  The in vivo effect of 3 different doses of FTY720 (2, 5, and 10 mg/kg/day) was tested in a mouse breast cancer model created by inoculating JygMC(A) cells (s.c.) into the flank region of BALB/c-nu/nu mice.  Tumor growth was markedly suppressed without notable side effects.  In addn., tumor metastasis, which was evident in control mice, was prevented even at the low dose (2 mg/kg/day), resulting in prolongation of animal survival.  FTY720 treatment (2 μM) of the cancer cells caused marked cytoskeletal change, with deformed and decreased filopodias, in cancer cells.  In addn., it decreased the ability of the cancer cells to adhere and migrate to extracellular matrix components and markedly reduced the expression of integrins on the cancer cell surface.  These results indicate that FTY720 is a potent anticancer agent that induces apoptosis and is markedly effective for prevention of metastasis.  The changes of cellular structure with redn. of integrin expression may be one of its underlying mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd_Xhpm-HtJ7Vg90H21EOLACvtfcHk0lgKyTzjp1adFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xit1Khur4%253D&md5=fa650d7e1d6ae59cb9e5f8b1a09f3704</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAzuma%26aufirst%3DH.%26aulast%3DTakahara%26aufirst%3DS.%26aulast%3DIchimaru%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DJ.%2BD.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DOtsuki%26aufirst%3DY.%26aulast%3DMorimoto%26aufirst%3DJ.%26aulast%3DFukui%26aufirst%3DR.%26aulast%3DHoshiga%26aufirst%3DM.%26aulast%3DIshihara%26aufirst%3DT.%26aulast%3DNonomura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DOkuyama%26aufirst%3DA.%26aulast%3DKatsuoka%26aufirst%3DY.%26atitle%3DMarked%2520prevention%2520of%2520tumor%2520growth%2520and%2520metastasis%2520by%2520a%2520novel%2520immunosuppressive%2520agent%252C%2520FTY720%252C%2520in%2520mouse%2520breast%2520cancer%2520models%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D1410%26epage%3D1419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Azuma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuoka, Y.</span><span> </span><span class="NLM_article-title">Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">2372</span><span class="NLM_x">–</span> <span class="NLM_lpage">2377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1097%2F01.ju.0000064938.32318.91" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=12771800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktlOisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2003&pages=2372-2377&author=H.+Azumaauthor=S.+Takaharaauthor=S.+Horieauthor=S.+Mutoauthor=Y.+Otsukiauthor=Y.+Katsuoka&title=Induction+of+apoptosis+in+human+bladder+cancer+cells+in+vitro+and+in+vivo+caused+by+FTY720+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of Apoptosis in Human Bladder Cancer Cells In Vitro and In Vivo Caused by FTY720 Treatment</span></div><div class="casAuthors">Azuma, Haruhito; Takahara, Shiro; Horie, Shigeo; Muto, Satoru; Otsuki, Yoshinori; Katsuoka, Yoji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (Hagerstown, MD, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2372-2377</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">FTY720 is a unique immunosuppressant that induces apoptosis in activated lymphocytes but not in other hematopoietic cells.  We examd. whether FTY720 has anticancer effects on human bladder cancer cells by inducing apoptosis and we investigated its mol. pathway.  MATERIALS AND METHODS We used the 3 human bladder cancer cell lines T24, UMUC3 and HT1197, and the human fibroblast derived cell line CRL-2096 (American Type Tissue Collection, Rockville, Maryland) in this study.  The difference in drug susceptibility to FTY720 in cancer cells and fibroblasts was examd. by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and cell growth assays.  FTY720 induced apoptosis was detd. by morphol. anal. under light and electron microscopy, and DNA electrophoresis, and its mol. pathway was evaluated by Western blot anal. focusing on the p42/p44 mitogen activated protein kinase pathway.  We then tested the in vivo effect of this agent using 2 mouse models of human bladder cancer xenograft.  RESULTS FTY720 treatment in vitro induced selective apoptosis in cancer cells at a concn. of less than 10 μM. Morphol. anal. revealed features characteristic of apoptosis, including small cytoplasm with fragmented nuclei and condensed chromatin.  DNA electrophoresis confirmed apoptosis, as evidenced by a distinct oligosomal ladder.  Western blot anal. revealed that the agent significantly inhibited hepatocyte growth factor induced p42/p44 mitogen activated protein kinase activity.  The in vivo anticancer effect was clearly confirmed by significantly decreased tumor growth without notable side effects in the 2 xenograft models.  CONCLUSIONS FTY720 treatment may induce selective apoptosis in vitro as well as in vivo in cancer cells.  We suggest that FTY720 is a potent and clin. applicable anticancer agent for bladder cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLUVoMc3LO8rVg90H21EOLACvtfcHk0lgKyTzjp1adFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktlOisLY%253D&md5=48b7aff671b4fcb1f64117dd3b62614c</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1097%2F01.ju.0000064938.32318.91&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.ju.0000064938.32318.91%26sid%3Dliteratum%253Aachs%26aulast%3DAzuma%26aufirst%3DH.%26aulast%3DTakahara%26aufirst%3DS.%26aulast%3DHorie%26aufirst%3DS.%26aulast%3DMuto%26aufirst%3DS.%26aulast%3DOtsuki%26aufirst%3DY.%26aulast%3DKatsuoka%26aufirst%3DY.%26atitle%3DInduction%2520of%2520apoptosis%2520in%2520human%2520bladder%2520cancer%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%2520caused%2520by%2520FTY720%2520treatment%26jtitle%3DJ.%2520Urol.%26date%3D2003%26volume%3D169%26spage%3D2372%26epage%3D2377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimaru, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morozumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, H.</span><span> </span><span class="NLM_article-title">A novel immunosuppressive drug, FTY720, prevents the cancer progression induced by cyclosporine</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">181</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2FS0304-3835%2801%2900799-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=12175531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFyhtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2002&pages=165-171&author=T.+Tanakaauthor=S.+Takaharaauthor=M.+Hatoriauthor=K.+Suzukiauthor=J.+Wangauthor=N.+Ichimaruauthor=S.+Suzukiauthor=K.+Morozumiauthor=A.+Okuyamaauthor=H.+Yamanaka&title=A+novel+immunosuppressive+drug%2C+FTY720%2C+prevents+the+cancer+progression+induced+by+cyclosporine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">A novel immunosuppressive drug, FTY720, prevents the cancer progression induced by cyclosporine</span></div><div class="casAuthors">Tanaka, Toshiyuki; Takahara, Shiro; Hatori, Motoaki; Suzuki, Kazuhiro; Wang, Jing-Ding; Ichimaru, Naotsugu; Suzuki, Seiichi; Morozumi, Kunio; Okuyama, Akihiko; Yamanaka, Hidetoshi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-171</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Cyclosporine A (CsA), the most frequently used immunosuppressive drug, has been reported to induce cancer by a cell-autonomous mechanism.  Herein, we report that FTY720, a novel immunosuppressant, prevents CsA-induced alterations in both morphol. and cell motility at a low concn. (0.1 μM) and induces the CsA-treated cancer cells to undergo apoptosis at a higher concn. (more than 5 μM).  The inhibitory activity of FTY720 is unrelated to the decrease of TGF-β.  We believe that a combination treatment with FTY720 and CsA not only results in a synergistic effect on allografts, but also, reduces the incidence of cancer in transplant patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW7OE56oNZ9rVg90H21EOLACvtfcHk0lgKyTzjp1adFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFyhtLw%253D&md5=0058cb67c2ef95cfe70d70e10650713c</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2FS0304-3835%2801%2900799-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3835%252801%252900799-6%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DTakahara%26aufirst%3DS.%26aulast%3DHatori%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DIchimaru%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DMorozumi%26aufirst%3DK.%26aulast%3DOkuyama%26aufirst%3DA.%26aulast%3DYamanaka%26aufirst%3DH.%26atitle%3DA%2520novel%2520immunosuppressive%2520drug%252C%2520FTY720%252C%2520prevents%2520the%2520cancer%2520progression%2520induced%2520by%2520cyclosporine%26jtitle%3DCancer%2520Lett.%26date%3D2002%26volume%3D181%26spage%3D165%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Ubai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azuma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotake, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuoka, Y.</span><span> </span><span class="NLM_article-title">FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=17352219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs1Wnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=75-88&author=T.+Ubaiauthor=H.+Azumaauthor=Y.+Kotakeauthor=T.+Inamotoauthor=K.+Takaharaauthor=Y.+Itoauthor=S.+Kiyamaauthor=T.+Sakamotoauthor=S.+Horieauthor=S.+Mutoauthor=S.+Takaharaauthor=Y.+Otsukiauthor=Y.+Katsuoka&title=FTY720+induced+Bcl-associated+and+Fas-independent+apoptosis+in+human+renal+cancer+cells+in+vitro+and+significantly+reduced+in+vivo+tumor+growth+in+mouse+xenograft"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720 induced bcl-associated and fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft</span></div><div class="casAuthors">Ubai, Takanobu; Azuma, Haruhito; Kotake, Yatsugu; Inamoto, Teruo; Takahara, Kiyoshi; Ito, Yuko; Kiyama, Satoshi; Sakamoto, Takeshi; Horie, Shigeo; Muto, Satoru; Takahara, Shiro; Otsuki, Yoshinori; Katsuoka, Yoji</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1A</span>),
    <span class="NLM_cas:pages">75-88</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">A unique immunosuppressant, FTY720, selectively induces apoptosis in activated lymphocytes, but not in other hematopoietic cells.  The potential that this unique mechanism could provide anticancer potential by inducing apoptosis in the human renal cancer cell line, ACHN, which is resistant to cisplatin, and its mol. pathway was investigated.  The difference in drug susceptibility to FTY720 between cancer cells and non-cancer cells was examd. by MTT assay and flow cytometry.  Apoptosis assay, including TUNEL staining, electron microscopy and DNA electrophoresis, was performed and the mol. pathway of FTY720 was evaluated by real time RT-PCR and Western blot.  The in vivo effect of FTY720 was evaluated using a murine zenograft model.  The susceptibility to FTY720 was significantly higher in ACHN cancer cells than in normal renal tubular cells (HK-2) at a concn. of less than 30 μM, while the susceptibility to cisplatin was even higher in HK-2 than in ACHN.  Cancer cells treated with FTY720 showed findings typical of apoptosis with highly condensed nuclear chromatin and fragmented nuclei.  The mol. anal. revealed that FTY720-induced apoptosis was mediated by a Fas-independent, Bcl-assocd. signal transduction pathway, and that inhibition of extracellular signal-regulated kinase (ERK) activity was involved in its underlying mechanism of action.  FTY720 treatment significantly prevented in vivo tumor growth without any severe adverse reactions, while cisplatin treatment did not inhibit tumor growth despite exhibiting severe side-effects.  FTY720 may be a promising candidate for a new anticancer therapy of renal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZLNZFAtYm4rVg90H21EOLACvtfcHk0lgAVqlHYgT_iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs1Wnsrs%253D&md5=0e878aa779dd89c3eef3b1dd2e47972e</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUbai%26aufirst%3DT.%26aulast%3DAzuma%26aufirst%3DH.%26aulast%3DKotake%26aufirst%3DY.%26aulast%3DInamoto%26aufirst%3DT.%26aulast%3DTakahara%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DKiyama%26aufirst%3DS.%26aulast%3DSakamoto%26aufirst%3DT.%26aulast%3DHorie%26aufirst%3DS.%26aulast%3DMuto%26aufirst%3DS.%26aulast%3DTakahara%26aufirst%3DS.%26aulast%3DOtsuki%26aufirst%3DY.%26aulast%3DKatsuoka%26aufirst%3DY.%26atitle%3DFTY720%2520induced%2520Bcl-associated%2520and%2520Fas-independent%2520apoptosis%2520in%2520human%2520renal%2520cancer%2520cells%2520in%2520vitro%2520and%2520significantly%2520reduced%2520in%2520vivo%2520tumor%2520growth%2520in%2520mouse%2520xenograft%26jtitle%3DAnticancer%2520Res.%26date%3D2007%26volume%3D27%26spage%3D75%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Zheng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span> </span><span class="NLM_article-title">PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2010&pages=218-228&author=T.+Zhengauthor=X.+Mengauthor=J.+Wangauthor=X.+Chenauthor=D.+Yinauthor=Y.+Liangauthor=X.+Songauthor=S.+Panauthor=H.+Jiangauthor=L.+Liu&title=PTEN-+and+p53-mediated+apoptosis+and+cell+cycle+arrest+by+FTY720+in+gastric+cancer+cells+and+nude+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DT.%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DYin%26aufirst%3DD.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DPTEN-%2520and%2520p53-mediated%2520apoptosis%2520and%2520cell%2520cycle%2520arrest%2520by%2520FTY720%2520in%2520gastric%2520cancer%2520cells%2520and%2520nude%2520mice%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2010%26volume%3D111%26spage%3D218%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Takabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paugh, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">“Inside-out” signaling of sphingosine-1-phosphate: therapeutic targets</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=181-195&author=K.+Takabeauthor=S.+W.+Paughauthor=S.+Milstienauthor=S.+Spiegel&title=%E2%80%9CInside-out%E2%80%9D+signaling+of+sphingosine-1-phosphate%3A+therapeutic+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakabe%26aufirst%3DK.%26aulast%3DPaugh%26aufirst%3DS.%2BW.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3D%25E2%2580%259CInside-out%25E2%2580%259D%2520signaling%2520of%2520sphingosine-1-phosphate%253A%2520therapeutic%2520targets%26jtitle%3DPharmacol.%2520Rev.%26date%3D2008%26volume%3D60%26spage%3D181%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Kunkel, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maceyka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">702</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=688-702&author=G.+T.+Kunkelauthor=M.+Maceykaauthor=S.+Milstienauthor=S.+Spiegel&title=Targeting+the+sphingosine-1-phosphate+axis+in+cancer%2C+inflammation+and+beyond"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKunkel%26aufirst%3DG.%2BT.%26aulast%3DMaceyka%26aufirst%3DM.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DTargeting%2520the%2520sphingosine-1-phosphate%2520axis%2520in%2520cancer%252C%2520inflammation%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D688%26epage%3D702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cong, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span> </span><span class="NLM_article-title">FTY720 for cancer therapy (review)</span> <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2571</span><span class="NLM_x">–</span> <span class="NLM_lpage">2578</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=24100923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFens7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=2571-2578&author=L.+Zhangauthor=H.+D.+Wangauthor=X.+J.+Jiauthor=Z.+X.+Congauthor=J.+H.+Zhuauthor=Y.+Zhou&title=FTY720+for+cancer+therapy+%28review%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720 for cancer therapy (review)</span></div><div class="casAuthors">Zhang, Li; Wang, Han-Dong; Ji, Xiang-Jun; Cong, Zi-Xiang; Zhu, Jian-Hong; Zhou, Yuan</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2571-2578</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  2-Amino-2-[2-(4-octylphenyl)]-1,3-propanediol hydrochloride (FTY720) is a potent immunosuppressant which has been approved by the Food and Drug Administration (FDA) as a new treatment for multiple sclerosis.  As an immunosuppressant, it displays its anti-multiple sclerosis, immunosuppressive effects by activating sphingosine-1-phosphate receptors (S1PRs).  In addn. to the immunosuppressive effects, FTY720 also shows preclin. antitumor efficacy in several cancer models.  In most cases, phosphorylation of FTY720 is not required for its cytotoxic effect, indicating the involvement of S1PR-independent mechanisms which are starkly different from the immunosuppressive property of FTY720.  In the present study, we reviewed the rapidly advancing field of FTY720 in cancer therapy as well as some mol. targets of the unphosphorylated form of FTY720.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoweV7s8B10rbVg90H21EOLACvtfcHk0lgAVqlHYgT_iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFens7%252FN&md5=7d7ada798b3758ec9d0ac10291e575d1</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%2BD.%26aulast%3DJi%26aufirst%3DX.%2BJ.%26aulast%3DCong%26aufirst%3DZ.%2BX.%26aulast%3DZhu%26aufirst%3DJ.%2BH.%26aulast%3DZhou%26aufirst%3DY.%26atitle%3DFTY720%2520for%2520cancer%2520therapy%2520%2528review%2529%26jtitle%3DOncol.%2520Rep.%26date%3D2013%26volume%3D30%26spage%3D2571%26epage%3D2578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradhan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span> </span><span class="NLM_article-title">Fingolimod (FTY720): first approved oral therapy for multiple sclerosis</span> <span class="citation_source-journal">J. Pharmacol. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.4103%2F0976-500X.77118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A280%3ADC%252BC3Mnjt1Srtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=49-51&author=S.+Sharmaauthor=A.+G.+Mathurauthor=S.+Pradhanauthor=D.+B.+Singhauthor=S.+Gupta&title=Fingolimod+%28FTY720%29%3A+first+approved+oral+therapy+for+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720): First approved oral therapy for multiple sclerosis</span></div><div class="casAuthors">Sharma Sushil; Mathur A G; Pradhan Sapna; Singh D B; Gupta Sparsh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacology & pharmacotherapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ4qpZm1OlRojAyhZbj3lKdfW6udTcc2eaLCR-KJ_CAs7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mnjt1Srtg%253D%253D&md5=424019d3e63ead4c6e6198ad3a9de9d7</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.4103%2F0976-500X.77118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F0976-500X.77118%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DMathur%26aufirst%3DA.%2BG.%26aulast%3DPradhan%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DD.%2BB.%26aulast%3DGupta%26aufirst%3DS.%26atitle%3DFingolimod%2520%2528FTY720%2529%253A%2520first%2520approved%2520oral%2520therapy%2520for%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Pharmacol.%2520Pharmacother.%26date%3D2011%26volume%3D2%26spage%3D49%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Parrill, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bautista, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brocklyn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorincz, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liliom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span> </span><span class="NLM_article-title">Identification of Edg1 receptor residues that recognize sphingosine 1-phosphate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">39379</span><span class="NLM_x">–</span> <span class="NLM_lpage">39384</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1074%2Fjbc.M007680200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=10982820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptFSrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=39379-39384&author=A.+L.+Parrillauthor=D.+Wangauthor=D.+L.+Bautistaauthor=J.+R.+Van+Brocklynauthor=Z.+Lorinczauthor=D.+J.+Fischerauthor=D.+L.+Bakerauthor=K.+Liliomauthor=S.+Spiegelauthor=G.+Tigyi&title=Identification+of+Edg1+receptor+residues+that+recognize+sphingosine+1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Edg1 receptor residues that recognize sphingosine 1-phosphate</span></div><div class="casAuthors">Parrill, Abby L.; Wang, De-An; Bautista, Debra L.; Van Brocklyn, James R.; Lorincz, Zsolt; Fischer, David J.; Baker, Daniel L.; Liliom, Karoly; Spiegel, Sarah; Tigyi, Gabor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">39379-39384</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Originating from its DNA sequence, a computational model of the Edg1 receptor has been developed that predicts crit. interactions with its ligand, sphingosine 1-phosphate.  The basic amino acids Arg120 and Arg292 ion pair with the phosphate, whereas the acidic Glu121 residue ion pairs with the ammonium moiety of sphingosine 1-phosphate.  The requirement of these interactions for specific ligand recognition has been confirmed through examn. of site-directed mutants by radioligand binding, ligand-induced [35S]GTPγS binding, and receptor internalization assays.  These ion-pairing interactions explain the ligand specificity of the Edg1 receptor and provide insight into ligand specificity differences within the Edg receptor family.  This computational map of the ligand binding pocket provides information necessary for understanding the mol. pharmacol. of this receptor, thus underlining the potential of the computational method in predicting ligand-receptor interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8bLS2jWZ-dbVg90H21EOLACvtfcHk0litrTGK29nUlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptFSrsbg%253D&md5=2ff5a71db88fab6ff901d4c07e02f26c</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M007680200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M007680200%26sid%3Dliteratum%253Aachs%26aulast%3DParrill%26aufirst%3DA.%2BL.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DBautista%26aufirst%3DD.%2BL.%26aulast%3DVan%2BBrocklyn%26aufirst%3DJ.%2BR.%26aulast%3DLorincz%26aufirst%3DZ.%26aulast%3DFischer%26aufirst%3DD.%2BJ.%26aulast%3DBaker%26aufirst%3DD.%2BL.%26aulast%3DLiliom%26aufirst%3DK.%26aulast%3DSpiegel%26aufirst%3DS.%26aulast%3DTigyi%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520Edg1%2520receptor%2520residues%2520that%2520recognize%2520sphingosine%25201-phosphate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D39379%26epage%3D39384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Deng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, S. A.</span><span> </span><span class="NLM_article-title">Identification of Leu276 of the S1P1 receptor and Phe263 of the S1P3 receptor in interaction with receptor specific agonists by molecular modeling, site-directed mutagenesis, and affinity studies</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">724</span><span class="NLM_x">–</span> <span class="NLM_lpage">735</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=724-735&author=Q.+Dengauthor=J.+A.+Clemasauthor=G.+Chrebetauthor=P.+Fischerauthor=J.+J.+Haleauthor=Z.+Liauthor=S.+G.+Millsauthor=J.+Bergstromauthor=S.+Mandalaauthor=R.+Mosleyauthor=S.+A.+Parent&title=Identification+of+Leu276+of+the+S1P1+receptor+and+Phe263+of+the+S1P3+receptor+in+interaction+with+receptor+specific+agonists+by+molecular+modeling%2C+site-directed+mutagenesis%2C+and+affinity+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DQ.%26aulast%3DClemas%26aufirst%3DJ.%2BA.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DFischer%26aufirst%3DP.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DMosley%26aufirst%3DR.%26aulast%3DParent%26aufirst%3DS.%2BA.%26atitle%3DIdentification%2520of%2520Leu276%2520of%2520the%2520S1P1%2520receptor%2520and%2520Phe263%2520of%2520the%2520S1P3%2520receptor%2520in%2520interaction%2520with%2520receptor%2520specific%2520agonists%2520by%2520molecular%2520modeling%252C%2520site-directed%2520mutagenesis%252C%2520and%2520affinity%2520studies%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D71%26spage%3D724%26epage%3D735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Lim, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, N. J.</span><span> </span><span class="NLM_article-title">FTY720 analogues as sphingosine kinase 1 inhibitors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">18633</span><span class="NLM_x">–</span> <span class="NLM_lpage">18640</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=18633-18640&author=K.+G.+Limauthor=F.+Tonelliauthor=Z.+Liauthor=X.+Luauthor=R.+Bittmanauthor=S.+Pyneauthor=N.+J.+Pyne&title=FTY720+analogues+as+sphingosine+kinase+1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DK.%2BG.%26aulast%3DTonelli%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26atitle%3DFTY720%2520analogues%2520as%2520sphingosine%2520kinase%25201%2520inhibitors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D18633%26epage%3D18640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Lim, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdyshev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorshkova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leclercq, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, N. J.</span><span> </span><span class="NLM_article-title">Inhibition kinetics and regulation of sphingosine kinase 1 expression in prostate cancer cells: functional differences between sphingosine kinase 1a and 1b</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1457</span><span class="NLM_x">–</span> <span class="NLM_lpage">1464</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2Fj.biocel.2012.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=22634604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVektbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2012&pages=1457-1464&author=K.+G.+Limauthor=F.+Tonelliauthor=E.+Berdyshevauthor=I.+Gorshkovaauthor=T.+Leclercqauthor=S.+M.+Pitsonauthor=R.+Bittmanauthor=S.+Pyneauthor=N.+J.+Pyne&title=Inhibition+kinetics+and+regulation+of+sphingosine+kinase+1+expression+in+prostate+cancer+cells%3A+functional+differences+between+sphingosine+kinase+1a+and+1b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition kinetics and regulation of sphingosine kinase 1 expression in prostate cancer cells: Functional differences between sphingosine kinase 1a and 1b</span></div><div class="casAuthors">Lim, Keng Gat; Tonelli, Francesca; Berdyshev, Evgeny; Gorshkova, Irina; Leclercq, Tamara; Pitson, Stuart M.; Bittman, Robert; Pyne, Susan; Pyne, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1457-1464</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Sphingosine kinase 1 catalyzes the formation of the bioactive lipid, sphingosine 1-phosphate and is a target for anti-cancer agents.  We demonstrate here that 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole (SKi, also referred to as SKI-II), FTY720 (Fingolimod), and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 activity with distinct kinetics, indicating that these compds. exhibit different binding modalities with sphingosine kinase 1.  Thus, SKi is a mixed inhibitor of sphingosine and ATP binding, whereas FTY720 is competitive with sphingosine and uncompetitive with ATP, and (S)-FTY720 vinylphosphonate is uncompetitive with sphingosine and is a mixed inhibitor with respect to ATP.  A novel see-saw' model is proposed for the binding of inhibitor to catalytic and allosteric sites, the latter dependent on substrate binding, that provides an explanation for the different inhibitor kinetics.  In addn., we demonstrate that the expression level and properties unique to an N-terminal 86 amino-acid isoform variant of sphingosine kinase 1 (SK1b) in prostate cancer cells reduce its sensitivity to SKi-induced proteasomal degrdn. in comparison to SK1a, i.e. these two N-terminal variants of sphingosine kinase 1 (SK1a and SK1b) have different properties.  The reduced sensitivity of SK1b to proteasomal degrdn. in response to SKi is translated into specific changes in ceramide and S1P levels that leads to apoptosis of androgen-sensitive but not androgen-independent LNCaP prostate cancer cells.  Therefore, our proposed see-saw' model might be usefully employed in the design of sphingosine kinase inhibitors to promote apoptosis of chemotherapeutic resistant cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1g1AAUtLNBLVg90H21EOLACvtfcHk0lhPhfxmx0olXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVektbnL&md5=3ffa9b6af3a1012c10150e297ffcf69c</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2012.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2012.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DK.%2BG.%26aulast%3DTonelli%26aufirst%3DF.%26aulast%3DBerdyshev%26aufirst%3DE.%26aulast%3DGorshkova%26aufirst%3DI.%26aulast%3DLeclercq%26aufirst%3DT.%26aulast%3DPitson%26aufirst%3DS.%2BM.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26atitle%3DInhibition%2520kinetics%2520and%2520regulation%2520of%2520sphingosine%2520kinase%25201%2520expression%2520in%2520prostate%2520cancer%2520cells%253A%2520functional%2520differences%2520between%2520sphingosine%2520kinase%25201a%2520and%25201b%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2012%26volume%3D44%26spage%3D1457%26epage%3D1464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Pyne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, N. J.</span><span> </span><span class="NLM_article-title">New perspectives on the role of sphingosine 1-phosphate in cancer</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">216</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1007%2F978-3-7091-1511-4_3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=23563651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKls73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=2013&pages=55-71&author=S.+Pyneauthor=N.+J.+Pyne&title=New+perspectives+on+the+role+of+sphingosine+1-phosphate+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">New perspectives on the role of sphingosine 1-phosphate in cancer</span></div><div class="casAuthors">Pyne, Susan; Pyne, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">216</span>
        (<span class="NLM_cas:issue">Sphingolipids in Disease</span>),
    <span class="NLM_cas:pages">55-71</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">In this chapter, we review the latest developments concerning the role of sphingosine 1-phosphate (S1P) in cancer.  Particular focus is paid to the role of sphingosine kinases 1 and 2, S1P lyase and S1P-dependent signalling networks in both solid tumors and haematol. cancer.  The potential of this S1P-dependent pathophysiol. as a therapeutic target for the treatment of cancer is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPNhVc8oIFGrVg90H21EOLACvtfcHk0lhPhfxmx0olXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKls73F&md5=69036ae2d4279f36f45bb631fbe3feaf</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1007%2F978-3-7091-1511-4_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-7091-1511-4_3%26sid%3Dliteratum%253Aachs%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26atitle%3DNew%2520perspectives%2520on%2520the%2520role%2520of%2520sphingosine%25201-phosphate%2520in%2520cancer%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2013%26volume%3D216%26spage%3D55%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Pyne, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate signalling in cancer</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1042%2FBST20110602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=22260672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=94-100&author=N.+J.+Pyneauthor=F.+Tonelliauthor=K.+G.+Limauthor=J.+S.+Longauthor=J.+Edwardsauthor=S.+Pyne&title=Sphingosine+1-phosphate+signalling+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate signalling in cancer</span></div><div class="casAuthors">Pyne, Nigel J.; Tonelli, Francesca; Lim, Keng Gat; Long, Jaclyn S.; Edwards, Joanne; Pyne, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-100</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  There is an increasing body of evidence demonstrating a crit. role for the bioactive lipid S1P (sphingosine 1-phosphate) in cancer.  S1P is synthesized and metabolized by a no. of enzymes, including sphingosine kinase, S1P lyase and S1P phosphatases.  S1P binds to cell-surface G-protein-coupled receptors (S1P1-S1P5) to elicit cell responses and can also regulate, by direct binding, a no. of intracellular targets such as HDAC (histone deacetylase) 1/2 to induce epigenetic regulation.  S1P is involved in cancer progression including cell transformation/oncogenesis, cell survival/apoptosis, cell migration/metastasis and tumor microenvironment neovascularization.  In the present paper, we describe our research findings regarding the correlation of sphingosine kinase 1 and S1P receptor expression in tumors with clin. outcome and we define some of the mol. mechanisms underlying the involvement of sphingosine kinase 1 and S1P receptors in the formation of a cancer cell migratory phenotype.  The role of sphingosine kinase 1 in the acquisition of chemotherapeutic resistance and the interaction of S1P receptors with oncogenes such as HER2 is also reviewed.  We also discuss novel aspects of the use of small-mol. inhibitors of sphingosine kinase 1 in terms of allosterism, ubiquitin-proteasomal degrdn. of sphingosine kinase 1 and anticancer activity.  Finally, we describe how S1P receptor-modulating agents abrogate S1P receptor-receptor tyrosine kinase interactions, with potential to inhibit growth-factor-dependent cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryryplFV-76bVg90H21EOLACvtfcHk0lhPhfxmx0olXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCqurc%253D&md5=e0f90be10095c1d682345caaf8cce2c0</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1042%2FBST20110602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20110602%26sid%3Dliteratum%253Aachs%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DTonelli%26aufirst%3DF.%26aulast%3DLim%26aufirst%3DK.%2BG.%26aulast%3DLong%26aufirst%3DJ.%2BS.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DPyne%26aufirst%3DS.%26atitle%3DSphingosine%25201-phosphate%2520signalling%2520in%2520cancer%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2012%26volume%3D40%26spage%3D94%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Kim, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsutake, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of sphingoid analogs as inhibitors of sphingosine kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3475</span><span class="NLM_x">–</span> <span class="NLM_lpage">3485</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=3475-3485&author=J.+W.+Kimauthor=Y.+W.+Kimauthor=Y.+Inagakiauthor=Y.+A.+Hwangauthor=S.+Mitsutakeauthor=Y.+W.+Ryuauthor=W.+K.+Leeauthor=H.+J.+Haauthor=C.+S.+Parkauthor=Y.+Igarashi&title=Synthesis+and+evaluation+of+sphingoid+analogs+as+inhibitors+of+sphingosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DKim%26aufirst%3DY.%2BW.%26aulast%3DInagaki%26aufirst%3DY.%26aulast%3DHwang%26aufirst%3DY.%2BA.%26aulast%3DMitsutake%26aufirst%3DS.%26aulast%3DRyu%26aufirst%3DY.%2BW.%26aulast%3DLee%26aufirst%3DW.%2BK.%26aulast%3DHa%26aufirst%3DH.%2BJ.%26aulast%3DPark%26aufirst%3DC.%2BS.%26aulast%3DIgarashi%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520sphingoid%2520analogs%2520as%2520inhibitors%2520of%2520sphingosine%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D3475%26epage%3D3485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Hara-Yokoyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terasawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirabayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagishita, M.</span><span> </span><span class="NLM_article-title">Sphingosine kinase 2 inhibitor accelerates Fas-mediated cell death progression in A2O/2J cells</span> <span class="citation_source-journal">Open Bioact. Compd. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.2174%2F1874847300801010022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFym" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2008&pages=22-27&author=M.+Hara-Yokoyamaauthor=K.+Terasawaauthor=A.+Kiharaauthor=J.+W.+Kimauthor=C.+S.+Parkauthor=Y.+Hirabayashiauthor=Y.+Igarashiauthor=M.+Yanagishita&title=Sphingosine+kinase+2+inhibitor+accelerates+Fas-mediated+cell+death+progression+in+A2O%2F2J+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine kinase 2 inhibitor accelerates Fas-mediated cell death progression in A20/2J cells</span></div><div class="casAuthors">Hara-Yokoyama, Miki; Terasawa, Kazue; Kihara, Akio; Kim, Jin-Wook; Park, Chan-Seo; Hirabayashi, Yoshio; Igarashi, Yasuyuki; Yanagishita, Masaki</div><div class="citationInfo"><span class="NLM_cas:title">Open Bioactive Compounds Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22-27</span>CODEN:
                <span class="NLM_cas:coden">OBCJAU</span>;
        ISSN:<span class="NLM_cas:issn">1874-8473</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A sphingosine kinase (SPHK) type 2 inhibitor, SG-12, inhibited the SPHK2 activity in A20/2J cells and promoted Fas-dependent cell death.  The effect of SG-12 on cell death was relieved by SPHK2 transfection but not by SPHK1 transfection.  The results suggest a SPHK2-specific suppression of Fas-dependent cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv9ZypgRQQc7Vg90H21EOLACvtfcHk0ljHApOmCchG_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFym&md5=6c49cc5f85613fcd73839322992cfbec</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.2174%2F1874847300801010022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1874847300801010022%26sid%3Dliteratum%253Aachs%26aulast%3DHara-Yokoyama%26aufirst%3DM.%26aulast%3DTerasawa%26aufirst%3DK.%26aulast%3DKihara%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DPark%26aufirst%3DC.%2BS.%26aulast%3DHirabayashi%26aufirst%3DY.%26aulast%3DIgarashi%26aufirst%3DY.%26aulast%3DYanagishita%26aufirst%3DM.%26atitle%3DSphingosine%2520kinase%25202%2520inhibitor%2520accelerates%2520Fas-mediated%2520cell%2520death%2520progression%2520in%2520A2O%252F2J%2520cells%26jtitle%3DOpen%2520Bioact.%2520Compd.%2520J.%26date%3D2008%26volume%3D1%26spage%3D22%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Hara-Yokoyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terasawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichinose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podyma-Inoue, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyoshi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagishita, M.</span><span> </span><span class="NLM_article-title">Sphingosine kinase 2 inhibitor SG-12 induces apoptosis via phosphorylation by sphingosine kinase 2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2220</span><span class="NLM_x">–</span> <span class="NLM_lpage">2224</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=2220-2224&author=M.+Hara-Yokoyamaauthor=K.+Terasawaauthor=S.+Ichinoseauthor=A.+Watanabeauthor=K.+A.+Podyma-Inoueauthor=K.+Akiyoshiauthor=Y.+Igarashiauthor=M.+Yanagishita&title=Sphingosine+kinase+2+inhibitor+SG-12+induces+apoptosis+via+phosphorylation+by+sphingosine+kinase+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHara-Yokoyama%26aufirst%3DM.%26aulast%3DTerasawa%26aufirst%3DK.%26aulast%3DIchinose%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DPodyma-Inoue%26aufirst%3DK.%2BA.%26aulast%3DAkiyoshi%26aufirst%3DK.%26aulast%3DIgarashi%26aufirst%3DY.%26aulast%3DYanagishita%26aufirst%3DM.%26atitle%3DSphingosine%2520kinase%25202%2520inhibitor%2520SG-12%2520induces%2520apoptosis%2520via%2520phosphorylation%2520by%2520sphingosine%2520kinase%25202%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D2220%26epage%3D2224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Nishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iio, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawase, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nara, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inaba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomisato, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimozato, T.</span><span> </span><span class="NLM_article-title">Discovery of CS-0777: a potent, selective, and orally active S1P1 agonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">368</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100301k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=368-372&author=T.+Nishiauthor=S.+Miyazakiauthor=T.+Takemotoauthor=K.+Suzukiauthor=Y.+Iioauthor=K.+Nakajimaauthor=T.+Ohnukiauthor=Y.+Kawaseauthor=F.+Naraauthor=S.+Inabaauthor=T.+Izumiauthor=H.+Yuitaauthor=K.+Oshimaauthor=H.+Doiauthor=R.+Inoueauthor=W.+Tomisatoauthor=T.+Kagariauthor=T.+Shimozato&title=Discovery+of+CS-0777%3A+a+potent%2C+selective%2C+and+orally+active+S1P1+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fml100301k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100301k%26sid%3Dliteratum%253Aachs%26aulast%3DNishi%26aufirst%3DT.%26aulast%3DMiyazaki%26aufirst%3DS.%26aulast%3DTakemoto%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DIio%26aufirst%3DY.%26aulast%3DNakajima%26aufirst%3DK.%26aulast%3DOhnuki%26aufirst%3DT.%26aulast%3DKawase%26aufirst%3DY.%26aulast%3DNara%26aufirst%3DF.%26aulast%3DInaba%26aufirst%3DS.%26aulast%3DIzumi%26aufirst%3DT.%26aulast%3DYuita%26aufirst%3DH.%26aulast%3DOshima%26aufirst%3DK.%26aulast%3DDoi%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DR.%26aulast%3DTomisato%26aufirst%3DW.%26aulast%3DKagari%26aufirst%3DT.%26aulast%3DShimozato%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520CS-0777%253A%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520S1P1%2520agonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D368%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Moberly, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truitt, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollmer, T. L.</span><span> </span><span class="NLM_article-title">Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: results from a 12-week, open-label pilot study in multiple sclerosis patients</span> <span class="citation_source-journal">J. Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">246</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2Fj.jneuroim.2012.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=22465063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvF2jtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=2012&pages=100-107&author=J.+B.+Moberlyauthor=D.+M.+Fordauthor=H.+Zahirauthor=S.+Chenauthor=T.+Mochizukiauthor=K.+E.+Truittauthor=T.+L.+Vollmer&title=Pharmacological+effects+of+CS-0777%2C+a+selective+sphingosine+1-phosphate+receptor-1+modulator%3A+results+from+a+12-week%2C+open-label+pilot+study+in+multiple+sclerosis+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: Results from a 12-week, open-label pilot study in multiple sclerosis patients</span></div><div class="casAuthors">Moberly, James B.; Ford, Daniel M.; Zahir, Hamim; Chen, Shuquan; Mochizuki, Takashi; Truitt, Kenneth E.; Vollmer, Timothy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">100-107</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">CS-0777 is a selective sphingosine 1-phosphate receptor-1 modulator under investigation for treatment of multiple sclerosis (MS).  We conducted an open-label, pilot study in 25 MS patients to assess the safety, pharmacokinetics, pharmacodynamics and exploratory efficacy of oral CS-0777 (0.1, 0.3 and 0.6 mg), administered once weekly or every other week for 12 wk.  CS-0777 resulted in a pronounced, dose-dependent decrease in lymphocytes and CD4 T cell subsets, which returned to baseline within 4 wk after the last dose.  Overall, CS-0777 was safe and well-tolerated.  These results require confirmation in a double-blind, placebo-controlled and adequately powered phase 2 study in MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnUDMmZ5gpHLVg90H21EOLACvtfcHk0ljHApOmCchG_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvF2jtbY%253D&md5=ce750c33bbfd69ba65304cb02f7c22f9</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2012.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2012.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DMoberly%26aufirst%3DJ.%2BB.%26aulast%3DFord%26aufirst%3DD.%2BM.%26aulast%3DZahir%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DMochizuki%26aufirst%3DT.%26aulast%3DTruitt%26aufirst%3DK.%2BE.%26aulast%3DVollmer%26aufirst%3DT.%2BL.%26atitle%3DPharmacological%2520effects%2520of%2520CS-0777%252C%2520a%2520selective%2520sphingosine%25201-phosphate%2520receptor-1%2520modulator%253A%2520results%2520from%2520a%252012-week%252C%2520open-label%2520pilot%2520study%2520in%2520multiple%2520sclerosis%2520patients%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2012%26volume%3D246%26spage%3D100%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Humpf, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmelz, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesper, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vales, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menaldino, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrill, A. H.,  Jr.</span><span> </span><span class="NLM_article-title">Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase. Formation of <i>N</i>-palmitoyl-aminopentol produces a toxic metabolite of hydrolyzed fumonisin, AP1, and a new category of ceramide synthase inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">19060</span><span class="NLM_x">–</span> <span class="NLM_lpage">19064</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=19060-19064&author=H.+U.+Humpfauthor=E.+M.+Schmelzauthor=F.+I.+Meredithauthor=H.+Vesperauthor=T.+R.+Valesauthor=E.+Wangauthor=D.+S.+Menaldinoauthor=D.+C.+Liottaauthor=A.+H.+Merrill&title=Acylation+of+naturally+occurring+and+synthetic+1-deoxysphinganines+by+ceramide+synthase.+Formation+of+N-palmitoyl-aminopentol+produces+a+toxic+metabolite+of+hydrolyzed+fumonisin%2C+AP1%2C+and+a+new+category+of+ceramide+synthase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHumpf%26aufirst%3DH.%2BU.%26aulast%3DSchmelz%26aufirst%3DE.%2BM.%26aulast%3DMeredith%26aufirst%3DF.%2BI.%26aulast%3DVesper%26aufirst%3DH.%26aulast%3DVales%26aufirst%3DT.%2BR.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DMenaldino%26aufirst%3DD.%2BS.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26atitle%3DAcylation%2520of%2520naturally%2520occurring%2520and%2520synthetic%25201-deoxysphinganines%2520by%2520ceramide%2520synthase.%2520Formation%2520of%2520N-palmitoyl-aminopentol%2520produces%2520a%2520toxic%2520metabolite%2520of%2520hydrolyzed%2520fumonisin%252C%2520AP1%252C%2520and%2520a%2520new%2520category%2520of%2520ceramide%2520synthase%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D19060%26epage%3D19064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Symolon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushnev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramaraju, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mays, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegood, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruett, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullards, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillehay, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrill, A. H.,  Jr.</span><span> </span><span class="NLM_article-title">Enigmol: a novel sphingolipid analogue with anticancer activity against cancer cell lines and in vivo models for intestinal and prostate cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">648</span><span class="NLM_x">–</span> <span class="NLM_lpage">657</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1158%2F1535-7163.MCT-10-0754" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=21398423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSrtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=648-657&author=H.+Symolonauthor=A.+Bushnevauthor=Q.+Pengauthor=H.+Ramarajuauthor=S.+G.+Maysauthor=J.+C.+Allegoodauthor=S.+T.+Pruettauthor=M.+C.+Sullardsauthor=D.+L.+Dillehayauthor=D.+C.+Liottaauthor=A.+H.+Merrill&title=Enigmol%3A+a+novel+sphingolipid+analogue+with+anticancer+activity+against+cancer+cell+lines+and+in+vivo+models+for+intestinal+and+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Enigmol: A Novel Sphingolipid Analogue with Anticancer Activity against Cancer Cell Lines and In vivo Models for Intestinal and Prostate Cancer</span></div><div class="casAuthors">Symolon, Holly; Bushnev, Anatoliy; Peng, Qiong; Ramaraju, Harsha; Mays, Suzanne G.; Allegood, Jeremy C.; Pruett, Sarah T.; Sullards, M. Cameron; Dillehay, Dirck L.; Liotta, Dennis C.; Merrill, Alfred H., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">648-657</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Sphingoid bases are cytotoxic for many cancer cell lines and are thought to contribute to suppression of intestinal tumorigenesis in vivo by ingested sphingolipids.  This study explored the behavior of a sphingoid base analog, (2S,3S,5S)-2-amino-3,5-dihydroxyoctadecane (Enigmol), that cannot be phosphorylated by sphingosine kinases and is slowly N-acylated and therefore is more persistent than natural sphingoid bases.  Enigmol had potential anticancer activity in a National Cancer Institute (NCI-60) cell line screen and was confirmed to be more cytotoxic and persistent than naturally occurring sphingoid bases using HT29 cells, a colon cancer cell line.  Although the mol. targets of sphingoid bases are not well delineated, Enigmol shared one of the mechanisms that has been found for naturally occurring sphingoid bases: normalization of the aberrant accumulation of β-catenin in the nucleus and cytoplasm of colon cancer cells due to defect(s) in the adenomatous polyposis coli (APC)/β-catenin regulatory system.  Enigmol also had antitumor efficacy when administered orally to Min mice, a mouse model with a truncated APC gene product (C57Bl/6JMin/+ mice), decreasing the no. of intestinal tumors by half at 0.025% of the diet (wt./wt.), with no evidence of host toxicity until higher dosages.  Enigmol was also tested against the prostate cancer cell lines DU145 and PC-3 in nude mouse xenografts and suppressed tumor growth in both.  Thus, Enigmol represents a novel category of sphingoid base analog that is orally bioavailable and has the potential to be effective against multiple types of cancer.  Mol Cancer Ther; 10(4); 648-57.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAT97RiH5ehrVg90H21EOLACvtfcHk0liqpr-EzWhcTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSrtLo%253D&md5=ddfa116c8344f76b548d45a27081b0d1</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0754%26sid%3Dliteratum%253Aachs%26aulast%3DSymolon%26aufirst%3DH.%26aulast%3DBushnev%26aufirst%3DA.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DRamaraju%26aufirst%3DH.%26aulast%3DMays%26aufirst%3DS.%2BG.%26aulast%3DAllegood%26aufirst%3DJ.%2BC.%26aulast%3DPruett%26aufirst%3DS.%2BT.%26aulast%3DSullards%26aufirst%3DM.%2BC.%26aulast%3DDillehay%26aufirst%3DD.%2BL.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26atitle%3DEnigmol%253A%2520a%2520novel%2520sphingolipid%2520analogue%2520with%2520anticancer%2520activity%2520against%2520cancer%2520cell%2520lines%2520and%2520in%2520vivo%2520models%2520for%2520intestinal%2520and%2520prostate%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D648%26epage%3D657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Garnier-Amblard, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mays, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrendale, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushnev, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culver, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebeskind, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menaldino, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natchus, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petros, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramaraju, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span> </span><span class="NLM_article-title">Novel synthesis and biological evaluation of enigmols as therapeutic agents for treating prostate cancer</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">438</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml2000164" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=438-443&author=E.+C.+Garnier-Amblardauthor=S.+G.+Maysauthor=R.+F.+Arrendaleauthor=M.+T.+Baillieauthor=A.+S.+Bushnevauthor=D.+G.+Culverauthor=T.+J.+Eversauthor=J.+J.+Holtauthor=R.+B.+Howardauthor=L.+S.+Liebeskindauthor=D.+S.+Menaldinoauthor=M.+G.+Natchusauthor=J.+A.+Petrosauthor=H.+Ramarajuauthor=G.+P.+Reddyauthor=D.+C.+Liotta&title=Novel+synthesis+and+biological+evaluation+of+enigmols+as+therapeutic+agents+for+treating+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fml2000164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2000164%26sid%3Dliteratum%253Aachs%26aulast%3DGarnier-Amblard%26aufirst%3DE.%2BC.%26aulast%3DMays%26aufirst%3DS.%2BG.%26aulast%3DArrendale%26aufirst%3DR.%2BF.%26aulast%3DBaillie%26aufirst%3DM.%2BT.%26aulast%3DBushnev%26aufirst%3DA.%2BS.%26aulast%3DCulver%26aufirst%3DD.%2BG.%26aulast%3DEvers%26aufirst%3DT.%2BJ.%26aulast%3DHolt%26aufirst%3DJ.%2BJ.%26aulast%3DHoward%26aufirst%3DR.%2BB.%26aulast%3DLiebeskind%26aufirst%3DL.%2BS.%26aulast%3DMenaldino%26aufirst%3DD.%2BS.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DPetros%26aufirst%3DJ.%2BA.%26aulast%3DRamaraju%26aufirst%3DH.%26aulast%3DReddy%26aufirst%3DG.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26atitle%3DNovel%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520enigmols%2520as%2520therapeutic%2520agents%2520for%2520treating%2520prostate%2520cancer%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D438%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Mays, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushnev, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruett, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culver, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natchus, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrendale, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petros, J. A.</span><span> </span><span class="NLM_article-title">330 Fluorination of enigmol improves tissue uptake and effects in vivo prostate cancer efficacy</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">189</span><span class="NLM_x">, </span> <span class="NLM_fpage">e133</span><span class="NLM_x">–</span> <span class="NLM_lpage">e134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2013&pages=e133-e134&author=S.+G.+Maysauthor=M.+T.+Baillieauthor=E.+J.+Millerauthor=A.+S.+Bushnevauthor=S.+T.+Pruettauthor=D.+G.+Culverauthor=T.+J.+Eversauthor=J.+Gaoauthor=G.+P.+Reddyauthor=M.+G.+Natchusauthor=R.+F.+Arrendaleauthor=R.+B.+Howardauthor=D.+C.+Liottaauthor=J.+A.+Petros&title=330+Fluorination+of+enigmol+improves+tissue+uptake+and+effects+in+vivo+prostate+cancer+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMays%26aufirst%3DS.%2BG.%26aulast%3DBaillie%26aufirst%3DM.%2BT.%26aulast%3DMiller%26aufirst%3DE.%2BJ.%26aulast%3DBushnev%26aufirst%3DA.%2BS.%26aulast%3DPruett%26aufirst%3DS.%2BT.%26aulast%3DCulver%26aufirst%3DD.%2BG.%26aulast%3DEvers%26aufirst%3DT.%2BJ.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DReddy%26aufirst%3DG.%2BP.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DArrendale%26aufirst%3DR.%2BF.%26aulast%3DHoward%26aufirst%3DR.%2BB.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DPetros%26aufirst%3DJ.%2BA.%26atitle%3D330%2520Fluorination%2520of%2520enigmol%2520improves%2520tissue%2520uptake%2520and%2520effects%2520in%2520vivo%2520prostate%2520cancer%2520efficacy%26jtitle%3DJ.%2520Urol.%26date%3D2013%26volume%3D189%26spage%3De133%26epage%3De134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Foss, F. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okusa, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=663-677&author=F.+W.+Fossauthor=A.+H.+Snyderauthor=M.+D.+Davisauthor=M.+Rouseauthor=M.+D.+Okusaauthor=K.+R.+Lynchauthor=T.+L.+Macdonald&title=Synthesis+and+biological+evaluation+of+gamma-aminophosphonates+as+potent%2C+subtype-selective+sphingosine+1-phosphate+receptor+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoss%26aufirst%3DF.%2BW.%26aulast%3DSnyder%26aufirst%3DA.%2BH.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DRouse%26aufirst%3DM.%26aulast%3DOkusa%26aufirst%3DM.%2BD.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520gamma-aminophosphonates%2520as%2520potent%252C%2520subtype-selective%2520sphingosine%25201-phosphate%2520receptor%2520agonists%2520and%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D663%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Foss, F. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6123</span><span class="NLM_x">–</span> <span class="NLM_lpage">6136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2Fj.bmc.2009.04.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=19632123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1Crsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=6123-6136&author=F.+W.+Fossauthor=T.+P.+Mathewsauthor=Y.+Kharelauthor=P.+C.+Kennedyauthor=A.+H.+Snyderauthor=M.+D.+Davisauthor=K.+R.+Lynchauthor=T.+L.+Macdonald&title=Synthesis+and+biological+evaluation+of+sphingosine+kinase+substrates+as+sphingosine-1-phosphate+receptor+prodrugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs</span></div><div class="casAuthors">Foss, Frank W.; Mathews, Thomas P.; Kharel, Yugesh; Kennedy, Perry C.; Snyder, Ashley H.; Davis, Michael D.; Lynch, Kevin R.; MacDonald, Timothy L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6123-6136</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In the search for bioactive sphingosine 1-phosphate (S1P) receptor ligands, a series of 2-amino-2-heterocyclic-propanols were synthesized.  These mols. were discovered to be substrates of human-sphingosine kinases 1 and 2 (SPHK1 and SPHK2).  When phosphorylated, the resultant phosphates showed varied activities at the five sphingosine-1-phosphate (S1P) receptors (S1P1-5).  Agonism at S1P1 was displayed in vivo by induction of lymphopenia.  A stereochem. preference of the quaternary carbon was crucial for phosphorylation by the kinases and alters binding affinities at the S1P receptors.  Oxazole and oxadiazole compds. are superior kinase substrates to FTY720, the prototypical prodrug immunomodulator, fingolimod (FTY720).  The oxazole-derived structure was the most active for human SPHK2.  Imidazole analogs were less active substrates for SPHKs, but more potent and selective agonists of the S1P1 receptor; addnl., the imidazole class of compds. rendered mice lymphopenic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmuspJ6izmqbVg90H21EOLACvtfcHk0lhNsMLBXQ2j7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1Crsbk%253D&md5=4756f9c22f4ba11c04e52b5e74adc630</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.04.015%26sid%3Dliteratum%253Aachs%26aulast%3DFoss%26aufirst%3DF.%2BW.%26aulast%3DMathews%26aufirst%3DT.%2BP.%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DKennedy%26aufirst%3DP.%2BC.%26aulast%3DSnyder%26aufirst%3DA.%2BH.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520sphingosine%2520kinase%2520substrates%2520as%2520sphingosine-1-phosphate%2520receptor%2520prodrugs%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D6123%26epage%3D6136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Mathews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoara, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunkara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wamhoff, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span> </span><span class="NLM_article-title">Discovery, biological evaluation, and structure–activity relationship of amidine based sphingosine kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2766</span><span class="NLM_x">–</span> <span class="NLM_lpage">2778</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901860h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2766-2778&author=T.+P.+Mathewsauthor=A.+J.+Kennedyauthor=Y.+Kharelauthor=P.+C.+Kennedyauthor=O.+Nicoaraauthor=M.+Sunkaraauthor=A.+J.+Morrisauthor=B.+R.+Wamhoffauthor=K.+R.+Lynchauthor=T.+L.+Macdonald&title=Discovery%2C+biological+evaluation%2C+and+structure%E2%80%93activity+relationship+of+amidine+based+sphingosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjm901860h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901860h%26sid%3Dliteratum%253Aachs%26aulast%3DMathews%26aufirst%3DT.%2BP.%26aulast%3DKennedy%26aufirst%3DA.%2BJ.%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DKennedy%26aufirst%3DP.%2BC.%26aulast%3DNicoara%26aufirst%3DO.%26aulast%3DSunkara%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DA.%2BJ.%26aulast%3DWamhoff%26aufirst%3DB.%2BR.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DDiscovery%252C%2520biological%2520evaluation%252C%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520amidine%2520based%2520sphingosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2766%26epage%3D2778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Kennedy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Field, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">East, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houck, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span> </span><span class="NLM_article-title">Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3524</span><span class="NLM_x">–</span> <span class="NLM_lpage">3548</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2001053" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVyhs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3524-3548&author=A.+J.+Kennedyauthor=T.+P.+Mathewsauthor=Y.+Kharelauthor=S.+D.+Fieldauthor=M.+L.+Moyerauthor=J.+E.+Eastauthor=J.+D.+Houckauthor=K.+R.+Lynchauthor=T.+L.+Macdonald&title=Development+of+amidine-based+sphingosine+kinase+1+nanomolar+inhibitors+and+reduction+of+sphingosine+1-phosphate+in+human+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Amidine-Based Sphingosine Kinase 1 Nanomolar Inhibitors and Reduction of Sphingosine 1-Phosphate in Human Leukemia Cells</span></div><div class="casAuthors">Kennedy, Andrew J.; Mathews, Thomas P.; Kharel, Yugesh; Field, Saundra D.; Moyer, Morgan L.; East, James E.; Houck, Joseph D.; Lynch, Kevin R.; MacDonald, Timothy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3524-3548</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a bioactive lipid that has been identified as an accelerant of cancer progression.  The sphingosine kinases (SphKs) are the sole producers of S1P, and thus, SphK inhibitors may prove effective in cancer mitigation and chemosensitization.  Of the two SphKs, SphK1 overexpression has been obsd. in a myriad of cancer cell lines and tissues and has been recognized as the presumptive target over that of the poorly characterized SphK2.  Herein, the authors present the design and synthesis of amidine-based nanomolar SphK1 subtype-selective inhibitors.  A homol. model of SphK1, trained with this library of amidine inhibitors, was then used to predict the activity of addnl., more potent, inhibitors.  Lastly, select amidine inhibitors were validated in human leukemia U937 cells, where they significantly reduced endogenous S1P levels at nanomolar concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiiQaZkSe6UrVg90H21EOLACvtfcHk0lhNsMLBXQ2j7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVyhs7c%253D&md5=a8a72acfa6b5893deb75a91cec2e8938</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm2001053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2001053%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DA.%2BJ.%26aulast%3DMathews%26aufirst%3DT.%2BP.%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DField%26aufirst%3DS.%2BD.%26aulast%3DMoyer%26aufirst%3DM.%2BL.%26aulast%3DEast%26aufirst%3DJ.%2BE.%26aulast%3DHouck%26aufirst%3DJ.%2BD.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DDevelopment%2520of%2520amidine-based%2520sphingosine%2520kinase%25201%2520nanomolar%2520inhibitors%2520and%2520reduction%2520of%2520sphingosine%25201-phosphate%2520in%2520human%2520leukemia%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3524%26epage%3D3548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Kharel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellett, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomsig, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, W. L.</span><span> </span><span class="NLM_article-title">Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">447</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1042%2FBJ20120609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=22747486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlCjsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2012&pages=149-157&author=Y.+Kharelauthor=M.+Rajeauthor=M.+Gaoauthor=A.+M.+Gellettauthor=J.+L.+Tomsigauthor=K.+R.+Lynchauthor=W.+L.+Santos&title=Sphingosine+kinase+type+2+inhibition+elevates+circulating+sphingosine+1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate</span></div><div class="casAuthors">Kharel, Yugesh; Raje, Mithun; Gao, Ming; Gellett, Amanda M.; Tomsig, Jose L.; Lynch, Kevin R.; Santos, Webster L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">447</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">149-157</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">S1P (sphingosine 1-phosphate) is a pleiotropic lipid mediator involved in numerous cellular and physiol. functions.  Of note among these are cell survival and migration, as well as lymphocyte trafficking.  S1P, which exerts its effects via five GPCRs (G-protein-coupled receptors) (S1P1-S1P5), is formed by the action of two SphKs (sphingosine kinases).  Although SphK1 is the more intensively studied isotype, SphK2 is unique in it nuclear localization and has been reported to oppose some of the actions ascribed to SphK1.  Although several scaffolds of SphK1 inhibitors have been described, there is a scarcity of selective SphK2 inhibitors that are necessary to evaluate the downstream effects of inhibition of this isotype.  In the present paper we report a cationic amphiphilic small mol. that is a selective SphK2 inhibitor.  In the course of characterizing this compd. in wild-type and SphK-null mice, we discovered that administration of the inhibitor to wild-type mice resulted in a rapid increase in blood S1P, which is in contrast with our SphK1 inhibitor that drives circulating S1P levels down.  Using a cohort of F2 hybrid mice, we confirmed, compared with wild-type mice, that circulating S1P levels were higher in SphK2-null mice and lower in SphK1-null mice.  Thus both SphK1 and SphK2 inhibitors recapitulate the blood S1P levels obsd. in the corresponding null mice.  Moreover, circulating S1P levels mirror SphK2 inhibitor levels, providing a convenient biomarker of target engagement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKDtUfuqfG5bVg90H21EOLACvtfcHk0lg4sAgaC2lXkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlCjsLrE&md5=dbd6766a0d93b120155a2c0caa69ceda</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1042%2FBJ20120609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20120609%26sid%3Dliteratum%253Aachs%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DRaje%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DGellett%26aufirst%3DA.%2BM.%26aulast%3DTomsig%26aufirst%3DJ.%2BL.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DSantos%26aufirst%3DW.%2BL.%26atitle%3DSphingosine%2520kinase%2520type%25202%2520inhibition%2520elevates%2520circulating%2520sphingosine%25201-phosphate%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D447%26spage%3D149%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Liu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hait, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parikh, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellogg, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span> </span><span class="NLM_article-title">Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e56471</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1371%2Fjournal.pone.0056471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=23437140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsF2ju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e56471&author=K.+Liuauthor=T.+L.+Guoauthor=N.+C.+Haitauthor=J.+Allegoodauthor=H.+I.+Parikhauthor=W.+Xuauthor=G.+E.+Kelloggauthor=S.+Grantauthor=S.+Spiegelauthor=S.+Zhang&title=Biological+characterization+of+3-%282-amino-ethyl%29-5-%5B3-%284-butoxyl-phenyl%29-propylidene%5D-thiazolidine-2%2C4-dione+%28K145%29+as+a+selective+sphingosine+kinase-2+inhibitor+and+anticancer+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent</span></div><div class="casAuthors">Liu, Kai; Guo, Tai L.; Hait, Nitai C.; Allegood, Jeremy; Parikh, Hardik I.; Xu, Wenfang; Kellogg, Glen E.; Grant, Steven; Spiegel, Sarah; Zhang, Shijun</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e56471</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">In our effort to develop selective sphingosine kinase-2 (SphK2) inhibitors as pharmacol. tools, a thiazolidine-2,4-dione analog, 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione(K145), was synthesized and biol. characterized.  Biochem. assay results indicate that K145 is a selective SphK2 inhibitor.  Mol. modeling studies also support this notion.  In vitro studies using human leukemia U937 cells demonstrated that K145 accumulates in U937 cells, suppresses the S1P level, and inhibits SphK2.  K145 also exhibited inhibitory effects on the growth of U937 cells as well as apoptotic effects in U937 cells, and that these effects may be through the inhibition of down-stream ERK and Akt signaling pathways.  K145 also significantly inhibited the growth of U937 tumors in nude mice by both i.p. and oral administration, thus demonstrating its in vivo efficacy as a potential lead anticancer agent.  The antitumor activity of K145 was also confirmed in a syngeneic mouse model by implanting murine breast cancer JC cells in BALB/c mice.  Collectively, these results strongly encourage further optimization of K145 as a novel lead compd. for development of more potent and selective SphK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXIc2J15Fc-bVg90H21EOLACvtfcHk0lg4sAgaC2lXkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsF2ju7s%253D&md5=bddb4fe0ce70a76f3b2adcdcd1cb9ec8</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0056471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0056471%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DGuo%26aufirst%3DT.%2BL.%26aulast%3DHait%26aufirst%3DN.%2BC.%26aulast%3DAllegood%26aufirst%3DJ.%26aulast%3DParikh%26aufirst%3DH.%2BI.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DKellogg%26aufirst%3DG.%2BE.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26atitle%3DBiological%2520characterization%2520of%25203-%25282-amino-ethyl%2529-5-%255B3-%25284-butoxyl-phenyl%2529-propylidene%255D-thiazolidine-2%252C4-dione%2520%2528K145%2529%2520as%2520a%2520selective%2520sphingosine%2520kinase-2%2520inhibitor%2520and%2520anticancer%2520agent%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De56471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">French, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. D.</span><span> </span><span class="NLM_article-title">Antitumor activity of sphingosine kinase inhibitors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">603</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1124%2Fjpet.106.101345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=16632640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD28XnslOlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2006&pages=596-603&author=K.+J.+Frenchauthor=J.+J.+Upsonauthor=S.+N.+Kellerauthor=Y.+Zhuangauthor=J.+K.+Yunauthor=C.+D.+Smith&title=Antitumor+activity+of+sphingosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of sphingosine kinase inhibitors</span></div><div class="casAuthors">French, Kevin J.; Upson, John J.; Keller, Staci N.; Zhuang, Yan; Yun, Jong K.; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">596-603</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingosine kinase (SK) is an oncogenic sphingolipid-metabolizing enzyme that catalyzes the formation of the mitogenic second messenger sphingosine-1-phosphate (S1P) at the expense of proapoptotic ceramide.  Thus, SK is an attractive target for cancer therapy because blockage of S1P formation leads to inhibition of proliferation, as well as the induction of apoptosis in cancer cells.  We have recently identified novel SK inhibitors with nanomolar to low micromolar potencies toward recombinant human SK.  This study describes the continuing anal. of these inhibitors through in vitro and in vivo expts.  All three structurally diverse SK inhibitors tested showed antitumor activity in mice without exhibiting toxicity.  Blood and tumor inhibitor concns. exceeded in vitro potency levels.  Cell signaling analyses in vitro revealed mixed inhibition of mitogen-activated protein kinase kinase and Akt phosphorylation by the SK inhibitors.  Importantly, 4-[4-(4-chloro-phenyl)-thiazol-2-ylamino]-phenol (SKI-II) is orally bioavailable, detected in the blood for at least 8 h, and showed a significant inhibition of tumor growth in mice.  These compds. are the first examples of nonlipid selective inhibitors of SK with in vivo antitumor activity and provide leads for further development of inhibitors of this important mol. target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOz-4ODWl8HbVg90H21EOLACvtfcHk0lg4sAgaC2lXkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnslOlsLs%253D&md5=625e4f9f3c438f2ee00f9039ffb76690</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.101345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.101345%26sid%3Dliteratum%253Aachs%26aulast%3DFrench%26aufirst%3DK.%2BJ.%26aulast%3DUpson%26aufirst%3DJ.%2BJ.%26aulast%3DKeller%26aufirst%3DS.%2BN.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DYun%26aufirst%3DJ.%2BK.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DAntitumor%2520activity%2520of%2520sphingosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D318%26spage%3D596%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Leroux, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auzenne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hail, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spohn, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farquhar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klostergaard, J.</span><span> </span><span class="NLM_article-title">Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1699</span><span class="NLM_x">–</span> <span class="NLM_lpage">1717</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=1699-1717&author=M.+E.+Lerouxauthor=E.+Auzenneauthor=R.+Evansauthor=N.+Hailauthor=W.+Spohnauthor=S.+C.+Ghoshauthor=D.+Farquharauthor=T.+McDonnellauthor=J.+Klostergaard&title=Sphingolipids+and+the+sphingosine+kinase+inhibitor%2C+SKI+II%2C+induce+BCL-2-independent+apoptosis+in+human+prostatic+adenocarcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeroux%26aufirst%3DM.%2BE.%26aulast%3DAuzenne%26aufirst%3DE.%26aulast%3DEvans%26aufirst%3DR.%26aulast%3DHail%26aufirst%3DN.%26aulast%3DSpohn%26aufirst%3DW.%26aulast%3DGhosh%26aufirst%3DS.%2BC.%26aulast%3DFarquhar%26aufirst%3DD.%26aulast%3DMcDonnell%26aufirst%3DT.%26aulast%3DKlostergaard%26aufirst%3DJ.%26atitle%3DSphingolipids%2520and%2520the%2520sphingosine%2520kinase%2520inhibitor%252C%2520SKI%2520II%252C%2520induce%2520BCL-2-independent%2520apoptosis%2520in%2520human%2520prostatic%2520adenocarcinoma%2520cells%26jtitle%3DProstate%26date%3D2007%26volume%3D67%26spage%3D1699%26epage%3D1717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Bektas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poe, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H. S.</span><span> </span><span class="NLM_article-title">A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cells</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1053</span><span class="NLM_x">–</span> <span class="NLM_lpage">1058</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1007%2Fs00280-009-1063-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=19597728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSitLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2009&pages=1053-1058&author=M.+Bektasauthor=S.+P.+Johnsonauthor=W.+E.+Poeauthor=D.+D.+Bignerauthor=H.+S.+Friedman&title=A+sphingosine+kinase+inhibitor+induces+cell+death+in+temozolomide+resistant+glioblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cells</span></div><div class="casAuthors">Bektas, Meryem; Johnson, Stewart P.; Poe, William E.; Bigner, Darell D.; Friedman, Henry S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1053-1058</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Sphingosine kinase is an oncogene that is up-regulated in several solid tumors.  The product of the sphingosine kinase activity, sphingosine-1-phosphate is a potent mitogen involved in diverse cell processes such as cell survival and migration.  Current std. therapy in the treatment of glioblastoma multiforme (GBM) is a combination of surgery, radiation, and chemotherapy using the drug temozolomide (TMZ).  However, virtually all tumors become resistant to TMZ.  Therefore, new drug targets are necessary.  In this study, we investigated whether inhibiting sphingosine kinase could induce cell death in TMZ-resistant GBM cells.  Methods: To study TMZ resistance in vitro, we have generated TMZ-resistant cell lines from established GBM cells.  We used a potent inhibitor of sphingosine kinase to study its effect on colony formation and cell growth in GBM cells with a limited diln. and WST assay.  Moreover, cell death was detd. by measuring caspase-3 activity using flow cytometry.  Results: A sphingosine kinase inhibitor reduced cell colony formation and activated caspase-3 in both TMZ-sensitive and resistant GBM cells.  Conclusion: Addn. of a sphingosine kinase inhibitor to the std. chemotherapy regimen against GBM may be beneficial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofRTn3a_Tk57Vg90H21EOLACvtfcHk0lj0tb0IV59qNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSitLzO&md5=fd6dc751d0ae4ebd5380bbc6c6dd874c</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1007%2Fs00280-009-1063-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-009-1063-0%26sid%3Dliteratum%253Aachs%26aulast%3DBektas%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DS.%2BP.%26aulast%3DPoe%26aufirst%3DW.%2BE.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DFriedman%26aufirst%3DH.%2BS.%26atitle%3DA%2520sphingosine%2520kinase%2520inhibitor%2520induces%2520cell%2520death%2520in%2520temozolomide%2520resistant%2520glioblastoma%2520cells%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2009%26volume%3D64%26spage%3D1053%26epage%3D1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Loveridge, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leclercq, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdyshev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span> </span><span class="NLM_article-title">The sphingosine kinase 1 inhibitor 2-(<i>p</i>-hydroxyanilino)-4-(<i>p</i>-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">38841</span><span class="NLM_x">–</span> <span class="NLM_lpage">38852</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=38841-38852&author=C.+Loveridgeauthor=F.+Tonelliauthor=T.+Leclercqauthor=K.+G.+Limauthor=J.+S.+Longauthor=E.+Berdyshevauthor=R.+J.+Tateauthor=V.+Natarajanauthor=S.+M.+Pitsonauthor=N.+J.+Pyneauthor=S.+Pyne&title=The+sphingosine+kinase+1+inhibitor+2-%28p-hydroxyanilino%29-4-%28p-chlorophenyl%29thiazole+induces+proteasomal+degradation+of+sphingosine+kinase+1+in+mammalian+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLoveridge%26aufirst%3DC.%26aulast%3DTonelli%26aufirst%3DF.%26aulast%3DLeclercq%26aufirst%3DT.%26aulast%3DLim%26aufirst%3DK.%2BG.%26aulast%3DLong%26aufirst%3DJ.%2BS.%26aulast%3DBerdyshev%26aufirst%3DE.%26aulast%3DTate%26aufirst%3DR.%2BJ.%26aulast%3DNatarajan%26aufirst%3DV.%26aulast%3DPitson%26aufirst%3DS.%2BM.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DPyne%26aufirst%3DS.%26atitle%3DThe%2520sphingosine%2520kinase%25201%2520inhibitor%25202-%2528p-hydroxyanilino%2529-4-%2528p-chlorophenyl%2529thiazole%2520induces%2520proteasomal%2520degradation%2520of%2520sphingosine%2520kinase%25201%2520in%2520mammalian%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D38841%26epage%3D38852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Ren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeilschifter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huwiler, A.</span><span> </span><span class="NLM_article-title">A novel mode of action of the putative sphingosine kinase inhibitor 2-(<i>p</i>-hydroxyanilino)-4-(<i>p</i>-chlorophenyl) thiazole (SKI II): induction of lysosomal sphingosine kinase 1 degradation</span> <span class="citation_source-journal">Cell. Physiol. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1159%2F000315110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=20502009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVOms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=97-104&author=S.+Renauthor=C.+Xinauthor=J.+Pfeilschifterauthor=A.+Huwiler&title=A+novel+mode+of+action+of+the+putative+sphingosine+kinase+inhibitor+2-%28p-hydroxyanilino%29-4-%28p-chlorophenyl%29+thiazole+%28SKI+II%29%3A+induction+of+lysosomal+sphingosine+kinase+1+degradation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Mode of Action of the Putative Sphingosine Kinase Inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) Thiazole (SKI II): Induction of Lysosomal Sphingosine Kinase 1 Degradation</span></div><div class="casAuthors">Ren, Shuyu; Xin, Cuiyan; Pfeilschifter, Josef; Huwiler, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-104</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: Sphingosine kinase 1 (SK1) is a key enzyme in the generation of sphingosine 1-phosphate (S1P) which critically regulates a variety of important cell responses such as proliferation and migration.  Therefore, inhibition of SK-1 has been suggested to be an attractive approach to treat tumor growth and metastasis formation.  Results: We show here that the previously developed putative SK-1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole (SKI II) displays an addnl. facet of action complementary to the known inhibition of enzymic SK-1 activity.  In various human cell lines including glomerular podocytes and mesangial cells, the human endothelial cell line EA.hy 926, and the lung cancer cell line NCI H358, SKI II reduced TGFβ- and TPA-stimulated cellular SK-1 activity by downregulating SK-1 protein expression without affecting SK-1 mRNA expression.  By using cycloheximide to block the de novo protein synthesis, the protein expression of SK-1 under untreated conditions was stable over 24h.  Under SKI II treatment, the half-live drastically decreased to approx. 0.8h.  Mechanistically, this degrdn. occurred through a lysosomal pathway and involved cathepsin B since the general lysosomal inhibitor chloroquine and the specific cathepsin B inhibitor CA-074ME were able to reverse the effect of SKI II.  Surprisingly, in vitro SK-1 activity assays revealed only a very weak direct inhibitory effect of SKI II on SK-1 overexpressed HEK293 cell lysates.  Conclusion: These data show for the first time that the previously developed SK inhibitor SKI II hardly inhibits SK-1 directly but rather acts by triggering the lysosomal degrdn. of SK-1 in various cell types.  This finding discloses a new mode of action of SKI II and strongly suggests that addnl. direct targets of SKI II may exist other than SK-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp5euCa4C_ULVg90H21EOLACvtfcHk0lj0tb0IV59qNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVOms78%253D&md5=8c9a34963bce0264bcc1fa13f066bd42</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1159%2F000315110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000315110%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DS.%26aulast%3DXin%26aufirst%3DC.%26aulast%3DPfeilschifter%26aufirst%3DJ.%26aulast%3DHuwiler%26aufirst%3DA.%26atitle%3DA%2520novel%2520mode%2520of%2520action%2520of%2520the%2520putative%2520sphingosine%2520kinase%2520inhibitor%25202-%2528p-hydroxyanilino%2529-4-%2528p-chlorophenyl%2529%2520thiazole%2520%2528SKI%2520II%2529%253A%2520induction%2520of%2520lysosomal%2520sphingosine%2520kinase%25201%2520degradation%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2010%26volume%3D26%26spage%3D97%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Antoon, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meacham, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bratton, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaughter, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashe, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burow, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckman, B. S.</span><span> </span><span class="NLM_article-title">Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer</span> <span class="citation_source-journal">J. Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1530%2FJME-10-0116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=21321095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovV2hsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=205-216&author=J.+W.+Antoonauthor=W.+D.+Meachamauthor=M.+R.+Brattonauthor=E.+M.+Slaughterauthor=L.+V.+Rhodesauthor=H.+B.+Asheauthor=T.+E.+Wieseauthor=M.+E.+Burowauthor=B.+S.+Beckman&title=Pharmacological+inhibition+of+sphingosine+kinase+isoforms+alters+estrogen+receptor+signaling+in+human+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer</span></div><div class="casAuthors">Antoon, James W.; Meacham, William D.; Bratton, Melyssa R.; Slaughter, Evelyn M.; Rhodes, Lyndsay V.; Ashe, Hasina B.; Wiese, Thomas E.; Burow, Matthew E.; Beckman, Barbara S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">205-216</span>CODEN:
                <span class="NLM_cas:coden">JMLEEI</span>;
        ISSN:<span class="NLM_cas:issn">0952-5041</span>.
    
            (<span class="NLM_cas:orgname">BioScientifica Ltd.</span>)
        </div><div class="casAbstract">Recently, crosstalk between sphingolipid signaling pathways and steroid hormones has been illuminated as a possible therapeutic target.  Sphingosine kinase (SK), the key enzyme metabolizing pro-apoptotic ceramide to pro-survival sphingosine-1-phosphate (S1P), is a promising therapeutic target for solid tumor cancers.  In this study, we examd. the ability of pharmacol. inhibition of S1P formation to block estrogen signaling as a targeted breast cancer therapy.  We found that the Sphk1/2 selective inhibitor (SK inhibitor (SKI))-II, blocked breast cancer viability, clonogenic survival and proliferation.  Furthermore, SKI-II dose-dependently decreased estrogen-stimulated estrogen response element transcriptional activity and diminished mRNA levels of the estrogen receptor (ER)-regulated genes progesterone receptor and steroid derived factor-1.  This inhibitor binds the ER directly in the antagonist ligand-binding domain.  Taken together, our results suggest that SKIs have the ability to act as novel ER signaling inhibitors in breast carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbB00lH8kWNbVg90H21EOLACvtfcHk0lgqvPTNNRR80g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovV2hsLo%253D&md5=1c5c38f99375e272468b1c567f25b156</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1530%2FJME-10-0116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252FJME-10-0116%26sid%3Dliteratum%253Aachs%26aulast%3DAntoon%26aufirst%3DJ.%2BW.%26aulast%3DMeacham%26aufirst%3DW.%2BD.%26aulast%3DBratton%26aufirst%3DM.%2BR.%26aulast%3DSlaughter%26aufirst%3DE.%2BM.%26aulast%3DRhodes%26aufirst%3DL.%2BV.%26aulast%3DAshe%26aufirst%3DH.%2BB.%26aulast%3DWiese%26aufirst%3DT.%2BE.%26aulast%3DBurow%26aufirst%3DM.%2BE.%26aulast%3DBeckman%26aufirst%3DB.%2BS.%26atitle%3DPharmacological%2520inhibition%2520of%2520sphingosine%2520kinase%2520isoforms%2520alters%2520estrogen%2520receptor%2520signaling%2520in%2520human%2520breast%2520cancer%26jtitle%3DJ.%2520Mol.%2520Endocrinol.%26date%3D2011%26volume%3D46%26spage%3D205%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Sharma, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sk, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimbor, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hengst, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amin, S.</span><span> </span><span class="NLM_article-title">Synthesis and bioactivity of sphingosine kinase inhibitors and their novel aspirinyl conjugated analogs</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4149</span><span class="NLM_x">–</span> <span class="NLM_lpage">4156</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=4149-4156&author=A.+K.+Sharmaauthor=U.+H.+Skauthor=M.+A.+Gimborauthor=J.+A.+Hengstauthor=X.+Wangauthor=J.+Yunauthor=S.+Amin&title=Synthesis+and+bioactivity+of+sphingosine+kinase+inhibitors+and+their+novel+aspirinyl+conjugated+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DSk%26aufirst%3DU.%2BH.%26aulast%3DGimbor%26aufirst%3DM.%2BA.%26aulast%3DHengst%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DYun%26aufirst%3DJ.%26aulast%3DAmin%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520bioactivity%2520of%2520sphingosine%2520kinase%2520inhibitors%2520and%2520their%2520novel%2520aspirinyl%2520conjugated%2520analogs%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D4149%26epage%3D4156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Hengst, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sk, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, J. K.</span><span> </span><span class="NLM_article-title">Development of a sphingosine kinase 1 specific small-molecule inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7498</span><span class="NLM_x">–</span> <span class="NLM_lpage">7502</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7498-7502&author=J.+A.+Hengstauthor=X.+Wangauthor=U.+H.+Skauthor=A.+K.+Sharmaauthor=S.+Aminauthor=J.+K.+Yun&title=Development+of+a+sphingosine+kinase+1+specific+small-molecule+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHengst%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSk%26aufirst%3DU.%2BH.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DYun%26aufirst%3DJ.%2BK.%26atitle%3DDevelopment%2520of%2520a%2520sphingosine%2520kinase%25201%2520specific%2520small-molecule%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7498%26epage%3D7502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">French, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maines, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beljanski, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. D.</span><span> </span><span class="NLM_article-title">Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1124%2Fjpet.109.163444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=20061445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFGktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=129-139&author=K.+J.+Frenchauthor=Y.+Zhuangauthor=L.+W.+Mainesauthor=P.+Gaoauthor=W.+Wangauthor=V.+Beljanskiauthor=J.+J.+Upsonauthor=C.+L.+Greenauthor=S.+N.+Kellerauthor=C.+D.+Smith&title=Pharmacology+and+antitumor+activity+of+ABC294640%2C+a+selective+inhibitor+of+sphingosine+kinase-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2</span></div><div class="casAuthors">French, Kevin J.; Zhuang, Yan; Maines, Lynn W.; Gao, Peng; Wang, Wenxue; Beljanski, Vladimir; Upson, John J.; Green, Cecelia L.; Keller, Staci N.; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-139</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingolipid-metabolizing enzymes control the dynamic balance of the cellular levels of important bioactive lipids, including the apoptotic compd. ceramide and the proliferative compd. sphingosine 1-phosphate (S1P).  Many growth factors and inflammatory cytokines promote the cleavage of sphingomyelin and ceramide leading to rapid elevation of S1P levels through the action of sphingosine kinases (SK1 and SK2).  SK1 and SK2 are overexpressed in a variety of human cancers, making these enzymes potential mol. targets for cancer therapy.  We have identified an aryladamantane compd., termed ABC294640 [3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide], that selectively inhibits SK2 activity in vitro, acting as a competitive inhibitor with respect to sphingosine with a Ki of 9.8 μM, and attenuates S1P formation in intact cells.  In tissue culture, ABC294640 suppresses the proliferation of a broad panel of tumor cell lines, and inhibits tumor cell migration concomitant with loss of microfilaments.  In vivo, ABC294640 has excellent oral bioavailability, and demonstrates a plasma clearance half-time of 4.5 h in mice.  Acute and chronic toxicol. studies indicate that ABC294640 induces a transient minor decrease in the hematocrit of rats and mice; however, this normalizes by 28 days of treatment.  No other changes in hematol. parameters, or gross or microscopic tissue pathol., result from treatment with ABC294640.  Oral administration of ABC294640 to mice bearing mammary adenocarcinoma xenografts results in dose-dependent antitumor activity assocd. with depletion of S1P levels in the tumors and progressive tumor cell apoptosis.  Therefore, this newly developed SK2 inhibitor provides an orally available drug candidate for the treatment of cancer and other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsJFYxYhWjhbVg90H21EOLACvtfcHk0liNuwIEwun8Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFGktro%253D&md5=63e0792b887d9ad70c76f209e577a693</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.163444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.163444%26sid%3Dliteratum%253Aachs%26aulast%3DFrench%26aufirst%3DK.%2BJ.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DMaines%26aufirst%3DL.%2BW.%26aulast%3DGao%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DBeljanski%26aufirst%3DV.%26aulast%3DUpson%26aufirst%3DJ.%2BJ.%26aulast%3DGreen%26aufirst%3DC.%2BL.%26aulast%3DKeller%26aufirst%3DS.%2BN.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DPharmacology%2520and%2520antitumor%2520activity%2520of%2520ABC294640%252C%2520a%2520selective%2520inhibitor%2520of%2520sphingosine%2520kinase-2%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D129%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Beljanski, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knaak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. D.</span><span> </span><span class="NLM_article-title">A novel sphingosine kinase inhibitor induces autophagy in tumor cells</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">454</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1124%2Fjpet.109.163337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=20179157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFKhtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=454-464&author=V.+Beljanskiauthor=C.+Knaakauthor=C.+D.+Smith&title=A+novel+sphingosine+kinase+inhibitor+induces+autophagy+in+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">A novel sphingosine kinase inhibitor induces autophagy in tumor cells</span></div><div class="casAuthors">Beljanski, Vladimir; Knaak, Christian; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">454-464</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The sphingolipids ceramide, sphingosine, and sphingosine 1-phosphate (S1P) regulate cell signaling, proliferation, apoptosis, and autophagy.  Sphingosine kinase-1 and -2 (SK1 and SK2) phosphorylate sphingosine to form S1P, shifting the balanced activity of these lipids toward cell proliferation.  We have previously reported that pharmacol. inhibition of SK activity delays tumor growth in vivo.  The present studies demonstrate that the SK2-selective inhibitor 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide (ABC294640) induces nonapoptotic cell death that is preceded by microtubule-assocd. protein light chain 3 cleavage, morphol. changes in lysosomes, formation of autophagosomes, and increases in acidic vesicles in A-498 kidney carcinoma cells.  ABC294640 caused similar autophagic responses in PC-3 prostate and MDA-MB-231 breast adenocarcinoma cells.  Simultaneous exposure of A-498 cells to ABC294640 and 3-methyladenine, an inhibitor of autophagy, switched the mechanism of toxicity to apoptosis, but decreased the potency of the SK2 inhibitor, indicating that autophagy is a major mechanism for tumor cell killing by this compd.  Induction of the unfolded protein response by the proteasome inhibitor N-(benzyloxycarbonyl)leucinylleucinylleucinal Z-Leu-Leu-Leu-al (MG-132) or the heat shock protein 90 inhibitor geldanamycin synergistically increased the cytotoxicity of ABC294640 in vitro.  In severe combined immunodeficient mice bearing A-498 xenografts, daily administration of ABC294640 delayed tumor growth and elevated autophagy markers, but did not increase terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling-pos. cells in the tumors.  These data suggest that ABC294640 promotes tumor cell autophagy, which ultimately results in nonapoptotic cell death and a delay of tumor growth in vivo.  Consequently, ABC294640 may effectively complement anticancer drugs that induce tumor cell apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKrohC6YQacrVg90H21EOLACvtfcHk0liNuwIEwun8Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFKhtb4%253D&md5=5a3545b993705f7a1f16f9d3c9567061</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.163337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.163337%26sid%3Dliteratum%253Aachs%26aulast%3DBeljanski%26aufirst%3DV.%26aulast%3DKnaak%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DA%2520novel%2520sphingosine%2520kinase%2520inhibitor%2520induces%2520autophagy%2520in%2520tumor%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D454%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Antoon, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meacham, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaughter, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashe, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burow, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckman, B. S.</span><span> </span><span class="NLM_article-title">Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">5124</span><span class="NLM_x">–</span> <span class="NLM_lpage">5135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2010&pages=5124-5135&author=J.+W.+Antoonauthor=M.+D.+Whiteauthor=W.+D.+Meachamauthor=E.+M.+Slaughterauthor=S.+E.+Muirauthor=S.+Elliottauthor=L.+V.+Rhodesauthor=H.+B.+Asheauthor=T.+E.+Wieseauthor=C.+D.+Smithauthor=M.+E.+Burowauthor=B.+S.+Beckman&title=Antiestrogenic+effects+of+the+novel+sphingosine+kinase-2+inhibitor+ABC294640"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAntoon%26aufirst%3DJ.%2BW.%26aulast%3DWhite%26aufirst%3DM.%2BD.%26aulast%3DMeacham%26aufirst%3DW.%2BD.%26aulast%3DSlaughter%26aufirst%3DE.%2BM.%26aulast%3DMuir%26aufirst%3DS.%2BE.%26aulast%3DElliott%26aufirst%3DS.%26aulast%3DRhodes%26aufirst%3DL.%2BV.%26aulast%3DAshe%26aufirst%3DH.%2BB.%26aulast%3DWiese%26aufirst%3DT.%2BE.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26aulast%3DBurow%26aufirst%3DM.%2BE.%26aulast%3DBeckman%26aufirst%3DB.%2BS.%26atitle%3DAntiestrogenic%2520effects%2520of%2520the%2520novel%2520sphingosine%2520kinase-2%2520inhibitor%2520ABC294640%26jtitle%3DEndocrinology%26date%3D2010%26volume%3D151%26spage%3D5124%26epage%3D5135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Antoon, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaughter, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driver, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khalili, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burow, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckman, B. S.</span><span> </span><span class="NLM_article-title">Targeting NFkB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">678</span><span class="NLM_x">–</span> <span class="NLM_lpage">689</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.4161%2Fcbt.11.7.14903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=21307639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlslKqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=678-689&author=J.+W.+Antoonauthor=M.+D.+Whiteauthor=E.+M.+Slaughterauthor=J.+L.+Driverauthor=H.+S.+Khaliliauthor=S.+Elliottauthor=C.+D.+Smithauthor=M.+E.+Burowauthor=B.+S.+Beckman&title=Targeting+NFkB+mediated+breast+cancer+chemoresistance+through+selective+inhibition+of+sphingosine+kinase-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting NFκB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2</span></div><div class="casAuthors">Antoon, James W.; White, Martin D.; Slaughter, Evelyn M.; Driver, Jennifer L.; Khalili, Hafez S.; Elliott, Steven; Smith, Charles D.; Burow, Matthew E.; Beckman, Barbara S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">678-689</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Resistance to chemotherapy remains a significant obstacle in the treatment of hormone-independent breast cancer.  Recent evidence suggests that altered sphingolipid signaling through increased sphingosine kinase activity may be an important mediator of breast cancer drug resistance.  Sphingosine kinase-1 (Sphk1) is a proposed key regulator of breast cancer tumorigenesis, proliferation and resistance.  There is, however, conflicting data on the role of sphingosine kinase-2 (Sphk2) in cancer biol. and resistance, with some suggesting that Sphk2 has an opposing role to that of Sphk1.  Here, we studied the effects of the novel selective Sphk2 inhibitor, ABC294640 (3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl) amide), on human breast cancer.  ABC294640 blocked both viability and survival at low micromolar IC50 concns. in the endocrine therapy-resistant MDA-MB-231 and chemoresistant MCF-7TN-R cell systems.  Treatment with the inhibitor significantly reduced proliferation, as seen in immunofluorescence staining of Ki-67 in vitro.  Interestingly, pharmacol. inhibition of Sphk2 induced apoptosis through the intrinsic programmed cell death pathway.  Furthermore, ABC294640 also diminished NFκB survival signaling, through decreased activation of the Ser536 phosphorylation site on the p65 subunit.  Xenografts of MCF-7TN-R cells growing in immunocompromised mice were utilized to validate the therapeutic efficacy of the sphingosine kinase-2 inhibitor.  Treatment with 50 mg of ABC294640/kg completely blocked tumor vol. in this model.  These results indicate that pharmacol. inhibition of Sphk2 with the orally bioavailable selective inhibitor, ABC294640, has therapeutic potential in the treatment of chemo- and endocrine therapy-resistant breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_Xeo_aYQALrVg90H21EOLACvtfcHk0liNuwIEwun8Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlslKqtbc%253D&md5=998f07f58fad7fb0852fc972e5ecf445</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.4161%2Fcbt.11.7.14903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.11.7.14903%26sid%3Dliteratum%253Aachs%26aulast%3DAntoon%26aufirst%3DJ.%2BW.%26aulast%3DWhite%26aufirst%3DM.%2BD.%26aulast%3DSlaughter%26aufirst%3DE.%2BM.%26aulast%3DDriver%26aufirst%3DJ.%2BL.%26aulast%3DKhalili%26aufirst%3DH.%2BS.%26aulast%3DElliott%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26aulast%3DBurow%26aufirst%3DM.%2BE.%26aulast%3DBeckman%26aufirst%3DB.%2BS.%26atitle%3DTargeting%2520NFkB%2520mediated%2520breast%2520cancer%2520chemoresistance%2520through%2520selective%2520inhibition%2520of%2520sphingosine%2520kinase-2%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2011%26volume%3D11%26spage%3D678%26epage%3D689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Beljanski, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knaak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. D.</span><span> </span><span class="NLM_article-title">Combined anticancer effects of sphingosine kinase inhibitors and sorafenib</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1132</span><span class="NLM_x">–</span> <span class="NLM_lpage">1142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1132-1142&author=V.+Beljanskiauthor=C.+Knaakauthor=Y.+Zhuangauthor=C.+D.+Smith&title=Combined+anticancer+effects+of+sphingosine+kinase+inhibitors+and+sorafenib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeljanski%26aufirst%3DV.%26aulast%3DKnaak%26aufirst%3DC.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DCombined%2520anticancer%2520effects%2520of%2520sphingosine%2520kinase%2520inhibitors%2520and%2520sorafenib%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2011%26volume%3D29%26spage%3D1132%26epage%3D1142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Gao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. D.</span><span> </span><span class="NLM_article-title">Characterization of isoenzyme-selective inhibitors of human sphingosine kinases</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e44543</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e44543&author=P.+Gaoauthor=Y.+K.+Petersonauthor=R.+A.+Smithauthor=C.+D.+Smith&title=Characterization+of+isoenzyme-selective+inhibitors+of+human+sphingosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DP.%26aulast%3DPeterson%26aufirst%3DY.%2BK.%26aulast%3DSmith%26aufirst%3DR.%2BA.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DCharacterization%2520of%2520isoenzyme-selective%2520inhibitors%2520of%2520human%2520sphingosine%2520kinases%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De44543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, K. K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickrell, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frohn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanman, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElvain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnett, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cee, V. J.</span><span> </span><span class="NLM_article-title">4-Methoxy-<i>N</i>-[2-(trifluoromethyl)biphenyl-4-ylcarbamoyl]nicotinamide: a potent and selective agonist of S1P1</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">752</span><span class="NLM_x">–</span> <span class="NLM_lpage">757</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml2001399" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=752-757&author=L.+D.+Penningtonauthor=K.+K.+C.+Shamauthor=A.+J.+Pickrellauthor=P.+E.+Harringtonauthor=M.+J.+Frohnauthor=B.+A.+Lanmanauthor=A.+B.+Reedauthor=M.+D.+Croghanauthor=M.+R.+Leeauthor=H.+Xuauthor=M.+McElvainauthor=Y.+Xuauthor=X.+Zhangauthor=M.+Fiorinoauthor=M.+Hornerauthor=H.+G.+Morrisonauthor=H.+A.+Arnettauthor=C.+Fotschauthor=M.+Wongauthor=V.+J.+Cee&title=4-Methoxy-N-%5B2-%28trifluoromethyl%29biphenyl-4-ylcarbamoyl%5Dnicotinamide%3A+a+potent+and+selective+agonist+of+S1P1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fml2001399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2001399%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DSham%26aufirst%3DK.%2BK.%2BC.%26aulast%3DPickrell%26aufirst%3DA.%2BJ.%26aulast%3DHarrington%26aufirst%3DP.%2BE.%26aulast%3DFrohn%26aufirst%3DM.%2BJ.%26aulast%3DLanman%26aufirst%3DB.%2BA.%26aulast%3DReed%26aufirst%3DA.%2BB.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DMcElvain%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DFiorino%26aufirst%3DM.%26aulast%3DHorner%26aufirst%3DM.%26aulast%3DMorrison%26aufirst%3DH.%2BG.%26aulast%3DArnett%26aufirst%3DH.%2BA.%26aulast%3DFotsch%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26atitle%3D4-Methoxy-N-%255B2-%2528trifluoromethyl%2529biphenyl-4-ylcarbamoyl%255Dnicotinamide%253A%2520a%2520potent%2520and%2520selective%2520agonist%2520of%2520S1P1%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D752%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Kurata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shioya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habashita, H.</span><span> </span><span class="NLM_article-title">Discovery of S1P agonists with a dihydronaphthalene scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3885</span><span class="NLM_x">–</span> <span class="NLM_lpage">3889</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3885-3889&author=H.+Kurataauthor=K.+Kusumiauthor=K.+Otsukiauthor=R.+Suzukiauthor=M.+Kuronoauthor=Y.+Takadaauthor=H.+Shioyaauthor=T.+Komiyaauthor=H.+Mizunoauthor=T.+Onoauthor=H.+Hagiyaauthor=M.+Minamiauthor=S.+Nakadeauthor=H.+Habashita&title=Discovery+of+S1P+agonists+with+a+dihydronaphthalene+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DKusumi%26aufirst%3DK.%26aulast%3DOtsuki%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DKurono%26aufirst%3DM.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DShioya%26aufirst%3DH.%26aulast%3DKomiya%26aufirst%3DT.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DT.%26aulast%3DHagiya%26aufirst%3DH.%26aulast%3DMinami%26aufirst%3DM.%26aulast%3DNakade%26aufirst%3DS.%26aulast%3DHabashita%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520S1P%2520agonists%2520with%2520a%2520dihydronaphthalene%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3885%26epage%3D3889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Kurata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shioya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habashita, H.</span><span> </span><span class="NLM_article-title">Structure–activity relationship studies of S1P agonists with a dihydronaphthalene scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=144-148&author=H.+Kurataauthor=K.+Kusumiauthor=K.+Otsukiauthor=R.+Suzukiauthor=M.+Kuronoauthor=N.+Tokudaauthor=Y.+Takadaauthor=H.+Shioyaauthor=H.+Mizunoauthor=T.+Komiyaauthor=T.+Onoauthor=H.+Hagiyaauthor=M.+Minamiauthor=S.+Nakadeauthor=H.+Habashita&title=Structure%E2%80%93activity+relationship+studies+of+S1P+agonists+with+a+dihydronaphthalene+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DKusumi%26aufirst%3DK.%26aulast%3DOtsuki%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DKurono%26aufirst%3DM.%26aulast%3DTokuda%26aufirst%3DN.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DShioya%26aufirst%3DH.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DKomiya%26aufirst%3DT.%26aulast%3DOno%26aufirst%3DT.%26aulast%3DHagiya%26aufirst%3DH.%26aulast%3DMinami%26aufirst%3DM.%26aulast%3DNakade%26aufirst%3DS.%26aulast%3DHabashita%26aufirst%3DH.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520studies%2520of%2520S1P%2520agonists%2520with%2520a%2520dihydronaphthalene%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D144%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Kurata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terakado, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habashita, H.</span><span> </span><span class="NLM_article-title">Structure–activity relationship studies of sphingosine-1-phosphate receptor agonists with <i>N</i>-cinnamyl-beta-alanine moiety</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1390</span><span class="NLM_x">–</span> <span class="NLM_lpage">1393</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1390-1393&author=H.+Kurataauthor=K.+Otsukiauthor=K.+Kusumiauthor=M.+Kuronoauthor=M.+Terakadoauthor=T.+Sekoauthor=H.+Mizunoauthor=T.+Onoauthor=H.+Hagiyaauthor=M.+Minamiauthor=S.+Nakadeauthor=H.+Habashita&title=Structure%E2%80%93activity+relationship+studies+of+sphingosine-1-phosphate+receptor+agonists+with+N-cinnamyl-beta-alanine+moiety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DOtsuki%26aufirst%3DK.%26aulast%3DKusumi%26aufirst%3DK.%26aulast%3DKurono%26aufirst%3DM.%26aulast%3DTerakado%26aufirst%3DM.%26aulast%3DSeko%26aufirst%3DT.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DT.%26aulast%3DHagiya%26aufirst%3DH.%26aulast%3DMinami%26aufirst%3DM.%26aulast%3DNakade%26aufirst%3DS.%26aulast%3DHabashita%26aufirst%3DH.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520studies%2520of%2520sphingosine-1-phosphate%2520receptor%2520agonists%2520with%2520N-cinnamyl-beta-alanine%2520moiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1390%26epage%3D1393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.+Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0lizCBG1LpFGNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.%2BY.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Sanada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizushima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uejima, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span> </span><span class="NLM_article-title">Therapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e23933</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e23933&author=Y.+Sanadaauthor=T.+Mizushimaauthor=Y.+Kaiauthor=J.+Nishimuraauthor=H.+Hagiyaauthor=H.+Kurataauthor=H.+Mizunoauthor=E.+Uejimaauthor=T.+Ito&title=Therapeutic+effects+of+novel+sphingosine-1-phosphate+receptor+agonist+W-061+in+murine+DSS+colitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanada%26aufirst%3DY.%26aulast%3DMizushima%26aufirst%3DT.%26aulast%3DKai%26aufirst%3DY.%26aulast%3DNishimura%26aufirst%3DJ.%26aulast%3DHagiya%26aufirst%3DH.%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DUejima%26aufirst%3DE.%26aulast%3DIto%26aufirst%3DT.%26atitle%3DTherapeutic%2520effects%2520of%2520novel%2520sphingosine-1-phosphate%2520receptor%2520agonist%2520W-061%2520in%2520murine%2520DSS%2520colitis%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De23933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Kotelevets, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huwiler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zangemeister-Wittke, U.</span><span> </span><span class="NLM_article-title">Targeting sphingosine kinase 1 in carcinoma cells decreases proliferation and survival by compromising PKC activity and cytokinesis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e39209</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e39209&author=N.+Kotelevetsauthor=D.+Fabbroauthor=A.+Huwilerauthor=U.+Zangemeister-Wittke&title=Targeting+sphingosine+kinase+1+in+carcinoma+cells+decreases+proliferation+and+survival+by+compromising+PKC+activity+and+cytokinesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKotelevets%26aufirst%3DN.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DHuwiler%26aufirst%3DA.%26aulast%3DZangemeister-Wittke%26aufirst%3DU.%26atitle%3DTargeting%2520sphingosine%2520kinase%25201%2520in%2520carcinoma%2520cells%2520decreases%2520proliferation%2520and%2520survival%2520by%2520compromising%2520PKC%2520activity%2520and%2520cytokinesis%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De39209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Cragg, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snader, K. M.</span><span> </span><span class="NLM_article-title">Natural products in drug discovery and development</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks">[<a href="/doi/10.1021/np9604893" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADyaK2sXitVOiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1997&pages=52-60&author=G.+M.+Craggauthor=D.+J.+Newmanauthor=K.+M.+Snader&title=Natural+products+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products in Drug Discovery and Development</span></div><div class="casAuthors">Cragg, Gordon M.; Newman, David J.; Snader, Kenneth M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-60</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, with 38 refs., highlighting the invaluable role that natural products have played, and continue to play, in the drug discovery process, particularly in the areas of cancer and infectious diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrydB_TVNym8rVg90H21EOLACvtfcHk0lizCBG1LpFGNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitVOiug%253D%253D&md5=944832f883f1b8f3e54f2abe8cdc851e</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1021%2Fnp9604893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp9604893%26sid%3Dliteratum%253Aachs%26aulast%3DCragg%26aufirst%3DG.%2BM.%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DSnader%26aufirst%3DK.%2BM.%26atitle%3DNatural%2520products%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1997%26volume%3D60%26spage%3D52%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Kuroda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtani, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichiba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gravalos, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higa, T.</span><span> </span><span class="NLM_article-title">Pachastrissamine, a cytotoxic anhydrophytosphingosine from a marine sponge, <i>Pachastrissa</i> sp</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1505</span><span class="NLM_x">–</span> <span class="NLM_lpage">1506</span></span><div class="citationLinks">[<a href="/doi/10.1021/np010659y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2002&pages=1505-1506&author=I.+Kurodaauthor=M.+Musmanauthor=I.+I.+Ohtaniauthor=T.+Ichibaauthor=J.+Tanakaauthor=D.+G.+Gravalosauthor=T.+Higa&title=Pachastrissamine%2C+a+cytotoxic+anhydrophytosphingosine+from+a+marine+sponge%2C+Pachastrissa+sp"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fnp010659y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp010659y%26sid%3Dliteratum%253Aachs%26aulast%3DKuroda%26aufirst%3DI.%26aulast%3DMusman%26aufirst%3DM.%26aulast%3DOhtani%26aufirst%3DI.%2BI.%26aulast%3DIchiba%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DJ.%26aulast%3DGravalos%26aufirst%3DD.%2BG.%26aulast%3DHiga%26aufirst%3DT.%26atitle%3DPachastrissamine%252C%2520a%2520cytotoxic%2520anhydrophytosphingosine%2520from%2520a%2520marine%2520sponge%252C%2520Pachastrissa%2520sp%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2002%26volume%3D65%26spage%3D1505%26epage%3D1506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Ballereau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baltas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genisson, Y.</span><span> </span><span class="NLM_article-title">Sphingolipids cyclic derivatives: occurrence, biological relevance and synthetic approaches</span> <span class="citation_source-journal">Curr. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">986</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.2174%2F138527211794785127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslajsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=953-986&author=S.+Ballereauauthor=M.+Baltasauthor=Y.+Genisson&title=Sphingolipids+cyclic+derivatives%3A+occurrence%2C+biological+relevance+and+synthetic+approaches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipids cyclic derivatives: occurrence, biological relevance and synthetic approaches</span></div><div class="casAuthors">Ballereau, Stephanie; Baltas, Michel; Genisson, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Current Organic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">953-986</span>CODEN:
                <span class="NLM_cas:coden">CORCFE</span>;
        ISSN:<span class="NLM_cas:issn">1385-2728</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids (SLs) are ubiquitous membrane constituents that have emerged as essential lipid mediators involved in signal transduction and cancer development.  Due to the implication of SLs in the alteration of cell proliferation, adhesion or migration, their metab. has been targeted in search for novel anti-cancer therapeutic approaches.  In this context, much attention has been directed towards SLs analogs interfering with these complex signalization pathways as well as the immune system.  A general structural modulation of the basic sphingosine backbone of SLs concerns its cyclization into various types of conformationally constrained derivs.  Different series of both natural and synthetic compds. can be considered according to this common structural feature.  The present review article lists these naturally occurring sphingolipids cyclic derivs. including anhydrophytosphingosine-type marine products pachastrissamine (jaspine B), penaresidine/penazetidine, broussonetine, prosopine/prosopinine/prosophylline derivs., as well as conceptually related synthetic products.  A brief statement of their biol. activity is presented.  Detailed informations concerning the org. synthetic aspects are given with emphasize on the natural azetidine, pyrrolidine and synthetic analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7RgSbMAIUX7Vg90H21EOLACvtfcHk0lhcb2IfwmU8Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslajsLY%253D&md5=e68deca66265b3572ed01fd8e5f629b8</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.2174%2F138527211794785127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138527211794785127%26sid%3Dliteratum%253Aachs%26aulast%3DBallereau%26aufirst%3DS.%26aulast%3DBaltas%26aufirst%3DM.%26aulast%3DGenisson%26aufirst%3DY.%26atitle%3DSphingolipids%2520cyclic%2520derivatives%253A%2520occurrence%252C%2520biological%2520relevance%2520and%2520synthetic%2520approaches%26jtitle%3DCurr.%2520Org.%2520Chem.%26date%3D2011%26volume%3D15%26spage%3D953%26epage%3D986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Yoshimitsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span> </span><span class="NLM_article-title">Pachastrissamine (jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5402</span><span class="NLM_x">–</span> <span class="NLM_lpage">5408</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=5402-5408&author=Y.+Yoshimitsuauthor=S.+Oishiauthor=J.+Miyagakiauthor=S.+Inukiauthor=H.+Ohnoauthor=N.+Fujii&title=Pachastrissamine+%28jaspine+B%29+and+its+stereoisomers+inhibit+sphingosine+kinases+and+atypical+protein+kinase+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimitsu%26aufirst%3DY.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DMiyagaki%26aufirst%3DJ.%26aulast%3DInuki%26aufirst%3DS.%26aulast%3DOhno%26aufirst%3DH.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DPachastrissamine%2520%2528jaspine%2520B%2529%2520and%2520its%2520stereoisomers%2520inhibit%2520sphingosine%2520kinases%2520and%2520atypical%2520protein%2520kinase%2520C%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D5402%26epage%3D5408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Ledroit, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debitus, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavaud, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massiot, G.</span><span> </span><span class="NLM_article-title">Jaspines A and B: two new cytotoxic sphingosine derivatives from the marine sponge Jaspis sp</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=225-228&author=V.+Ledroitauthor=C.+Debitusauthor=C.+Lavaudauthor=G.+Massiot&title=Jaspines+A+and+B%3A+two+new+cytotoxic+sphingosine+derivatives+from+the+marine+sponge+Jaspis+sp"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLedroit%26aufirst%3DV.%26aulast%3DDebitus%26aufirst%3DC.%26aulast%3DLavaud%26aufirst%3DC.%26aulast%3DMassiot%26aufirst%3DG.%26atitle%3DJaspines%2520A%2520and%2520B%253A%2520two%2520new%2520cytotoxic%2520sphingosine%2520derivatives%2520from%2520the%2520marine%2520sponge%2520Jaspis%2520sp%26jtitle%3DTetrahedron%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D225%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Salma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therville, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpentier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnafe, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levade, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genisson, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrieu-Abadie, N.</span><span> </span><span class="NLM_article-title">The natural marine anhydrophytosphingosine, Jaspine B, induces apoptosis in melanoma cells by interfering with ceramide metabolism</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">485</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=477-485&author=Y.+Salmaauthor=E.+Lafontauthor=N.+Thervilleauthor=S.+Carpentierauthor=M.+J.+Bonnafeauthor=T.+Levadeauthor=Y.+Genissonauthor=N.+Andrieu-Abadie&title=The+natural+marine+anhydrophytosphingosine%2C+Jaspine+B%2C+induces+apoptosis+in+melanoma+cells+by+interfering+with+ceramide+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalma%26aufirst%3DY.%26aulast%3DLafont%26aufirst%3DE.%26aulast%3DTherville%26aufirst%3DN.%26aulast%3DCarpentier%26aufirst%3DS.%26aulast%3DBonnafe%26aufirst%3DM.%2BJ.%26aulast%3DLevade%26aufirst%3DT.%26aulast%3DGenisson%26aufirst%3DY.%26aulast%3DAndrieu-Abadie%26aufirst%3DN.%26atitle%3DThe%2520natural%2520marine%2520anhydrophytosphingosine%252C%2520Jaspine%2520B%252C%2520induces%2520apoptosis%2520in%2520melanoma%2520cells%2520by%2520interfering%2520with%2520ceramide%2520metabolism%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D477%26epage%3D485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Yoo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. Y.</span><span> </span><span class="NLM_article-title">Pachastrissamine from <i>Pachastrissa</i> sp. inhibits melanoma cell growth by dual inhibition of Cdk2 and ERK-mediated FOXO3 downregulation</span> <span class="citation_source-journal">Phytother. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1927</span><span class="NLM_x">–</span> <span class="NLM_lpage">1933</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1002%2Fptr.4673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=22451302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVeksL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=1927-1933&author=H.+Yooauthor=Y.+S.+Leeauthor=S.+Leeauthor=S.+Kimauthor=T.+Y.+Kim&title=Pachastrissamine+from+Pachastrissa+sp.+inhibits+melanoma+cell+growth+by+dual+inhibition+of+Cdk2+and+ERK-mediated+FOXO3+downregulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Pachastrissamine from Pachastrissa sp. Inhibits Melanoma Cell Growth by Dual Inhibition of Cdk2 and ERK-mediated FOXO3 Downregulation</span></div><div class="casAuthors">Yoo, Hyun; Lee, Yun Sang; Lee, Sukjin; Kim, Sanghee; Kim, Tae-Yoon</div><div class="citationInfo"><span class="NLM_cas:title">Phytotherapy Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1927-1933</span>CODEN:
                <span class="NLM_cas:coden">PHYREH</span>;
        ISSN:<span class="NLM_cas:issn">0951-418X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Melanoma cells are relatively resistant to apoptosis compared with other tumor cell types, and thus, chemotherapy, radiotherapy and immunotherapy are not effective in treating melanoma.  Pachastrissamine (PA) exhibits cytotoxic activity and promotes apoptosis in several cancer cells.  However, its specific mol. mechanisms have not been characterized fully.  This study investigated the antimelanoma effect of PA, an anhydrophytosphingosine derived from marine sponge, and its underlying mol. mechanisms.  The data demonstrated that treatment with PA inhibited the phosphorylation of ERK and subsequent ERK-mediated FOXO3 phosphorylation in melanoma cells.  Interestingly, PA did not inhibit AKT-mediated FOXO3 phosphorylation.  Therefore, it appears that PA-induced apoptosis results from the inhibition of ERK.  Furthermore, i.v. administration of PA was found to suppress melanoma cell growth in a C57BL6 mouse without causing side effects.  Addnl., PA inhibited the prodn. of Cdk2, which is involved in cell cycle regulation.  Taken together, inhibition of melanoma cell growth by PA is a result of the inhibition of ERK-mediated FOXO3 downregulation and decreased Cdk2 levels.  The results of this study imply that dual inhibition of the ERK pathway and cell cycle progression could be an effective approach to control the growth of melanoma cells.  Copyright © 2012 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbHwUVmNKcnbVg90H21EOLACvtfcHk0lhcb2IfwmU8Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVeksL7L&md5=0c6ea84a0623f7b85752c7f793590b51</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1002%2Fptr.4673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fptr.4673%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DT.%2BY.%26atitle%3DPachastrissamine%2520from%2520Pachastrissa%2520sp.%2520inhibits%2520melanoma%2520cell%2520growth%2520by%2520dual%2520inhibition%2520of%2520Cdk2%2520and%2520ERK-mediated%2520FOXO3%2520downregulation%26jtitle%3DPhytother.%2520Res.%26date%3D2012%26volume%3D26%26spage%3D1927%26epage%3D1933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Canals, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mormeneo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabrias, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llebaria, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, A.</span><span> </span><span class="NLM_article-title">Synthesis and biological properties of pachastrissamine (jaspine B) and diastereoisomeric jaspines</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=235-241&author=D.+Canalsauthor=D.+Mormeneoauthor=G.+Fabriasauthor=A.+Llebariaauthor=J.+Casasauthor=A.+Delgado&title=Synthesis+and+biological+properties+of+pachastrissamine+%28jaspine+B%29+and+diastereoisomeric+jaspines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCanals%26aufirst%3DD.%26aulast%3DMormeneo%26aufirst%3DD.%26aulast%3DFabrias%26aufirst%3DG.%26aulast%3DLlebaria%26aufirst%3DA.%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DDelgado%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520biological%2520properties%2520of%2520pachastrissamine%2520%2528jaspine%2520B%2529%2520and%2520diastereoisomeric%2520jaspines%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D235%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Jeon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baek, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span> </span><span class="NLM_article-title">Syntheses of sulfur and selenium analogues of pachastrissamine via double displacements of cyclic sulfate</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">7237</span><span class="NLM_x">–</span> <span class="NLM_lpage">7242</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=7237-7242&author=H.+Jeonauthor=H.+Baeauthor=D.+J.+Baekauthor=Y.+S.+Kwakauthor=D.+Kimauthor=S.+Kim&title=Syntheses+of+sulfur+and+selenium+analogues+of+pachastrissamine+via+double+displacements+of+cyclic+sulfate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJeon%26aufirst%3DH.%26aulast%3DBae%26aufirst%3DH.%26aulast%3DBaek%26aufirst%3DD.%2BJ.%26aulast%3DKwak%26aufirst%3DY.%2BS.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DS.%26atitle%3DSyntheses%2520of%2520sulfur%2520and%2520selenium%2520analogues%2520of%2520pachastrissamine%2520via%2520double%2520displacements%2520of%2520cyclic%2520sulfate%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2011%26volume%3D9%26spage%3D7237%26epage%3D7242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Salma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballereau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maaliki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladeira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrieu-Abadie, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genisson, Y.</span><span> </span><span class="NLM_article-title">Flexible and enantioselective access to jaspine B and biologically active chain-modified analogues thereof</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">3227</span><span class="NLM_x">–</span> <span class="NLM_lpage">3243</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=3227-3243&author=Y.+Salmaauthor=S.+Ballereauauthor=C.+Maalikiauthor=S.+Ladeiraauthor=N.+Andrieu-Abadieauthor=Y.+Genisson&title=Flexible+and+enantioselective+access+to+jaspine+B+and+biologically+active+chain-modified+analogues+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalma%26aufirst%3DY.%26aulast%3DBallereau%26aufirst%3DS.%26aulast%3DMaaliki%26aufirst%3DC.%26aulast%3DLadeira%26aufirst%3DS.%26aulast%3DAndrieu-Abadie%26aufirst%3DN.%26aulast%3DGenisson%26aufirst%3DY.%26atitle%3DFlexible%2520and%2520enantioselective%2520access%2520to%2520jaspine%2520B%2520and%2520biologically%2520active%2520chain-modified%2520analogues%2520thereof%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2010%26volume%3D8%26spage%3D3227%26epage%3D3243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Rives, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladeira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levade, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrieu-Abadie, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genisson, Y.</span><span> </span><span class="NLM_article-title">Synthesis of cytotoxic aza analogues of jaspine B</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=18&author=A.+Rivesauthor=S.+Ladeiraauthor=T.+Levadeauthor=N.+Andrieu-Abadieauthor=Y.+Genisson&title=Synthesis+of+cytotoxic+aza+analogues+of+jaspine+B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRives%26aufirst%3DA.%26aulast%3DLadeira%26aufirst%3DS.%26aulast%3DLevade%26aufirst%3DT.%26aulast%3DAndrieu-Abadie%26aufirst%3DN.%26aulast%3DGenisson%26aufirst%3DY.%26atitle%3DSynthesis%2520of%2520cytotoxic%2520aza%2520analogues%2520of%2520jaspine%2520B%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Kono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohama, T.</span><span> </span><span class="NLM_article-title">B-535a, b and c, new sphingosine kinase inhibitors, produced by a marine bacterium; taxonomy, fermentation, isolation, physico-chemical properties and structure determination</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">758</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2000&pages=753-758&author=K.+Konoauthor=M.+Tanakaauthor=T.+Mizunoauthor=K.+Kodamaauthor=T.+Ogitaauthor=T.+Kohama&title=B-535a%2C+b+and+c%2C+new+sphingosine+kinase+inhibitors%2C+produced+by+a+marine+bacterium%3B+taxonomy%2C+fermentation%2C+isolation%2C+physico-chemical+properties+and+structure+determination"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKono%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DMizuno%26aufirst%3DT.%26aulast%3DKodama%26aufirst%3DK.%26aulast%3DOgita%26aufirst%3DT.%26aulast%3DKohama%26aufirst%3DT.%26atitle%3DB-535a%252C%2520b%2520and%2520c%252C%2520new%2520sphingosine%2520kinase%2520inhibitors%252C%2520produced%2520by%2520a%2520marine%2520bacterium%253B%2520taxonomy%252C%2520fermentation%252C%2520isolation%252C%2520physico-chemical%2520properties%2520and%2520structure%2520determination%26jtitle%3DJ.%2520Antibiot.%26date%3D2000%26volume%3D53%26spage%3D753%26epage%3D758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Kono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohama, T.</span><span> </span><span class="NLM_article-title">Characterization of B-5354c, a new sphingosine kinase inhibitor, produced by a marine bacterium</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2000&pages=759-764&author=K.+Konoauthor=M.+Tanakaauthor=T.+Ogitaauthor=T.+Kohama&title=Characterization+of+B-5354c%2C+a+new+sphingosine+kinase+inhibitor%2C+produced+by+a+marine+bacterium"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKono%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DOgita%26aufirst%3DT.%26aulast%3DKohama%26aufirst%3DT.%26atitle%3DCharacterization%2520of%2520B-5354c%252C%2520a%2520new%2520sphingosine%2520kinase%2520inhibitor%252C%2520produced%2520by%2520a%2520marine%2520bacterium%26jtitle%3DJ.%2520Antibiot.%26date%3D2000%26volume%3D53%26spage%3D759%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nava, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edsall, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">19513</span><span class="NLM_x">–</span> <span class="NLM_lpage">19520</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=19513-19520&author=H.+Liuauthor=M.+Sugiuraauthor=V.+E.+Navaauthor=L.+C.+Edsallauthor=K.+Konoauthor=S.+Poultonauthor=S.+Milstienauthor=T.+Kohamaauthor=S.+Spiegel&title=Molecular+cloning+and+functional+characterization+of+a+novel+mammalian+sphingosine+kinase+type+2+isoform"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DSugiura%26aufirst%3DM.%26aulast%3DNava%26aufirst%3DV.%2BE.%26aulast%3DEdsall%26aufirst%3DL.%2BC.%26aulast%3DKono%26aufirst%3DK.%26aulast%3DPoulton%26aufirst%3DS.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DKohama%26aufirst%3DT.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DMolecular%2520cloning%2520and%2520functional%2520characterization%2520of%2520a%2520novel%2520mammalian%2520sphingosine%2520kinase%2520type%25202%2520isoform%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D19513%26epage%3D19520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Park, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span> </span><span class="NLM_article-title">Phytosphingosine induces apoptotic cell death via caspase 8 activation and Bax translocation in human cancer cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">878</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=12576463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVKktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=878-885&author=M.+T.+Parkauthor=J.+A.+Kangauthor=J.+A.+Choiauthor=C.+M.+Kangauthor=T.+H.+Kimauthor=S.+Baeauthor=S.+Kangauthor=S.+Kimauthor=W.+I.+Choiauthor=C.+K.+Choauthor=H.+Y.+Chungauthor=Y.+S.+Leeauthor=S.+J.+Lee&title=Phytosphingosine+induces+apoptotic+cell+death+via+caspase+8+activation+and+Bax+translocation+in+human+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Phytosphingosine Induces Apoptotic Cell Death via Caspase 8 Activation and Bax Translocation in Human Cancer Cells</span></div><div class="casAuthors">Park, Moon-Taek; Kang, Jung A.; Choi, Jung-A.; Kang, Chang-Mo; Kim, Tae-Hwan; Bae, Sangwoo; Kang, Seongman; Kim, Sujong; Choi, Weon-Ik; Cho, Chul-Koo; Chung, Hee-Yong; Lee, Yun-Sil; Lee, Su-Jae</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">878-885</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Sphingolipid metabolites, such as sphingosine and ceramide, are highly bioactive compds. and are involved in diverse cell processes, including cell-cell interaction, cell proliferation, differentiation, and apoptosis.  However, the physiol. roles of phytosphingosine are poorly understood.  In this study, we report that phytosphingosine can potently induce apoptotic cell death in human cancer cells via caspase activation and caspase-independent cytochrome c release.  Phytosphingosine-induced apoptosis was detd. by Hoechst 33258 staining, flow cytometric anal., and DNA fragmentation assay.  Involvement of caspases was detd. by immunoblot anal. and cell death detection assays after treatment with synthetic inhibitor z-Val-Ala-Asp-fluoromethyl ketone, z-DEVD-fmk, or z-IETD-fmk.  Death receptor (DR) dependency was analyzed by examg. expression of DRs (Fas, DR4, DR5, TNFR1, and R2), and interaction of Fas-assocd. death domain and caspase 8.  Involvement of the mitochondria pathway was examd. by monitoring of the mitochondria membrane potential, cytochrome c release, and Bax translocation.  Phytosphingosine-treated cells displayed several features of apoptosis, including increase of sub-G1 population, DNA fragmentation, and poly(ADP-ribose) polymerase cleavage.  We obsd. that phytosphingosine cause activation of caspase 8 in a DR-independent fashion.  Phytosphingosine also induced activation of caspase 9 and 3, loss of mitochondrial membrane potential, and the cytochrome c release from mitochondria.  However, we failed to detect Bid cleavage.  Moreover, caspase 8 inhibitor z-IETD-fmk did not affect phytosphingosine-induced cytochrome c release and caspase 9 activation, suggesting that phytosphingosine-induced cytochrome c release is caused by caspase 8-independent manner.  Phytosphingosine induced mitochondrial translocation of Bax from the cytosol without changes in the protein levels of Bcl-2, Bcl-xL, and Bax.  In addn., Bcl-2/Bax interaction was diminished after addn. of phytosphingosine.  These findings indicate that phytosphingosine induces apoptotic cell death in human cancer cells by direct activation of caspase 8, and by mitochondrial translocation of Bax and subsequent release of cytochrome c into cytoplasm, providing a potential mechanism for the anticancer activity of phytosphingosine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRvCcH_z38drVg90H21EOLACvtfcHk0lhFlxi2YiIAXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVKktrg%253D&md5=c060d9f013b765775d6d8479cc4c851c</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DM.%2BT.%26aulast%3DKang%26aufirst%3DJ.%2BA.%26aulast%3DChoi%26aufirst%3DJ.%2BA.%26aulast%3DKang%26aufirst%3DC.%2BM.%26aulast%3DKim%26aufirst%3DT.%2BH.%26aulast%3DBae%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DW.%2BI.%26aulast%3DCho%26aufirst%3DC.%2BK.%26aulast%3DChung%26aufirst%3DH.%2BY.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26atitle%3DPhytosphingosine%2520induces%2520apoptotic%2520cell%2520death%2520via%2520caspase%25208%2520activation%2520and%2520Bax%2520translocation%2520in%2520human%2520cancer%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D878%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Nagahara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinomiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikekita, M.</span><span> </span><span class="NLM_article-title">Phytosphingosine induced mitochondria-involved apoptosis</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1111%2Fj.1349-7006.2005.00012.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=15723652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislOhs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2005&pages=83-92&author=Y.+Nagaharaauthor=T.+Shinomiyaauthor=S.+Kurodaauthor=N.+Kanekoauthor=R.+Nishioauthor=M.+Ikekita&title=Phytosphingosine+induced+mitochondria-involved+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Phytosphingosine induced mitochondria-involved apoptosis</span></div><div class="casAuthors">Nagahara, Yukitoshi; Shinomiya, Takahisa; Kuroda, Sachiko; Kaneko, Naoki; Nishio, Reiji; Ikekita, Masahiko</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-92</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">Sphingolipids are putative intracellular signal mediators in cell differentiation, growth inhibition, and apoptosis.  Sphingosine, sphinganine, and phytosphingosine are structural analogs of sphingolipids and are classified as long-chain sphingoid bases.  Sphingosine and sphinganine are known to play important roles in apoptosis.  In the present study, the authors examd. the phytosphingosine-induced apoptosis mechanism, focusing on mitochondria in human T-cell lymphoma Jurkat cells.  Phytosphingosine significantly induced chromatin DNA fragmentation, which is a hallmark of apoptosis.  Enzymic activity measurements of caspases revealed that caspase-3 and caspase-9 are activated in phytosphingosine-induced apoptosis, but there is little activation of caspase-8 suggesting that phytosphingosine influences mitochondrial functions.  In agreement with this hypothesis, a decrease in ΔΨm and the release of cytochrome c to the cytosol were obsd. upon phytosphingosine treatment.  Furthermore, overexpression of mitochondria-localized anti-apoptotic protein Bcl-2 prevented phytosphingosine apoptotic stimuli.  Western blot assays revealed that phytosphingosine decreases phosphorylated Akt and p70S6k.  Dephosphorylation of Akt was partially inhibited by protein phosphatase inhibitor OA and OA attenuated phytosphingosine-induced apoptosis.  Moreover, using a cell-free system, phytosphingosine directly reduced ΔΨm.  These results indicate that phytosphingosine perturbs mitochondria both directly and indirectly to induce apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQWdaUUnvNQrVg90H21EOLACvtfcHk0liMI4o0xgn5tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislOhs70%253D&md5=9c17dfd6d2770da9b61e6190d1d120f1</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2005.00012.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2005.00012.x%26sid%3Dliteratum%253Aachs%26aulast%3DNagahara%26aufirst%3DY.%26aulast%3DShinomiya%26aufirst%3DT.%26aulast%3DKuroda%26aufirst%3DS.%26aulast%3DKaneko%26aufirst%3DN.%26aulast%3DNishio%26aufirst%3DR.%26aulast%3DIkekita%26aufirst%3DM.%26atitle%3DPhytosphingosine%2520induced%2520mitochondria-involved%2520apoptosis%26jtitle%3DCancer%2520Sci.%26date%3D2005%26volume%3D96%26spage%3D83%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Choi, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, Y. J.</span><span> </span><span class="NLM_article-title">Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5</span> <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=17143496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFagtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=175-184&author=S.+Y.+Choiauthor=M.+J.+Kimauthor=H.+Y.+Chungauthor=S.+J.+Leeauthor=Y.+J.+Jang&title=Phytosphingosine+in+combination+with+TRAIL+sensitizes+cancer+cells+to+TRAIL+through+synergistic+up-regulation+of+DR4+and+DR5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5</span></div><div class="casAuthors">Choi, Soon-Young; Kim, Min-Jung; Chung, Hee Yong; Lee, Su-Jae; Jang, Young-Ju</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-184</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Oncology Reports</span>)
        </div><div class="casAbstract">Sensitization of cancer cells to TRAIL could improve the effectiveness of TRAIL as an anticancer agent.  We explored whether TRAIL in combination with phytosphingosine could sensitize cancer cells to TRAIL.  The combined treatment enhanced synergistic apoptotic cell death of Jurkat T cells, compared to TRAIL or phytosphingosine alone.  Enhanced apoptosis in response to the combination treatment was assocd. with caspase-8 activation-mediated Bax and Bak activation and mitochondrial dysfunction.  The combination treatment also resulted in synergistic up-regulation of TRAIL receptor R1 (DR4) and R2 (DR5).  SiRNA targeting of DR5 significantly attenuated the combination treatment-induced caspase-8 activation, mitochondrial dysfunction, and apoptotic cell death.  Upon stimulation of cells with the combination treatment, NF-κB was activated.  Moreover, siRNA targeting of NF-κB significantly attenuated the combination treatment-induced DR4 and DR5 expression and receptor-mediated caspase-8 activation.  These results indicate that phytosphingosine sensitizes cancer cells to TRAIL through the synergistic up-regulation of DR4 and DR5 in an NF-κB-dependent fashion resulting in caspase-8 activation and subsequent mitochondrial dysfunction.  These findings support the potential application of combination treatment with TRAIL and phytosphingosine in the treatment of cancers that are less sensitive to TRAIL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiZZwDEfXm0rVg90H21EOLACvtfcHk0liMI4o0xgn5tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFagtLc%253D&md5=229ed07e322960d2a2001ffbe6d7c955</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DChung%26aufirst%3DH.%2BY.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DJang%26aufirst%3DY.%2BJ.%26atitle%3DPhytosphingosine%2520in%2520combination%2520with%2520TRAIL%2520sensitizes%2520cancer%2520cells%2520to%2520TRAIL%2520through%2520synergistic%2520up-regulation%2520of%2520DR4%2520and%2520DR5%26jtitle%3DOncol.%2520Rep.%26date%3D2007%26volume%3D17%26spage%3D175%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Park, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span> </span><span class="NLM_article-title">Phytosphingosine in combination with ionizing radiation enhances apoptotic cell death in radiation-resistant cancer cells through ROS-dependent and -independent AIF release</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1724</span><span class="NLM_x">–</span> <span class="NLM_lpage">1733</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=1724-1733&author=M.+T.+Parkauthor=M.+J.+Kimauthor=Y.+H.+Kangauthor=S.+Y.+Choiauthor=J.+H.+Leeauthor=J.+A.+Choiauthor=C.+M.+Kangauthor=C.+K.+Choauthor=S.+Kangauthor=S.+Baeauthor=Y.+S.+Leeauthor=H.+Y.+Chungauthor=S.+J.+Lee&title=Phytosphingosine+in+combination+with+ionizing+radiation+enhances+apoptotic+cell+death+in+radiation-resistant+cancer+cells+through+ROS-dependent+and+-independent+AIF+release"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DM.%2BT.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DKang%26aufirst%3DY.%2BH.%26aulast%3DChoi%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DChoi%26aufirst%3DJ.%2BA.%26aulast%3DKang%26aufirst%3DC.%2BM.%26aulast%3DCho%26aufirst%3DC.%2BK.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DBae%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DChung%26aufirst%3DH.%2BY.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26atitle%3DPhytosphingosine%2520in%2520combination%2520with%2520ionizing%2520radiation%2520enhances%2520apoptotic%2520cell%2520death%2520in%2520radiation-resistant%2520cancer%2520cells%2520through%2520ROS-dependent%2520and%2520-independent%2520AIF%2520release%26jtitle%3DBlood%26date%3D2005%26volume%3D105%26spage%3D1724%26epage%3D1733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Kim, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S. H.</span><span> </span><span class="NLM_article-title"><i>N</i>,<i>N</i>-Dimethyl phytosphingosine induces caspase-8-dependent cytochrome c release and apoptosis through ROS generation in human leukemia cells</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">239</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2Fj.taap.2009.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=19481559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVCisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=239&publication_year=2009&pages=87-97&author=B.+M.+Kimauthor=Y.+J.+Choiauthor=Y.+Hanauthor=Y.+S.+Yunauthor=S.+H.+Hong&title=N%2CN-Dimethyl+phytosphingosine+induces+caspase-8-dependent+cytochrome+c+release+and+apoptosis+through+ROS+generation+in+human+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">N,N-dimethyl phytosphingosine induces caspase-8-dependent cytochrome c release and apoptosis through ROS generation in human leukemia cells</span></div><div class="casAuthors">Kim, Byeong Mo; Choi, Yun Jung; Han, Youngsoo; Yun, Yeon-Sook; Hong, Sung Hee</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">239</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-97</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N,N-di-Me phytosphingosine (DMPS) blocks the conversion of sphingosine to sphingosine-1-phosphate (S1P) by the enzyme sphingosine kinase (SK).  In this study, we elucidated the apoptotic mechanisms of DMPS action on a human leukemia cell line using functional pharmacol. and genetic approaches.  First, we demonstrated that DMPS-induced apoptosis is evidenced by nuclear morphol. change, distinct internucleosomal DNA fragmentation, and an increased sub-G1 cell population.  DMPS treatment led to the activation of caspase-9 and caspase-3, accompanied by the cleavage of poly(ADP-ribose) polymerase (PARP) and led to cytochrome c release, depolarization of the mitochondrial membrane potential, and downregulation of the anti-apoptotic members of the bcl-2 family.  Ectopic expression of bcl-2 and bcl-xL conferred resistance of HL-60 cells to DMPS-induced cell death, suggesting that DMPS-induced apoptosis occurs predominantly through the activation of the intrinsic mitochondrial pathway.  We also obsd. that DMPS activated the caspase-8-Bid-Bax pathway and that the inhibition of caspase-8 by z-IETD-fmk or small interfering RNA suppressed the cleavage of Bid, cytochrome c release, caspase-3 activation, and apoptotic cell death.  In addn., cells subjected to DMPS exhibited significantly increased reactive oxygen species (ROS) generation, and ROS scavengers, such as quercetin and Tiron, but not N-acetylcysteine (NAC), inhibited DMPS-induced activations of caspase-8, -3 and subsequent apoptotic cell death, indicating the role of ROS in caspase-8-mediated apoptosis.  Taken together, these results indicate that caspase-8 acts upstream of caspase-3, and that the caspase-8-mediated mitochondrial pathway is important in DMPS-induced apoptosis.  Our results also suggest that ROS are crit. regulators of caspase-8-mediated apoptosis in DMPS-treated leukemia cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow6fzN5zQBGLVg90H21EOLACvtfcHk0lislZd_LkAufA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVCisr0%253D&md5=07d5a68ecb65dd901f9afad19ccc99ff</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2009.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2009.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DB.%2BM.%26aulast%3DChoi%26aufirst%3DY.%2BJ.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DYun%26aufirst%3DY.%2BS.%26aulast%3DHong%26aufirst%3DS.%2BH.%26atitle%3DN%252CN-Dimethyl%2520phytosphingosine%2520induces%2520caspase-8-dependent%2520cytochrome%2520c%2520release%2520and%2520apoptosis%2520through%2520ROS%2520generation%2520in%2520human%2520leukemia%2520cells%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2009%26volume%3D239%26spage%3D87%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Park, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S.</span><span> </span><span class="NLM_article-title">Cytotoxic effects of novel phytosphingosine derivatives, including <i>N</i>,<i>N</i>-dimethylphytosphingosine and <i>N</i>-monomethylphytosphingosine, in human leukemia cell line HL60</span> <span class="citation_source-journal">Leuk. Lymphoma</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.3109%2F10428190903383419" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=20001229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlyqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=132-145&author=S.+R.+Parkauthor=H.+J.+Choauthor=K.+J.+Moonauthor=K.+H.+Chunauthor=S.+Y.+Kongauthor=S.+S.+Yoonauthor=J.+S.+Leeauthor=S.+Park&title=Cytotoxic+effects+of+novel+phytosphingosine+derivatives%2C+including+N%2CN-dimethylphytosphingosine+and+N-monomethylphytosphingosine%2C+in+human+leukemia+cell+line+HL60"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic effects of novel phytosphingosine derivatives, including N,N-dimethylphytosphingosine and N-monomethylphytosphingosine, in human leukemia cell line HL60</span></div><div class="casAuthors">Park, Sook Ryun; Cho, Hyo Jin; Moon, Kyung Jin; Chun, Kyung-Hee; Kong, Sun-Young; Yoon, Sung-Soo; Lee, Jong Seok; Park, Seonyang</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">132-145</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1042-8194</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Novel phytosphingosine derivs. have been developed based on the inhibition of sphingosine kinase, which has been implicated in cell growth and inhibition of ceramide-mediated apoptosis.  This study evaluated the cytotoxic effects and underlying mechanisms of action of novel phytosphingosine derivs., including N-monomethylphytosphingosine (MMPH) and N,N-dimethylphytosphingosine (DMPH) and the pegylated forms MMPH-PEG and DMPH-PEG, in human leukemia HL60 cells.  In viability and proliferation assays using WST-1, all four drugs induced suppression of cell growth and viability in a concn.-dependent manner.  Among them, DMPH had the highest antileukemic activity and induced apoptosis via caspase-8, caspase-3, and caspase-9 activation.  The apoptotic effect was also assocd. with Fas/FasL upregulation, Bid cleavage, Bcl-2 downregulation, Bax upregulation, mitochondrial membrane depolarization, and cytochrome c release.  DMPH decreased the phosphorylation of ERK and inhibited daunorubicin-induced ERK activation.  Furthermore, DMPH displayed synergistic cytotoxicity with daunorubicin in a sequence-dependent manner.  Our findings indicate that DMPH has potential as an effective cytotoxic agent for leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5Gx5UhAeIT7Vg90H21EOLACvtfcHk0lislZd_LkAufA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlyqsg%253D%253D&md5=9782638e152920cfa74991ad577e0750</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.3109%2F10428190903383419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10428190903383419%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BR.%26aulast%3DCho%26aufirst%3DH.%2BJ.%26aulast%3DMoon%26aufirst%3DK.%2BJ.%26aulast%3DChun%26aufirst%3DK.%2BH.%26aulast%3DKong%26aufirst%3DS.%2BY.%26aulast%3DYoon%26aufirst%3DS.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DPark%26aufirst%3DS.%26atitle%3DCytotoxic%2520effects%2520of%2520novel%2520phytosphingosine%2520derivatives%252C%2520including%2520N%252CN-dimethylphytosphingosine%2520and%2520N-monomethylphytosphingosine%252C%2520in%2520human%2520leukemia%2520cell%2520line%2520HL60%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2010%26volume%3D51%26spage%3D132%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Moon, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheon, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span> </span><span class="NLM_article-title">Synthesis of novel phytosphingosine derivatives and their preliminary biological evaluation for enhancing radiation therapy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6643</span><span class="NLM_x">–</span> <span class="NLM_lpage">6646</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6643-6646&author=B.+S.+Moonauthor=M.+T.+Parkauthor=J.+H.+Parkauthor=S.+W.+Kimauthor=K.+C.+Leeauthor=G.+I.+Anauthor=S.+D.+Yangauthor=D.+Y.+Chiauthor=G.+J.+Cheonauthor=S.+J.+Lee&title=Synthesis+of+novel+phytosphingosine+derivatives+and+their+preliminary+biological+evaluation+for+enhancing+radiation+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DB.%2BS.%26aulast%3DPark%26aufirst%3DM.%2BT.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DK.%2BC.%26aulast%3DAn%26aufirst%3DG.%2BI.%26aulast%3DYang%26aufirst%3DS.%2BD.%26aulast%3DChi%26aufirst%3DD.%2BY.%26aulast%3DCheon%26aufirst%3DG.%2BJ.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26atitle%3DSynthesis%2520of%2520novel%2520phytosphingosine%2520derivatives%2520and%2520their%2520preliminary%2520biological%2520evaluation%2520for%2520enhancing%2520radiation%2520therapy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6643%26epage%3D6646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Kono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohama, T.</span><span> </span><span class="NLM_article-title">F-12509A, a new sphingosine kinase inhibitor, produced by a discomycete</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2000&pages=459-466&author=K.+Konoauthor=M.+Tanakaauthor=T.+Ogitaauthor=T.+Hosoyaauthor=T.+Kohama&title=F-12509A%2C+a+new+sphingosine+kinase+inhibitor%2C+produced+by+a+discomycete"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKono%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DOgita%26aufirst%3DT.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DKohama%26aufirst%3DT.%26atitle%3DF-12509A%252C%2520a%2520new%2520sphingosine%2520kinase%2520inhibitor%252C%2520produced%2520by%2520a%2520discomycete%26jtitle%3DJ.%2520Antibiot.%26date%3D2000%26volume%3D53%26spage%3D459%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Maezawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuichi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsumura, S.</span><span> </span><span class="NLM_article-title">Synthesis of a novel sphingosine kinase inhibitor (−)-F-12509A and determination of its absolute configuration</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4865</span><span class="NLM_x">–</span> <span class="NLM_lpage">4867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=4865-4867&author=N.+Maezawaauthor=N.+Furuichiauthor=H.+Tsuchikawaauthor=S.+Katsumura&title=Synthesis+of+a+novel+sphingosine+kinase+inhibitor+%28%E2%88%92%29-F-12509A+and+determination+of+its+absolute+configuration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaezawa%26aufirst%3DN.%26aulast%3DFuruichi%26aufirst%3DN.%26aulast%3DTsuchikawa%26aufirst%3DH.%26aulast%3DKatsumura%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520a%2520novel%2520sphingosine%2520kinase%2520inhibitor%2520%2528%25E2%2588%2592%2529-F-12509A%2520and%2520determination%2520of%2520its%2520absolute%2520configuration%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D4865%26epage%3D4867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Bonhoure, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pchejetski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aouali, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morjani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levade, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuvillier, O.</span><span> </span><span class="NLM_article-title">Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=95-102&author=E.+Bonhoureauthor=D.+Pchejetskiauthor=N.+Aoualiauthor=H.+Morjaniauthor=T.+Levadeauthor=T.+Kohamaauthor=O.+Cuvillier&title=Overcoming+MDR-associated+chemoresistance+in+HL-60+acute+myeloid+leukemia+cells+by+targeting+sphingosine+kinase-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonhoure%26aufirst%3DE.%26aulast%3DPchejetski%26aufirst%3DD.%26aulast%3DAouali%26aufirst%3DN.%26aulast%3DMorjani%26aufirst%3DH.%26aulast%3DLevade%26aufirst%3DT.%26aulast%3DKohama%26aufirst%3DT.%26aulast%3DCuvillier%26aufirst%3DO.%26atitle%3DOvercoming%2520MDR-associated%2520chemoresistance%2520in%2520HL-60%2520acute%2520myeloid%2520leukemia%2520cells%2520by%2520targeting%2520sphingosine%2520kinase-1%26jtitle%3DLeukemia%26date%3D2006%26volume%3D20%26spage%3D95%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Bonhoure, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauret, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malavaud, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melo, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuvillier, O.</span><span> </span><span class="NLM_article-title">Sphingosine kinase-1 is a downstream regulator of imatinib-induced apoptosis in chronic myeloid leukemia cells</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">979</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=971-979&author=E.+Bonhoureauthor=A.+Lauretauthor=D.+J.+Barnesauthor=C.+Martinauthor=B.+Malavaudauthor=T.+Kohamaauthor=J.+V.+Meloauthor=O.+Cuvillier&title=Sphingosine+kinase-1+is+a+downstream+regulator+of+imatinib-induced+apoptosis+in+chronic+myeloid+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonhoure%26aufirst%3DE.%26aulast%3DLauret%26aufirst%3DA.%26aulast%3DBarnes%26aufirst%3DD.%2BJ.%26aulast%3DMartin%26aufirst%3DC.%26aulast%3DMalavaud%26aufirst%3DB.%26aulast%3DKohama%26aufirst%3DT.%26aulast%3DMelo%26aufirst%3DJ.%2BV.%26aulast%3DCuvillier%26aufirst%3DO.%26atitle%3DSphingosine%2520kinase-1%2520is%2520a%2520downstream%2520regulator%2520of%2520imatinib-induced%2520apoptosis%2520in%2520chronic%2520myeloid%2520leukemia%2520cells%26jtitle%3DLeukemia%26date%3D2008%26volume%3D22%26spage%3D971%26epage%3D979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Brizuela, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doumerc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ader, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golzio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izard, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malavaud, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuvillier, O.</span><span> </span><span class="NLM_article-title">The sphingosine kinase-1 survival pathway is a molecular target for the tumor-suppressive tea and wine polyphenols in prostate cancer</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">3882</span><span class="NLM_x">–</span> <span class="NLM_lpage">3894</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=3882-3894&author=L.+Brizuelaauthor=A.+Dayonauthor=N.+Doumercauthor=I.+Aderauthor=M.+Golzioauthor=J.+C.+Izardauthor=Y.+Haraauthor=B.+Malavaudauthor=O.+Cuvillier&title=The+sphingosine+kinase-1+survival+pathway+is+a+molecular+target+for+the+tumor-suppressive+tea+and+wine+polyphenols+in+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrizuela%26aufirst%3DL.%26aulast%3DDayon%26aufirst%3DA.%26aulast%3DDoumerc%26aufirst%3DN.%26aulast%3DAder%26aufirst%3DI.%26aulast%3DGolzio%26aufirst%3DM.%26aulast%3DIzard%26aufirst%3DJ.%2BC.%26aulast%3DHara%26aufirst%3DY.%26aulast%3DMalavaud%26aufirst%3DB.%26aulast%3DCuvillier%26aufirst%3DO.%26atitle%3DThe%2520sphingosine%2520kinase-1%2520survival%2520pathway%2520is%2520a%2520molecular%2520target%2520for%2520the%2520tumor-suppressive%2520tea%2520and%2520wine%2520polyphenols%2520in%2520prostate%2520cancer%26jtitle%3DFASEB%2520J.%26date%3D2010%26volume%3D24%26spage%3D3882%26epage%3D3894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Zu Heringdorf, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihlefeld, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeilschifter, J.</span><span> </span><span class="NLM_article-title">Pharmacology of the sphingosine-1-phosphate signalling system</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">215</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1007%2F978-3-7091-1368-4_13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=23579459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2htL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2013&pages=239-253&author=D.+M.+Zu+Heringdorfauthor=K.+Ihlefeldauthor=J.+Pfeilschifter&title=Pharmacology+of+the+sphingosine-1-phosphate+signalling+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of the sphingosine-1-phosphate signalling system</span></div><div class="casAuthors">zu Heringdorf, Dagmar Meyer; Ihlefeld, Katja; Pfeilschifter, Josef</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">Sphingolipids: Basic Science and Drug Development</span>),
    <span class="NLM_cas:pages">239-253</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  The recent success of FTY720 (Fingolimod, Gilenya), which has been approved for the treatment of relapsing-remitting multiple sclerosis and is the first-in-class sphingosine-1-phosphate (S1P) receptor modulating drug, has boosted the interest in further drug development in this area.  Several selective S1P1 receptor-modulating drugs are being investigated in clin. trials for the treatment of diverse autoimmune disorders.  Sphingosine kinase inhibitors are under development for the treatment of cancer, aberrant angiogenesis and inflammatory diseases; an inhibitor of SK2 with relatively low affinity is being analyzed in patients with advanced solid tumors.  While an indirect S1P lyase inhibitor has just failed the proof of concept in patients with rheumatoid arthritis, S1P lyase is still a promising target for the treatment of inflammatory and autoimmune diseases.  Another approach is the development of S1P-scavenging or -clearing agents, including a monoclonal S1P antibody that has successfully passed phase I clin. trials and will be further developed for age-related macular degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL_KbFggq0WbVg90H21EOLACvtfcHk0li6uuOqCmeb3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2htL%252FO&md5=a448f07ec75327d721973b9cc77ba7e0</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1007%2F978-3-7091-1368-4_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-7091-1368-4_13%26sid%3Dliteratum%253Aachs%26aulast%3DZu%2BHeringdorf%26aufirst%3DD.%2BM.%26aulast%3DIhlefeld%26aufirst%3DK.%26aulast%3DPfeilschifter%26aufirst%3DJ.%26atitle%3DPharmacology%2520of%2520the%2520sphingosine-1-phosphate%2520signalling%2520system%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2013%26volume%3D215%26spage%3D239%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Edmonds, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Development of small-molecule inhibitors of sphingosine-1-phosphate signaling</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2Fj.pharmthera.2011.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=21906625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtl2ntrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2011&pages=352-360&author=Y.+Edmondsauthor=S.+Milstienauthor=S.+Spiegel&title=Development+of+small-molecule+inhibitors+of+sphingosine-1-phosphate+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Development of small-molecule inhibitors of sphingosine-1-phosphate signaling</span></div><div class="casAuthors">Edmonds, Yvette; Milstien, Sheldon; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">352-360</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The pleiotropic sphingolipid mediator, sphingosine-1-phosphate, produced in cells by two sphingosine kinase isoenzymes, SphK1 and SphK2, regulates many cellular and physiol. processes important for homeostasis and development and pathophysiol.  Many of the actions of S1P are mediated by a family of five specific cell surface receptors that are ubiquitously and specifically expressed, although important direct intracellular targets of S1P have also recently been identified.  S1P, SphK1, and or S1P receptors have been linked to onset and progression of numerous diseases, including many types of cancer, and esp. inflammatory disorders, such as multiple sclerosis, asthma, rheumatoid arthritis, inflammatory bowel disease, and sepsis.  S1P formation and signaling are attractive targets for development of new therapeutics.  The effects of a no. of inhibitors of SphKs and S1PRs have been examd. in animal models of human diseases.  The effectiveness of the immunosuppressant FTY720 (known as Fingolimod or Gilenya), recently approved for the treatment of multiple sclerosis, whose actions are mediated by downregulation of S1PR1, has become the gold std. for S1P-centric drugs.  Here, we review S1P biol. and signaling with an emphasis on potential therapeutic benefits of specific interventions and discuss recent development of small mol. antagonists and agonists that target specific subtypes of S1P receptors as well as inhibitors of SphKs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6EDQC_6khNrVg90H21EOLACvtfcHk0li6uuOqCmeb3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtl2ntrzL&md5=2a265498dfa77a25a0ef9e6199fcbbc8</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2011.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2011.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DEdmonds%26aufirst%3DY.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DDevelopment%2520of%2520small-molecule%2520inhibitors%2520of%2520sphingosine-1-phosphate%2520signaling%26jtitle%3DPharmacol.%2520Ther.%26date%3D2011%26volume%3D132%26spage%3D352%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Song, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span> </span><span class="NLM_article-title">Prevention of GVHD and graft rejection by a new S1P receptor agonist, W-061, in rat small bowel transplantation</span> <span class="citation_source-journal">Transpl. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2Fj.trim.2011.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=22210496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVChu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=163-170&author=J.+Songauthor=H.+Hagiyaauthor=H.+Kurataauthor=H.+Mizunoauthor=T.+Ito&title=Prevention+of+GVHD+and+graft+rejection+by+a+new+S1P+receptor+agonist%2C+W-061%2C+in+rat+small+bowel+transplantation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of GVHD and graft rejection by a new S1P receptor agonist, W-061, in rat small bowel transplantation</span></div><div class="casAuthors">Song, Jinghai; Hagiya, Hiroshi; Kurata, Haruto; Mizuno, Hirotaka; Ito, Toshinori</div><div class="citationInfo"><span class="NLM_cas:title">Transplant Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">163-170</span>CODEN:
                <span class="NLM_cas:coden">TRIME2</span>;
        ISSN:<span class="NLM_cas:issn">0966-3274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Background: In small bowel transplantation (SBTx), inhibition of both graft-vs.-host disease (GVHD) and allograft rejection is necessary.  Methods: We investigated the potency of a new sphingosine-1-phosphate receptor agonist, W-061, for these two immune responses in SBTx.  W-061 has a completely different mol. structure from FTY720.  Heterotopic SBTx was performed from Wistar-Furth (WF) into (WF × ACI) F1 rats as a GVHD model or F1 to WF rats as a rejection model.  Recipients were orally given 3 mg/kg/day W-061 for 14 days after SBTx.  Recipient survival, body wt., histopathol., lymphocyte subpopulations, and the cytokine profile were evaluated.  Results: W-061 treatment significantly prolonged graft survival over 100 days in four out of six recipients in the GVHD group and over 60 days in three out of six recipients in the rejection group.  W-061 strongly inhibited GVHD and rejection as seen histopathol. in comparison with untreated control rats.  W-061 caused a significant redn. in donor-derived T cells in target organs and infiltrating T cells in allografts by promoting these cells to home into the secondary lymphoid tissues and sequestrating those cells there.  W-061 significantly decreased prodn. of interferon-γ in target organs and allografts.  Conclusion: Therefore, these data suggest that W-061 has considerable potential as a new therapeutic immunosuppressant in patients with SBTx.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPmIrYa6ttSbVg90H21EOLACvtfcHk0ljiYC8v43_MXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVChu70%253D&md5=1cbafd0f401b5984e81798f527391ac5</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2Fj.trim.2011.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trim.2011.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DHagiya%26aufirst%3DH.%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DT.%26atitle%3DPrevention%2520of%2520GVHD%2520and%2520graft%2520rejection%2520by%2520a%2520new%2520S1P%2520receptor%2520agonist%252C%2520W-061%252C%2520in%2520rat%2520small%2520bowel%2520transplantation%26jtitle%3DTranspl.%2520Immunol.%26date%3D2012%26volume%3D26%26spage%3D163%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Lauer, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghori, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haldar, K.</span><span> </span><span class="NLM_article-title">Sphingolipid synthesis as a target for chemotherapy against malaria parasites</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">9181</span><span class="NLM_x">–</span> <span class="NLM_lpage">9185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=9181-9185&author=S.+A.+Lauerauthor=N.+Ghoriauthor=K.+Haldar&title=Sphingolipid+synthesis+as+a+target+for+chemotherapy+against+malaria+parasites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLauer%26aufirst%3DS.%2BA.%26aulast%3DGhori%26aufirst%3DN.%26aulast%3DHaldar%26aufirst%3DK.%26atitle%3DSphingolipid%2520synthesis%2520as%2520a%2520target%2520for%2520chemotherapy%2520against%2520malaria%2520parasites%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1995%26volume%3D92%26spage%3D9181%26epage%3D9185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Meyer, E. V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballie, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushnev, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menaldino, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrendale, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culver, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galinski, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natchus, M. G.</span><span> </span><span class="NLM_article-title">Sphingolipid analogues inhibit development of malaria parasites</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=43-47&author=E.+V.+S.+Meyerauthor=J.+J.+Holtauthor=K.+R.+Girardauthor=M.+T.+Ballieauthor=A.+S.+Bushnevauthor=S.+Lappauthor=D.+S.+Menaldinoauthor=R.+F.+Arrendaleauthor=G.+P.+Reddyauthor=T.+J.+Eversauthor=R.+B.+Howardauthor=D.+G.+Culverauthor=D.+C.+Liottaauthor=M.+R.+Galinskiauthor=M.+G.+Natchus&title=Sphingolipid+analogues+inhibit+development+of+malaria+parasites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DE.%2BV.%2BS.%26aulast%3DHolt%26aufirst%3DJ.%2BJ.%26aulast%3DGirard%26aufirst%3DK.%2BR.%26aulast%3DBallie%26aufirst%3DM.%2BT.%26aulast%3DBushnev%26aufirst%3DA.%2BS.%26aulast%3DLapp%26aufirst%3DS.%26aulast%3DMenaldino%26aufirst%3DD.%2BS.%26aulast%3DArrendale%26aufirst%3DR.%2BF.%26aulast%3DReddy%26aufirst%3DG.%2BP.%26aulast%3DEvers%26aufirst%3DT.%2BJ.%26aulast%3DHoward%26aufirst%3DR.%2BB.%26aulast%3DCulver%26aufirst%3DD.%2BG.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DGalinski%26aufirst%3DM.%2BR.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26atitle%3DSphingolipid%2520analogues%2520inhibit%2520development%2520of%2520malaria%2520parasites%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D3%26spage%3D43%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Alexander, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swatson, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, H.</span><span> </span><span class="NLM_article-title">Pharmacogenetics of resistance to cisplatin and other anticancer drugs and the role of sphingolipid metabolism</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">983</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1007%2F978-1-62703-302-2_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=23494308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A280%3ADC%252BC3svntVWjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=983&publication_year=2013&pages=185-204&author=S.+Alexanderauthor=W.+S.+Swatsonauthor=H.+Alexander&title=Pharmacogenetics+of+resistance+to+cisplatin+and+other+anticancer+drugs+and+the+role+of+sphingolipid+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacogenetics of resistance to Cisplatin and other anticancer drugs and the role of sphingolipid metabolism</span></div><div class="casAuthors">Alexander Stephen; Swatson William S; Alexander Hannah</div><div class="citationInfo"><span class="NLM_cas:title">Methods in molecular biology (Clifton, N.J.)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">983</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">185-204</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dictyostelium discoideum has proven to be a useful lead genetic system for identifying novel genes and pathways responsible for the regulation of sensitivity to the widely used anticancer drug cisplatin.  Resistance to cisplatin is a major factor limiting the efficacy of the drug in treating many types of cancer.  Studies using unbiased insertional mutagenesis in D. discoideum have identified the pathway of sphingolipid metabolism as a key regulator in controlling sensitivity to cisplatin.  Using the genetic tools including directed homologous recombination and ectopic gene expression available with D. discoideum has shown how pharmacological modulation of this pathway can increase sensitivity to cisplatin, and these results have been extensively translated to, and validated in, human cells.  Strategies, experimental conditions, and methods are presented to enable further study of resistance to cisplatin as well as other important drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQYO-J6ygKsqM25P7XSLhESfW6udTcc2eYhmLZ3-aU1VLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svntVWjuw%253D%253D&md5=d8039cec3b2ea4007e72741087ceb881</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1007%2F978-1-62703-302-2_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-62703-302-2_10%26sid%3Dliteratum%253Aachs%26aulast%3DAlexander%26aufirst%3DS.%26aulast%3DSwatson%26aufirst%3DW.%2BS.%26aulast%3DAlexander%26aufirst%3DH.%26atitle%3DPharmacogenetics%2520of%2520resistance%2520to%2520cisplatin%2520and%2520other%2520anticancer%2520drugs%2520and%2520the%2520role%2520of%2520sphingolipid%2520metabolism%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2013%26volume%3D983%26spage%3D185%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Salas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponnusamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senkal, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers-Needham, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selvam, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saddoughi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apohan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentelle, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gault, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeid, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Shewy, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oaks, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhanam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuart, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrotti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogretmen, B.</span><span> </span><span class="NLM_article-title">Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">5941</span><span class="NLM_x">–</span> <span class="NLM_lpage">5952</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=5941-5952&author=A.+Salasauthor=S.+Ponnusamyauthor=C.+E.+Senkalauthor=M.+Meyers-Needhamauthor=S.+P.+Selvamauthor=S.+A.+Saddoughiauthor=E.+Apohanauthor=R.+D.+Sentelleauthor=C.+Smithauthor=C.+R.+Gaultauthor=L.+M.+Obeidauthor=H.+M.+El-Shewyauthor=J.+Oaksauthor=R.+Santhanamauthor=G.+Marcucciauthor=Y.+Baranauthor=S.+Mahajanauthor=D.+Fernandesauthor=R.+Stuartauthor=D.+Perrottiauthor=B.+Ogretmen&title=Sphingosine+kinase-1+and+sphingosine+1-phosphate+receptor+2+mediate+Bcr-Abl1+stability+and+drug+resistance+by+modulation+of+protein+phosphatase+2A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalas%26aufirst%3DA.%26aulast%3DPonnusamy%26aufirst%3DS.%26aulast%3DSenkal%26aufirst%3DC.%2BE.%26aulast%3DMeyers-Needham%26aufirst%3DM.%26aulast%3DSelvam%26aufirst%3DS.%2BP.%26aulast%3DSaddoughi%26aufirst%3DS.%2BA.%26aulast%3DApohan%26aufirst%3DE.%26aulast%3DSentelle%26aufirst%3DR.%2BD.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DGault%26aufirst%3DC.%2BR.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26aulast%3DEl-Shewy%26aufirst%3DH.%2BM.%26aulast%3DOaks%26aufirst%3DJ.%26aulast%3DSanthanam%26aufirst%3DR.%26aulast%3DMarcucci%26aufirst%3DG.%26aulast%3DBaran%26aufirst%3DY.%26aulast%3DMahajan%26aufirst%3DS.%26aulast%3DFernandes%26aufirst%3DD.%26aulast%3DStuart%26aufirst%3DR.%26aulast%3DPerrotti%26aufirst%3DD.%26aulast%3DOgretmen%26aufirst%3DB.%26atitle%3DSphingosine%2520kinase-1%2520and%2520sphingosine%25201-phosphate%2520receptor%25202%2520mediate%2520Bcr-Abl1%2520stability%2520and%2520drug%2520resistance%2520by%2520modulation%2520of%2520protein%2520phosphatase%25202A%26jtitle%3DBlood%26date%3D2011%26volume%3D117%26spage%3D5941%26epage%3D5952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Schnitzer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brune, B.</span><span> </span><span class="NLM_article-title">Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1158%2F1541-7786.MCR-08-0156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=19240180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtF2js7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=393-401&author=S.+E.+Schnitzerauthor=A.+Weigertauthor=J.+Zhouauthor=B.+Brune&title=Hypoxia+enhances+sphingosine+kinase+2+activity+and+provokes+sphingosine-1-phosphate-mediated+chemoresistance+in+A549+lung+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia Enhances Sphingosine Kinase 2 Activity and Provokes Sphingosine-1-Phosphate-Mediated Chemoresistance in A549 Lung Cancer Cells</span></div><div class="casAuthors">Schnitzer, Steffen E.; Weigert, Andreas; Zhou, Jie; Bruene, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">393-401</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hypoxia and signaling via hypoxia-inducible factor-1 (HIF-1) is a key feature of solid tumors and is related to tumor progression as well as treatment failure.  Although it is generally accepted that HIF-1 provokes tumor cell survival and induces chemoresistance under hypoxia, HIF-1-independent mechanisms operate as well.  We present evidence that conditioned medium obtained from A549 cells, incubated for 24 h under hypoxia, protected naive A549 cells from etoposide-induced cell death.  Lipid exts. generated from hypoxia-conditioned medium still rescued cells from apoptosis induced by etoposide.  Specifically, the bioactive lipid sphingosine-1-phosphate (S1P) not only was essential for cell viability of A549 cells but also protected cells from apoptosis.  We noticed an increase in sphingosine kinase 2 (SphK2) protein level and enzymic activity under hypoxia, which correlated with the release of S1P into the medium.  Knockdown of SphK2 using specific small interfering RNA relieved chemoresistance of A549 cells under hypoxia and conditioned medium obtained from SphK2 knockdown cells was only partially protective.  Coincubations of conditioned medium with VPC23019, a S1P1/S1P3 antagonist, reduced protection of conditioned medium, with the further notion that p42/44 mitogen-activated protein kinase transmits autocrine or paracrine survival signaling downstream of S1P1/S1P3 receptors.  Our data suggest that hypoxia activates SphK2 to promote the synthesis and release of S1P, which in turn binds to S1P1/S1P3 receptors, thus activating p42/44 mitogen-activated protein kinase to convey autocrine or paracrine protection of A549 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLBtrq0j1xzrVg90H21EOLACvtfcHk0lgGlfxoVJgwsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtF2js7c%253D&md5=c2b24fd14e4cab36c4b9c076aaeaafab</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-08-0156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-08-0156%26sid%3Dliteratum%253Aachs%26aulast%3DSchnitzer%26aufirst%3DS.%2BE.%26aulast%3DWeigert%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DBrune%26aufirst%3DB.%26atitle%3DHypoxia%2520enhances%2520sphingosine%2520kinase%25202%2520activity%2520and%2520provokes%2520sphingosine-1-phosphate-mediated%2520chemoresistance%2520in%2520A549%2520lung%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2009%26volume%3D7%26spage%3D393%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Gustin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connors, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffries, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franks, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesche, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">Structure guided design of a series of sphingosine kinase (SphK) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4608</span><span class="NLM_x">–</span> <span class="NLM_lpage">4616</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.1016%2Fj.bmcl.2013.06.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=23845219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2lsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4608-4616&author=D.+J.+Gustinauthor=Y.+Liauthor=M.+L.+Brownauthor=X.+Minauthor=M.+J.+Schmittauthor=M.+Wanskaauthor=X.+Wangauthor=R.+Connorsauthor=S.+Johnstoneauthor=M.+Cardozoauthor=A.+C.+Chengauthor=S.+Jeffriesauthor=B.+Franksauthor=S.+Liauthor=S.+Shenauthor=M.+Wongauthor=H.+Wescheauthor=G.+Xuauthor=T.+J.+Carlsonauthor=M.+Plantauthor=K.+Morgensternauthor=K.+Rexauthor=J.+Schmittauthor=A.+Coxonauthor=N.+Walkerauthor=F.+Kayserauthor=Z.+Wang&title=Structure+guided+design+of+a+series+of+sphingosine+kinase+%28SphK%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Structure guided design of a series of sphingosine kinase (SphK) inhibitors</span></div><div class="casAuthors">Gustin, Darin J.; Li, Yihong; Brown, Matthew L.; Min, Xiaoshan; Schmitt, Mike J.; Wanska, Malgorzata; Wang, Xiaodong; Connors, Richard; Johnstone, Sheere; Cardozo, Mario; Cheng, Alan C.; Jeffries, Shawn; Franks, Brendon; Li, Shyun; Shen, Shanling; Wong, Mariwil; Wesche, Holger; Xu, Guifen; Carlson, Timothy J.; Plant, Matthew; Morgenstern, Kurt; Rex, Karen; Schmitt, Joanna; Coxon, Angela; Walker, Nigel; Kayser, Frank; Wang, Zhulun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4608-4616</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sphingosine-1-phosphate (S1P) signaling plays a vital role in mitogenesis, cell migration and angiogenesis.  Sphingosine kinases (SphKs) catalyze a key step in sphingomyelin metab. that leads to the prodn. of S1P.  There are two isoforms of SphK and observations made with SphK deficient mice show the two isoforms can compensate for each other's loss.  Thus, inhibition of both isoforms is likely required to block SphK dependent angiogenesis.  A structure based approach was used to design and synthesize a series of SphK inhibitors resulting in the identification of the first potent inhibitors of both isoforms of human SphK.  Addnl., to our knowledge, this series of inhibitors contains the only sufficiently potent inhibitors of murine SphK1 with suitable physico-chem. properties to pharmacol. interrogate the role of SphK1 in rodent models and to reproduce the phenotype of SphK1 (-/-) mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovzWgmT5jALrVg90H21EOLACvtfcHk0lgGlfxoVJgwsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2lsb%252FN&md5=42c7f013299278232f62a9f70bccd08c</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.030%26sid%3Dliteratum%253Aachs%26aulast%3DGustin%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DSchmitt%26aufirst%3DM.%2BJ.%26aulast%3DWanska%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DConnors%26aufirst%3DR.%26aulast%3DJohnstone%26aufirst%3DS.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DJeffries%26aufirst%3DS.%26aulast%3DFranks%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DWesche%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DCarlson%26aufirst%3DT.%2BJ.%26aulast%3DPlant%26aufirst%3DM.%26aulast%3DMorgenstern%26aufirst%3DK.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DWalker%26aufirst%3DN.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DStructure%2520guided%2520design%2520of%2520a%2520series%2520of%2520sphingosine%2520kinase%2520%2528SphK%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4608%26epage%3D4616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Neubauer, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitson, S. M.</span><span> </span><span class="NLM_article-title">Roles, regulation and inhibitors of sphingosine kinase 2</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">5317</span><span class="NLM_x">–</span> <span class="NLM_lpage">5336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=5317-5336&author=H.+A.+Neubauerauthor=S.+M.+Pitson&title=Roles%2C+regulation+and+inhibitors+of+sphingosine+kinase+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeubauer%26aufirst%3DH.%2BA.%26aulast%3DPitson%26aufirst%3DS.%2BM.%26atitle%3DRoles%252C%2520regulation%2520and%2520inhibitors%2520of%2520sphingosine%2520kinase%25202%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D5317%26epage%3D5336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Urbano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, E.</span><span> </span><span class="NLM_article-title">Modulators of the sphingosine 1-phosphate receptor 1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6377</span><span class="NLM_x">–</span> <span class="NLM_lpage">6389</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6377-6389&author=M.+Urbanoauthor=M.+Guerreroauthor=H.+Rosenauthor=E.+Roberts&title=Modulators+of+the+sphingosine+1-phosphate+receptor+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUrbano%26aufirst%3DM.%26aulast%3DGuerrero%26aufirst%3DM.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DRoberts%26aufirst%3DE.%26atitle%3DModulators%2520of%2520the%2520sphingosine%25201-phosphate%2520receptor%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6377%26epage%3D6389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffries, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fajardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassner, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruefli-Brasse, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swearingen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickramasinghe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesche, H.</span><span> </span><span class="NLM_article-title">Sphingosine kinase activity is not required for tumor cell viability</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e68328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e68328&author=K.+Rexauthor=S.+Jeffriesauthor=M.+L.+Brownauthor=T.+Carlsonauthor=A.+Coxonauthor=F.+Fajardoauthor=B.+Frankauthor=D.+Gustinauthor=A.+Kambauthor=P.+D.+Kassnerauthor=S.+Liauthor=Y.+Liauthor=K.+Morgensternauthor=M.+Plantauthor=K.+Quonauthor=A.+Ruefli-Brasseauthor=J.+Schmidtauthor=E.+Swearingenauthor=N.+Walkerauthor=Z.+Wangauthor=J.+E.+V.+Watsonauthor=D.+Wickramasingheauthor=M.+Wongauthor=G.+Xuauthor=H.+Wesche&title=Sphingosine+kinase+activity+is+not+required+for+tumor+cell+viability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRex%26aufirst%3DK.%26aulast%3DJeffries%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DCarlson%26aufirst%3DT.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DFajardo%26aufirst%3DF.%26aulast%3DFrank%26aufirst%3DB.%26aulast%3DGustin%26aufirst%3DD.%26aulast%3DKamb%26aufirst%3DA.%26aulast%3DKassner%26aufirst%3DP.%2BD.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMorgenstern%26aufirst%3DK.%26aulast%3DPlant%26aufirst%3DM.%26aulast%3DQuon%26aufirst%3DK.%26aulast%3DRuefli-Brasse%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DSwearingen%26aufirst%3DE.%26aulast%3DWalker%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWatson%26aufirst%3DJ.%2BE.%2BV.%26aulast%3DWickramasinghe%26aufirst%3DD.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DWesche%26aufirst%3DH.%26atitle%3DSphingosine%2520kinase%2520activity%2520is%2520not%2520required%2520for%2520tumor%2520cell%2520viability%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De68328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Beljanski, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. D.</span><span> </span><span class="NLM_article-title">Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">524</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Fjm4011687&amp;key=10.4161%2Fcbt.11.5.14677" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Fjm4011687&amp;key=21258214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Fjm4011687&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktl2ms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=524-534&author=V.+Beljanskiauthor=C.+S.+Lewisauthor=C.+D.+Smith&title=Antitumor+activity+of+sphingosine+kinase+2+inhibitor+ABC294640+and+sorafenib+in+hepatocellular+carcinoma+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts</span></div><div class="casAuthors">Beljanski, Vladimir; Lewis, Clayton S.; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">524-534</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">The balance between the pro-apoptotic lipids ceramide and sphingosine and the pro-survival lipid sphingosine 1-phosphate (S1P) is termed the "sphingosine rheostat".  Two isoenzymes, sphingosine kinase 1 and 2 (SK1 and SK2), are responsible for phosphorylation of pro-apoptotic sphingosine to form pro-survival S1P.  We have previously reported the antitumor properties of an SK2 selective inhibitor, ABC294640, alone or in combination with the multikinase inhibitor sorafenib in mouse models of kidney carcinoma and pancreatic adenocarcinoma.  Here, we evaluated the combined antitumor effects of the aforementioned drug combination in two mouse models of hepatocellular carcinoma.  Although combining the SK2 inhibitor, ABC294640 and sorafenib in vitro only afforded additive drug-drug effects, their combined antitumor properties in the mouse model bearing HepG2 cells mirrored effects previously obsd. in animals bearing kidney carcinoma and pancreatic adenocarcinoma cells.  Combining ABC294640 and sorafenib led to a decrease in the levels of phosphorylated ERK in SK-HEP-1 cells, indicating that the antitumor effect of this drug combination is likely mediated through a suppression of the MAPK pathway in hepatocellular models.  We also measured levels of S1P in the plasma of mice treated with two different doses of ABC294640 and sorafenib.  We found decreases in the levels of S1P in plasma of mice treated daily with 100 mg/kg of ABC294640 for 5 wk, and this decrease was not affected by co-administration of sorafenib.  Taken together, these data support combining ABC294640 and sorafenib in clin. trials in HCC patients.  Furthermore, monitoring levels of S1P may provide a pharmacodynamic marker of ABC294640 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVXNclr6Hb-LVg90H21EOLACvtfcHk0lgl4uTdlEDp0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktl2ms70%253D&md5=a4ddc2eb4b02d27365db41f57be7172c</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.4161%2Fcbt.11.5.14677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.11.5.14677%26sid%3Dliteratum%253Aachs%26aulast%3DBeljanski%26aufirst%3DV.%26aulast%3DLewis%26aufirst%3DC.%2BS.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DAntitumor%2520activity%2520of%2520sphingosine%2520kinase%25202%2520inhibitor%2520ABC294640%2520and%2520sorafenib%2520in%2520hepatocellular%2520carcinoma%2520xenografts%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2011%26volume%3D11%26spage%3D524%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Li, Q. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. S.</span><span> </span><span class="NLM_article-title">Bortezomib and sphingosine kinase inhibitor interact synergistically to induces apoptosis in BCR/ABl+ cells sensitive and resistant to STI571 through down-regulation Mcl-1</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">405</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2011&pages=31-36&author=Q.+F.+Liauthor=J.+Yanauthor=K.+Zhangauthor=Y.+F.+Yangauthor=F.+J.+Xiaoauthor=C.+T.+Wuauthor=H.+Wangauthor=L.+S.+Wang&title=Bortezomib+and+sphingosine+kinase+inhibitor+interact+synergistically+to+induces+apoptosis+in+BCR%2FABl%2B+cells+sensitive+and+resistant+to+STI571+through+down-regulation+Mcl-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%2BF.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DY.%2BF.%26aulast%3DXiao%26aufirst%3DF.%2BJ.%26aulast%3DWu%26aufirst%3DC.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%2BS.%26atitle%3DBortezomib%2520and%2520sphingosine%2520kinase%2520inhibitor%2520interact%2520synergistically%2520to%2520induces%2520apoptosis%2520in%2520BCR%252FABl%252B%2520cells%2520sensitive%2520and%2520resistant%2520to%2520STI571%2520through%2520down-regulation%2520Mcl-1%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2011%26volume%3D405%26spage%3D31%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Chatzakos, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rundlof, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Verdier, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flygare, J.</span><span> </span><span class="NLM_article-title">Inhibition of sphingosine kinase 1 enhances cytotoxicity, ceramide levels and ROS formation in liver cancer cells treated with selenite</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=712-721&author=V.+Chatzakosauthor=A.+K.+Rundlofauthor=D.+Ahmedauthor=P.+J.+de+Verdierauthor=J.+Flygare&title=Inhibition+of+sphingosine+kinase+1+enhances+cytotoxicity%2C+ceramide+levels+and+ROS+formation+in+liver+cancer+cells+treated+with+selenite"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChatzakos%26aufirst%3DV.%26aulast%3DRundlof%26aufirst%3DA.%2BK.%26aulast%3DAhmed%26aufirst%3DD.%26aulast%3Dde%2BVerdier%26aufirst%3DP.%2BJ.%26aulast%3DFlygare%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520sphingosine%2520kinase%25201%2520enhances%2520cytotoxicity%252C%2520ceramide%2520levels%2520and%2520ROS%2520formation%2520in%2520liver%2520cancer%2520cells%2520treated%2520with%2520selenite%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26spage%3D712%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VZB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VZB','PDB','3VZB'); return false;">PDB: 3VZB</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm4011687&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-13%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm4011687%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm4011687" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b32093a803cf4","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
